{
  "measureId": "40280382649c54c30164b3e14334084e",
  "modified": "2020-02-25T18:03:40.133Z",
  "errorReason": "Measure validation failed",
  "outcome": "MEASURE_VALIDATION_FAILED",
  "conversionType": "VALIDATION",
  "valueSetConversionResults": [
    {
      "oid": "2.16.840.1.113762.1.4.1",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.113762.1.4.1\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T01:54:21.234+00:00\",\n    \"source\": \"#LN3uBCcID1pOlrjp\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.113762.1.4.1\"\n    }\n  ],\n  \"name\": \"ONC Administrative Sex\",\n  \"status\": \"active\",\n  \"publisher\": \"Office of the National Coordinator for Health Information Technology\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.5.1\",\n        \"version\": \"HL7V3.0_2019-03\",\n        \"concept\": [\n          {\n            \"code\": \"F\",\n            \"display\": \"Female\"\n          },\n          {\n            \"code\": \"M\",\n            \"display\": \"Male\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    },
    {
      "oid": "2.16.840.1.114222.4.11.836",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.114222.4.11.836",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.114222.4.11.836\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T01:54:22.789+00:00\",\n    \"source\": \"#2vdecSMBmqc9bCWZ\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.114222.4.11.836\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.114222.4.11.836\"\n    }\n  ],\n  \"name\": \"Race\",\n  \"status\": \"active\",\n  \"publisher\": \"Centers for Disease Control National Center for Health Statistics\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.6.238\",\n        \"version\": \"1.2\",\n        \"concept\": [\n          {\n            \"code\": \"1002-5\",\n            \"display\": \"American Indian or Alaska Native\"\n          },\n          {\n            \"code\": \"2028-9\",\n            \"display\": \"Asian\"\n          },\n          {\n            \"code\": \"2054-5\",\n            \"display\": \"Black or African American\"\n          },\n          {\n            \"code\": \"2076-8\",\n            \"display\": \"Native Hawaiian or Other Pacific Islander\"\n          },\n          {\n            \"code\": \"2106-3\",\n            \"display\": \"White\"\n          },\n          {\n            \"code\": \"2131-1\",\n            \"display\": \"Other Race\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    },
    {
      "oid": "2.16.840.1.114222.4.11.837",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.114222.4.11.837",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.114222.4.11.837\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T01:54:21.234+00:00\",\n    \"source\": \"#L5c6BrMvKdtwHm8T\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.114222.4.11.837\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.114222.4.11.837\"\n    }\n  ],\n  \"name\": \"Ethnicity\",\n  \"status\": \"active\",\n  \"publisher\": \"Centers for Disease Control National Center for Health Statistics\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.6.238\",\n        \"version\": \"1.2\",\n        \"concept\": [\n          {\n            \"code\": \"2135-2\",\n            \"display\": \"Hispanic or Latino\"\n          },\n          {\n            \"code\": \"2186-5\",\n            \"display\": \"Not Hispanic or Latino\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    },
    {
      "oid": "2.16.840.1.114222.4.11.3591",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.114222.4.11.3591",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.114222.4.11.3591\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T01:54:23.810+00:00\",\n    \"source\": \"#bhP1KAr4udYJsx0X\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.114222.4.11.3591\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.114222.4.11.3591\"\n    }\n  ],\n  \"name\": \"Payer\",\n  \"status\": \"active\",\n  \"publisher\": \"HL7 Terminology\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.3.221.5\",\n        \"version\": \"8.0\",\n        \"concept\": [\n          {\n            \"code\": \"1\",\n            \"display\": \"MEDICARE\"\n          },\n          {\n            \"code\": \"11\",\n            \"display\": \"Medicare (Managed Care)\"\n          },\n          {\n            \"code\": \"111\",\n            \"display\": \"Medicare HMO\"\n          },\n          {\n            \"code\": \"112\",\n            \"display\": \"Medicare PPO\"\n          },\n          {\n            \"code\": \"113\",\n            \"display\": \"Medicare POS\"\n          },\n          {\n            \"code\": \"119\",\n            \"display\": \"Medicare Managed Care Other\"\n          },\n          {\n            \"code\": \"12\",\n            \"display\": \"Medicare (Non-managed Care)\"\n          },\n          {\n            \"code\": \"121\",\n            \"display\": \"Medicare FFS\"\n          },\n          {\n            \"code\": \"122\",\n            \"display\": \"Medicare Drug Benefit\"\n          },\n          {\n            \"code\": \"123\",\n            \"display\": \"Medicare Medical Savings Account (MSA)\"\n          },\n          {\n            \"code\": \"129\",\n            \"display\": \"Medicare Non-managed Care Other\"\n          },\n          {\n            \"code\": \"13\",\n            \"display\": \"Medicare Hospice\"\n          },\n          {\n            \"code\": \"14\",\n            \"display\": \"Dual Eligibility Medicare/Medicaid Organization\"\n          },\n          {\n            \"code\": \"19\",\n            \"display\": \"Medicare Other\"\n          },\n          {\n            \"code\": \"191\",\n            \"display\": \"Medicare Pharmacy Benefit Manager\"\n          },\n          {\n            \"code\": \"2\",\n            \"display\": \"MEDICAID\"\n          },\n          {\n            \"code\": \"21\",\n            \"display\": \"Medicaid (Managed Care)\"\n          },\n          {\n            \"code\": \"211\",\n            \"display\": \"Medicaid HMO\"\n          },\n          {\n            \"code\": \"212\",\n            \"display\": \"Medicaid PPO\"\n          },\n          {\n            \"code\": \"213\",\n            \"display\": \"Medicaid PCCM (Primary Care Case Management)\"\n          },\n          {\n            \"code\": \"219\",\n            \"display\": \"Medicaid Managed Care Other\"\n          },\n          {\n            \"code\": \"22\",\n            \"display\": \"Medicaid (Non-managed Care Plan)\"\n          },\n          {\n            \"code\": \"23\",\n            \"display\": \"Medicaid/SCHIP\"\n          },\n          {\n            \"code\": \"25\",\n            \"display\": \"Medicaid - Out of State\"\n          },\n          {\n            \"code\": \"26\",\n            \"display\": \"Medicaid -- Long Term Care\"\n          },\n          {\n            \"code\": \"29\",\n            \"display\": \"Medicaid Other\"\n          },\n          {\n            \"code\": \"291\",\n            \"display\": \"Medicaid Pharmacy Benefit Manager\"\n          },\n          {\n            \"code\": \"299\",\n            \"display\": \"Medicaid - Dental\"\n          },\n          {\n            \"code\": \"3\",\n            \"display\": \"OTHER GOVERNMENT (Federal/State/Local) (excluding Department of Corrections)\"\n          },\n          {\n            \"code\": \"31\",\n            \"display\": \"Department of Defense\"\n          },\n          {\n            \"code\": \"311\",\n            \"display\": \"TRICARE (CHAMPUS)\"\n          },\n          {\n            \"code\": \"3111\",\n            \"display\": \"TRICARE Prime--HMO\"\n          },\n          {\n            \"code\": \"3112\",\n            \"display\": \"TRICARE Extra--PPO\"\n          },\n          {\n            \"code\": \"3113\",\n            \"display\": \"TRICARE Standard - Fee For Service\"\n          },\n          {\n            \"code\": \"3114\",\n            \"display\": \"TRICARE For Life--Medicare Supplement\"\n          },\n          {\n            \"code\": \"3115\",\n            \"display\": \"TRICARE Reserve Select\"\n          },\n          {\n            \"code\": \"3116\",\n            \"display\": \"Uniformed Services Family Health Plan (USFHP) -- HMO\"\n          },\n          {\n            \"code\": \"3119\",\n            \"display\": \"Department of Defense - (other)\"\n          },\n          {\n            \"code\": \"312\",\n            \"display\": \"Military Treatment Facility\"\n          },\n          {\n            \"code\": \"3121\",\n            \"display\": \"Enrolled Prime--HMO\"\n          },\n          {\n            \"code\": \"3122\",\n            \"display\": \"Non-enrolled Space Available\"\n          },\n          {\n            \"code\": \"3123\",\n            \"display\": \"TRICARE For Life (TFL)\"\n          },\n          {\n            \"code\": \"313\",\n            \"display\": \"Dental --Stand Alone\"\n          },\n          {\n            \"code\": \"32\",\n            \"display\": \"Department of Veterans Affairs\"\n          },\n          {\n            \"code\": \"321\",\n            \"display\": \"Veteran care--Care provided to Veterans\"\n          },\n          {\n            \"code\": \"3211\",\n            \"display\": \"Direct Care--Care provided in VA facilities\"\n          },\n          {\n            \"code\": \"3212\",\n            \"display\": \"Indirect Care--Care provided outside VA facilities\"\n          },\n          {\n            \"code\": \"32121\",\n            \"display\": \"Fee Basis\"\n          },\n          {\n            \"code\": \"32122\",\n            \"display\": \"Foreign Fee/Foreign Medical Program (FMP)\"\n          },\n          {\n            \"code\": \"32123\",\n            \"display\": \"Contract Nursing Home/Community Nursing Home\"\n          },\n          {\n            \"code\": \"32124\",\n            \"display\": \"State Veterans Home\"\n          },\n          {\n            \"code\": \"32125\",\n            \"display\": \"Sharing Agreements\"\n          },\n          {\n            \"code\": \"32126\",\n            \"display\": \"Other Federal Agency\"\n          },\n          {\n            \"code\": \"32127\",\n            \"display\": \"Dental Care\"\n          },\n          {\n            \"code\": \"32128\",\n            \"display\": \"Vision Care\"\n          },\n          {\n            \"code\": \"322\",\n            \"display\": \"Non-veteran care\"\n          },\n          {\n            \"code\": \"3221\",\n            \"display\": \"Civilian Health and Medical Program for the VA (CHAMPVA)\"\n          },\n          {\n            \"code\": \"3222\",\n            \"display\": \"Spina Bifida Health Care Program (SB)\"\n          },\n          {\n            \"code\": \"3223\",\n            \"display\": \"Children of Women Vietnam Veterans (CWVV)\"\n          },\n          {\n            \"code\": \"3229\",\n            \"display\": \"Other non-veteran care\"\n          },\n          {\n            \"code\": \"33\",\n            \"display\": \"Indian Health Service or Tribe\"\n          },\n          {\n            \"code\": \"331\",\n            \"display\": \"Indian Health Service -- Regular\"\n          },\n          {\n            \"code\": \"332\",\n            \"display\": \"Indian Health Service -- Contract\"\n          },\n          {\n            \"code\": \"333\",\n            \"display\": \"Indian Health Service - Managed Care\"\n          },\n          {\n            \"code\": \"334\",\n            \"display\": \"Indian Tribe - Sponsored Coverage\"\n          },\n          {\n            \"code\": \"34\",\n            \"display\": \"HRSA Program\"\n          },\n          {\n            \"code\": \"341\",\n            \"display\": \"Title V (MCH Block Grant)\"\n          },\n          {\n            \"code\": \"342\",\n            \"display\": \"Migrant Health Program\"\n          },\n          {\n            \"code\": \"343\",\n            \"display\": \"Ryan White Act\"\n          },\n          {\n            \"code\": \"349\",\n            \"display\": \"Other\"\n          },\n          {\n            \"code\": \"35\",\n            \"display\": \"Black Lung\"\n          },\n          {\n            \"code\": \"36\",\n            \"display\": \"State Government\"\n          },\n          {\n            \"code\": \"361\",\n            \"display\": \"State SCHIP program (codes for individual states)\"\n          },\n          {\n            \"code\": \"362\",\n            \"display\": \"Specific state programs (list/ local code)\"\n          },\n          {\n            \"code\": \"369\",\n            \"display\": \"State, not otherwise specified (other state)\"\n          },\n          {\n            \"code\": \"37\",\n            \"display\": \"Local Government\"\n          },\n          {\n            \"code\": \"371\",\n            \"display\": \"Local - Managed care\"\n          },\n          {\n            \"code\": \"3711\",\n            \"display\": \"HMO\"\n          },\n          {\n            \"code\": \"3712\",\n            \"display\": \"PPO\"\n          },\n          {\n            \"code\": \"3713\",\n            \"display\": \"POS\"\n          },\n          {\n            \"code\": \"372\",\n            \"display\": \"FFS/Indemnity\"\n          },\n          {\n            \"code\": \"379\",\n            \"display\": \"Local, not otherwise specified (other local, county)\"\n          },\n          {\n            \"code\": \"38\",\n            \"display\": \"Other Government (Federal, State, Local not specified)\"\n          },\n          {\n            \"code\": \"381\",\n            \"display\": \"Federal, State, Local not specified managed care\"\n          },\n          {\n            \"code\": \"3811\",\n            \"display\": \"Federal, State, Local not specified - HMO\"\n          },\n          {\n            \"code\": \"3812\",\n            \"display\": \"Federal, State, Local not specified - PPO\"\n          },\n          {\n            \"code\": \"3813\",\n            \"display\": \"Federal, State, Local not specified - POS\"\n          },\n          {\n            \"code\": \"3819\",\n            \"display\": \"Federal, State, Local not specified - not specified managed care\"\n          },\n          {\n            \"code\": \"382\",\n            \"display\": \"Federal, State, Local not specified - FFS\"\n          },\n          {\n            \"code\": \"389\",\n            \"display\": \"Federal, State, Local not specified - Other\"\n          },\n          {\n            \"code\": \"39\",\n            \"display\": \"Other Federal\"\n          },\n          {\n            \"code\": \"391\",\n            \"display\": \"Federal Employee Health Plan - Use when known\"\n          },\n          {\n            \"code\": \"4\",\n            \"display\": \"DEPARTMENTS OF CORRECTIONS\"\n          },\n          {\n            \"code\": \"41\",\n            \"display\": \"Corrections Federal\"\n          },\n          {\n            \"code\": \"42\",\n            \"display\": \"Corrections State\"\n          },\n          {\n            \"code\": \"43\",\n            \"display\": \"Corrections Local\"\n          },\n          {\n            \"code\": \"44\",\n            \"display\": \"Corrections Unknown Level\"\n          },\n          {\n            \"code\": \"5\",\n            \"display\": \"PRIVATE HEALTH INSURANCE\"\n          },\n          {\n            \"code\": \"51\",\n            \"display\": \"Managed Care (Private)\"\n          },\n          {\n            \"code\": \"511\",\n            \"display\": \"Commercial Managed Care - HMO\"\n          },\n          {\n            \"code\": \"512\",\n            \"display\": \"Commercial Managed Care - PPO\"\n          },\n          {\n            \"code\": \"513\",\n            \"display\": \"Commercial Managed Care - POS\"\n          },\n          {\n            \"code\": \"514\",\n            \"display\": \"Exclusive Provider Organization\"\n          },\n          {\n            \"code\": \"515\",\n            \"display\": \"Gatekeeper PPO (GPPO)\"\n          },\n          {\n            \"code\": \"516\",\n            \"display\": \"Commercial Managed Care - Pharmacy Benefit Manager\"\n          },\n          {\n            \"code\": \"517\",\n            \"display\": \"Commercial Managed Care - Dental\"\n          },\n          {\n            \"code\": \"519\",\n            \"display\": \"Managed Care, Other (non HMO)\"\n          },\n          {\n            \"code\": \"52\",\n            \"display\": \"Private Health Insurance - Indemnity\"\n          },\n          {\n            \"code\": \"521\",\n            \"display\": \"Commercial Indemnity\"\n          },\n          {\n            \"code\": \"522\",\n            \"display\": \"Self-insured (ERISA) Administrative Services Only (ASO) plan\"\n          },\n          {\n            \"code\": \"523\",\n            \"display\": \"Medicare supplemental policy (as second payer)\"\n          },\n          {\n            \"code\": \"524\",\n            \"display\": \"Indemnity Insurance - Dental\"\n          },\n          {\n            \"code\": \"529\",\n            \"display\": \"Private health insurance--other commercial Indemnity\"\n          },\n          {\n            \"code\": \"53\",\n            \"display\": \"Managed Care (private) or private health insurance (indemnity), not otherwise specified\"\n          },\n          {\n            \"code\": \"54\",\n            \"display\": \"Organized Delivery System\"\n          },\n          {\n            \"code\": \"55\",\n            \"display\": \"Small Employer Purchasing Group\"\n          },\n          {\n            \"code\": \"56\",\n            \"display\": \"Specialized Stand Alone Plan\"\n          },\n          {\n            \"code\": \"561\",\n            \"display\": \"Dental\"\n          },\n          {\n            \"code\": \"562\",\n            \"display\": \"Vision\"\n          },\n          {\n            \"code\": \"59\",\n            \"display\": \"Other Private Insurance\"\n          },\n          {\n            \"code\": \"6\",\n            \"display\": \"BLUE CROSS/BLUE SHIELD\"\n          },\n          {\n            \"code\": \"61\",\n            \"display\": \"BC Managed Care\"\n          },\n          {\n            \"code\": \"611\",\n            \"display\": \"BC Managed Care -- HMO\"\n          },\n          {\n            \"code\": \"612\",\n            \"display\": \"BC Managed Care -- PPO\"\n          },\n          {\n            \"code\": \"613\",\n            \"display\": \"BC Managed Care -- POS\"\n          },\n          {\n            \"code\": \"614\",\n            \"display\": \"BC Managed Care - Dental\"\n          },\n          {\n            \"code\": \"619\",\n            \"display\": \"BC Managed Care -- Other\"\n          },\n          {\n            \"code\": \"62\",\n            \"display\": \"BC Insurance Indemnity\"\n          },\n          {\n            \"code\": \"621\",\n            \"display\": \"BC Indemnity\"\n          },\n          {\n            \"code\": \"622\",\n            \"display\": \"BC Self-insured (ERISA) Administrative Services Only (ASO)Plan\"\n          },\n          {\n            \"code\": \"623\",\n            \"display\": \"BC Medicare Supplemental Plan\"\n          },\n          {\n            \"code\": \"629\",\n            \"display\": \"BC Indemnity - Dental\"\n          },\n          {\n            \"code\": \"7\",\n            \"display\": \"MANAGED CARE, UNSPECIFIED (to be used only if one can't distinguish public from private)\"\n          },\n          {\n            \"code\": \"71\",\n            \"display\": \"HMO\"\n          },\n          {\n            \"code\": \"72\",\n            \"display\": \"PPO\"\n          },\n          {\n            \"code\": \"73\",\n            \"display\": \"POS\"\n          },\n          {\n            \"code\": \"79\",\n            \"display\": \"Other Managed Care\"\n          },\n          {\n            \"code\": \"8\",\n            \"display\": \"NO PAYMENT from an Organization/Agency/Program/Private Payer Listed\"\n          },\n          {\n            \"code\": \"81\",\n            \"display\": \"Self-pay (Includes applicants for insurance and Medicaid applicants)\"\n          },\n          {\n            \"code\": \"82\",\n            \"display\": \"No Charge\"\n          },\n          {\n            \"code\": \"821\",\n            \"display\": \"Charity\"\n          },\n          {\n            \"code\": \"822\",\n            \"display\": \"Professional Courtesy\"\n          },\n          {\n            \"code\": \"823\",\n            \"display\": \"Research/Clinical Trial\"\n          },\n          {\n            \"code\": \"83\",\n            \"display\": \"Refusal to Pay/Bad Debt\"\n          },\n          {\n            \"code\": \"84\",\n            \"display\": \"Hill Burton Free Care\"\n          },\n          {\n            \"code\": \"85\",\n            \"display\": \"Research/Donor\"\n          },\n          {\n            \"code\": \"89\",\n            \"display\": \"No Payment, Other\"\n          },\n          {\n            \"code\": \"9\",\n            \"display\": \"MISCELLANEOUS/OTHER\"\n          },\n          {\n            \"code\": \"91\",\n            \"display\": \"Foreign National\"\n          },\n          {\n            \"code\": \"92\",\n            \"display\": \"Other (Non-government)\"\n          },\n          {\n            \"code\": \"93\",\n            \"display\": \"Disability Insurance\"\n          },\n          {\n            \"code\": \"94\",\n            \"display\": \"Long-term Care Insurance\"\n          },\n          {\n            \"code\": \"95\",\n            \"display\": \"Worker's Compensation\"\n          },\n          {\n            \"code\": \"951\",\n            \"display\": \"Worker's Comp HMO\"\n          },\n          {\n            \"code\": \"953\",\n            \"display\": \"Worker's Comp Fee-for-Service\"\n          },\n          {\n            \"code\": \"954\",\n            \"display\": \"Worker's Comp Other Managed Care\"\n          },\n          {\n            \"code\": \"959\",\n            \"display\": \"Worker's Comp, Other unspecified\"\n          },\n          {\n            \"code\": \"96\",\n            \"display\": \"Auto Insurance (includes no fault)\"\n          },\n          {\n            \"code\": \"97\",\n            \"display\": \"Legal Liability / Liability Insurance\"\n          },\n          {\n            \"code\": \"98\",\n            \"display\": \"Other specified but not otherwise classifiable (includes Hospice - Unspecified plan)\"\n          },\n          {\n            \"code\": \"99\",\n            \"display\": \"No Typology Code available for payment source\"\n          },\n          {\n            \"code\": \"9999\",\n            \"display\": \"Unavailable / No Payer Specified / Blank\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    },
    {
      "oid": "2.16.840.1.113762.1.4.1116.150",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.150",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.113762.1.4.1116.150\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T02:11:18.657+00:00\",\n    \"source\": \"#OxVC8lnqD5JxGF46\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.150\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.113762.1.4.1116.150\"\n    }\n  ],\n  \"name\": \"Clinical Trial Participant\",\n  \"status\": \"active\",\n  \"publisher\": \"American Society of Clinical Oncology\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.6.96\",\n        \"version\": \"2019-09\",\n        \"concept\": [\n          {\n            \"code\": \"185923000\",\n            \"display\": \"Patient entered into trial (finding)\"\n          },\n          {\n            \"code\": \"428024001\",\n            \"display\": \"Clinical trial participant (person)\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    },
    {
      "oid": "2.16.840.1.113762.1.4.1116.231",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.231",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.113762.1.4.1116.231\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T02:11:22.782+00:00\",\n    \"source\": \"#yU7W5EUedv2iugrd\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.231\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.113762.1.4.1116.231\"\n    }\n  ],\n  \"name\": \"Cancer\",\n  \"status\": \"active\",\n  \"publisher\": \"American Society of Clinical Oncology\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.6.90\",\n        \"version\": \"2020\",\n        \"concept\": [\n          {\n            \"code\": \"C00.0\",\n            \"display\": \"Malignant neoplasm of external upper lip\"\n          },\n          {\n            \"code\": \"C00.1\",\n            \"display\": \"Malignant neoplasm of external lower lip\"\n          },\n          {\n            \"code\": \"C00.2\",\n            \"display\": \"Malignant neoplasm of external lip, unspecified\"\n          },\n          {\n            \"code\": \"C00.3\",\n            \"display\": \"Malignant neoplasm of upper lip, inner aspect\"\n          },\n          {\n            \"code\": \"C00.4\",\n            \"display\": \"Malignant neoplasm of lower lip, inner aspect\"\n          },\n          {\n            \"code\": \"C00.5\",\n            \"display\": \"Malignant neoplasm of lip, unspecified, inner aspect\"\n          },\n          {\n            \"code\": \"C00.6\",\n            \"display\": \"Malignant neoplasm of commissure of lip, unspecified\"\n          },\n          {\n            \"code\": \"C00.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of lip\"\n          },\n          {\n            \"code\": \"C00.9\",\n            \"display\": \"Malignant neoplasm of lip, unspecified\"\n          },\n          {\n            \"code\": \"C01\",\n            \"display\": \"Malignant neoplasm of base of tongue\"\n          },\n          {\n            \"code\": \"C02.0\",\n            \"display\": \"Malignant neoplasm of dorsal surface of tongue\"\n          },\n          {\n            \"code\": \"C02.1\",\n            \"display\": \"Malignant neoplasm of border of tongue\"\n          },\n          {\n            \"code\": \"C02.2\",\n            \"display\": \"Malignant neoplasm of ventral surface of tongue\"\n          },\n          {\n            \"code\": \"C02.3\",\n            \"display\": \"Malignant neoplasm of anterior two-thirds of tongue, part unspecified\"\n          },\n          {\n            \"code\": \"C02.4\",\n            \"display\": \"Malignant neoplasm of lingual tonsil\"\n          },\n          {\n            \"code\": \"C02.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of tongue\"\n          },\n          {\n            \"code\": \"C02.9\",\n            \"display\": \"Malignant neoplasm of tongue, unspecified\"\n          },\n          {\n            \"code\": \"C03.0\",\n            \"display\": \"Malignant neoplasm of upper gum\"\n          },\n          {\n            \"code\": \"C03.1\",\n            \"display\": \"Malignant neoplasm of lower gum\"\n          },\n          {\n            \"code\": \"C03.9\",\n            \"display\": \"Malignant neoplasm of gum, unspecified\"\n          },\n          {\n            \"code\": \"C04.0\",\n            \"display\": \"Malignant neoplasm of anterior floor of mouth\"\n          },\n          {\n            \"code\": \"C04.1\",\n            \"display\": \"Malignant neoplasm of lateral floor of mouth\"\n          },\n          {\n            \"code\": \"C04.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of floor of mouth\"\n          },\n          {\n            \"code\": \"C04.9\",\n            \"display\": \"Malignant neoplasm of floor of mouth, unspecified\"\n          },\n          {\n            \"code\": \"C05.0\",\n            \"display\": \"Malignant neoplasm of hard palate\"\n          },\n          {\n            \"code\": \"C05.1\",\n            \"display\": \"Malignant neoplasm of soft palate\"\n          },\n          {\n            \"code\": \"C05.2\",\n            \"display\": \"Malignant neoplasm of uvula\"\n          },\n          {\n            \"code\": \"C05.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of palate\"\n          },\n          {\n            \"code\": \"C05.9\",\n            \"display\": \"Malignant neoplasm of palate, unspecified\"\n          },\n          {\n            \"code\": \"C06.0\",\n            \"display\": \"Malignant neoplasm of cheek mucosa\"\n          },\n          {\n            \"code\": \"C06.1\",\n            \"display\": \"Malignant neoplasm of vestibule of mouth\"\n          },\n          {\n            \"code\": \"C06.2\",\n            \"display\": \"Malignant neoplasm of retromolar area\"\n          },\n          {\n            \"code\": \"C06.80\",\n            \"display\": \"Malignant neoplasm of overlapping sites of unspecified parts of mouth\"\n          },\n          {\n            \"code\": \"C06.89\",\n            \"display\": \"Malignant neoplasm of overlapping sites of other parts of mouth\"\n          },\n          {\n            \"code\": \"C06.9\",\n            \"display\": \"Malignant neoplasm of mouth, unspecified\"\n          },\n          {\n            \"code\": \"C07\",\n            \"display\": \"Malignant neoplasm of parotid gland\"\n          },\n          {\n            \"code\": \"C08.0\",\n            \"display\": \"Malignant neoplasm of submandibular gland\"\n          },\n          {\n            \"code\": \"C08.1\",\n            \"display\": \"Malignant neoplasm of sublingual gland\"\n          },\n          {\n            \"code\": \"C08.9\",\n            \"display\": \"Malignant neoplasm of major salivary gland, unspecified\"\n          },\n          {\n            \"code\": \"C09.0\",\n            \"display\": \"Malignant neoplasm of tonsillar fossa\"\n          },\n          {\n            \"code\": \"C09.1\",\n            \"display\": \"Malignant neoplasm of tonsillar pillar (anterior) (posterior)\"\n          },\n          {\n            \"code\": \"C09.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of tonsil\"\n          },\n          {\n            \"code\": \"C09.9\",\n            \"display\": \"Malignant neoplasm of tonsil, unspecified\"\n          },\n          {\n            \"code\": \"C10.0\",\n            \"display\": \"Malignant neoplasm of vallecula\"\n          },\n          {\n            \"code\": \"C10.1\",\n            \"display\": \"Malignant neoplasm of anterior surface of epiglottis\"\n          },\n          {\n            \"code\": \"C10.2\",\n            \"display\": \"Malignant neoplasm of lateral wall of oropharynx\"\n          },\n          {\n            \"code\": \"C10.3\",\n            \"display\": \"Malignant neoplasm of posterior wall of oropharynx\"\n          },\n          {\n            \"code\": \"C10.4\",\n            \"display\": \"Malignant neoplasm of branchial cleft\"\n          },\n          {\n            \"code\": \"C10.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of oropharynx\"\n          },\n          {\n            \"code\": \"C10.9\",\n            \"display\": \"Malignant neoplasm of oropharynx, unspecified\"\n          },\n          {\n            \"code\": \"C11.0\",\n            \"display\": \"Malignant neoplasm of superior wall of nasopharynx\"\n          },\n          {\n            \"code\": \"C11.1\",\n            \"display\": \"Malignant neoplasm of posterior wall of nasopharynx\"\n          },\n          {\n            \"code\": \"C11.2\",\n            \"display\": \"Malignant neoplasm of lateral wall of nasopharynx\"\n          },\n          {\n            \"code\": \"C11.3\",\n            \"display\": \"Malignant neoplasm of anterior wall of nasopharynx\"\n          },\n          {\n            \"code\": \"C11.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of nasopharynx\"\n          },\n          {\n            \"code\": \"C11.9\",\n            \"display\": \"Malignant neoplasm of nasopharynx, unspecified\"\n          },\n          {\n            \"code\": \"C12\",\n            \"display\": \"Malignant neoplasm of pyriform sinus\"\n          },\n          {\n            \"code\": \"C13.0\",\n            \"display\": \"Malignant neoplasm of postcricoid region\"\n          },\n          {\n            \"code\": \"C13.1\",\n            \"display\": \"Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect\"\n          },\n          {\n            \"code\": \"C13.2\",\n            \"display\": \"Malignant neoplasm of posterior wall of hypopharynx\"\n          },\n          {\n            \"code\": \"C13.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of hypopharynx\"\n          },\n          {\n            \"code\": \"C13.9\",\n            \"display\": \"Malignant neoplasm of hypopharynx, unspecified\"\n          },\n          {\n            \"code\": \"C14.0\",\n            \"display\": \"Malignant neoplasm of pharynx, unspecified\"\n          },\n          {\n            \"code\": \"C14.2\",\n            \"display\": \"Malignant neoplasm of Waldeyer's ring\"\n          },\n          {\n            \"code\": \"C14.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of lip, oral cavity and pharynx\"\n          },\n          {\n            \"code\": \"C15.3\",\n            \"display\": \"Malignant neoplasm of upper third of esophagus\"\n          },\n          {\n            \"code\": \"C15.4\",\n            \"display\": \"Malignant neoplasm of middle third of esophagus\"\n          },\n          {\n            \"code\": \"C15.5\",\n            \"display\": \"Malignant neoplasm of lower third of esophagus\"\n          },\n          {\n            \"code\": \"C15.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of esophagus\"\n          },\n          {\n            \"code\": \"C15.9\",\n            \"display\": \"Malignant neoplasm of esophagus, unspecified\"\n          },\n          {\n            \"code\": \"C16.0\",\n            \"display\": \"Malignant neoplasm of cardia\"\n          },\n          {\n            \"code\": \"C16.1\",\n            \"display\": \"Malignant neoplasm of fundus of stomach\"\n          },\n          {\n            \"code\": \"C16.2\",\n            \"display\": \"Malignant neoplasm of body of stomach\"\n          },\n          {\n            \"code\": \"C16.3\",\n            \"display\": \"Malignant neoplasm of pyloric antrum\"\n          },\n          {\n            \"code\": \"C16.4\",\n            \"display\": \"Malignant neoplasm of pylorus\"\n          },\n          {\n            \"code\": \"C16.5\",\n            \"display\": \"Malignant neoplasm of lesser curvature of stomach, unspecified\"\n          },\n          {\n            \"code\": \"C16.6\",\n            \"display\": \"Malignant neoplasm of greater curvature of stomach, unspecified\"\n          },\n          {\n            \"code\": \"C16.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of stomach\"\n          },\n          {\n            \"code\": \"C16.9\",\n            \"display\": \"Malignant neoplasm of stomach, unspecified\"\n          },\n          {\n            \"code\": \"C17.0\",\n            \"display\": \"Malignant neoplasm of duodenum\"\n          },\n          {\n            \"code\": \"C17.1\",\n            \"display\": \"Malignant neoplasm of jejunum\"\n          },\n          {\n            \"code\": \"C17.2\",\n            \"display\": \"Malignant neoplasm of ileum\"\n          },\n          {\n            \"code\": \"C17.3\",\n            \"display\": \"Meckel's diverticulum, malignant\"\n          },\n          {\n            \"code\": \"C17.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of small intestine\"\n          },\n          {\n            \"code\": \"C17.9\",\n            \"display\": \"Malignant neoplasm of small intestine, unspecified\"\n          },\n          {\n            \"code\": \"C18.0\",\n            \"display\": \"Malignant neoplasm of cecum\"\n          },\n          {\n            \"code\": \"C18.1\",\n            \"display\": \"Malignant neoplasm of appendix\"\n          },\n          {\n            \"code\": \"C18.2\",\n            \"display\": \"Malignant neoplasm of ascending colon\"\n          },\n          {\n            \"code\": \"C18.3\",\n            \"display\": \"Malignant neoplasm of hepatic flexure\"\n          },\n          {\n            \"code\": \"C18.4\",\n            \"display\": \"Malignant neoplasm of transverse colon\"\n          },\n          {\n            \"code\": \"C18.5\",\n            \"display\": \"Malignant neoplasm of splenic flexure\"\n          },\n          {\n            \"code\": \"C18.6\",\n            \"display\": \"Malignant neoplasm of descending colon\"\n          },\n          {\n            \"code\": \"C18.7\",\n            \"display\": \"Malignant neoplasm of sigmoid colon\"\n          },\n          {\n            \"code\": \"C18.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of colon\"\n          },\n          {\n            \"code\": \"C18.9\",\n            \"display\": \"Malignant neoplasm of colon, unspecified\"\n          },\n          {\n            \"code\": \"C19\",\n            \"display\": \"Malignant neoplasm of rectosigmoid junction\"\n          },\n          {\n            \"code\": \"C20\",\n            \"display\": \"Malignant neoplasm of rectum\"\n          },\n          {\n            \"code\": \"C21.0\",\n            \"display\": \"Malignant neoplasm of anus, unspecified\"\n          },\n          {\n            \"code\": \"C21.1\",\n            \"display\": \"Malignant neoplasm of anal canal\"\n          },\n          {\n            \"code\": \"C21.2\",\n            \"display\": \"Malignant neoplasm of cloacogenic zone\"\n          },\n          {\n            \"code\": \"C21.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of rectum, anus and anal canal\"\n          },\n          {\n            \"code\": \"C22.0\",\n            \"display\": \"Liver cell carcinoma\"\n          },\n          {\n            \"code\": \"C22.1\",\n            \"display\": \"Intrahepatic bile duct carcinoma\"\n          },\n          {\n            \"code\": \"C22.2\",\n            \"display\": \"Hepatoblastoma\"\n          },\n          {\n            \"code\": \"C22.3\",\n            \"display\": \"Angiosarcoma of liver\"\n          },\n          {\n            \"code\": \"C22.4\",\n            \"display\": \"Other sarcomas of liver\"\n          },\n          {\n            \"code\": \"C22.7\",\n            \"display\": \"Other specified carcinomas of liver\"\n          },\n          {\n            \"code\": \"C22.8\",\n            \"display\": \"Malignant neoplasm of liver, primary, unspecified as to type\"\n          },\n          {\n            \"code\": \"C22.9\",\n            \"display\": \"Malignant neoplasm of liver, not specified as primary or secondary\"\n          },\n          {\n            \"code\": \"C23\",\n            \"display\": \"Malignant neoplasm of gallbladder\"\n          },\n          {\n            \"code\": \"C24.0\",\n            \"display\": \"Malignant neoplasm of extrahepatic bile duct\"\n          },\n          {\n            \"code\": \"C24.1\",\n            \"display\": \"Malignant neoplasm of ampulla of Vater\"\n          },\n          {\n            \"code\": \"C24.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of biliary tract\"\n          },\n          {\n            \"code\": \"C24.9\",\n            \"display\": \"Malignant neoplasm of biliary tract, unspecified\"\n          },\n          {\n            \"code\": \"C25.0\",\n            \"display\": \"Malignant neoplasm of head of pancreas\"\n          },\n          {\n            \"code\": \"C25.1\",\n            \"display\": \"Malignant neoplasm of body of pancreas\"\n          },\n          {\n            \"code\": \"C25.2\",\n            \"display\": \"Malignant neoplasm of tail of pancreas\"\n          },\n          {\n            \"code\": \"C25.3\",\n            \"display\": \"Malignant neoplasm of pancreatic duct\"\n          },\n          {\n            \"code\": \"C25.4\",\n            \"display\": \"Malignant neoplasm of endocrine pancreas\"\n          },\n          {\n            \"code\": \"C25.7\",\n            \"display\": \"Malignant neoplasm of other parts of pancreas\"\n          },\n          {\n            \"code\": \"C25.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of pancreas\"\n          },\n          {\n            \"code\": \"C25.9\",\n            \"display\": \"Malignant neoplasm of pancreas, unspecified\"\n          },\n          {\n            \"code\": \"C26.0\",\n            \"display\": \"Malignant neoplasm of intestinal tract, part unspecified\"\n          },\n          {\n            \"code\": \"C26.1\",\n            \"display\": \"Malignant neoplasm of spleen\"\n          },\n          {\n            \"code\": \"C26.9\",\n            \"display\": \"Malignant neoplasm of ill-defined sites within the digestive system\"\n          },\n          {\n            \"code\": \"C30.0\",\n            \"display\": \"Malignant neoplasm of nasal cavity\"\n          },\n          {\n            \"code\": \"C30.1\",\n            \"display\": \"Malignant neoplasm of middle ear\"\n          },\n          {\n            \"code\": \"C31.0\",\n            \"display\": \"Malignant neoplasm of maxillary sinus\"\n          },\n          {\n            \"code\": \"C31.1\",\n            \"display\": \"Malignant neoplasm of ethmoidal sinus\"\n          },\n          {\n            \"code\": \"C31.2\",\n            \"display\": \"Malignant neoplasm of frontal sinus\"\n          },\n          {\n            \"code\": \"C31.3\",\n            \"display\": \"Malignant neoplasm of sphenoid sinus\"\n          },\n          {\n            \"code\": \"C31.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of accessory sinuses\"\n          },\n          {\n            \"code\": \"C31.9\",\n            \"display\": \"Malignant neoplasm of accessory sinus, unspecified\"\n          },\n          {\n            \"code\": \"C32.0\",\n            \"display\": \"Malignant neoplasm of glottis\"\n          },\n          {\n            \"code\": \"C32.1\",\n            \"display\": \"Malignant neoplasm of supraglottis\"\n          },\n          {\n            \"code\": \"C32.2\",\n            \"display\": \"Malignant neoplasm of subglottis\"\n          },\n          {\n            \"code\": \"C32.3\",\n            \"display\": \"Malignant neoplasm of laryngeal cartilage\"\n          },\n          {\n            \"code\": \"C32.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of larynx\"\n          },\n          {\n            \"code\": \"C32.9\",\n            \"display\": \"Malignant neoplasm of larynx, unspecified\"\n          },\n          {\n            \"code\": \"C33\",\n            \"display\": \"Malignant neoplasm of trachea\"\n          },\n          {\n            \"code\": \"C34.00\",\n            \"display\": \"Malignant neoplasm of unspecified main bronchus\"\n          },\n          {\n            \"code\": \"C34.01\",\n            \"display\": \"Malignant neoplasm of right main bronchus\"\n          },\n          {\n            \"code\": \"C34.02\",\n            \"display\": \"Malignant neoplasm of left main bronchus\"\n          },\n          {\n            \"code\": \"C34.10\",\n            \"display\": \"Malignant neoplasm of upper lobe, unspecified bronchus or lung\"\n          },\n          {\n            \"code\": \"C34.11\",\n            \"display\": \"Malignant neoplasm of upper lobe, right bronchus or lung\"\n          },\n          {\n            \"code\": \"C34.12\",\n            \"display\": \"Malignant neoplasm of upper lobe, left bronchus or lung\"\n          },\n          {\n            \"code\": \"C34.2\",\n            \"display\": \"Malignant neoplasm of middle lobe, bronchus or lung\"\n          },\n          {\n            \"code\": \"C34.30\",\n            \"display\": \"Malignant neoplasm of lower lobe, unspecified bronchus or lung\"\n          },\n          {\n            \"code\": \"C34.31\",\n            \"display\": \"Malignant neoplasm of lower lobe, right bronchus or lung\"\n          },\n          {\n            \"code\": \"C34.32\",\n            \"display\": \"Malignant neoplasm of lower lobe, left bronchus or lung\"\n          },\n          {\n            \"code\": \"C34.80\",\n            \"display\": \"Malignant neoplasm of overlapping sites of unspecified bronchus and lung\"\n          },\n          {\n            \"code\": \"C34.81\",\n            \"display\": \"Malignant neoplasm of overlapping sites of right bronchus and lung\"\n          },\n          {\n            \"code\": \"C34.82\",\n            \"display\": \"Malignant neoplasm of overlapping sites of left bronchus and lung\"\n          },\n          {\n            \"code\": \"C34.90\",\n            \"display\": \"Malignant neoplasm of unspecified part of unspecified bronchus or lung\"\n          },\n          {\n            \"code\": \"C34.91\",\n            \"display\": \"Malignant neoplasm of unspecified part of right bronchus or lung\"\n          },\n          {\n            \"code\": \"C34.92\",\n            \"display\": \"Malignant neoplasm of unspecified part of left bronchus or lung\"\n          },\n          {\n            \"code\": \"C37\",\n            \"display\": \"Malignant neoplasm of thymus\"\n          },\n          {\n            \"code\": \"C38.0\",\n            \"display\": \"Malignant neoplasm of heart\"\n          },\n          {\n            \"code\": \"C38.1\",\n            \"display\": \"Malignant neoplasm of anterior mediastinum\"\n          },\n          {\n            \"code\": \"C38.2\",\n            \"display\": \"Malignant neoplasm of posterior mediastinum\"\n          },\n          {\n            \"code\": \"C38.3\",\n            \"display\": \"Malignant neoplasm of mediastinum, part unspecified\"\n          },\n          {\n            \"code\": \"C38.4\",\n            \"display\": \"Malignant neoplasm of pleura\"\n          },\n          {\n            \"code\": \"C38.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of heart, mediastinum and pleura\"\n          },\n          {\n            \"code\": \"C39.0\",\n            \"display\": \"Malignant neoplasm of upper respiratory tract, part unspecified\"\n          },\n          {\n            \"code\": \"C39.9\",\n            \"display\": \"Malignant neoplasm of lower respiratory tract, part unspecified\"\n          },\n          {\n            \"code\": \"C40.00\",\n            \"display\": \"Malignant neoplasm of scapula and long bones of unspecified upper limb\"\n          },\n          {\n            \"code\": \"C40.01\",\n            \"display\": \"Malignant neoplasm of scapula and long bones of right upper limb\"\n          },\n          {\n            \"code\": \"C40.02\",\n            \"display\": \"Malignant neoplasm of scapula and long bones of left upper limb\"\n          },\n          {\n            \"code\": \"C40.10\",\n            \"display\": \"Malignant neoplasm of short bones of unspecified upper limb\"\n          },\n          {\n            \"code\": \"C40.11\",\n            \"display\": \"Malignant neoplasm of short bones of right upper limb\"\n          },\n          {\n            \"code\": \"C40.12\",\n            \"display\": \"Malignant neoplasm of short bones of left upper limb\"\n          },\n          {\n            \"code\": \"C40.20\",\n            \"display\": \"Malignant neoplasm of long bones of unspecified lower limb\"\n          },\n          {\n            \"code\": \"C40.21\",\n            \"display\": \"Malignant neoplasm of long bones of right lower limb\"\n          },\n          {\n            \"code\": \"C40.22\",\n            \"display\": \"Malignant neoplasm of long bones of left lower limb\"\n          },\n          {\n            \"code\": \"C40.30\",\n            \"display\": \"Malignant neoplasm of short bones of unspecified lower limb\"\n          },\n          {\n            \"code\": \"C40.31\",\n            \"display\": \"Malignant neoplasm of short bones of right lower limb\"\n          },\n          {\n            \"code\": \"C40.32\",\n            \"display\": \"Malignant neoplasm of short bones of left lower limb\"\n          },\n          {\n            \"code\": \"C40.80\",\n            \"display\": \"Malignant neoplasm of overlapping sites of bone and articular cartilage of unspecified limb\"\n          },\n          {\n            \"code\": \"C40.81\",\n            \"display\": \"Malignant neoplasm of overlapping sites of bone and articular cartilage of right limb\"\n          },\n          {\n            \"code\": \"C40.82\",\n            \"display\": \"Malignant neoplasm of overlapping sites of bone and articular cartilage of left limb\"\n          },\n          {\n            \"code\": \"C40.90\",\n            \"display\": \"Malignant neoplasm of unspecified bones and articular cartilage of unspecified limb\"\n          },\n          {\n            \"code\": \"C40.91\",\n            \"display\": \"Malignant neoplasm of unspecified bones and articular cartilage of right limb\"\n          },\n          {\n            \"code\": \"C40.92\",\n            \"display\": \"Malignant neoplasm of unspecified bones and articular cartilage of left limb\"\n          },\n          {\n            \"code\": \"C41.0\",\n            \"display\": \"Malignant neoplasm of bones of skull and face\"\n          },\n          {\n            \"code\": \"C41.1\",\n            \"display\": \"Malignant neoplasm of mandible\"\n          },\n          {\n            \"code\": \"C41.2\",\n            \"display\": \"Malignant neoplasm of vertebral column\"\n          },\n          {\n            \"code\": \"C41.3\",\n            \"display\": \"Malignant neoplasm of ribs, sternum and clavicle\"\n          },\n          {\n            \"code\": \"C41.4\",\n            \"display\": \"Malignant neoplasm of pelvic bones, sacrum and coccyx\"\n          },\n          {\n            \"code\": \"C41.9\",\n            \"display\": \"Malignant neoplasm of bone and articular cartilage, unspecified\"\n          },\n          {\n            \"code\": \"C43.0\",\n            \"display\": \"Malignant melanoma of lip\"\n          },\n          {\n            \"code\": \"C43.10\",\n            \"display\": \"Malignant melanoma of unspecified eyelid, including canthus\"\n          },\n          {\n            \"code\": \"C43.11\",\n            \"display\": \"Malignant melanoma of right eyelid, including canthus\"\n          },\n          {\n            \"code\": \"C43.12\",\n            \"display\": \"Malignant melanoma of left eyelid, including canthus\"\n          },\n          {\n            \"code\": \"C43.20\",\n            \"display\": \"Malignant melanoma of unspecified ear and external auricular canal\"\n          },\n          {\n            \"code\": \"C43.21\",\n            \"display\": \"Malignant melanoma of right ear and external auricular canal\"\n          },\n          {\n            \"code\": \"C43.22\",\n            \"display\": \"Malignant melanoma of left ear and external auricular canal\"\n          },\n          {\n            \"code\": \"C43.30\",\n            \"display\": \"Malignant melanoma of unspecified part of face\"\n          },\n          {\n            \"code\": \"C43.31\",\n            \"display\": \"Malignant melanoma of nose\"\n          },\n          {\n            \"code\": \"C43.39\",\n            \"display\": \"Malignant melanoma of other parts of face\"\n          },\n          {\n            \"code\": \"C43.4\",\n            \"display\": \"Malignant melanoma of scalp and neck\"\n          },\n          {\n            \"code\": \"C43.51\",\n            \"display\": \"Malignant melanoma of anal skin\"\n          },\n          {\n            \"code\": \"C43.52\",\n            \"display\": \"Malignant melanoma of skin of breast\"\n          },\n          {\n            \"code\": \"C43.59\",\n            \"display\": \"Malignant melanoma of other part of trunk\"\n          },\n          {\n            \"code\": \"C43.60\",\n            \"display\": \"Malignant melanoma of unspecified upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C43.61\",\n            \"display\": \"Malignant melanoma of right upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C43.62\",\n            \"display\": \"Malignant melanoma of left upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C43.70\",\n            \"display\": \"Malignant melanoma of unspecified lower limb, including hip\"\n          },\n          {\n            \"code\": \"C43.71\",\n            \"display\": \"Malignant melanoma of right lower limb, including hip\"\n          },\n          {\n            \"code\": \"C43.72\",\n            \"display\": \"Malignant melanoma of left lower limb, including hip\"\n          },\n          {\n            \"code\": \"C43.8\",\n            \"display\": \"Malignant melanoma of overlapping sites of skin\"\n          },\n          {\n            \"code\": \"C43.9\",\n            \"display\": \"Malignant melanoma of skin, unspecified\"\n          },\n          {\n            \"code\": \"C44.00\",\n            \"display\": \"Unspecified malignant neoplasm of skin of lip\"\n          },\n          {\n            \"code\": \"C44.01\",\n            \"display\": \"Basal cell carcinoma of skin of lip\"\n          },\n          {\n            \"code\": \"C44.02\",\n            \"display\": \"Squamous cell carcinoma of skin of lip\"\n          },\n          {\n            \"code\": \"C44.09\",\n            \"display\": \"Other specified malignant neoplasm of skin of lip\"\n          },\n          {\n            \"code\": \"C44.101\",\n            \"display\": \"Unspecified malignant neoplasm of skin of unspecified eyelid, including canthus\"\n          },\n          {\n            \"code\": \"C44.102\",\n            \"display\": \"Unspecified malignant neoplasm of skin of right eyelid, including canthus\"\n          },\n          {\n            \"code\": \"C44.109\",\n            \"display\": \"Unspecified malignant neoplasm of skin of left eyelid, including canthus\"\n          },\n          {\n            \"code\": \"C44.111\",\n            \"display\": \"Basal cell carcinoma of skin of unspecified eyelid, including canthus\"\n          },\n          {\n            \"code\": \"C44.112\",\n            \"display\": \"Basal cell carcinoma of skin of right eyelid, including canthus\"\n          },\n          {\n            \"code\": \"C44.119\",\n            \"display\": \"Basal cell carcinoma of skin of left eyelid, including canthus\"\n          },\n          {\n            \"code\": \"C44.121\",\n            \"display\": \"Squamous cell carcinoma of skin of unspecified eyelid, including canthus\"\n          },\n          {\n            \"code\": \"C44.122\",\n            \"display\": \"Squamous cell carcinoma of skin of right eyelid, including canthus\"\n          },\n          {\n            \"code\": \"C44.129\",\n            \"display\": \"Squamous cell carcinoma of skin of left eyelid, including canthus\"\n          },\n          {\n            \"code\": \"C44.191\",\n            \"display\": \"Other specified malignant neoplasm of skin of unspecified eyelid, including canthus\"\n          },\n          {\n            \"code\": \"C44.192\",\n            \"display\": \"Other specified malignant neoplasm of skin of right eyelid, including canthus\"\n          },\n          {\n            \"code\": \"C44.199\",\n            \"display\": \"Other specified malignant neoplasm of skin of left eyelid, including canthus\"\n          },\n          {\n            \"code\": \"C44.201\",\n            \"display\": \"Unspecified malignant neoplasm of skin of unspecified ear and external auricular canal\"\n          },\n          {\n            \"code\": \"C44.202\",\n            \"display\": \"Unspecified malignant neoplasm of skin of right ear and external auricular canal\"\n          },\n          {\n            \"code\": \"C44.209\",\n            \"display\": \"Unspecified malignant neoplasm of skin of left ear and external auricular canal\"\n          },\n          {\n            \"code\": \"C44.211\",\n            \"display\": \"Basal cell carcinoma of skin of unspecified ear and external auricular canal\"\n          },\n          {\n            \"code\": \"C44.212\",\n            \"display\": \"Basal cell carcinoma of skin of right ear and external auricular canal\"\n          },\n          {\n            \"code\": \"C44.219\",\n            \"display\": \"Basal cell carcinoma of skin of left ear and external auricular canal\"\n          },\n          {\n            \"code\": \"C44.221\",\n            \"display\": \"Squamous cell carcinoma of skin of unspecified ear and external auricular canal\"\n          },\n          {\n            \"code\": \"C44.222\",\n            \"display\": \"Squamous cell carcinoma of skin of right ear and external auricular canal\"\n          },\n          {\n            \"code\": \"C44.229\",\n            \"display\": \"Squamous cell carcinoma of skin of left ear and external auricular canal\"\n          },\n          {\n            \"code\": \"C44.291\",\n            \"display\": \"Other specified malignant neoplasm of skin of unspecified ear and external auricular canal\"\n          },\n          {\n            \"code\": \"C44.292\",\n            \"display\": \"Other specified malignant neoplasm of skin of right ear and external auricular canal\"\n          },\n          {\n            \"code\": \"C44.299\",\n            \"display\": \"Other specified malignant neoplasm of skin of left ear and external auricular canal\"\n          },\n          {\n            \"code\": \"C44.300\",\n            \"display\": \"Unspecified malignant neoplasm of skin of unspecified part of face\"\n          },\n          {\n            \"code\": \"C44.301\",\n            \"display\": \"Unspecified malignant neoplasm of skin of nose\"\n          },\n          {\n            \"code\": \"C44.309\",\n            \"display\": \"Unspecified malignant neoplasm of skin of other parts of face\"\n          },\n          {\n            \"code\": \"C44.310\",\n            \"display\": \"Basal cell carcinoma of skin of unspecified parts of face\"\n          },\n          {\n            \"code\": \"C44.311\",\n            \"display\": \"Basal cell carcinoma of skin of nose\"\n          },\n          {\n            \"code\": \"C44.319\",\n            \"display\": \"Basal cell carcinoma of skin of other parts of face\"\n          },\n          {\n            \"code\": \"C44.320\",\n            \"display\": \"Squamous cell carcinoma of skin of unspecified parts of face\"\n          },\n          {\n            \"code\": \"C44.321\",\n            \"display\": \"Squamous cell carcinoma of skin of nose\"\n          },\n          {\n            \"code\": \"C44.329\",\n            \"display\": \"Squamous cell carcinoma of skin of other parts of face\"\n          },\n          {\n            \"code\": \"C44.390\",\n            \"display\": \"Other specified malignant neoplasm of skin of unspecified parts of face\"\n          },\n          {\n            \"code\": \"C44.391\",\n            \"display\": \"Other specified malignant neoplasm of skin of nose\"\n          },\n          {\n            \"code\": \"C44.399\",\n            \"display\": \"Other specified malignant neoplasm of skin of other parts of face\"\n          },\n          {\n            \"code\": \"C44.40\",\n            \"display\": \"Unspecified malignant neoplasm of skin of scalp and neck\"\n          },\n          {\n            \"code\": \"C44.41\",\n            \"display\": \"Basal cell carcinoma of skin of scalp and neck\"\n          },\n          {\n            \"code\": \"C44.42\",\n            \"display\": \"Squamous cell carcinoma of skin of scalp and neck\"\n          },\n          {\n            \"code\": \"C44.49\",\n            \"display\": \"Other specified malignant neoplasm of skin of scalp and neck\"\n          },\n          {\n            \"code\": \"C44.500\",\n            \"display\": \"Unspecified malignant neoplasm of anal skin\"\n          },\n          {\n            \"code\": \"C44.501\",\n            \"display\": \"Unspecified malignant neoplasm of skin of breast\"\n          },\n          {\n            \"code\": \"C44.509\",\n            \"display\": \"Unspecified malignant neoplasm of skin of other part of trunk\"\n          },\n          {\n            \"code\": \"C44.510\",\n            \"display\": \"Basal cell carcinoma of anal skin\"\n          },\n          {\n            \"code\": \"C44.511\",\n            \"display\": \"Basal cell carcinoma of skin of breast\"\n          },\n          {\n            \"code\": \"C44.519\",\n            \"display\": \"Basal cell carcinoma of skin of other part of trunk\"\n          },\n          {\n            \"code\": \"C44.520\",\n            \"display\": \"Squamous cell carcinoma of anal skin\"\n          },\n          {\n            \"code\": \"C44.521\",\n            \"display\": \"Squamous cell carcinoma of skin of breast\"\n          },\n          {\n            \"code\": \"C44.529\",\n            \"display\": \"Squamous cell carcinoma of skin of other part of trunk\"\n          },\n          {\n            \"code\": \"C44.590\",\n            \"display\": \"Other specified malignant neoplasm of anal skin\"\n          },\n          {\n            \"code\": \"C44.591\",\n            \"display\": \"Other specified malignant neoplasm of skin of breast\"\n          },\n          {\n            \"code\": \"C44.599\",\n            \"display\": \"Other specified malignant neoplasm of skin of other part of trunk\"\n          },\n          {\n            \"code\": \"C44.601\",\n            \"display\": \"Unspecified malignant neoplasm of skin of unspecified upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C44.602\",\n            \"display\": \"Unspecified malignant neoplasm of skin of right upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C44.609\",\n            \"display\": \"Unspecified malignant neoplasm of skin of left upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C44.611\",\n            \"display\": \"Basal cell carcinoma of skin of unspecified upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C44.612\",\n            \"display\": \"Basal cell carcinoma of skin of right upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C44.619\",\n            \"display\": \"Basal cell carcinoma of skin of left upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C44.621\",\n            \"display\": \"Squamous cell carcinoma of skin of unspecified upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C44.622\",\n            \"display\": \"Squamous cell carcinoma of skin of right upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C44.629\",\n            \"display\": \"Squamous cell carcinoma of skin of left upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C44.691\",\n            \"display\": \"Other specified malignant neoplasm of skin of unspecified upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C44.692\",\n            \"display\": \"Other specified malignant neoplasm of skin of right upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C44.699\",\n            \"display\": \"Other specified malignant neoplasm of skin of left upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C44.701\",\n            \"display\": \"Unspecified malignant neoplasm of skin of unspecified lower limb, including hip\"\n          },\n          {\n            \"code\": \"C44.702\",\n            \"display\": \"Unspecified malignant neoplasm of skin of right lower limb, including hip\"\n          },\n          {\n            \"code\": \"C44.709\",\n            \"display\": \"Unspecified malignant neoplasm of skin of left lower limb, including hip\"\n          },\n          {\n            \"code\": \"C44.711\",\n            \"display\": \"Basal cell carcinoma of skin of unspecified lower limb, including hip\"\n          },\n          {\n            \"code\": \"C44.712\",\n            \"display\": \"Basal cell carcinoma of skin of right lower limb, including hip\"\n          },\n          {\n            \"code\": \"C44.719\",\n            \"display\": \"Basal cell carcinoma of skin of left lower limb, including hip\"\n          },\n          {\n            \"code\": \"C44.721\",\n            \"display\": \"Squamous cell carcinoma of skin of unspecified lower limb, including hip\"\n          },\n          {\n            \"code\": \"C44.722\",\n            \"display\": \"Squamous cell carcinoma of skin of right lower limb, including hip\"\n          },\n          {\n            \"code\": \"C44.729\",\n            \"display\": \"Squamous cell carcinoma of skin of left lower limb, including hip\"\n          },\n          {\n            \"code\": \"C44.791\",\n            \"display\": \"Other specified malignant neoplasm of skin of unspecified lower limb, including hip\"\n          },\n          {\n            \"code\": \"C44.792\",\n            \"display\": \"Other specified malignant neoplasm of skin of right lower limb, including hip\"\n          },\n          {\n            \"code\": \"C44.799\",\n            \"display\": \"Other specified malignant neoplasm of skin of left lower limb, including hip\"\n          },\n          {\n            \"code\": \"C44.80\",\n            \"display\": \"Unspecified malignant neoplasm of overlapping sites of skin\"\n          },\n          {\n            \"code\": \"C44.81\",\n            \"display\": \"Basal cell carcinoma of overlapping sites of skin\"\n          },\n          {\n            \"code\": \"C44.82\",\n            \"display\": \"Squamous cell carcinoma of overlapping sites of skin\"\n          },\n          {\n            \"code\": \"C44.89\",\n            \"display\": \"Other specified malignant neoplasm of overlapping sites of skin\"\n          },\n          {\n            \"code\": \"C44.90\",\n            \"display\": \"Unspecified malignant neoplasm of skin, unspecified\"\n          },\n          {\n            \"code\": \"C44.91\",\n            \"display\": \"Basal cell carcinoma of skin, unspecified\"\n          },\n          {\n            \"code\": \"C44.92\",\n            \"display\": \"Squamous cell carcinoma of skin, unspecified\"\n          },\n          {\n            \"code\": \"C44.99\",\n            \"display\": \"Other specified malignant neoplasm of skin, unspecified\"\n          },\n          {\n            \"code\": \"C45.0\",\n            \"display\": \"Mesothelioma of pleura\"\n          },\n          {\n            \"code\": \"C45.1\",\n            \"display\": \"Mesothelioma of peritoneum\"\n          },\n          {\n            \"code\": \"C45.2\",\n            \"display\": \"Mesothelioma of pericardium\"\n          },\n          {\n            \"code\": \"C45.7\",\n            \"display\": \"Mesothelioma of other sites\"\n          },\n          {\n            \"code\": \"C45.9\",\n            \"display\": \"Mesothelioma, unspecified\"\n          },\n          {\n            \"code\": \"C46.0\",\n            \"display\": \"Kaposi's sarcoma of skin\"\n          },\n          {\n            \"code\": \"C46.1\",\n            \"display\": \"Kaposi's sarcoma of soft tissue\"\n          },\n          {\n            \"code\": \"C46.2\",\n            \"display\": \"Kaposi's sarcoma of palate\"\n          },\n          {\n            \"code\": \"C46.3\",\n            \"display\": \"Kaposi's sarcoma of lymph nodes\"\n          },\n          {\n            \"code\": \"C46.4\",\n            \"display\": \"Kaposi's sarcoma of gastrointestinal sites\"\n          },\n          {\n            \"code\": \"C46.50\",\n            \"display\": \"Kaposi's sarcoma of unspecified lung\"\n          },\n          {\n            \"code\": \"C46.51\",\n            \"display\": \"Kaposi's sarcoma of right lung\"\n          },\n          {\n            \"code\": \"C46.52\",\n            \"display\": \"Kaposi's sarcoma of left lung\"\n          },\n          {\n            \"code\": \"C46.7\",\n            \"display\": \"Kaposi's sarcoma of other sites\"\n          },\n          {\n            \"code\": \"C46.9\",\n            \"display\": \"Kaposi's sarcoma, unspecified\"\n          },\n          {\n            \"code\": \"C47.0\",\n            \"display\": \"Malignant neoplasm of peripheral nerves of head, face and neck\"\n          },\n          {\n            \"code\": \"C47.10\",\n            \"display\": \"Malignant neoplasm of peripheral nerves of unspecified upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C47.11\",\n            \"display\": \"Malignant neoplasm of peripheral nerves of right upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C47.12\",\n            \"display\": \"Malignant neoplasm of peripheral nerves of left upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C47.20\",\n            \"display\": \"Malignant neoplasm of peripheral nerves of unspecified lower limb, including hip\"\n          },\n          {\n            \"code\": \"C47.21\",\n            \"display\": \"Malignant neoplasm of peripheral nerves of right lower limb, including hip\"\n          },\n          {\n            \"code\": \"C47.22\",\n            \"display\": \"Malignant neoplasm of peripheral nerves of left lower limb, including hip\"\n          },\n          {\n            \"code\": \"C47.3\",\n            \"display\": \"Malignant neoplasm of peripheral nerves of thorax\"\n          },\n          {\n            \"code\": \"C47.4\",\n            \"display\": \"Malignant neoplasm of peripheral nerves of abdomen\"\n          },\n          {\n            \"code\": \"C47.5\",\n            \"display\": \"Malignant neoplasm of peripheral nerves of pelvis\"\n          },\n          {\n            \"code\": \"C47.6\",\n            \"display\": \"Malignant neoplasm of peripheral nerves of trunk, unspecified\"\n          },\n          {\n            \"code\": \"C47.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of peripheral nerves and autonomic nervous system\"\n          },\n          {\n            \"code\": \"C47.9\",\n            \"display\": \"Malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified\"\n          },\n          {\n            \"code\": \"C48.0\",\n            \"display\": \"Malignant neoplasm of retroperitoneum\"\n          },\n          {\n            \"code\": \"C48.1\",\n            \"display\": \"Malignant neoplasm of specified parts of peritoneum\"\n          },\n          {\n            \"code\": \"C48.2\",\n            \"display\": \"Malignant neoplasm of peritoneum, unspecified\"\n          },\n          {\n            \"code\": \"C48.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum\"\n          },\n          {\n            \"code\": \"C49.0\",\n            \"display\": \"Malignant neoplasm of connective and soft tissue of head, face and neck\"\n          },\n          {\n            \"code\": \"C49.10\",\n            \"display\": \"Malignant neoplasm of connective and soft tissue of unspecified upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C49.11\",\n            \"display\": \"Malignant neoplasm of connective and soft tissue of right upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C49.12\",\n            \"display\": \"Malignant neoplasm of connective and soft tissue of left upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C49.20\",\n            \"display\": \"Malignant neoplasm of connective and soft tissue of unspecified lower limb, including hip\"\n          },\n          {\n            \"code\": \"C49.21\",\n            \"display\": \"Malignant neoplasm of connective and soft tissue of right lower limb, including hip\"\n          },\n          {\n            \"code\": \"C49.22\",\n            \"display\": \"Malignant neoplasm of connective and soft tissue of left lower limb, including hip\"\n          },\n          {\n            \"code\": \"C49.3\",\n            \"display\": \"Malignant neoplasm of connective and soft tissue of thorax\"\n          },\n          {\n            \"code\": \"C49.4\",\n            \"display\": \"Malignant neoplasm of connective and soft tissue of abdomen\"\n          },\n          {\n            \"code\": \"C49.5\",\n            \"display\": \"Malignant neoplasm of connective and soft tissue of pelvis\"\n          },\n          {\n            \"code\": \"C49.6\",\n            \"display\": \"Malignant neoplasm of connective and soft tissue of trunk, unspecified\"\n          },\n          {\n            \"code\": \"C49.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of connective and soft tissue\"\n          },\n          {\n            \"code\": \"C49.9\",\n            \"display\": \"Malignant neoplasm of connective and soft tissue, unspecified\"\n          },\n          {\n            \"code\": \"C4A.0\",\n            \"display\": \"Merkel cell carcinoma of lip\"\n          },\n          {\n            \"code\": \"C4A.10\",\n            \"display\": \"Merkel cell carcinoma of unspecified eyelid, including canthus\"\n          },\n          {\n            \"code\": \"C4A.11\",\n            \"display\": \"Merkel cell carcinoma of right eyelid, including canthus\"\n          },\n          {\n            \"code\": \"C4A.12\",\n            \"display\": \"Merkel cell carcinoma of left eyelid, including canthus\"\n          },\n          {\n            \"code\": \"C4A.20\",\n            \"display\": \"Merkel cell carcinoma of unspecified ear and external auricular canal\"\n          },\n          {\n            \"code\": \"C4A.21\",\n            \"display\": \"Merkel cell carcinoma of right ear and external auricular canal\"\n          },\n          {\n            \"code\": \"C4A.22\",\n            \"display\": \"Merkel cell carcinoma of left ear and external auricular canal\"\n          },\n          {\n            \"code\": \"C4A.30\",\n            \"display\": \"Merkel cell carcinoma of unspecified part of face\"\n          },\n          {\n            \"code\": \"C4A.31\",\n            \"display\": \"Merkel cell carcinoma of nose\"\n          },\n          {\n            \"code\": \"C4A.39\",\n            \"display\": \"Merkel cell carcinoma of other parts of face\"\n          },\n          {\n            \"code\": \"C4A.4\",\n            \"display\": \"Merkel cell carcinoma of scalp and neck\"\n          },\n          {\n            \"code\": \"C4A.51\",\n            \"display\": \"Merkel cell carcinoma of anal skin\"\n          },\n          {\n            \"code\": \"C4A.52\",\n            \"display\": \"Merkel cell carcinoma of skin of breast\"\n          },\n          {\n            \"code\": \"C4A.59\",\n            \"display\": \"Merkel cell carcinoma of other part of trunk\"\n          },\n          {\n            \"code\": \"C4A.60\",\n            \"display\": \"Merkel cell carcinoma of unspecified upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C4A.61\",\n            \"display\": \"Merkel cell carcinoma of right upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C4A.62\",\n            \"display\": \"Merkel cell carcinoma of left upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"C4A.70\",\n            \"display\": \"Merkel cell carcinoma of unspecified lower limb, including hip\"\n          },\n          {\n            \"code\": \"C4A.71\",\n            \"display\": \"Merkel cell carcinoma of right lower limb, including hip\"\n          },\n          {\n            \"code\": \"C4A.72\",\n            \"display\": \"Merkel cell carcinoma of left lower limb, including hip\"\n          },\n          {\n            \"code\": \"C4A.8\",\n            \"display\": \"Merkel cell carcinoma of overlapping sites\"\n          },\n          {\n            \"code\": \"C4A.9\",\n            \"display\": \"Merkel cell carcinoma, unspecified\"\n          },\n          {\n            \"code\": \"C50.011\",\n            \"display\": \"Malignant neoplasm of nipple and areola, right female breast\"\n          },\n          {\n            \"code\": \"C50.012\",\n            \"display\": \"Malignant neoplasm of nipple and areola, left female breast\"\n          },\n          {\n            \"code\": \"C50.019\",\n            \"display\": \"Malignant neoplasm of nipple and areola, unspecified female breast\"\n          },\n          {\n            \"code\": \"C50.021\",\n            \"display\": \"Malignant neoplasm of nipple and areola, right male breast\"\n          },\n          {\n            \"code\": \"C50.022\",\n            \"display\": \"Malignant neoplasm of nipple and areola, left male breast\"\n          },\n          {\n            \"code\": \"C50.029\",\n            \"display\": \"Malignant neoplasm of nipple and areola, unspecified male breast\"\n          },\n          {\n            \"code\": \"C50.111\",\n            \"display\": \"Malignant neoplasm of central portion of right female breast\"\n          },\n          {\n            \"code\": \"C50.112\",\n            \"display\": \"Malignant neoplasm of central portion of left female breast\"\n          },\n          {\n            \"code\": \"C50.119\",\n            \"display\": \"Malignant neoplasm of central portion of unspecified female breast\"\n          },\n          {\n            \"code\": \"C50.121\",\n            \"display\": \"Malignant neoplasm of central portion of right male breast\"\n          },\n          {\n            \"code\": \"C50.122\",\n            \"display\": \"Malignant neoplasm of central portion of left male breast\"\n          },\n          {\n            \"code\": \"C50.129\",\n            \"display\": \"Malignant neoplasm of central portion of unspecified male breast\"\n          },\n          {\n            \"code\": \"C50.211\",\n            \"display\": \"Malignant neoplasm of upper-inner quadrant of right female breast\"\n          },\n          {\n            \"code\": \"C50.212\",\n            \"display\": \"Malignant neoplasm of upper-inner quadrant of left female breast\"\n          },\n          {\n            \"code\": \"C50.219\",\n            \"display\": \"Malignant neoplasm of upper-inner quadrant of unspecified female breast\"\n          },\n          {\n            \"code\": \"C50.221\",\n            \"display\": \"Malignant neoplasm of upper-inner quadrant of right male breast\"\n          },\n          {\n            \"code\": \"C50.222\",\n            \"display\": \"Malignant neoplasm of upper-inner quadrant of left male breast\"\n          },\n          {\n            \"code\": \"C50.229\",\n            \"display\": \"Malignant neoplasm of upper-inner quadrant of unspecified male breast\"\n          },\n          {\n            \"code\": \"C50.311\",\n            \"display\": \"Malignant neoplasm of lower-inner quadrant of right female breast\"\n          },\n          {\n            \"code\": \"C50.312\",\n            \"display\": \"Malignant neoplasm of lower-inner quadrant of left female breast\"\n          },\n          {\n            \"code\": \"C50.319\",\n            \"display\": \"Malignant neoplasm of lower-inner quadrant of unspecified female breast\"\n          },\n          {\n            \"code\": \"C50.321\",\n            \"display\": \"Malignant neoplasm of lower-inner quadrant of right male breast\"\n          },\n          {\n            \"code\": \"C50.322\",\n            \"display\": \"Malignant neoplasm of lower-inner quadrant of left male breast\"\n          },\n          {\n            \"code\": \"C50.329\",\n            \"display\": \"Malignant neoplasm of lower-inner quadrant of unspecified male breast\"\n          },\n          {\n            \"code\": \"C50.411\",\n            \"display\": \"Malignant neoplasm of upper-outer quadrant of right female breast\"\n          },\n          {\n            \"code\": \"C50.412\",\n            \"display\": \"Malignant neoplasm of upper-outer quadrant of left female breast\"\n          },\n          {\n            \"code\": \"C50.419\",\n            \"display\": \"Malignant neoplasm of upper-outer quadrant of unspecified female breast\"\n          },\n          {\n            \"code\": \"C50.421\",\n            \"display\": \"Malignant neoplasm of upper-outer quadrant of right male breast\"\n          },\n          {\n            \"code\": \"C50.422\",\n            \"display\": \"Malignant neoplasm of upper-outer quadrant of left male breast\"\n          },\n          {\n            \"code\": \"C50.429\",\n            \"display\": \"Malignant neoplasm of upper-outer quadrant of unspecified male breast\"\n          },\n          {\n            \"code\": \"C50.511\",\n            \"display\": \"Malignant neoplasm of lower-outer quadrant of right female breast\"\n          },\n          {\n            \"code\": \"C50.512\",\n            \"display\": \"Malignant neoplasm of lower-outer quadrant of left female breast\"\n          },\n          {\n            \"code\": \"C50.519\",\n            \"display\": \"Malignant neoplasm of lower-outer quadrant of unspecified female breast\"\n          },\n          {\n            \"code\": \"C50.521\",\n            \"display\": \"Malignant neoplasm of lower-outer quadrant of right male breast\"\n          },\n          {\n            \"code\": \"C50.522\",\n            \"display\": \"Malignant neoplasm of lower-outer quadrant of left male breast\"\n          },\n          {\n            \"code\": \"C50.529\",\n            \"display\": \"Malignant neoplasm of lower-outer quadrant of unspecified male breast\"\n          },\n          {\n            \"code\": \"C50.611\",\n            \"display\": \"Malignant neoplasm of axillary tail of right female breast\"\n          },\n          {\n            \"code\": \"C50.612\",\n            \"display\": \"Malignant neoplasm of axillary tail of left female breast\"\n          },\n          {\n            \"code\": \"C50.619\",\n            \"display\": \"Malignant neoplasm of axillary tail of unspecified female breast\"\n          },\n          {\n            \"code\": \"C50.621\",\n            \"display\": \"Malignant neoplasm of axillary tail of right male breast\"\n          },\n          {\n            \"code\": \"C50.622\",\n            \"display\": \"Malignant neoplasm of axillary tail of left male breast\"\n          },\n          {\n            \"code\": \"C50.629\",\n            \"display\": \"Malignant neoplasm of axillary tail of unspecified male breast\"\n          },\n          {\n            \"code\": \"C50.811\",\n            \"display\": \"Malignant neoplasm of overlapping sites of right female breast\"\n          },\n          {\n            \"code\": \"C50.812\",\n            \"display\": \"Malignant neoplasm of overlapping sites of left female breast\"\n          },\n          {\n            \"code\": \"C50.819\",\n            \"display\": \"Malignant neoplasm of overlapping sites of unspecified female breast\"\n          },\n          {\n            \"code\": \"C50.821\",\n            \"display\": \"Malignant neoplasm of overlapping sites of right male breast\"\n          },\n          {\n            \"code\": \"C50.822\",\n            \"display\": \"Malignant neoplasm of overlapping sites of left male breast\"\n          },\n          {\n            \"code\": \"C50.829\",\n            \"display\": \"Malignant neoplasm of overlapping sites of unspecified male breast\"\n          },\n          {\n            \"code\": \"C50.911\",\n            \"display\": \"Malignant neoplasm of unspecified site of right female breast\"\n          },\n          {\n            \"code\": \"C50.912\",\n            \"display\": \"Malignant neoplasm of unspecified site of left female breast\"\n          },\n          {\n            \"code\": \"C50.919\",\n            \"display\": \"Malignant neoplasm of unspecified site of unspecified female breast\"\n          },\n          {\n            \"code\": \"C50.921\",\n            \"display\": \"Malignant neoplasm of unspecified site of right male breast\"\n          },\n          {\n            \"code\": \"C50.922\",\n            \"display\": \"Malignant neoplasm of unspecified site of left male breast\"\n          },\n          {\n            \"code\": \"C50.929\",\n            \"display\": \"Malignant neoplasm of unspecified site of unspecified male breast\"\n          },\n          {\n            \"code\": \"C51.0\",\n            \"display\": \"Malignant neoplasm of labium majus\"\n          },\n          {\n            \"code\": \"C51.1\",\n            \"display\": \"Malignant neoplasm of labium minus\"\n          },\n          {\n            \"code\": \"C51.2\",\n            \"display\": \"Malignant neoplasm of clitoris\"\n          },\n          {\n            \"code\": \"C51.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of vulva\"\n          },\n          {\n            \"code\": \"C51.9\",\n            \"display\": \"Malignant neoplasm of vulva, unspecified\"\n          },\n          {\n            \"code\": \"C52\",\n            \"display\": \"Malignant neoplasm of vagina\"\n          },\n          {\n            \"code\": \"C53.0\",\n            \"display\": \"Malignant neoplasm of endocervix\"\n          },\n          {\n            \"code\": \"C53.1\",\n            \"display\": \"Malignant neoplasm of exocervix\"\n          },\n          {\n            \"code\": \"C53.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of cervix uteri\"\n          },\n          {\n            \"code\": \"C53.9\",\n            \"display\": \"Malignant neoplasm of cervix uteri, unspecified\"\n          },\n          {\n            \"code\": \"C54.0\",\n            \"display\": \"Malignant neoplasm of isthmus uteri\"\n          },\n          {\n            \"code\": \"C54.1\",\n            \"display\": \"Malignant neoplasm of endometrium\"\n          },\n          {\n            \"code\": \"C54.2\",\n            \"display\": \"Malignant neoplasm of myometrium\"\n          },\n          {\n            \"code\": \"C54.3\",\n            \"display\": \"Malignant neoplasm of fundus uteri\"\n          },\n          {\n            \"code\": \"C54.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of corpus uteri\"\n          },\n          {\n            \"code\": \"C54.9\",\n            \"display\": \"Malignant neoplasm of corpus uteri, unspecified\"\n          },\n          {\n            \"code\": \"C55\",\n            \"display\": \"Malignant neoplasm of uterus, part unspecified\"\n          },\n          {\n            \"code\": \"C56.1\",\n            \"display\": \"Malignant neoplasm of right ovary\"\n          },\n          {\n            \"code\": \"C56.2\",\n            \"display\": \"Malignant neoplasm of left ovary\"\n          },\n          {\n            \"code\": \"C56.9\",\n            \"display\": \"Malignant neoplasm of unspecified ovary\"\n          },\n          {\n            \"code\": \"C57.00\",\n            \"display\": \"Malignant neoplasm of unspecified fallopian tube\"\n          },\n          {\n            \"code\": \"C57.01\",\n            \"display\": \"Malignant neoplasm of right fallopian tube\"\n          },\n          {\n            \"code\": \"C57.02\",\n            \"display\": \"Malignant neoplasm of left fallopian tube\"\n          },\n          {\n            \"code\": \"C57.10\",\n            \"display\": \"Malignant neoplasm of unspecified broad ligament\"\n          },\n          {\n            \"code\": \"C57.11\",\n            \"display\": \"Malignant neoplasm of right broad ligament\"\n          },\n          {\n            \"code\": \"C57.12\",\n            \"display\": \"Malignant neoplasm of left broad ligament\"\n          },\n          {\n            \"code\": \"C57.20\",\n            \"display\": \"Malignant neoplasm of unspecified round ligament\"\n          },\n          {\n            \"code\": \"C57.21\",\n            \"display\": \"Malignant neoplasm of right round ligament\"\n          },\n          {\n            \"code\": \"C57.22\",\n            \"display\": \"Malignant neoplasm of left round ligament\"\n          },\n          {\n            \"code\": \"C57.3\",\n            \"display\": \"Malignant neoplasm of parametrium\"\n          },\n          {\n            \"code\": \"C57.4\",\n            \"display\": \"Malignant neoplasm of uterine adnexa, unspecified\"\n          },\n          {\n            \"code\": \"C57.7\",\n            \"display\": \"Malignant neoplasm of other specified female genital organs\"\n          },\n          {\n            \"code\": \"C57.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of female genital organs\"\n          },\n          {\n            \"code\": \"C57.9\",\n            \"display\": \"Malignant neoplasm of female genital organ, unspecified\"\n          },\n          {\n            \"code\": \"C58\",\n            \"display\": \"Malignant neoplasm of placenta\"\n          },\n          {\n            \"code\": \"C60.0\",\n            \"display\": \"Malignant neoplasm of prepuce\"\n          },\n          {\n            \"code\": \"C60.1\",\n            \"display\": \"Malignant neoplasm of glans penis\"\n          },\n          {\n            \"code\": \"C60.2\",\n            \"display\": \"Malignant neoplasm of body of penis\"\n          },\n          {\n            \"code\": \"C60.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of penis\"\n          },\n          {\n            \"code\": \"C60.9\",\n            \"display\": \"Malignant neoplasm of penis, unspecified\"\n          },\n          {\n            \"code\": \"C61\",\n            \"display\": \"Malignant neoplasm of prostate\"\n          },\n          {\n            \"code\": \"C62.00\",\n            \"display\": \"Malignant neoplasm of unspecified undescended testis\"\n          },\n          {\n            \"code\": \"C62.01\",\n            \"display\": \"Malignant neoplasm of undescended right testis\"\n          },\n          {\n            \"code\": \"C62.02\",\n            \"display\": \"Malignant neoplasm of undescended left testis\"\n          },\n          {\n            \"code\": \"C62.10\",\n            \"display\": \"Malignant neoplasm of unspecified descended testis\"\n          },\n          {\n            \"code\": \"C62.11\",\n            \"display\": \"Malignant neoplasm of descended right testis\"\n          },\n          {\n            \"code\": \"C62.12\",\n            \"display\": \"Malignant neoplasm of descended left testis\"\n          },\n          {\n            \"code\": \"C62.90\",\n            \"display\": \"Malignant neoplasm of unspecified testis, unspecified whether descended or undescended\"\n          },\n          {\n            \"code\": \"C62.91\",\n            \"display\": \"Malignant neoplasm of right testis, unspecified whether descended or undescended\"\n          },\n          {\n            \"code\": \"C62.92\",\n            \"display\": \"Malignant neoplasm of left testis, unspecified whether descended or undescended\"\n          },\n          {\n            \"code\": \"C63.00\",\n            \"display\": \"Malignant neoplasm of unspecified epididymis\"\n          },\n          {\n            \"code\": \"C63.01\",\n            \"display\": \"Malignant neoplasm of right epididymis\"\n          },\n          {\n            \"code\": \"C63.02\",\n            \"display\": \"Malignant neoplasm of left epididymis\"\n          },\n          {\n            \"code\": \"C63.10\",\n            \"display\": \"Malignant neoplasm of unspecified spermatic cord\"\n          },\n          {\n            \"code\": \"C63.11\",\n            \"display\": \"Malignant neoplasm of right spermatic cord\"\n          },\n          {\n            \"code\": \"C63.12\",\n            \"display\": \"Malignant neoplasm of left spermatic cord\"\n          },\n          {\n            \"code\": \"C63.2\",\n            \"display\": \"Malignant neoplasm of scrotum\"\n          },\n          {\n            \"code\": \"C63.7\",\n            \"display\": \"Malignant neoplasm of other specified male genital organs\"\n          },\n          {\n            \"code\": \"C63.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of male genital organs\"\n          },\n          {\n            \"code\": \"C63.9\",\n            \"display\": \"Malignant neoplasm of male genital organ, unspecified\"\n          },\n          {\n            \"code\": \"C64.1\",\n            \"display\": \"Malignant neoplasm of right kidney, except renal pelvis\"\n          },\n          {\n            \"code\": \"C64.2\",\n            \"display\": \"Malignant neoplasm of left kidney, except renal pelvis\"\n          },\n          {\n            \"code\": \"C64.9\",\n            \"display\": \"Malignant neoplasm of unspecified kidney, except renal pelvis\"\n          },\n          {\n            \"code\": \"C65.1\",\n            \"display\": \"Malignant neoplasm of right renal pelvis\"\n          },\n          {\n            \"code\": \"C65.2\",\n            \"display\": \"Malignant neoplasm of left renal pelvis\"\n          },\n          {\n            \"code\": \"C65.9\",\n            \"display\": \"Malignant neoplasm of unspecified renal pelvis\"\n          },\n          {\n            \"code\": \"C66.1\",\n            \"display\": \"Malignant neoplasm of right ureter\"\n          },\n          {\n            \"code\": \"C66.2\",\n            \"display\": \"Malignant neoplasm of left ureter\"\n          },\n          {\n            \"code\": \"C66.9\",\n            \"display\": \"Malignant neoplasm of unspecified ureter\"\n          },\n          {\n            \"code\": \"C67.0\",\n            \"display\": \"Malignant neoplasm of trigone of bladder\"\n          },\n          {\n            \"code\": \"C67.1\",\n            \"display\": \"Malignant neoplasm of dome of bladder\"\n          },\n          {\n            \"code\": \"C67.2\",\n            \"display\": \"Malignant neoplasm of lateral wall of bladder\"\n          },\n          {\n            \"code\": \"C67.3\",\n            \"display\": \"Malignant neoplasm of anterior wall of bladder\"\n          },\n          {\n            \"code\": \"C67.4\",\n            \"display\": \"Malignant neoplasm of posterior wall of bladder\"\n          },\n          {\n            \"code\": \"C67.5\",\n            \"display\": \"Malignant neoplasm of bladder neck\"\n          },\n          {\n            \"code\": \"C67.6\",\n            \"display\": \"Malignant neoplasm of ureteric orifice\"\n          },\n          {\n            \"code\": \"C67.7\",\n            \"display\": \"Malignant neoplasm of urachus\"\n          },\n          {\n            \"code\": \"C67.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of bladder\"\n          },\n          {\n            \"code\": \"C67.9\",\n            \"display\": \"Malignant neoplasm of bladder, unspecified\"\n          },\n          {\n            \"code\": \"C68.0\",\n            \"display\": \"Malignant neoplasm of urethra\"\n          },\n          {\n            \"code\": \"C68.1\",\n            \"display\": \"Malignant neoplasm of paraurethral glands\"\n          },\n          {\n            \"code\": \"C68.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of urinary organs\"\n          },\n          {\n            \"code\": \"C68.9\",\n            \"display\": \"Malignant neoplasm of urinary organ, unspecified\"\n          },\n          {\n            \"code\": \"C69.00\",\n            \"display\": \"Malignant neoplasm of unspecified conjunctiva\"\n          },\n          {\n            \"code\": \"C69.01\",\n            \"display\": \"Malignant neoplasm of right conjunctiva\"\n          },\n          {\n            \"code\": \"C69.02\",\n            \"display\": \"Malignant neoplasm of left conjunctiva\"\n          },\n          {\n            \"code\": \"C69.10\",\n            \"display\": \"Malignant neoplasm of unspecified cornea\"\n          },\n          {\n            \"code\": \"C69.11\",\n            \"display\": \"Malignant neoplasm of right cornea\"\n          },\n          {\n            \"code\": \"C69.12\",\n            \"display\": \"Malignant neoplasm of left cornea\"\n          },\n          {\n            \"code\": \"C69.20\",\n            \"display\": \"Malignant neoplasm of unspecified retina\"\n          },\n          {\n            \"code\": \"C69.21\",\n            \"display\": \"Malignant neoplasm of right retina\"\n          },\n          {\n            \"code\": \"C69.22\",\n            \"display\": \"Malignant neoplasm of left retina\"\n          },\n          {\n            \"code\": \"C69.30\",\n            \"display\": \"Malignant neoplasm of unspecified choroid\"\n          },\n          {\n            \"code\": \"C69.31\",\n            \"display\": \"Malignant neoplasm of right choroid\"\n          },\n          {\n            \"code\": \"C69.32\",\n            \"display\": \"Malignant neoplasm of left choroid\"\n          },\n          {\n            \"code\": \"C69.40\",\n            \"display\": \"Malignant neoplasm of unspecified ciliary body\"\n          },\n          {\n            \"code\": \"C69.41\",\n            \"display\": \"Malignant neoplasm of right ciliary body\"\n          },\n          {\n            \"code\": \"C69.42\",\n            \"display\": \"Malignant neoplasm of left ciliary body\"\n          },\n          {\n            \"code\": \"C69.50\",\n            \"display\": \"Malignant neoplasm of unspecified lacrimal gland and duct\"\n          },\n          {\n            \"code\": \"C69.51\",\n            \"display\": \"Malignant neoplasm of right lacrimal gland and duct\"\n          },\n          {\n            \"code\": \"C69.52\",\n            \"display\": \"Malignant neoplasm of left lacrimal gland and duct\"\n          },\n          {\n            \"code\": \"C69.60\",\n            \"display\": \"Malignant neoplasm of unspecified orbit\"\n          },\n          {\n            \"code\": \"C69.61\",\n            \"display\": \"Malignant neoplasm of right orbit\"\n          },\n          {\n            \"code\": \"C69.62\",\n            \"display\": \"Malignant neoplasm of left orbit\"\n          },\n          {\n            \"code\": \"C69.80\",\n            \"display\": \"Malignant neoplasm of overlapping sites of unspecified eye and adnexa\"\n          },\n          {\n            \"code\": \"C69.81\",\n            \"display\": \"Malignant neoplasm of overlapping sites of right eye and adnexa\"\n          },\n          {\n            \"code\": \"C69.82\",\n            \"display\": \"Malignant neoplasm of overlapping sites of left eye and adnexa\"\n          },\n          {\n            \"code\": \"C69.90\",\n            \"display\": \"Malignant neoplasm of unspecified site of unspecified eye\"\n          },\n          {\n            \"code\": \"C69.91\",\n            \"display\": \"Malignant neoplasm of unspecified site of right eye\"\n          },\n          {\n            \"code\": \"C69.92\",\n            \"display\": \"Malignant neoplasm of unspecified site of left eye\"\n          },\n          {\n            \"code\": \"C70.0\",\n            \"display\": \"Malignant neoplasm of cerebral meninges\"\n          },\n          {\n            \"code\": \"C70.1\",\n            \"display\": \"Malignant neoplasm of spinal meninges\"\n          },\n          {\n            \"code\": \"C70.9\",\n            \"display\": \"Malignant neoplasm of meninges, unspecified\"\n          },\n          {\n            \"code\": \"C71.0\",\n            \"display\": \"Malignant neoplasm of cerebrum, except lobes and ventricles\"\n          },\n          {\n            \"code\": \"C71.1\",\n            \"display\": \"Malignant neoplasm of frontal lobe\"\n          },\n          {\n            \"code\": \"C71.2\",\n            \"display\": \"Malignant neoplasm of temporal lobe\"\n          },\n          {\n            \"code\": \"C71.3\",\n            \"display\": \"Malignant neoplasm of parietal lobe\"\n          },\n          {\n            \"code\": \"C71.4\",\n            \"display\": \"Malignant neoplasm of occipital lobe\"\n          },\n          {\n            \"code\": \"C71.5\",\n            \"display\": \"Malignant neoplasm of cerebral ventricle\"\n          },\n          {\n            \"code\": \"C71.6\",\n            \"display\": \"Malignant neoplasm of cerebellum\"\n          },\n          {\n            \"code\": \"C71.7\",\n            \"display\": \"Malignant neoplasm of brain stem\"\n          },\n          {\n            \"code\": \"C71.8\",\n            \"display\": \"Malignant neoplasm of overlapping sites of brain\"\n          },\n          {\n            \"code\": \"C71.9\",\n            \"display\": \"Malignant neoplasm of brain, unspecified\"\n          },\n          {\n            \"code\": \"C72.0\",\n            \"display\": \"Malignant neoplasm of spinal cord\"\n          },\n          {\n            \"code\": \"C72.1\",\n            \"display\": \"Malignant neoplasm of cauda equina\"\n          },\n          {\n            \"code\": \"C72.20\",\n            \"display\": \"Malignant neoplasm of unspecified olfactory nerve\"\n          },\n          {\n            \"code\": \"C72.21\",\n            \"display\": \"Malignant neoplasm of right olfactory nerve\"\n          },\n          {\n            \"code\": \"C72.22\",\n            \"display\": \"Malignant neoplasm of left olfactory nerve\"\n          },\n          {\n            \"code\": \"C72.30\",\n            \"display\": \"Malignant neoplasm of unspecified optic nerve\"\n          },\n          {\n            \"code\": \"C72.31\",\n            \"display\": \"Malignant neoplasm of right optic nerve\"\n          },\n          {\n            \"code\": \"C72.32\",\n            \"display\": \"Malignant neoplasm of left optic nerve\"\n          },\n          {\n            \"code\": \"C72.40\",\n            \"display\": \"Malignant neoplasm of unspecified acoustic nerve\"\n          },\n          {\n            \"code\": \"C72.41\",\n            \"display\": \"Malignant neoplasm of right acoustic nerve\"\n          },\n          {\n            \"code\": \"C72.42\",\n            \"display\": \"Malignant neoplasm of left acoustic nerve\"\n          },\n          {\n            \"code\": \"C72.50\",\n            \"display\": \"Malignant neoplasm of unspecified cranial nerve\"\n          },\n          {\n            \"code\": \"C72.59\",\n            \"display\": \"Malignant neoplasm of other cranial nerves\"\n          },\n          {\n            \"code\": \"C72.9\",\n            \"display\": \"Malignant neoplasm of central nervous system, unspecified\"\n          },\n          {\n            \"code\": \"C73\",\n            \"display\": \"Malignant neoplasm of thyroid gland\"\n          },\n          {\n            \"code\": \"C74.00\",\n            \"display\": \"Malignant neoplasm of cortex of unspecified adrenal gland\"\n          },\n          {\n            \"code\": \"C74.01\",\n            \"display\": \"Malignant neoplasm of cortex of right adrenal gland\"\n          },\n          {\n            \"code\": \"C74.02\",\n            \"display\": \"Malignant neoplasm of cortex of left adrenal gland\"\n          },\n          {\n            \"code\": \"C74.10\",\n            \"display\": \"Malignant neoplasm of medulla of unspecified adrenal gland\"\n          },\n          {\n            \"code\": \"C74.11\",\n            \"display\": \"Malignant neoplasm of medulla of right adrenal gland\"\n          },\n          {\n            \"code\": \"C74.12\",\n            \"display\": \"Malignant neoplasm of medulla of left adrenal gland\"\n          },\n          {\n            \"code\": \"C74.90\",\n            \"display\": \"Malignant neoplasm of unspecified part of unspecified adrenal gland\"\n          },\n          {\n            \"code\": \"C74.91\",\n            \"display\": \"Malignant neoplasm of unspecified part of right adrenal gland\"\n          },\n          {\n            \"code\": \"C74.92\",\n            \"display\": \"Malignant neoplasm of unspecified part of left adrenal gland\"\n          },\n          {\n            \"code\": \"C75.0\",\n            \"display\": \"Malignant neoplasm of parathyroid gland\"\n          },\n          {\n            \"code\": \"C75.1\",\n            \"display\": \"Malignant neoplasm of pituitary gland\"\n          },\n          {\n            \"code\": \"C75.2\",\n            \"display\": \"Malignant neoplasm of craniopharyngeal duct\"\n          },\n          {\n            \"code\": \"C75.3\",\n            \"display\": \"Malignant neoplasm of pineal gland\"\n          },\n          {\n            \"code\": \"C75.4\",\n            \"display\": \"Malignant neoplasm of carotid body\"\n          },\n          {\n            \"code\": \"C75.5\",\n            \"display\": \"Malignant neoplasm of aortic body and other paraganglia\"\n          },\n          {\n            \"code\": \"C75.8\",\n            \"display\": \"Malignant neoplasm with pluriglandular involvement, unspecified\"\n          },\n          {\n            \"code\": \"C75.9\",\n            \"display\": \"Malignant neoplasm of endocrine gland, unspecified\"\n          },\n          {\n            \"code\": \"C76.0\",\n            \"display\": \"Malignant neoplasm of head, face and neck\"\n          },\n          {\n            \"code\": \"C76.1\",\n            \"display\": \"Malignant neoplasm of thorax\"\n          },\n          {\n            \"code\": \"C76.2\",\n            \"display\": \"Malignant neoplasm of abdomen\"\n          },\n          {\n            \"code\": \"C76.3\",\n            \"display\": \"Malignant neoplasm of pelvis\"\n          },\n          {\n            \"code\": \"C76.40\",\n            \"display\": \"Malignant neoplasm of unspecified upper limb\"\n          },\n          {\n            \"code\": \"C76.41\",\n            \"display\": \"Malignant neoplasm of right upper limb\"\n          },\n          {\n            \"code\": \"C76.42\",\n            \"display\": \"Malignant neoplasm of left upper limb\"\n          },\n          {\n            \"code\": \"C76.50\",\n            \"display\": \"Malignant neoplasm of unspecified lower limb\"\n          },\n          {\n            \"code\": \"C76.51\",\n            \"display\": \"Malignant neoplasm of right lower limb\"\n          },\n          {\n            \"code\": \"C76.52\",\n            \"display\": \"Malignant neoplasm of left lower limb\"\n          },\n          {\n            \"code\": \"C76.8\",\n            \"display\": \"Malignant neoplasm of other specified ill-defined sites\"\n          },\n          {\n            \"code\": \"C77.0\",\n            \"display\": \"Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck\"\n          },\n          {\n            \"code\": \"C77.1\",\n            \"display\": \"Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C77.2\",\n            \"display\": \"Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C77.3\",\n            \"display\": \"Secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes\"\n          },\n          {\n            \"code\": \"C77.4\",\n            \"display\": \"Secondary and unspecified malignant neoplasm of inguinal and lower limb lymph nodes\"\n          },\n          {\n            \"code\": \"C77.5\",\n            \"display\": \"Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C77.8\",\n            \"display\": \"Secondary and unspecified malignant neoplasm of lymph nodes of multiple regions\"\n          },\n          {\n            \"code\": \"C77.9\",\n            \"display\": \"Secondary and unspecified malignant neoplasm of lymph node, unspecified\"\n          },\n          {\n            \"code\": \"C78.00\",\n            \"display\": \"Secondary malignant neoplasm of unspecified lung\"\n          },\n          {\n            \"code\": \"C78.01\",\n            \"display\": \"Secondary malignant neoplasm of right lung\"\n          },\n          {\n            \"code\": \"C78.02\",\n            \"display\": \"Secondary malignant neoplasm of left lung\"\n          },\n          {\n            \"code\": \"C78.1\",\n            \"display\": \"Secondary malignant neoplasm of mediastinum\"\n          },\n          {\n            \"code\": \"C78.2\",\n            \"display\": \"Secondary malignant neoplasm of pleura\"\n          },\n          {\n            \"code\": \"C78.30\",\n            \"display\": \"Secondary malignant neoplasm of unspecified respiratory organ\"\n          },\n          {\n            \"code\": \"C78.39\",\n            \"display\": \"Secondary malignant neoplasm of other respiratory organs\"\n          },\n          {\n            \"code\": \"C78.4\",\n            \"display\": \"Secondary malignant neoplasm of small intestine\"\n          },\n          {\n            \"code\": \"C78.5\",\n            \"display\": \"Secondary malignant neoplasm of large intestine and rectum\"\n          },\n          {\n            \"code\": \"C78.6\",\n            \"display\": \"Secondary malignant neoplasm of retroperitoneum and peritoneum\"\n          },\n          {\n            \"code\": \"C78.7\",\n            \"display\": \"Secondary malignant neoplasm of liver and intrahepatic bile duct\"\n          },\n          {\n            \"code\": \"C78.80\",\n            \"display\": \"Secondary malignant neoplasm of unspecified digestive organ\"\n          },\n          {\n            \"code\": \"C78.89\",\n            \"display\": \"Secondary malignant neoplasm of other digestive organs\"\n          },\n          {\n            \"code\": \"C79.00\",\n            \"display\": \"Secondary malignant neoplasm of unspecified kidney and renal pelvis\"\n          },\n          {\n            \"code\": \"C79.01\",\n            \"display\": \"Secondary malignant neoplasm of right kidney and renal pelvis\"\n          },\n          {\n            \"code\": \"C79.02\",\n            \"display\": \"Secondary malignant neoplasm of left kidney and renal pelvis\"\n          },\n          {\n            \"code\": \"C79.10\",\n            \"display\": \"Secondary malignant neoplasm of unspecified urinary organs\"\n          },\n          {\n            \"code\": \"C79.11\",\n            \"display\": \"Secondary malignant neoplasm of bladder\"\n          },\n          {\n            \"code\": \"C79.19\",\n            \"display\": \"Secondary malignant neoplasm of other urinary organs\"\n          },\n          {\n            \"code\": \"C79.2\",\n            \"display\": \"Secondary malignant neoplasm of skin\"\n          },\n          {\n            \"code\": \"C79.31\",\n            \"display\": \"Secondary malignant neoplasm of brain\"\n          },\n          {\n            \"code\": \"C79.32\",\n            \"display\": \"Secondary malignant neoplasm of cerebral meninges\"\n          },\n          {\n            \"code\": \"C79.40\",\n            \"display\": \"Secondary malignant neoplasm of unspecified part of nervous system\"\n          },\n          {\n            \"code\": \"C79.49\",\n            \"display\": \"Secondary malignant neoplasm of other parts of nervous system\"\n          },\n          {\n            \"code\": \"C79.51\",\n            \"display\": \"Secondary malignant neoplasm of bone\"\n          },\n          {\n            \"code\": \"C79.52\",\n            \"display\": \"Secondary malignant neoplasm of bone marrow\"\n          },\n          {\n            \"code\": \"C79.60\",\n            \"display\": \"Secondary malignant neoplasm of unspecified ovary\"\n          },\n          {\n            \"code\": \"C79.61\",\n            \"display\": \"Secondary malignant neoplasm of right ovary\"\n          },\n          {\n            \"code\": \"C79.62\",\n            \"display\": \"Secondary malignant neoplasm of left ovary\"\n          },\n          {\n            \"code\": \"C79.70\",\n            \"display\": \"Secondary malignant neoplasm of unspecified adrenal gland\"\n          },\n          {\n            \"code\": \"C79.71\",\n            \"display\": \"Secondary malignant neoplasm of right adrenal gland\"\n          },\n          {\n            \"code\": \"C79.72\",\n            \"display\": \"Secondary malignant neoplasm of left adrenal gland\"\n          },\n          {\n            \"code\": \"C79.81\",\n            \"display\": \"Secondary malignant neoplasm of breast\"\n          },\n          {\n            \"code\": \"C79.82\",\n            \"display\": \"Secondary malignant neoplasm of genital organs\"\n          },\n          {\n            \"code\": \"C79.89\",\n            \"display\": \"Secondary malignant neoplasm of other specified sites\"\n          },\n          {\n            \"code\": \"C79.9\",\n            \"display\": \"Secondary malignant neoplasm of unspecified site\"\n          },\n          {\n            \"code\": \"C7A.00\",\n            \"display\": \"Malignant carcinoid tumor of unspecified site\"\n          },\n          {\n            \"code\": \"C7A.010\",\n            \"display\": \"Malignant carcinoid tumor of the duodenum\"\n          },\n          {\n            \"code\": \"C7A.011\",\n            \"display\": \"Malignant carcinoid tumor of the jejunum\"\n          },\n          {\n            \"code\": \"C7A.012\",\n            \"display\": \"Malignant carcinoid tumor of the ileum\"\n          },\n          {\n            \"code\": \"C7A.019\",\n            \"display\": \"Malignant carcinoid tumor of the small intestine, unspecified portion\"\n          },\n          {\n            \"code\": \"C7A.020\",\n            \"display\": \"Malignant carcinoid tumor of the appendix\"\n          },\n          {\n            \"code\": \"C7A.021\",\n            \"display\": \"Malignant carcinoid tumor of the cecum\"\n          },\n          {\n            \"code\": \"C7A.022\",\n            \"display\": \"Malignant carcinoid tumor of the ascending colon\"\n          },\n          {\n            \"code\": \"C7A.023\",\n            \"display\": \"Malignant carcinoid tumor of the transverse colon\"\n          },\n          {\n            \"code\": \"C7A.024\",\n            \"display\": \"Malignant carcinoid tumor of the descending colon\"\n          },\n          {\n            \"code\": \"C7A.025\",\n            \"display\": \"Malignant carcinoid tumor of the sigmoid colon\"\n          },\n          {\n            \"code\": \"C7A.026\",\n            \"display\": \"Malignant carcinoid tumor of the rectum\"\n          },\n          {\n            \"code\": \"C7A.029\",\n            \"display\": \"Malignant carcinoid tumor of the large intestine, unspecified portion\"\n          },\n          {\n            \"code\": \"C7A.090\",\n            \"display\": \"Malignant carcinoid tumor of the bronchus and lung\"\n          },\n          {\n            \"code\": \"C7A.091\",\n            \"display\": \"Malignant carcinoid tumor of the thymus\"\n          },\n          {\n            \"code\": \"C7A.092\",\n            \"display\": \"Malignant carcinoid tumor of the stomach\"\n          },\n          {\n            \"code\": \"C7A.093\",\n            \"display\": \"Malignant carcinoid tumor of the kidney\"\n          },\n          {\n            \"code\": \"C7A.094\",\n            \"display\": \"Malignant carcinoid tumor of the foregut, unspecified\"\n          },\n          {\n            \"code\": \"C7A.095\",\n            \"display\": \"Malignant carcinoid tumor of the midgut, unspecified\"\n          },\n          {\n            \"code\": \"C7A.096\",\n            \"display\": \"Malignant carcinoid tumor of the hindgut, unspecified\"\n          },\n          {\n            \"code\": \"C7A.098\",\n            \"display\": \"Malignant carcinoid tumors of other sites\"\n          },\n          {\n            \"code\": \"C7A.1\",\n            \"display\": \"Malignant poorly differentiated neuroendocrine tumors\"\n          },\n          {\n            \"code\": \"C7A.8\",\n            \"display\": \"Other malignant neuroendocrine tumors\"\n          },\n          {\n            \"code\": \"C7B.00\",\n            \"display\": \"Secondary carcinoid tumors, unspecified site\"\n          },\n          {\n            \"code\": \"C7B.01\",\n            \"display\": \"Secondary carcinoid tumors of distant lymph nodes\"\n          },\n          {\n            \"code\": \"C7B.02\",\n            \"display\": \"Secondary carcinoid tumors of liver\"\n          },\n          {\n            \"code\": \"C7B.03\",\n            \"display\": \"Secondary carcinoid tumors of bone\"\n          },\n          {\n            \"code\": \"C7B.04\",\n            \"display\": \"Secondary carcinoid tumors of peritoneum\"\n          },\n          {\n            \"code\": \"C7B.09\",\n            \"display\": \"Secondary carcinoid tumors of other sites\"\n          },\n          {\n            \"code\": \"C7B.1\",\n            \"display\": \"Secondary Merkel cell carcinoma\"\n          },\n          {\n            \"code\": \"C7B.8\",\n            \"display\": \"Other secondary neuroendocrine tumors\"\n          },\n          {\n            \"code\": \"C80.0\",\n            \"display\": \"Disseminated malignant neoplasm, unspecified\"\n          },\n          {\n            \"code\": \"C80.1\",\n            \"display\": \"Malignant (primary) neoplasm, unspecified\"\n          },\n          {\n            \"code\": \"C80.2\",\n            \"display\": \"Malignant neoplasm associated with transplanted organ\"\n          },\n          {\n            \"code\": \"C81.00\",\n            \"display\": \"Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site\"\n          },\n          {\n            \"code\": \"C81.01\",\n            \"display\": \"Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C81.02\",\n            \"display\": \"Nodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C81.03\",\n            \"display\": \"Nodular lymphocyte predominant Hodgkin lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C81.04\",\n            \"display\": \"Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C81.05\",\n            \"display\": \"Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C81.06\",\n            \"display\": \"Nodular lymphocyte predominant Hodgkin lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C81.07\",\n            \"display\": \"Nodular lymphocyte predominant Hodgkin lymphoma, spleen\"\n          },\n          {\n            \"code\": \"C81.08\",\n            \"display\": \"Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C81.09\",\n            \"display\": \"Nodular lymphocyte predominant Hodgkin lymphoma, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C81.10\",\n            \"display\": \"Nodular sclerosis Hodgkin lymphoma, unspecified site\"\n          },\n          {\n            \"code\": \"C81.11\",\n            \"display\": \"Nodular sclerosis Hodgkin lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C81.12\",\n            \"display\": \"Nodular sclerosis Hodgkin lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C81.13\",\n            \"display\": \"Nodular sclerosis Hodgkin lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C81.14\",\n            \"display\": \"Nodular sclerosis Hodgkin lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C81.15\",\n            \"display\": \"Nodular sclerosis Hodgkin lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C81.16\",\n            \"display\": \"Nodular sclerosis Hodgkin lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C81.17\",\n            \"display\": \"Nodular sclerosis Hodgkin lymphoma, spleen\"\n          },\n          {\n            \"code\": \"C81.18\",\n            \"display\": \"Nodular sclerosis Hodgkin lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C81.19\",\n            \"display\": \"Nodular sclerosis Hodgkin lymphoma, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C81.20\",\n            \"display\": \"Mixed cellularity Hodgkin lymphoma, unspecified site\"\n          },\n          {\n            \"code\": \"C81.21\",\n            \"display\": \"Mixed cellularity Hodgkin lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C81.22\",\n            \"display\": \"Mixed cellularity Hodgkin lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C81.23\",\n            \"display\": \"Mixed cellularity Hodgkin lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C81.24\",\n            \"display\": \"Mixed cellularity Hodgkin lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C81.25\",\n            \"display\": \"Mixed cellularity Hodgkin lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C81.26\",\n            \"display\": \"Mixed cellularity Hodgkin lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C81.27\",\n            \"display\": \"Mixed cellularity Hodgkin lymphoma, spleen\"\n          },\n          {\n            \"code\": \"C81.28\",\n            \"display\": \"Mixed cellularity Hodgkin lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C81.29\",\n            \"display\": \"Mixed cellularity Hodgkin lymphoma, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C81.30\",\n            \"display\": \"Lymphocyte depleted Hodgkin lymphoma, unspecified site\"\n          },\n          {\n            \"code\": \"C81.31\",\n            \"display\": \"Lymphocyte depleted Hodgkin lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C81.32\",\n            \"display\": \"Lymphocyte depleted Hodgkin lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C81.33\",\n            \"display\": \"Lymphocyte depleted Hodgkin lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C81.34\",\n            \"display\": \"Lymphocyte depleted Hodgkin lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C81.35\",\n            \"display\": \"Lymphocyte depleted Hodgkin lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C81.36\",\n            \"display\": \"Lymphocyte depleted Hodgkin lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C81.37\",\n            \"display\": \"Lymphocyte depleted Hodgkin lymphoma, spleen\"\n          },\n          {\n            \"code\": \"C81.38\",\n            \"display\": \"Lymphocyte depleted Hodgkin lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C81.39\",\n            \"display\": \"Lymphocyte depleted Hodgkin lymphoma, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C81.40\",\n            \"display\": \"Lymphocyte-rich Hodgkin lymphoma, unspecified site\"\n          },\n          {\n            \"code\": \"C81.41\",\n            \"display\": \"Lymphocyte-rich Hodgkin lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C81.42\",\n            \"display\": \"Lymphocyte-rich Hodgkin lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C81.43\",\n            \"display\": \"Lymphocyte-rich Hodgkin lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C81.44\",\n            \"display\": \"Lymphocyte-rich Hodgkin lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C81.45\",\n            \"display\": \"Lymphocyte-rich Hodgkin lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C81.46\",\n            \"display\": \"Lymphocyte-rich Hodgkin lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C81.47\",\n            \"display\": \"Lymphocyte-rich Hodgkin lymphoma, spleen\"\n          },\n          {\n            \"code\": \"C81.48\",\n            \"display\": \"Lymphocyte-rich Hodgkin lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C81.49\",\n            \"display\": \"Lymphocyte-rich Hodgkin lymphoma, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C81.70\",\n            \"display\": \"Other Hodgkin lymphoma, unspecified site\"\n          },\n          {\n            \"code\": \"C81.71\",\n            \"display\": \"Other Hodgkin lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C81.72\",\n            \"display\": \"Other Hodgkin lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C81.73\",\n            \"display\": \"Other Hodgkin lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C81.74\",\n            \"display\": \"Other Hodgkin lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C81.75\",\n            \"display\": \"Other Hodgkin lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C81.76\",\n            \"display\": \"Other Hodgkin lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C81.77\",\n            \"display\": \"Other Hodgkin lymphoma, spleen\"\n          },\n          {\n            \"code\": \"C81.78\",\n            \"display\": \"Other Hodgkin lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C81.79\",\n            \"display\": \"Other Hodgkin lymphoma, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C81.90\",\n            \"display\": \"Hodgkin lymphoma, unspecified, unspecified site\"\n          },\n          {\n            \"code\": \"C81.91\",\n            \"display\": \"Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C81.92\",\n            \"display\": \"Hodgkin lymphoma, unspecified, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C81.93\",\n            \"display\": \"Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C81.94\",\n            \"display\": \"Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C81.95\",\n            \"display\": \"Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C81.96\",\n            \"display\": \"Hodgkin lymphoma, unspecified, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C81.97\",\n            \"display\": \"Hodgkin lymphoma, unspecified, spleen\"\n          },\n          {\n            \"code\": \"C81.98\",\n            \"display\": \"Hodgkin lymphoma, unspecified, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C81.99\",\n            \"display\": \"Hodgkin lymphoma, unspecified, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C82.00\",\n            \"display\": \"Follicular lymphoma grade I, unspecified site\"\n          },\n          {\n            \"code\": \"C82.01\",\n            \"display\": \"Follicular lymphoma grade I, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C82.02\",\n            \"display\": \"Follicular lymphoma grade I, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C82.03\",\n            \"display\": \"Follicular lymphoma grade I, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C82.04\",\n            \"display\": \"Follicular lymphoma grade I, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C82.05\",\n            \"display\": \"Follicular lymphoma grade I, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C82.06\",\n            \"display\": \"Follicular lymphoma grade I, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C82.07\",\n            \"display\": \"Follicular lymphoma grade I, spleen\"\n          },\n          {\n            \"code\": \"C82.08\",\n            \"display\": \"Follicular lymphoma grade I, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C82.09\",\n            \"display\": \"Follicular lymphoma grade I, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C82.10\",\n            \"display\": \"Follicular lymphoma grade II, unspecified site\"\n          },\n          {\n            \"code\": \"C82.11\",\n            \"display\": \"Follicular lymphoma grade II, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C82.12\",\n            \"display\": \"Follicular lymphoma grade II, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C82.13\",\n            \"display\": \"Follicular lymphoma grade II, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C82.14\",\n            \"display\": \"Follicular lymphoma grade II, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C82.15\",\n            \"display\": \"Follicular lymphoma grade II, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C82.16\",\n            \"display\": \"Follicular lymphoma grade II, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C82.17\",\n            \"display\": \"Follicular lymphoma grade II, spleen\"\n          },\n          {\n            \"code\": \"C82.18\",\n            \"display\": \"Follicular lymphoma grade II, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C82.19\",\n            \"display\": \"Follicular lymphoma grade II, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C82.20\",\n            \"display\": \"Follicular lymphoma grade III, unspecified, unspecified site\"\n          },\n          {\n            \"code\": \"C82.21\",\n            \"display\": \"Follicular lymphoma grade III, unspecified, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C82.22\",\n            \"display\": \"Follicular lymphoma grade III, unspecified, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C82.23\",\n            \"display\": \"Follicular lymphoma grade III, unspecified, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C82.24\",\n            \"display\": \"Follicular lymphoma grade III, unspecified, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C82.25\",\n            \"display\": \"Follicular lymphoma grade III, unspecified, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C82.26\",\n            \"display\": \"Follicular lymphoma grade III, unspecified, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C82.27\",\n            \"display\": \"Follicular lymphoma grade III, unspecified, spleen\"\n          },\n          {\n            \"code\": \"C82.28\",\n            \"display\": \"Follicular lymphoma grade III, unspecified, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C82.29\",\n            \"display\": \"Follicular lymphoma grade III, unspecified, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C82.30\",\n            \"display\": \"Follicular lymphoma grade IIIa, unspecified site\"\n          },\n          {\n            \"code\": \"C82.31\",\n            \"display\": \"Follicular lymphoma grade IIIa, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C82.32\",\n            \"display\": \"Follicular lymphoma grade IIIa, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C82.33\",\n            \"display\": \"Follicular lymphoma grade IIIa, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C82.34\",\n            \"display\": \"Follicular lymphoma grade IIIa, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C82.35\",\n            \"display\": \"Follicular lymphoma grade IIIa, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C82.36\",\n            \"display\": \"Follicular lymphoma grade IIIa, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C82.37\",\n            \"display\": \"Follicular lymphoma grade IIIa, spleen\"\n          },\n          {\n            \"code\": \"C82.38\",\n            \"display\": \"Follicular lymphoma grade IIIa, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C82.39\",\n            \"display\": \"Follicular lymphoma grade IIIa, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C82.40\",\n            \"display\": \"Follicular lymphoma grade IIIb, unspecified site\"\n          },\n          {\n            \"code\": \"C82.41\",\n            \"display\": \"Follicular lymphoma grade IIIb, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C82.42\",\n            \"display\": \"Follicular lymphoma grade IIIb, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C82.43\",\n            \"display\": \"Follicular lymphoma grade IIIb, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C82.44\",\n            \"display\": \"Follicular lymphoma grade IIIb, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C82.45\",\n            \"display\": \"Follicular lymphoma grade IIIb, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C82.46\",\n            \"display\": \"Follicular lymphoma grade IIIb, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C82.47\",\n            \"display\": \"Follicular lymphoma grade IIIb, spleen\"\n          },\n          {\n            \"code\": \"C82.48\",\n            \"display\": \"Follicular lymphoma grade IIIb, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C82.49\",\n            \"display\": \"Follicular lymphoma grade IIIb, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C82.50\",\n            \"display\": \"Diffuse follicle center lymphoma, unspecified site\"\n          },\n          {\n            \"code\": \"C82.51\",\n            \"display\": \"Diffuse follicle center lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C82.52\",\n            \"display\": \"Diffuse follicle center lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C82.53\",\n            \"display\": \"Diffuse follicle center lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C82.54\",\n            \"display\": \"Diffuse follicle center lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C82.55\",\n            \"display\": \"Diffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C82.56\",\n            \"display\": \"Diffuse follicle center lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C82.57\",\n            \"display\": \"Diffuse follicle center lymphoma, spleen\"\n          },\n          {\n            \"code\": \"C82.58\",\n            \"display\": \"Diffuse follicle center lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C82.59\",\n            \"display\": \"Diffuse follicle center lymphoma, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C82.60\",\n            \"display\": \"Cutaneous follicle center lymphoma, unspecified site\"\n          },\n          {\n            \"code\": \"C82.61\",\n            \"display\": \"Cutaneous follicle center lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C82.62\",\n            \"display\": \"Cutaneous follicle center lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C82.63\",\n            \"display\": \"Cutaneous follicle center lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C82.64\",\n            \"display\": \"Cutaneous follicle center lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C82.65\",\n            \"display\": \"Cutaneous follicle center lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C82.66\",\n            \"display\": \"Cutaneous follicle center lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C82.67\",\n            \"display\": \"Cutaneous follicle center lymphoma, spleen\"\n          },\n          {\n            \"code\": \"C82.68\",\n            \"display\": \"Cutaneous follicle center lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C82.69\",\n            \"display\": \"Cutaneous follicle center lymphoma, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C82.80\",\n            \"display\": \"Other types of follicular lymphoma, unspecified site\"\n          },\n          {\n            \"code\": \"C82.81\",\n            \"display\": \"Other types of follicular lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C82.82\",\n            \"display\": \"Other types of follicular lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C82.83\",\n            \"display\": \"Other types of follicular lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C82.84\",\n            \"display\": \"Other types of follicular lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C82.85\",\n            \"display\": \"Other types of follicular lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C82.86\",\n            \"display\": \"Other types of follicular lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C82.87\",\n            \"display\": \"Other types of follicular lymphoma, spleen\"\n          },\n          {\n            \"code\": \"C82.88\",\n            \"display\": \"Other types of follicular lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C82.89\",\n            \"display\": \"Other types of follicular lymphoma, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C82.90\",\n            \"display\": \"Follicular lymphoma, unspecified, unspecified site\"\n          },\n          {\n            \"code\": \"C82.91\",\n            \"display\": \"Follicular lymphoma, unspecified, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C82.92\",\n            \"display\": \"Follicular lymphoma, unspecified, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C82.93\",\n            \"display\": \"Follicular lymphoma, unspecified, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C82.94\",\n            \"display\": \"Follicular lymphoma, unspecified, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C82.95\",\n            \"display\": \"Follicular lymphoma, unspecified, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C82.96\",\n            \"display\": \"Follicular lymphoma, unspecified, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C82.97\",\n            \"display\": \"Follicular lymphoma, unspecified, spleen\"\n          },\n          {\n            \"code\": \"C82.98\",\n            \"display\": \"Follicular lymphoma, unspecified, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C82.99\",\n            \"display\": \"Follicular lymphoma, unspecified, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C83.00\",\n            \"display\": \"Small cell B-cell lymphoma, unspecified site\"\n          },\n          {\n            \"code\": \"C83.01\",\n            \"display\": \"Small cell B-cell lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C83.02\",\n            \"display\": \"Small cell B-cell lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C83.03\",\n            \"display\": \"Small cell B-cell lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C83.04\",\n            \"display\": \"Small cell B-cell lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C83.05\",\n            \"display\": \"Small cell B-cell lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C83.06\",\n            \"display\": \"Small cell B-cell lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C83.07\",\n            \"display\": \"Small cell B-cell lymphoma, spleen\"\n          },\n          {\n            \"code\": \"C83.08\",\n            \"display\": \"Small cell B-cell lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C83.09\",\n            \"display\": \"Small cell B-cell lymphoma, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C83.10\",\n            \"display\": \"Mantle cell lymphoma, unspecified site\"\n          },\n          {\n            \"code\": \"C83.11\",\n            \"display\": \"Mantle cell lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C83.12\",\n            \"display\": \"Mantle cell lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C83.13\",\n            \"display\": \"Mantle cell lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C83.14\",\n            \"display\": \"Mantle cell lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C83.15\",\n            \"display\": \"Mantle cell lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C83.16\",\n            \"display\": \"Mantle cell lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C83.17\",\n            \"display\": \"Mantle cell lymphoma, spleen\"\n          },\n          {\n            \"code\": \"C83.18\",\n            \"display\": \"Mantle cell lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C83.19\",\n            \"display\": \"Mantle cell lymphoma, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C83.30\",\n            \"display\": \"Diffuse large B-cell lymphoma, unspecified site\"\n          },\n          {\n            \"code\": \"C83.31\",\n            \"display\": \"Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C83.32\",\n            \"display\": \"Diffuse large B-cell lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C83.33\",\n            \"display\": \"Diffuse large B-cell lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C83.34\",\n            \"display\": \"Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C83.35\",\n            \"display\": \"Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C83.36\",\n            \"display\": \"Diffuse large B-cell lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C83.37\",\n            \"display\": \"Diffuse large B-cell lymphoma, spleen\"\n          },\n          {\n            \"code\": \"C83.38\",\n            \"display\": \"Diffuse large B-cell lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C83.39\",\n            \"display\": \"Diffuse large B-cell lymphoma, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C83.50\",\n            \"display\": \"Lymphoblastic (diffuse) lymphoma, unspecified site\"\n          },\n          {\n            \"code\": \"C83.51\",\n            \"display\": \"Lymphoblastic (diffuse) lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C83.52\",\n            \"display\": \"Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C83.53\",\n            \"display\": \"Lymphoblastic (diffuse) lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C83.54\",\n            \"display\": \"Lymphoblastic (diffuse) lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C83.55\",\n            \"display\": \"Lymphoblastic (diffuse) lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C83.56\",\n            \"display\": \"Lymphoblastic (diffuse) lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C83.57\",\n            \"display\": \"Lymphoblastic (diffuse) lymphoma, spleen\"\n          },\n          {\n            \"code\": \"C83.58\",\n            \"display\": \"Lymphoblastic (diffuse) lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C83.59\",\n            \"display\": \"Lymphoblastic (diffuse) lymphoma, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C83.70\",\n            \"display\": \"Burkitt lymphoma, unspecified site\"\n          },\n          {\n            \"code\": \"C83.71\",\n            \"display\": \"Burkitt lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C83.72\",\n            \"display\": \"Burkitt lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C83.73\",\n            \"display\": \"Burkitt lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C83.74\",\n            \"display\": \"Burkitt lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C83.75\",\n            \"display\": \"Burkitt lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C83.76\",\n            \"display\": \"Burkitt lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C83.77\",\n            \"display\": \"Burkitt lymphoma, spleen\"\n          },\n          {\n            \"code\": \"C83.78\",\n            \"display\": \"Burkitt lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C83.79\",\n            \"display\": \"Burkitt lymphoma, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C83.80\",\n            \"display\": \"Other non-follicular lymphoma, unspecified site\"\n          },\n          {\n            \"code\": \"C83.81\",\n            \"display\": \"Other non-follicular lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C83.82\",\n            \"display\": \"Other non-follicular lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C83.83\",\n            \"display\": \"Other non-follicular lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C83.84\",\n            \"display\": \"Other non-follicular lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C83.85\",\n            \"display\": \"Other non-follicular lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C83.86\",\n            \"display\": \"Other non-follicular lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C83.87\",\n            \"display\": \"Other non-follicular lymphoma, spleen\"\n          },\n          {\n            \"code\": \"C83.88\",\n            \"display\": \"Other non-follicular lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C83.89\",\n            \"display\": \"Other non-follicular lymphoma, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C83.90\",\n            \"display\": \"Non-follicular (diffuse) lymphoma, unspecified, unspecified site\"\n          },\n          {\n            \"code\": \"C83.91\",\n            \"display\": \"Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C83.92\",\n            \"display\": \"Non-follicular (diffuse) lymphoma, unspecified, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C83.93\",\n            \"display\": \"Non-follicular (diffuse) lymphoma, unspecified, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C83.94\",\n            \"display\": \"Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C83.95\",\n            \"display\": \"Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C83.96\",\n            \"display\": \"Non-follicular (diffuse) lymphoma, unspecified, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C83.97\",\n            \"display\": \"Non-follicular (diffuse) lymphoma, unspecified, spleen\"\n          },\n          {\n            \"code\": \"C83.98\",\n            \"display\": \"Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C83.99\",\n            \"display\": \"Non-follicular (diffuse) lymphoma, unspecified, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C84.00\",\n            \"display\": \"Mycosis fungoides, unspecified site\"\n          },\n          {\n            \"code\": \"C84.01\",\n            \"display\": \"Mycosis fungoides, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C84.02\",\n            \"display\": \"Mycosis fungoides, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C84.03\",\n            \"display\": \"Mycosis fungoides, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C84.04\",\n            \"display\": \"Mycosis fungoides, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C84.05\",\n            \"display\": \"Mycosis fungoides, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C84.06\",\n            \"display\": \"Mycosis fungoides, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C84.07\",\n            \"display\": \"Mycosis fungoides, spleen\"\n          },\n          {\n            \"code\": \"C84.08\",\n            \"display\": \"Mycosis fungoides, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C84.09\",\n            \"display\": \"Mycosis fungoides, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C84.10\",\n            \"display\": \"Sézary disease, unspecified site\"\n          },\n          {\n            \"code\": \"C84.11\",\n            \"display\": \"Sézary disease, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C84.12\",\n            \"display\": \"Sézary disease, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C84.13\",\n            \"display\": \"Sézary disease, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C84.14\",\n            \"display\": \"Sézary disease, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C84.15\",\n            \"display\": \"Sézary disease, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C84.16\",\n            \"display\": \"Sézary disease, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C84.17\",\n            \"display\": \"Sézary disease, spleen\"\n          },\n          {\n            \"code\": \"C84.18\",\n            \"display\": \"Sézary disease, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C84.19\",\n            \"display\": \"Sézary disease, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C84.40\",\n            \"display\": \"Peripheral T-cell lymphoma, not classified, unspecified site\"\n          },\n          {\n            \"code\": \"C84.41\",\n            \"display\": \"Peripheral T-cell lymphoma, not classified, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C84.42\",\n            \"display\": \"Peripheral T-cell lymphoma, not classified, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C84.43\",\n            \"display\": \"Peripheral T-cell lymphoma, not classified, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C84.44\",\n            \"display\": \"Peripheral T-cell lymphoma, not classified, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C84.45\",\n            \"display\": \"Peripheral T-cell lymphoma, not classified, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C84.46\",\n            \"display\": \"Peripheral T-cell lymphoma, not classified, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C84.47\",\n            \"display\": \"Peripheral T-cell lymphoma, not classified, spleen\"\n          },\n          {\n            \"code\": \"C84.48\",\n            \"display\": \"Peripheral T-cell lymphoma, not classified, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C84.49\",\n            \"display\": \"Peripheral T-cell lymphoma, not classified, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C84.60\",\n            \"display\": \"Anaplastic large cell lymphoma, ALK-positive, unspecified site\"\n          },\n          {\n            \"code\": \"C84.61\",\n            \"display\": \"Anaplastic large cell lymphoma, ALK-positive, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C84.62\",\n            \"display\": \"Anaplastic large cell lymphoma, ALK-positive, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C84.63\",\n            \"display\": \"Anaplastic large cell lymphoma, ALK-positive, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C84.64\",\n            \"display\": \"Anaplastic large cell lymphoma, ALK-positive, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C84.65\",\n            \"display\": \"Anaplastic large cell lymphoma, ALK-positive, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C84.66\",\n            \"display\": \"Anaplastic large cell lymphoma, ALK-positive, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C84.67\",\n            \"display\": \"Anaplastic large cell lymphoma, ALK-positive, spleen\"\n          },\n          {\n            \"code\": \"C84.68\",\n            \"display\": \"Anaplastic large cell lymphoma, ALK-positive, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C84.69\",\n            \"display\": \"Anaplastic large cell lymphoma, ALK-positive, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C84.70\",\n            \"display\": \"Anaplastic large cell lymphoma, ALK-negative, unspecified site\"\n          },\n          {\n            \"code\": \"C84.71\",\n            \"display\": \"Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C84.72\",\n            \"display\": \"Anaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C84.73\",\n            \"display\": \"Anaplastic large cell lymphoma, ALK-negative, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C84.74\",\n            \"display\": \"Anaplastic large cell lymphoma, ALK-negative, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C84.75\",\n            \"display\": \"Anaplastic large cell lymphoma, ALK-negative, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C84.76\",\n            \"display\": \"Anaplastic large cell lymphoma, ALK-negative, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C84.77\",\n            \"display\": \"Anaplastic large cell lymphoma, ALK-negative, spleen\"\n          },\n          {\n            \"code\": \"C84.78\",\n            \"display\": \"Anaplastic large cell lymphoma, ALK-negative, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C84.79\",\n            \"display\": \"Anaplastic large cell lymphoma, ALK-negative, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C84.90\",\n            \"display\": \"Mature T/NK-cell lymphomas, unspecified, unspecified site\"\n          },\n          {\n            \"code\": \"C84.91\",\n            \"display\": \"Mature T/NK-cell lymphomas, unspecified, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C84.92\",\n            \"display\": \"Mature T/NK-cell lymphomas, unspecified, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C84.93\",\n            \"display\": \"Mature T/NK-cell lymphomas, unspecified, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C84.94\",\n            \"display\": \"Mature T/NK-cell lymphomas, unspecified, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C84.95\",\n            \"display\": \"Mature T/NK-cell lymphomas, unspecified, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C84.96\",\n            \"display\": \"Mature T/NK-cell lymphomas, unspecified, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C84.97\",\n            \"display\": \"Mature T/NK-cell lymphomas, unspecified, spleen\"\n          },\n          {\n            \"code\": \"C84.98\",\n            \"display\": \"Mature T/NK-cell lymphomas, unspecified, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C84.99\",\n            \"display\": \"Mature T/NK-cell lymphomas, unspecified, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C84.A0\",\n            \"display\": \"Cutaneous T-cell lymphoma, unspecified, unspecified site\"\n          },\n          {\n            \"code\": \"C84.A1\",\n            \"display\": \"Cutaneous T-cell lymphoma, unspecified lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C84.A2\",\n            \"display\": \"Cutaneous T-cell lymphoma, unspecified, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C84.A3\",\n            \"display\": \"Cutaneous T-cell lymphoma, unspecified, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C84.A4\",\n            \"display\": \"Cutaneous T-cell lymphoma, unspecified, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C84.A5\",\n            \"display\": \"Cutaneous T-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C84.A6\",\n            \"display\": \"Cutaneous T-cell lymphoma, unspecified, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C84.A7\",\n            \"display\": \"Cutaneous T-cell lymphoma, unspecified, spleen\"\n          },\n          {\n            \"code\": \"C84.A8\",\n            \"display\": \"Cutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C84.A9\",\n            \"display\": \"Cutaneous T-cell lymphoma, unspecified, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C84.Z0\",\n            \"display\": \"Other mature T/NK-cell lymphomas, unspecified site\"\n          },\n          {\n            \"code\": \"C84.Z1\",\n            \"display\": \"Other mature T/NK-cell lymphomas, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C84.Z2\",\n            \"display\": \"Other mature T/NK-cell lymphomas, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C84.Z3\",\n            \"display\": \"Other mature T/NK-cell lymphomas, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C84.Z4\",\n            \"display\": \"Other mature T/NK-cell lymphomas, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C84.Z5\",\n            \"display\": \"Other mature T/NK-cell lymphomas, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C84.Z6\",\n            \"display\": \"Other mature T/NK-cell lymphomas, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C84.Z7\",\n            \"display\": \"Other mature T/NK-cell lymphomas, spleen\"\n          },\n          {\n            \"code\": \"C84.Z8\",\n            \"display\": \"Other mature T/NK-cell lymphomas, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C84.Z9\",\n            \"display\": \"Other mature T/NK-cell lymphomas, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C85.10\",\n            \"display\": \"Unspecified B-cell lymphoma, unspecified site\"\n          },\n          {\n            \"code\": \"C85.11\",\n            \"display\": \"Unspecified B-cell lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C85.12\",\n            \"display\": \"Unspecified B-cell lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C85.13\",\n            \"display\": \"Unspecified B-cell lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C85.14\",\n            \"display\": \"Unspecified B-cell lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C85.15\",\n            \"display\": \"Unspecified B-cell lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C85.16\",\n            \"display\": \"Unspecified B-cell lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C85.17\",\n            \"display\": \"Unspecified B-cell lymphoma, spleen\"\n          },\n          {\n            \"code\": \"C85.18\",\n            \"display\": \"Unspecified B-cell lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C85.19\",\n            \"display\": \"Unspecified B-cell lymphoma, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C85.20\",\n            \"display\": \"Mediastinal (thymic) large B-cell lymphoma, unspecified site\"\n          },\n          {\n            \"code\": \"C85.21\",\n            \"display\": \"Mediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C85.22\",\n            \"display\": \"Mediastinal (thymic) large B-cell lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C85.23\",\n            \"display\": \"Mediastinal (thymic) large B-cell lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C85.24\",\n            \"display\": \"Mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C85.25\",\n            \"display\": \"Mediastinal (thymic) large B-cell lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C85.26\",\n            \"display\": \"Mediastinal (thymic) large B-cell lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C85.27\",\n            \"display\": \"Mediastinal (thymic) large B-cell lymphoma, spleen\"\n          },\n          {\n            \"code\": \"C85.28\",\n            \"display\": \"Mediastinal (thymic) large B-cell lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C85.29\",\n            \"display\": \"Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C85.80\",\n            \"display\": \"Other specified types of non-Hodgkin lymphoma, unspecified site\"\n          },\n          {\n            \"code\": \"C85.81\",\n            \"display\": \"Other specified types of non-Hodgkin lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C85.82\",\n            \"display\": \"Other specified types of non-Hodgkin lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C85.83\",\n            \"display\": \"Other specified types of non-Hodgkin lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C85.84\",\n            \"display\": \"Other specified types of non-Hodgkin lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C85.85\",\n            \"display\": \"Other specified types of non-Hodgkin lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C85.86\",\n            \"display\": \"Other specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C85.87\",\n            \"display\": \"Other specified types of non-Hodgkin lymphoma, spleen\"\n          },\n          {\n            \"code\": \"C85.88\",\n            \"display\": \"Other specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C85.89\",\n            \"display\": \"Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C85.90\",\n            \"display\": \"Non-Hodgkin lymphoma, unspecified, unspecified site\"\n          },\n          {\n            \"code\": \"C85.91\",\n            \"display\": \"Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"C85.92\",\n            \"display\": \"Non-Hodgkin lymphoma, unspecified, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"C85.93\",\n            \"display\": \"Non-Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"C85.94\",\n            \"display\": \"Non-Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"C85.95\",\n            \"display\": \"Non-Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"C85.96\",\n            \"display\": \"Non-Hodgkin lymphoma, unspecified, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"C85.97\",\n            \"display\": \"Non-Hodgkin lymphoma, unspecified, spleen\"\n          },\n          {\n            \"code\": \"C85.98\",\n            \"display\": \"Non-Hodgkin lymphoma, unspecified, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"C85.99\",\n            \"display\": \"Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites\"\n          },\n          {\n            \"code\": \"C86.0\",\n            \"display\": \"Extranodal NK/T-cell lymphoma, nasal type\"\n          },\n          {\n            \"code\": \"C86.1\",\n            \"display\": \"Hepatosplenic T-cell lymphoma\"\n          },\n          {\n            \"code\": \"C86.2\",\n            \"display\": \"Enteropathy-type (intestinal) T-cell lymphoma\"\n          },\n          {\n            \"code\": \"C86.3\",\n            \"display\": \"Subcutaneous panniculitis-like T-cell lymphoma\"\n          },\n          {\n            \"code\": \"C86.4\",\n            \"display\": \"Blastic NK-cell lymphoma\"\n          },\n          {\n            \"code\": \"C86.5\",\n            \"display\": \"Angioimmunoblastic T-cell lymphoma\"\n          },\n          {\n            \"code\": \"C86.6\",\n            \"display\": \"Primary cutaneous CD30-positive T-cell proliferations\"\n          },\n          {\n            \"code\": \"C88.0\",\n            \"display\": \"Waldenström macroglobulinemia\"\n          },\n          {\n            \"code\": \"C88.2\",\n            \"display\": \"Heavy chain disease\"\n          },\n          {\n            \"code\": \"C88.3\",\n            \"display\": \"Immunoproliferative small intestinal disease\"\n          },\n          {\n            \"code\": \"C88.4\",\n            \"display\": \"Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]\"\n          },\n          {\n            \"code\": \"C88.8\",\n            \"display\": \"Other malignant immunoproliferative diseases\"\n          },\n          {\n            \"code\": \"C88.9\",\n            \"display\": \"Malignant immunoproliferative disease, unspecified\"\n          },\n          {\n            \"code\": \"C90.00\",\n            \"display\": \"Multiple myeloma not having achieved remission\"\n          },\n          {\n            \"code\": \"C90.01\",\n            \"display\": \"Multiple myeloma in remission\"\n          },\n          {\n            \"code\": \"C90.10\",\n            \"display\": \"Plasma cell leukemia not having achieved remission\"\n          },\n          {\n            \"code\": \"C90.11\",\n            \"display\": \"Plasma cell leukemia in remission\"\n          },\n          {\n            \"code\": \"C90.20\",\n            \"display\": \"Extramedullary plasmacytoma not having achieved remission\"\n          },\n          {\n            \"code\": \"C90.21\",\n            \"display\": \"Extramedullary plasmacytoma in remission\"\n          },\n          {\n            \"code\": \"C90.30\",\n            \"display\": \"Solitary plasmacytoma not having achieved remission\"\n          },\n          {\n            \"code\": \"C90.31\",\n            \"display\": \"Solitary plasmacytoma in remission\"\n          },\n          {\n            \"code\": \"C91.00\",\n            \"display\": \"Acute lymphoblastic leukemia not having achieved remission\"\n          },\n          {\n            \"code\": \"C91.01\",\n            \"display\": \"Acute lymphoblastic leukemia, in remission\"\n          },\n          {\n            \"code\": \"C91.10\",\n            \"display\": \"Chronic lymphocytic leukemia of B-cell type not having achieved remission\"\n          },\n          {\n            \"code\": \"C91.11\",\n            \"display\": \"Chronic lymphocytic leukemia of B-cell type in remission\"\n          },\n          {\n            \"code\": \"C91.30\",\n            \"display\": \"Prolymphocytic leukemia of B-cell type not having achieved remission\"\n          },\n          {\n            \"code\": \"C91.31\",\n            \"display\": \"Prolymphocytic leukemia of B-cell type, in remission\"\n          },\n          {\n            \"code\": \"C91.40\",\n            \"display\": \"Hairy cell leukemia not having achieved remission\"\n          },\n          {\n            \"code\": \"C91.41\",\n            \"display\": \"Hairy cell leukemia, in remission\"\n          },\n          {\n            \"code\": \"C91.50\",\n            \"display\": \"Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission\"\n          },\n          {\n            \"code\": \"C91.51\",\n            \"display\": \"Adult T-cell lymphoma/leukemia (HTLV-1-associated), in remission\"\n          },\n          {\n            \"code\": \"C91.60\",\n            \"display\": \"Prolymphocytic leukemia of T-cell type not having achieved remission\"\n          },\n          {\n            \"code\": \"C91.61\",\n            \"display\": \"Prolymphocytic leukemia of T-cell type, in remission\"\n          },\n          {\n            \"code\": \"C91.90\",\n            \"display\": \"Lymphoid leukemia, unspecified not having achieved remission\"\n          },\n          {\n            \"code\": \"C91.91\",\n            \"display\": \"Lymphoid leukemia, unspecified, in remission\"\n          },\n          {\n            \"code\": \"C91.A0\",\n            \"display\": \"Mature B-cell leukemia Burkitt-type not having achieved remission\"\n          },\n          {\n            \"code\": \"C91.A1\",\n            \"display\": \"Mature B-cell leukemia Burkitt-type, in remission\"\n          },\n          {\n            \"code\": \"C91.Z0\",\n            \"display\": \"Other lymphoid leukemia not having achieved remission\"\n          },\n          {\n            \"code\": \"C91.Z1\",\n            \"display\": \"Other lymphoid leukemia, in remission\"\n          },\n          {\n            \"code\": \"C92.00\",\n            \"display\": \"Acute myeloblastic leukemia, not having achieved remission\"\n          },\n          {\n            \"code\": \"C92.01\",\n            \"display\": \"Acute myeloblastic leukemia, in remission\"\n          },\n          {\n            \"code\": \"C92.10\",\n            \"display\": \"Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission\"\n          },\n          {\n            \"code\": \"C92.11\",\n            \"display\": \"Chronic myeloid leukemia, BCR/ABL-positive, in remission\"\n          },\n          {\n            \"code\": \"C92.20\",\n            \"display\": \"Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission\"\n          },\n          {\n            \"code\": \"C92.21\",\n            \"display\": \"Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission\"\n          },\n          {\n            \"code\": \"C92.30\",\n            \"display\": \"Myeloid sarcoma, not having achieved remission\"\n          },\n          {\n            \"code\": \"C92.31\",\n            \"display\": \"Myeloid sarcoma, in remission\"\n          },\n          {\n            \"code\": \"C92.40\",\n            \"display\": \"Acute promyelocytic leukemia, not having achieved remission\"\n          },\n          {\n            \"code\": \"C92.41\",\n            \"display\": \"Acute promyelocytic leukemia, in remission\"\n          },\n          {\n            \"code\": \"C92.50\",\n            \"display\": \"Acute myelomonocytic leukemia, not having achieved remission\"\n          },\n          {\n            \"code\": \"C92.51\",\n            \"display\": \"Acute myelomonocytic leukemia, in remission\"\n          },\n          {\n            \"code\": \"C92.60\",\n            \"display\": \"Acute myeloid leukemia with 11q23-abnormality not having achieved remission\"\n          },\n          {\n            \"code\": \"C92.61\",\n            \"display\": \"Acute myeloid leukemia with 11q23-abnormality in remission\"\n          },\n          {\n            \"code\": \"C92.90\",\n            \"display\": \"Myeloid leukemia, unspecified, not having achieved remission\"\n          },\n          {\n            \"code\": \"C92.91\",\n            \"display\": \"Myeloid leukemia, unspecified in remission\"\n          },\n          {\n            \"code\": \"C92.A0\",\n            \"display\": \"Acute myeloid leukemia with multilineage dysplasia, not having achieved remission\"\n          },\n          {\n            \"code\": \"C92.A1\",\n            \"display\": \"Acute myeloid leukemia with multilineage dysplasia, in remission\"\n          },\n          {\n            \"code\": \"C92.Z0\",\n            \"display\": \"Other myeloid leukemia not having achieved remission\"\n          },\n          {\n            \"code\": \"C92.Z1\",\n            \"display\": \"Other myeloid leukemia, in remission\"\n          },\n          {\n            \"code\": \"C93.00\",\n            \"display\": \"Acute monoblastic/monocytic leukemia, not having achieved remission\"\n          },\n          {\n            \"code\": \"C93.01\",\n            \"display\": \"Acute monoblastic/monocytic leukemia, in remission\"\n          },\n          {\n            \"code\": \"C93.10\",\n            \"display\": \"Chronic myelomonocytic leukemia not having achieved remission\"\n          },\n          {\n            \"code\": \"C93.11\",\n            \"display\": \"Chronic myelomonocytic leukemia, in remission\"\n          },\n          {\n            \"code\": \"C93.30\",\n            \"display\": \"Juvenile myelomonocytic leukemia, not having achieved remission\"\n          },\n          {\n            \"code\": \"C93.31\",\n            \"display\": \"Juvenile myelomonocytic leukemia, in remission\"\n          },\n          {\n            \"code\": \"C93.90\",\n            \"display\": \"Monocytic leukemia, unspecified, not having achieved remission\"\n          },\n          {\n            \"code\": \"C93.91\",\n            \"display\": \"Monocytic leukemia, unspecified in remission\"\n          },\n          {\n            \"code\": \"C93.Z0\",\n            \"display\": \"Other monocytic leukemia, not having achieved remission\"\n          },\n          {\n            \"code\": \"C93.Z1\",\n            \"display\": \"Other monocytic leukemia, in remission\"\n          },\n          {\n            \"code\": \"C94.00\",\n            \"display\": \"Acute erythroid leukemia, not having achieved remission\"\n          },\n          {\n            \"code\": \"C94.01\",\n            \"display\": \"Acute erythroid leukemia, in remission\"\n          },\n          {\n            \"code\": \"C94.20\",\n            \"display\": \"Acute megakaryoblastic leukemia not having achieved remission\"\n          },\n          {\n            \"code\": \"C94.21\",\n            \"display\": \"Acute megakaryoblastic leukemia, in remission\"\n          },\n          {\n            \"code\": \"C94.30\",\n            \"display\": \"Mast cell leukemia not having achieved remission\"\n          },\n          {\n            \"code\": \"C94.31\",\n            \"display\": \"Mast cell leukemia, in remission\"\n          },\n          {\n            \"code\": \"C94.40\",\n            \"display\": \"Acute panmyelosis with myelofibrosis not having achieved remission\"\n          },\n          {\n            \"code\": \"C94.41\",\n            \"display\": \"Acute panmyelosis with myelofibrosis, in remission\"\n          },\n          {\n            \"code\": \"C94.6\",\n            \"display\": \"Myelodysplastic disease, not classified\"\n          },\n          {\n            \"code\": \"C94.80\",\n            \"display\": \"Other specified leukemias not having achieved remission\"\n          },\n          {\n            \"code\": \"C94.81\",\n            \"display\": \"Other specified leukemias, in remission\"\n          },\n          {\n            \"code\": \"C95.00\",\n            \"display\": \"Acute leukemia of unspecified cell type not having achieved remission\"\n          },\n          {\n            \"code\": \"C95.01\",\n            \"display\": \"Acute leukemia of unspecified cell type, in remission\"\n          },\n          {\n            \"code\": \"C95.10\",\n            \"display\": \"Chronic leukemia of unspecified cell type not having achieved remission\"\n          },\n          {\n            \"code\": \"C95.11\",\n            \"display\": \"Chronic leukemia of unspecified cell type, in remission\"\n          },\n          {\n            \"code\": \"C95.90\",\n            \"display\": \"Leukemia, unspecified not having achieved remission\"\n          },\n          {\n            \"code\": \"C95.91\",\n            \"display\": \"Leukemia, unspecified, in remission\"\n          },\n          {\n            \"code\": \"C96.0\",\n            \"display\": \"Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis\"\n          },\n          {\n            \"code\": \"C96.2\",\n            \"display\": \"Malignant mast cell neoplasm\"\n          },\n          {\n            \"code\": \"C96.4\",\n            \"display\": \"Sarcoma of dendritic cells (accessory cells)\"\n          },\n          {\n            \"code\": \"C96.5\",\n            \"display\": \"Multifocal and unisystemic Langerhans-cell histiocytosis\"\n          },\n          {\n            \"code\": \"C96.6\",\n            \"display\": \"Unifocal Langerhans-cell histiocytosis\"\n          },\n          {\n            \"code\": \"C96.9\",\n            \"display\": \"Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified\"\n          },\n          {\n            \"code\": \"C96.A\",\n            \"display\": \"Histiocytic sarcoma\"\n          },\n          {\n            \"code\": \"C96.Z\",\n            \"display\": \"Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue\"\n          },\n          {\n            \"code\": \"D46.0\",\n            \"display\": \"Refractory anemia without ring sideroblasts, so stated\"\n          },\n          {\n            \"code\": \"D46.1\",\n            \"display\": \"Refractory anemia with ring sideroblasts\"\n          },\n          {\n            \"code\": \"D46.20\",\n            \"display\": \"Refractory anemia with excess of blasts, unspecified\"\n          },\n          {\n            \"code\": \"D46.21\",\n            \"display\": \"Refractory anemia with excess of blasts 1\"\n          },\n          {\n            \"code\": \"D46.22\",\n            \"display\": \"Refractory anemia with excess of blasts 2\"\n          },\n          {\n            \"code\": \"D46.4\",\n            \"display\": \"Refractory anemia, unspecified\"\n          },\n          {\n            \"code\": \"D46.9\",\n            \"display\": \"Myelodysplastic syndrome, unspecified\"\n          },\n          {\n            \"code\": \"D46.A\",\n            \"display\": \"Refractory cytopenia with multilineage dysplasia\"\n          },\n          {\n            \"code\": \"D46.B\",\n            \"display\": \"Refractory cytopenia with multilineage dysplasia and ring sideroblasts\"\n          },\n          {\n            \"code\": \"D46.C\",\n            \"display\": \"Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality\"\n          },\n          {\n            \"code\": \"D46.Z\",\n            \"display\": \"Other myelodysplastic syndromes\"\n          },\n          {\n            \"code\": \"D47.1\",\n            \"display\": \"Chronic myeloproliferative disease\"\n          },\n          {\n            \"code\": \"D47.9\",\n            \"display\": \"Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified\"\n          },\n          {\n            \"code\": \"D47.Z9\",\n            \"display\": \"Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue\"\n          }\n        ]\n      },\n      {\n        \"system\": \"2.16.840.1.113883.6.103\",\n        \"version\": \"2013\",\n        \"concept\": [\n          {\n            \"code\": \"140\",\n            \"display\": \"Malignant neoplasm of lip\"\n          },\n          {\n            \"code\": \"140.1\",\n            \"display\": \"Malignant neoplasm of lower lip, vermilion border\"\n          },\n          {\n            \"code\": \"140.3\",\n            \"display\": \"Malignant neoplasm of upper lip, inner aspect\"\n          },\n          {\n            \"code\": \"140.4\",\n            \"display\": \"Malignant neoplasm of lower lip, inner aspect\"\n          },\n          {\n            \"code\": \"140.5\",\n            \"display\": \"Malignant neoplasm of lip, unspecified, inner aspect\"\n          },\n          {\n            \"code\": \"140.6\",\n            \"display\": \"Malignant neoplasm of commissure of lip\"\n          },\n          {\n            \"code\": \"140.8\",\n            \"display\": \"Malignant neoplasm of other sites of lip\"\n          },\n          {\n            \"code\": \"140.9\",\n            \"display\": \"Malignant neoplasm of lip, unspecified, vermilion border\"\n          },\n          {\n            \"code\": \"141\",\n            \"display\": \"Malignant neoplasm of tongue\"\n          },\n          {\n            \"code\": \"141.1\",\n            \"display\": \"Malignant neoplasm of dorsal surface of tongue\"\n          },\n          {\n            \"code\": \"141.2\",\n            \"display\": \"Malignant neoplasm of tip and lateral border of tongue\"\n          },\n          {\n            \"code\": \"141.3\",\n            \"display\": \"Malignant neoplasm of ventral surface of tongue\"\n          },\n          {\n            \"code\": \"141.4\",\n            \"display\": \"Malignant neoplasm of anterior two-thirds of tongue, part unspecified\"\n          },\n          {\n            \"code\": \"141.5\",\n            \"display\": \"Malignant neoplasm of junctional zone of tongue\"\n          },\n          {\n            \"code\": \"141.6\",\n            \"display\": \"Malignant neoplasm of lingual tonsil\"\n          },\n          {\n            \"code\": \"141.8\",\n            \"display\": \"Malignant neoplasm of other sites of tongue\"\n          },\n          {\n            \"code\": \"141.9\",\n            \"display\": \"Malignant neoplasm of tongue, unspecified\"\n          },\n          {\n            \"code\": \"142\",\n            \"display\": \"Malignant neoplasm of major salivary glands\"\n          },\n          {\n            \"code\": \"142.1\",\n            \"display\": \"Malignant neoplasm of submandibular gland\"\n          },\n          {\n            \"code\": \"142.2\",\n            \"display\": \"Malignant neoplasm of sublingual gland\"\n          },\n          {\n            \"code\": \"142.8\",\n            \"display\": \"Malignant neoplasm of other major salivary glands\"\n          },\n          {\n            \"code\": \"142.9\",\n            \"display\": \"Malignant neoplasm of salivary gland, unspecified\"\n          },\n          {\n            \"code\": \"143\",\n            \"display\": \"Malignant neoplasm of gum\"\n          },\n          {\n            \"code\": \"143.1\",\n            \"display\": \"Malignant neoplasm of lower gum\"\n          },\n          {\n            \"code\": \"143.8\",\n            \"display\": \"Malignant neoplasm of other sites of gum\"\n          },\n          {\n            \"code\": \"143.9\",\n            \"display\": \"Malignant neoplasm of gum, unspecified\"\n          },\n          {\n            \"code\": \"144\",\n            \"display\": \"Malignant neoplasm of floor of mouth\"\n          },\n          {\n            \"code\": \"144.1\",\n            \"display\": \"Malignant neoplasm of lateral portion of floor of mouth\"\n          },\n          {\n            \"code\": \"144.8\",\n            \"display\": \"Malignant neoplasm of other sites of floor of mouth\"\n          },\n          {\n            \"code\": \"144.9\",\n            \"display\": \"Malignant neoplasm of floor of mouth, part unspecified\"\n          },\n          {\n            \"code\": \"145\",\n            \"display\": \"Malignant neoplasm of other and unspecified parts of mouth\"\n          },\n          {\n            \"code\": \"145.1\",\n            \"display\": \"Malignant neoplasm of vestibule of mouth\"\n          },\n          {\n            \"code\": \"145.2\",\n            \"display\": \"Malignant neoplasm of hard palate\"\n          },\n          {\n            \"code\": \"145.3\",\n            \"display\": \"Malignant neoplasm of soft palate\"\n          },\n          {\n            \"code\": \"145.4\",\n            \"display\": \"Malignant neoplasm of uvula\"\n          },\n          {\n            \"code\": \"145.5\",\n            \"display\": \"Malignant neoplasm of palate, unspecified\"\n          },\n          {\n            \"code\": \"145.6\",\n            \"display\": \"Malignant neoplasm of retromolar area\"\n          },\n          {\n            \"code\": \"145.8\",\n            \"display\": \"Malignant neoplasm of other specified parts of mouth\"\n          },\n          {\n            \"code\": \"145.9\",\n            \"display\": \"Malignant neoplasm of mouth, unspecified\"\n          },\n          {\n            \"code\": \"146\",\n            \"display\": \"Malignant neoplasm of oropharynx\"\n          },\n          {\n            \"code\": \"146.1\",\n            \"display\": \"Malignant neoplasm of tonsillar fossa\"\n          },\n          {\n            \"code\": \"146.2\",\n            \"display\": \"Malignant neoplasm of tonsillar pillars (anterior) (posterior)\"\n          },\n          {\n            \"code\": \"146.3\",\n            \"display\": \"Malignant neoplasm of vallecula epiglottica\"\n          },\n          {\n            \"code\": \"146.4\",\n            \"display\": \"Malignant neoplasm of anterior aspect of epiglottis\"\n          },\n          {\n            \"code\": \"146.5\",\n            \"display\": \"Malignant neoplasm of junctional region of oropharynx\"\n          },\n          {\n            \"code\": \"146.6\",\n            \"display\": \"Malignant neoplasm of lateral wall of oropharynx\"\n          },\n          {\n            \"code\": \"146.7\",\n            \"display\": \"Malignant neoplasm of posterior wall of oropharynx\"\n          },\n          {\n            \"code\": \"146.8\",\n            \"display\": \"Malignant neoplasm of other specified sites of oropharynx\"\n          },\n          {\n            \"code\": \"146.9\",\n            \"display\": \"Malignant neoplasm of oropharynx, unspecified site\"\n          },\n          {\n            \"code\": \"147\",\n            \"display\": \"Malignant neoplasm of nasopharynx\"\n          },\n          {\n            \"code\": \"147.1\",\n            \"display\": \"Malignant neoplasm of posterior wall of nasopharynx\"\n          },\n          {\n            \"code\": \"147.2\",\n            \"display\": \"Malignant neoplasm of lateral wall of nasopharynx\"\n          },\n          {\n            \"code\": \"147.3\",\n            \"display\": \"Malignant neoplasm of anterior wall of nasopharynx\"\n          },\n          {\n            \"code\": \"147.8\",\n            \"display\": \"Malignant neoplasm of other specified sites of nasopharynx\"\n          },\n          {\n            \"code\": \"147.9\",\n            \"display\": \"Malignant neoplasm of nasopharynx, unspecified site\"\n          },\n          {\n            \"code\": \"148\",\n            \"display\": \"Malignant neoplasm of hypopharynx\"\n          },\n          {\n            \"code\": \"148.1\",\n            \"display\": \"Malignant neoplasm of pyriform sinus\"\n          },\n          {\n            \"code\": \"148.2\",\n            \"display\": \"Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect\"\n          },\n          {\n            \"code\": \"148.3\",\n            \"display\": \"Malignant neoplasm of posterior hypopharyngeal wall\"\n          },\n          {\n            \"code\": \"148.8\",\n            \"display\": \"Malignant neoplasm of other specified sites of hypopharynx\"\n          },\n          {\n            \"code\": \"148.9\",\n            \"display\": \"Malignant neoplasm of hypopharynx, unspecified site\"\n          },\n          {\n            \"code\": \"149\",\n            \"display\": \"Malignant neoplasm of other and ill-defined sites within the lip, oral cavity, and pharynx\"\n          },\n          {\n            \"code\": \"149.1\",\n            \"display\": \"Malignant neoplasm of waldeyer's ring\"\n          },\n          {\n            \"code\": \"149.8\",\n            \"display\": \"Malignant neoplasm of other sites within the lip and oral cavity\"\n          },\n          {\n            \"code\": \"149.9\",\n            \"display\": \"Malignant neoplasm of ill-defined sites within the lip and oral cavity\"\n          },\n          {\n            \"code\": \"150\",\n            \"display\": \"Malignant neoplasm of esophagus\"\n          },\n          {\n            \"code\": \"150.1\",\n            \"display\": \"Malignant neoplasm of thoracic esophagus\"\n          },\n          {\n            \"code\": \"150.2\",\n            \"display\": \"Malignant neoplasm of abdominal esophagus\"\n          },\n          {\n            \"code\": \"150.3\",\n            \"display\": \"Malignant neoplasm of upper third of esophagus\"\n          },\n          {\n            \"code\": \"150.4\",\n            \"display\": \"Malignant neoplasm of middle third of esophagus\"\n          },\n          {\n            \"code\": \"150.5\",\n            \"display\": \"Malignant neoplasm of lower third of esophagus\"\n          },\n          {\n            \"code\": \"150.8\",\n            \"display\": \"Malignant neoplasm of other specified part of esophagus\"\n          },\n          {\n            \"code\": \"150.9\",\n            \"display\": \"Malignant neoplasm of esophagus, unspecified site\"\n          },\n          {\n            \"code\": \"151\",\n            \"display\": \"Malignant neoplasm of stomach\"\n          },\n          {\n            \"code\": \"151.1\",\n            \"display\": \"Malignant neoplasm of pylorus\"\n          },\n          {\n            \"code\": \"151.2\",\n            \"display\": \"Malignant neoplasm of pyloric antrum\"\n          },\n          {\n            \"code\": \"151.3\",\n            \"display\": \"Malignant neoplasm of fundus of stomach\"\n          },\n          {\n            \"code\": \"151.4\",\n            \"display\": \"Malignant neoplasm of body of stomach\"\n          },\n          {\n            \"code\": \"151.5\",\n            \"display\": \"Malignant neoplasm of lesser curvature of stomach, unspecified\"\n          },\n          {\n            \"code\": \"151.6\",\n            \"display\": \"Malignant neoplasm of greater curvature of stomach, unspecified\"\n          },\n          {\n            \"code\": \"151.8\",\n            \"display\": \"Malignant neoplasm of other specified sites of stomach\"\n          },\n          {\n            \"code\": \"151.9\",\n            \"display\": \"Malignant neoplasm of stomach, unspecified site\"\n          },\n          {\n            \"code\": \"152\",\n            \"display\": \"Malignant neoplasm of small intestine, including duodenum\"\n          },\n          {\n            \"code\": \"152.1\",\n            \"display\": \"Malignant neoplasm of jejunum\"\n          },\n          {\n            \"code\": \"152.2\",\n            \"display\": \"Malignant neoplasm of ileum\"\n          },\n          {\n            \"code\": \"152.3\",\n            \"display\": \"Malignant neoplasm of Meckel's diverticulum\"\n          },\n          {\n            \"code\": \"152.8\",\n            \"display\": \"Malignant neoplasm of other specified sites of small intestine\"\n          },\n          {\n            \"code\": \"152.9\",\n            \"display\": \"Malignant neoplasm of small intestine, unspecified site\"\n          },\n          {\n            \"code\": \"153\",\n            \"display\": \"Malignant neoplasm of colon\"\n          },\n          {\n            \"code\": \"153.1\",\n            \"display\": \"Malignant neoplasm of transverse colon\"\n          },\n          {\n            \"code\": \"153.2\",\n            \"display\": \"Malignant neoplasm of descending colon\"\n          },\n          {\n            \"code\": \"153.3\",\n            \"display\": \"Malignant neoplasm of sigmoid colon\"\n          },\n          {\n            \"code\": \"153.4\",\n            \"display\": \"Malignant neoplasm of cecum\"\n          },\n          {\n            \"code\": \"153.5\",\n            \"display\": \"Malignant neoplasm of appendix vermiformis\"\n          },\n          {\n            \"code\": \"153.6\",\n            \"display\": \"Malignant neoplasm of ascending colon\"\n          },\n          {\n            \"code\": \"153.7\",\n            \"display\": \"Malignant neoplasm of splenic flexure\"\n          },\n          {\n            \"code\": \"153.8\",\n            \"display\": \"Malignant neoplasm of other specified sites of large intestine\"\n          },\n          {\n            \"code\": \"153.9\",\n            \"display\": \"Malignant neoplasm of colon, unspecified site\"\n          },\n          {\n            \"code\": \"154\",\n            \"display\": \"Malignant neoplasm of rectum, rectosigmoid junction, and anus\"\n          },\n          {\n            \"code\": \"154.1\",\n            \"display\": \"Malignant neoplasm of rectum\"\n          },\n          {\n            \"code\": \"154.2\",\n            \"display\": \"Malignant neoplasm of anal canal\"\n          },\n          {\n            \"code\": \"154.3\",\n            \"display\": \"Malignant neoplasm of anus, unspecified site\"\n          },\n          {\n            \"code\": \"154.8\",\n            \"display\": \"Malignant neoplasm of other sites of rectum, rectosigmoid junction, and anus\"\n          },\n          {\n            \"code\": \"155\",\n            \"display\": \"Malignant neoplasm of liver and intrahepatic bile ducts\"\n          },\n          {\n            \"code\": \"155.1\",\n            \"display\": \"Malignant neoplasm of intrahepatic bile ducts\"\n          },\n          {\n            \"code\": \"155.2\",\n            \"display\": \"Malignant neoplasm of liver, not specified as primary or secondary\"\n          },\n          {\n            \"code\": \"156\",\n            \"display\": \"Malignant neoplasm of gallbladder and extrahepatic bile ducts\"\n          },\n          {\n            \"code\": \"156.1\",\n            \"display\": \"Malignant neoplasm of extrahepatic bile ducts\"\n          },\n          {\n            \"code\": \"156.2\",\n            \"display\": \"Malignant neoplasm of ampulla of vater\"\n          },\n          {\n            \"code\": \"156.8\",\n            \"display\": \"Malignant neoplasm of other specified sites of gallbladder and extrahepatic bile ducts\"\n          },\n          {\n            \"code\": \"156.9\",\n            \"display\": \"Malignant neoplasm of biliary tract, part unspecified site\"\n          },\n          {\n            \"code\": \"157\",\n            \"display\": \"Malignant neoplasm of pancreas\"\n          },\n          {\n            \"code\": \"157.1\",\n            \"display\": \"Malignant neoplasm of body of pancreas\"\n          },\n          {\n            \"code\": \"157.2\",\n            \"display\": \"Malignant neoplasm of tail of pancreas\"\n          },\n          {\n            \"code\": \"157.3\",\n            \"display\": \"Malignant neoplasm of pancreatic duct\"\n          },\n          {\n            \"code\": \"157.4\",\n            \"display\": \"Malignant neoplasm of islets of langerhans\"\n          },\n          {\n            \"code\": \"157.8\",\n            \"display\": \"Malignant neoplasm of other specified sites of pancreas\"\n          },\n          {\n            \"code\": \"157.9\",\n            \"display\": \"Malignant neoplasm of pancreas, part unspecified\"\n          },\n          {\n            \"code\": \"158\",\n            \"display\": \"Malignant neoplasm of retroperitoneum and peritoneum\"\n          },\n          {\n            \"code\": \"158.8\",\n            \"display\": \"Malignant neoplasm of specified parts of peritoneum\"\n          },\n          {\n            \"code\": \"158.9\",\n            \"display\": \"Malignant neoplasm of peritoneum, unspecified\"\n          },\n          {\n            \"code\": \"159\",\n            \"display\": \"Malignant neoplasm of other and ill-defined sites within the digestive organs and peritoneum\"\n          },\n          {\n            \"code\": \"159.1\",\n            \"display\": \"Malignant neoplasm of spleen, not elsewhere classified\"\n          },\n          {\n            \"code\": \"159.8\",\n            \"display\": \"Malignant neoplasm of other sites of digestive system and intra-abdominal organs\"\n          },\n          {\n            \"code\": \"159.9\",\n            \"display\": \"Malignant neoplasm of ill-defined sites within the digestive organs and peritoneum\"\n          },\n          {\n            \"code\": \"160\",\n            \"display\": \"Malignant neoplasm of nasal cavities, middle ear, and accessory sinuses\"\n          },\n          {\n            \"code\": \"160.1\",\n            \"display\": \"Malignant neoplasm of auditory tube, middle ear, and mastoid air cells\"\n          },\n          {\n            \"code\": \"160.2\",\n            \"display\": \"Malignant neoplasm of maxillary sinus\"\n          },\n          {\n            \"code\": \"160.3\",\n            \"display\": \"Malignant neoplasm of ethmoidal sinus\"\n          },\n          {\n            \"code\": \"160.4\",\n            \"display\": \"Malignant neoplasm of frontal sinus\"\n          },\n          {\n            \"code\": \"160.5\",\n            \"display\": \"Malignant neoplasm of sphenoidal sinus\"\n          },\n          {\n            \"code\": \"160.8\",\n            \"display\": \"Malignant neoplasm of other accessory sinuses\"\n          },\n          {\n            \"code\": \"160.9\",\n            \"display\": \"Malignant neoplasm of accessory sinus, unspecified\"\n          },\n          {\n            \"code\": \"161\",\n            \"display\": \"Malignant neoplasm of larynx\"\n          },\n          {\n            \"code\": \"161.1\",\n            \"display\": \"Malignant neoplasm of supraglottis\"\n          },\n          {\n            \"code\": \"161.2\",\n            \"display\": \"Malignant neoplasm of subglottis\"\n          },\n          {\n            \"code\": \"161.3\",\n            \"display\": \"Malignant neoplasm of laryngeal cartilages\"\n          },\n          {\n            \"code\": \"161.8\",\n            \"display\": \"Malignant neoplasm of other specified sites of larynx\"\n          },\n          {\n            \"code\": \"161.9\",\n            \"display\": \"Malignant neoplasm of larynx, unspecified\"\n          },\n          {\n            \"code\": \"162\",\n            \"display\": \"Malignant neoplasm of trachea, bronchus, and lung\"\n          },\n          {\n            \"code\": \"162.2\",\n            \"display\": \"Malignant neoplasm of main bronchus\"\n          },\n          {\n            \"code\": \"162.3\",\n            \"display\": \"Malignant neoplasm of upper lobe, bronchus or lung\"\n          },\n          {\n            \"code\": \"162.4\",\n            \"display\": \"Malignant neoplasm of middle lobe, bronchus or lung\"\n          },\n          {\n            \"code\": \"162.5\",\n            \"display\": \"Malignant neoplasm of lower lobe, bronchus or lung\"\n          },\n          {\n            \"code\": \"162.8\",\n            \"display\": \"Malignant neoplasm of other parts of bronchus or lung\"\n          },\n          {\n            \"code\": \"162.9\",\n            \"display\": \"Malignant neoplasm of bronchus and lung, unspecified\"\n          },\n          {\n            \"code\": \"163\",\n            \"display\": \"Malignant neoplasm of pleura\"\n          },\n          {\n            \"code\": \"163.1\",\n            \"display\": \"Malignant neoplasm of visceral pleura\"\n          },\n          {\n            \"code\": \"163.8\",\n            \"display\": \"Malignant neoplasm of other specified sites of pleura\"\n          },\n          {\n            \"code\": \"163.9\",\n            \"display\": \"Malignant neoplasm of pleura, unspecified\"\n          },\n          {\n            \"code\": \"164\",\n            \"display\": \"Malignant neoplasm of thymus, heart, and mediastinum\"\n          },\n          {\n            \"code\": \"164.1\",\n            \"display\": \"Malignant neoplasm of heart\"\n          },\n          {\n            \"code\": \"164.2\",\n            \"display\": \"Malignant neoplasm of anterior mediastinum\"\n          },\n          {\n            \"code\": \"164.3\",\n            \"display\": \"Malignant neoplasm of posterior mediastinum\"\n          },\n          {\n            \"code\": \"164.8\",\n            \"display\": \"Malignant neoplasm of other parts of mediastinum\"\n          },\n          {\n            \"code\": \"164.9\",\n            \"display\": \"Malignant neoplasm of mediastinum, part unspecified\"\n          },\n          {\n            \"code\": \"165\",\n            \"display\": \"Malignant neoplasm of other and ill-defined sites within the respiratory system and intrathoracic organs\"\n          },\n          {\n            \"code\": \"165.8\",\n            \"display\": \"Malignant neoplasm of other sites within the respiratory system and intrathoracic organs\"\n          },\n          {\n            \"code\": \"165.9\",\n            \"display\": \"Malignant neoplasm of ill-defined sites within the respiratory system\"\n          },\n          {\n            \"code\": \"170\",\n            \"display\": \"Malignant neoplasm of bone and articular cartilage\"\n          },\n          {\n            \"code\": \"170.1\",\n            \"display\": \"Malignant neoplasm of mandible\"\n          },\n          {\n            \"code\": \"170.2\",\n            \"display\": \"Malignant neoplasm of vertebral column, excluding sacrum and coccyx\"\n          },\n          {\n            \"code\": \"170.3\",\n            \"display\": \"Malignant neoplasm of ribs, sternum, and clavicle\"\n          },\n          {\n            \"code\": \"170.4\",\n            \"display\": \"Malignant neoplasm of scapula and long bones of upper limb\"\n          },\n          {\n            \"code\": \"170.5\",\n            \"display\": \"Malignant neoplasm of short bones of upper limb\"\n          },\n          {\n            \"code\": \"170.6\",\n            \"display\": \"Malignant neoplasm of pelvic bones, sacrum, and coccyx\"\n          },\n          {\n            \"code\": \"170.7\",\n            \"display\": \"Malignant neoplasm of long bones of lower limb\"\n          },\n          {\n            \"code\": \"170.8\",\n            \"display\": \"Malignant neoplasm of short bones of lower limb\"\n          },\n          {\n            \"code\": \"170.9\",\n            \"display\": \"Malignant neoplasm of bone and articular cartilage, site unspecified\"\n          },\n          {\n            \"code\": \"171\",\n            \"display\": \"Malignant neoplasm of connective and other soft tissue\"\n          },\n          {\n            \"code\": \"171.2\",\n            \"display\": \"Malignant neoplasm of connective and other soft tissue of upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"171.3\",\n            \"display\": \"Malignant neoplasm of connective and other soft tissue of lower limb, including hip\"\n          },\n          {\n            \"code\": \"171.4\",\n            \"display\": \"Malignant neoplasm of connective and other soft tissue of thorax\"\n          },\n          {\n            \"code\": \"171.5\",\n            \"display\": \"Malignant neoplasm of connective and other soft tissue of abdomen\"\n          },\n          {\n            \"code\": \"171.6\",\n            \"display\": \"Malignant neoplasm of connective and other soft tissue of pelvis\"\n          },\n          {\n            \"code\": \"171.7\",\n            \"display\": \"Malignant neoplasm of connective and other soft tissue of trunk, unspecified\"\n          },\n          {\n            \"code\": \"171.8\",\n            \"display\": \"Malignant neoplasm of other specified sites of connective and other soft tissue\"\n          },\n          {\n            \"code\": \"171.9\",\n            \"display\": \"Malignant neoplasm of connective and other soft tissue, site unspecified\"\n          },\n          {\n            \"code\": \"172\",\n            \"display\": \"Malignant melanoma of skin\"\n          },\n          {\n            \"code\": \"172.1\",\n            \"display\": \"Malignant melanoma of skin of eyelid, including canthus\"\n          },\n          {\n            \"code\": \"172.2\",\n            \"display\": \"Malignant melanoma of skin of ear and external auditory canal\"\n          },\n          {\n            \"code\": \"172.3\",\n            \"display\": \"Malignant melanoma of skin of other and unspecified parts of face\"\n          },\n          {\n            \"code\": \"172.4\",\n            \"display\": \"Malignant melanoma of skin of scalp and neck\"\n          },\n          {\n            \"code\": \"172.5\",\n            \"display\": \"Malignant melanoma of skin of trunk, except scrotum\"\n          },\n          {\n            \"code\": \"172.6\",\n            \"display\": \"Malignant melanoma of skin of upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"172.7\",\n            \"display\": \"Malignant melanoma of skin of lower limb, including hip\"\n          },\n          {\n            \"code\": \"172.8\",\n            \"display\": \"Malignant melanoma of other specified sites of skin\"\n          },\n          {\n            \"code\": \"172.9\",\n            \"display\": \"Melanoma of skin, site unspecified\"\n          },\n          {\n            \"code\": \"173\",\n            \"display\": \"Other and unspecified malignant neoplasm of skin\"\n          },\n          {\n            \"code\": \"173.01\",\n            \"display\": \"Basal cell carcinoma of skin of lip\"\n          },\n          {\n            \"code\": \"173.02\",\n            \"display\": \"Squamous cell carcinoma of skin of lip\"\n          },\n          {\n            \"code\": \"173.09\",\n            \"display\": \"Other specified malignant neoplasm of skin of lip\"\n          },\n          {\n            \"code\": \"173.1\",\n            \"display\": \"Other and unspecified malignant neoplasm of skin of eyelid, including canthus\"\n          },\n          {\n            \"code\": \"173.11\",\n            \"display\": \"Basal cell carcinoma of eyelid, including canthus\"\n          },\n          {\n            \"code\": \"173.12\",\n            \"display\": \"Squamous cell carcinoma of eyelid, including canthus\"\n          },\n          {\n            \"code\": \"173.19\",\n            \"display\": \"Other specified malignant neoplasm of eyelid, including canthus\"\n          },\n          {\n            \"code\": \"173.2\",\n            \"display\": \"Other and unspecified malignant neoplasm of skin of ear and external auditory canal\"\n          },\n          {\n            \"code\": \"173.21\",\n            \"display\": \"Basal cell carcinoma of skin of ear and external auditory canal\"\n          },\n          {\n            \"code\": \"173.22\",\n            \"display\": \"Squamous cell carcinoma of skin of ear and external auditory canal\"\n          },\n          {\n            \"code\": \"173.29\",\n            \"display\": \"Other specified malignant neoplasm of skin of ear and external auditory canal\"\n          },\n          {\n            \"code\": \"173.3\",\n            \"display\": \"Other and unspecified malignant neoplasm of skin of other and unspecified parts of face\"\n          },\n          {\n            \"code\": \"173.31\",\n            \"display\": \"Basal cell carcinoma of skin of other and unspecified parts of face\"\n          },\n          {\n            \"code\": \"173.32\",\n            \"display\": \"Squamous cell carcinoma of skin of other and unspecified parts of face\"\n          },\n          {\n            \"code\": \"173.39\",\n            \"display\": \"Other specified malignant neoplasm of skin of other and unspecified parts of face\"\n          },\n          {\n            \"code\": \"173.4\",\n            \"display\": \"Other and unspecified malignant neoplasm of scalp and skin of neck\"\n          },\n          {\n            \"code\": \"173.41\",\n            \"display\": \"Basal cell carcinoma of scalp and skin of neck\"\n          },\n          {\n            \"code\": \"173.42\",\n            \"display\": \"Squamous cell carcinoma of scalp and skin of neck\"\n          },\n          {\n            \"code\": \"173.49\",\n            \"display\": \"Other specified malignant neoplasm of scalp and skin of neck\"\n          },\n          {\n            \"code\": \"173.5\",\n            \"display\": \"Other and unspecified malignant neoplasm of skin of trunk, except scrotum\"\n          },\n          {\n            \"code\": \"173.51\",\n            \"display\": \"Basal cell carcinoma of skin of trunk, except scrotum\"\n          },\n          {\n            \"code\": \"173.52\",\n            \"display\": \"Squamous cell carcinoma of skin of trunk, except scrotum\"\n          },\n          {\n            \"code\": \"173.59\",\n            \"display\": \"Other specified malignant neoplasm of skin of trunk, except scrotum\"\n          },\n          {\n            \"code\": \"173.6\",\n            \"display\": \"Other and unspecified malignant neoplasm of skin of upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"173.61\",\n            \"display\": \"Basal cell carcinoma of skin of upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"173.62\",\n            \"display\": \"Squamous cell carcinoma of skin of upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"173.69\",\n            \"display\": \"Other specified malignant neoplasm of skin of upper limb, including shoulder\"\n          },\n          {\n            \"code\": \"173.7\",\n            \"display\": \"Other and unspecified malignant neoplasm of skin of lower limb, including hip\"\n          },\n          {\n            \"code\": \"173.71\",\n            \"display\": \"Basal cell carcinoma of skin of lower limb, including hip\"\n          },\n          {\n            \"code\": \"173.72\",\n            \"display\": \"Squamous cell carcinoma of skin of lower limb, including hip\"\n          },\n          {\n            \"code\": \"173.79\",\n            \"display\": \"Other specified malignant neoplasm of skin of lower limb, including hip\"\n          },\n          {\n            \"code\": \"173.8\",\n            \"display\": \"Other and unspecified malignant neoplasm of other specified sites of skin\"\n          },\n          {\n            \"code\": \"173.81\",\n            \"display\": \"Basal cell carcinoma of other specified sites of skin\"\n          },\n          {\n            \"code\": \"173.82\",\n            \"display\": \"Squamous cell carcinoma of other specified sites of skin\"\n          },\n          {\n            \"code\": \"173.89\",\n            \"display\": \"Other specified malignant neoplasm of other specified sites of skin\"\n          },\n          {\n            \"code\": \"173.9\",\n            \"display\": \"Other and unspecified malignant neoplasm of skin, site unspecified\"\n          },\n          {\n            \"code\": \"173.91\",\n            \"display\": \"Basal cell carcinoma of skin, site unspecified\"\n          },\n          {\n            \"code\": \"173.92\",\n            \"display\": \"Squamous cell carcinoma of skin, site unspecified\"\n          },\n          {\n            \"code\": \"173.99\",\n            \"display\": \"Other specified malignant neoplasm of skin, site unspecified\"\n          },\n          {\n            \"code\": \"174\",\n            \"display\": \"Malignant neoplasm of female breast\"\n          },\n          {\n            \"code\": \"174.1\",\n            \"display\": \"Malignant neoplasm of central portion of female breast\"\n          },\n          {\n            \"code\": \"174.2\",\n            \"display\": \"Malignant neoplasm of upper-inner quadrant of female breast\"\n          },\n          {\n            \"code\": \"174.3\",\n            \"display\": \"Malignant neoplasm of lower-inner quadrant of female breast\"\n          },\n          {\n            \"code\": \"174.4\",\n            \"display\": \"Malignant neoplasm of upper-outer quadrant of female breast\"\n          },\n          {\n            \"code\": \"174.5\",\n            \"display\": \"Malignant neoplasm of lower-outer quadrant of female breast\"\n          },\n          {\n            \"code\": \"174.6\",\n            \"display\": \"Malignant neoplasm of axillary tail of female breast\"\n          },\n          {\n            \"code\": \"174.8\",\n            \"display\": \"Malignant neoplasm of other specified sites of female breast\"\n          },\n          {\n            \"code\": \"174.9\",\n            \"display\": \"Malignant neoplasm of breast (female), unspecified\"\n          },\n          {\n            \"code\": \"175\",\n            \"display\": \"Malignant neoplasm of male breast\"\n          },\n          {\n            \"code\": \"175.9\",\n            \"display\": \"Malignant neoplasm of other and unspecified sites of male breast\"\n          },\n          {\n            \"code\": \"176\",\n            \"display\": \"Kaposi's sarcoma\"\n          },\n          {\n            \"code\": \"176.1\",\n            \"display\": \"Kaposi's sarcoma, soft tissue\"\n          },\n          {\n            \"code\": \"176.2\",\n            \"display\": \"Kaposi's sarcoma, palate\"\n          },\n          {\n            \"code\": \"176.3\",\n            \"display\": \"Kaposi's sarcoma, gastrointestinal sites\"\n          },\n          {\n            \"code\": \"176.4\",\n            \"display\": \"Kaposi's sarcoma, lung\"\n          },\n          {\n            \"code\": \"176.5\",\n            \"display\": \"Kaposi's sarcoma, lymph nodes\"\n          },\n          {\n            \"code\": \"176.8\",\n            \"display\": \"Kaposi's sarcoma, other specified sites\"\n          },\n          {\n            \"code\": \"176.9\",\n            \"display\": \"Kaposi's sarcoma, unspecified site\"\n          },\n          {\n            \"code\": \"179\",\n            \"display\": \"Malignant neoplasm of uterus, part unspecified\"\n          },\n          {\n            \"code\": \"180\",\n            \"display\": \"Malignant neoplasm of cervix uteri\"\n          },\n          {\n            \"code\": \"180.1\",\n            \"display\": \"Malignant neoplasm of exocervix\"\n          },\n          {\n            \"code\": \"180.8\",\n            \"display\": \"Malignant neoplasm of other specified sites of cervix\"\n          },\n          {\n            \"code\": \"180.9\",\n            \"display\": \"Malignant neoplasm of cervix uteri, unspecified site\"\n          },\n          {\n            \"code\": \"181\",\n            \"display\": \"Malignant neoplasm of placenta\"\n          },\n          {\n            \"code\": \"182\",\n            \"display\": \"Malignant neoplasm of body of uterus\"\n          },\n          {\n            \"code\": \"182.1\",\n            \"display\": \"Malignant neoplasm of isthmus\"\n          },\n          {\n            \"code\": \"182.8\",\n            \"display\": \"Malignant neoplasm of other specified sites of body of uterus\"\n          },\n          {\n            \"code\": \"183\",\n            \"display\": \"Malignant neoplasm of ovary and other uterine adnexa\"\n          },\n          {\n            \"code\": \"183.2\",\n            \"display\": \"Malignant neoplasm of fallopian tube\"\n          },\n          {\n            \"code\": \"183.3\",\n            \"display\": \"Malignant neoplasm of broad ligament of uterus\"\n          },\n          {\n            \"code\": \"183.4\",\n            \"display\": \"Malignant neoplasm of parametrium\"\n          },\n          {\n            \"code\": \"183.5\",\n            \"display\": \"Malignant neoplasm of round ligament of uterus\"\n          },\n          {\n            \"code\": \"183.8\",\n            \"display\": \"Malignant neoplasm of other specified sites of uterine adnexa\"\n          },\n          {\n            \"code\": \"183.9\",\n            \"display\": \"Malignant neoplasm of uterine adnexa, unspecified site\"\n          },\n          {\n            \"code\": \"184\",\n            \"display\": \"Malignant neoplasm of other and unspecified female genital organs\"\n          },\n          {\n            \"code\": \"184.1\",\n            \"display\": \"Malignant neoplasm of labia majora\"\n          },\n          {\n            \"code\": \"184.2\",\n            \"display\": \"Malignant neoplasm of labia minora\"\n          },\n          {\n            \"code\": \"184.3\",\n            \"display\": \"Malignant neoplasm of clitoris\"\n          },\n          {\n            \"code\": \"184.4\",\n            \"display\": \"Malignant neoplasm of vulva, unspecified site\"\n          },\n          {\n            \"code\": \"184.8\",\n            \"display\": \"Malignant neoplasm of other specified sites of female genital organs\"\n          },\n          {\n            \"code\": \"184.9\",\n            \"display\": \"Malignant neoplasm of female genital organ, site unspecified\"\n          },\n          {\n            \"code\": \"185\",\n            \"display\": \"Malignant neoplasm of prostate\"\n          },\n          {\n            \"code\": \"186\",\n            \"display\": \"Malignant neoplasm of testis\"\n          },\n          {\n            \"code\": \"186.9\",\n            \"display\": \"Malignant neoplasm of other and unspecified testis\"\n          },\n          {\n            \"code\": \"187.1\",\n            \"display\": \"Malignant neoplasm of prepuce\"\n          },\n          {\n            \"code\": \"187.2\",\n            \"display\": \"Malignant neoplasm of glans penis\"\n          },\n          {\n            \"code\": \"187.3\",\n            \"display\": \"Malignant neoplasm of body of penis\"\n          },\n          {\n            \"code\": \"187.4\",\n            \"display\": \"Malignant neoplasm of penis, part unspecified\"\n          },\n          {\n            \"code\": \"187.5\",\n            \"display\": \"Malignant neoplasm of epididymis\"\n          },\n          {\n            \"code\": \"187.6\",\n            \"display\": \"Malignant neoplasm of spermatic cord\"\n          },\n          {\n            \"code\": \"187.7\",\n            \"display\": \"Malignant neoplasm of scrotum\"\n          },\n          {\n            \"code\": \"187.8\",\n            \"display\": \"Malignant neoplasm of other specified sites of male genital organs\"\n          },\n          {\n            \"code\": \"187.9\",\n            \"display\": \"Malignant neoplasm of male genital organ, site unspecified\"\n          },\n          {\n            \"code\": \"188\",\n            \"display\": \"Malignant neoplasm of bladder\"\n          },\n          {\n            \"code\": \"188.1\",\n            \"display\": \"Malignant neoplasm of dome of urinary bladder\"\n          },\n          {\n            \"code\": \"188.2\",\n            \"display\": \"Malignant neoplasm of lateral wall of urinary bladder\"\n          },\n          {\n            \"code\": \"188.3\",\n            \"display\": \"Malignant neoplasm of anterior wall of urinary bladder\"\n          },\n          {\n            \"code\": \"188.4\",\n            \"display\": \"Malignant neoplasm of posterior wall of urinary bladder\"\n          },\n          {\n            \"code\": \"188.5\",\n            \"display\": \"Malignant neoplasm of bladder neck\"\n          },\n          {\n            \"code\": \"188.6\",\n            \"display\": \"Malignant neoplasm of ureteric orifice\"\n          },\n          {\n            \"code\": \"188.7\",\n            \"display\": \"Malignant neoplasm of urachus\"\n          },\n          {\n            \"code\": \"188.8\",\n            \"display\": \"Malignant neoplasm of other specified sites of bladder\"\n          },\n          {\n            \"code\": \"188.9\",\n            \"display\": \"Malignant neoplasm of bladder, part unspecified\"\n          },\n          {\n            \"code\": \"189\",\n            \"display\": \"Malignant neoplasm of kidney and other and unspecified urinary organs\"\n          },\n          {\n            \"code\": \"189.1\",\n            \"display\": \"Malignant neoplasm of renal pelvis\"\n          },\n          {\n            \"code\": \"189.2\",\n            \"display\": \"Malignant neoplasm of ureter\"\n          },\n          {\n            \"code\": \"189.3\",\n            \"display\": \"Malignant neoplasm of urethra\"\n          },\n          {\n            \"code\": \"189.4\",\n            \"display\": \"Malignant neoplasm of paraurethral glands\"\n          },\n          {\n            \"code\": \"189.8\",\n            \"display\": \"Malignant neoplasm of other specified sites of urinary organs\"\n          },\n          {\n            \"code\": \"189.9\",\n            \"display\": \"Malignant neoplasm of urinary organ, site unspecified\"\n          },\n          {\n            \"code\": \"190\",\n            \"display\": \"Malignant neoplasm of eye\"\n          },\n          {\n            \"code\": \"190.1\",\n            \"display\": \"Malignant neoplasm of orbit\"\n          },\n          {\n            \"code\": \"190.2\",\n            \"display\": \"Malignant neoplasm of lacrimal gland\"\n          },\n          {\n            \"code\": \"190.3\",\n            \"display\": \"Malignant neoplasm of conjunctiva\"\n          },\n          {\n            \"code\": \"190.4\",\n            \"display\": \"Malignant neoplasm of cornea\"\n          },\n          {\n            \"code\": \"190.5\",\n            \"display\": \"Malignant neoplasm of retina\"\n          },\n          {\n            \"code\": \"190.6\",\n            \"display\": \"Malignant neoplasm of choroid\"\n          },\n          {\n            \"code\": \"190.7\",\n            \"display\": \"Malignant neoplasm of lacrimal duct\"\n          },\n          {\n            \"code\": \"190.8\",\n            \"display\": \"Malignant neoplasm of other specified sites of eye\"\n          },\n          {\n            \"code\": \"190.9\",\n            \"display\": \"Malignant neoplasm of eye, part unspecified\"\n          },\n          {\n            \"code\": \"191\",\n            \"display\": \"Malignant neoplasm of brain\"\n          },\n          {\n            \"code\": \"191.1\",\n            \"display\": \"Malignant neoplasm of frontal lobe\"\n          },\n          {\n            \"code\": \"191.2\",\n            \"display\": \"Malignant neoplasm of temporal lobe\"\n          },\n          {\n            \"code\": \"191.3\",\n            \"display\": \"Malignant neoplasm of parietal lobe\"\n          },\n          {\n            \"code\": \"191.4\",\n            \"display\": \"Malignant neoplasm of occipital lobe\"\n          },\n          {\n            \"code\": \"191.5\",\n            \"display\": \"Malignant neoplasm of ventricles\"\n          },\n          {\n            \"code\": \"191.6\",\n            \"display\": \"Malignant neoplasm of cerebellum nos\"\n          },\n          {\n            \"code\": \"191.7\",\n            \"display\": \"Malignant neoplasm of brain stem\"\n          },\n          {\n            \"code\": \"191.8\",\n            \"display\": \"Malignant neoplasm of other parts of brain\"\n          },\n          {\n            \"code\": \"191.9\",\n            \"display\": \"Malignant neoplasm of brain, unspecified\"\n          },\n          {\n            \"code\": \"192\",\n            \"display\": \"Malignant neoplasm of other and unspecified parts of nervous system\"\n          },\n          {\n            \"code\": \"192.1\",\n            \"display\": \"Malignant neoplasm of cerebral meninges\"\n          },\n          {\n            \"code\": \"192.2\",\n            \"display\": \"Malignant neoplasm of spinal cord\"\n          },\n          {\n            \"code\": \"192.3\",\n            \"display\": \"Malignant neoplasm of spinal meninges\"\n          },\n          {\n            \"code\": \"192.8\",\n            \"display\": \"Malignant neoplasm of other specified sites of nervous system\"\n          },\n          {\n            \"code\": \"192.9\",\n            \"display\": \"Malignant neoplasm of nervous system, part unspecified\"\n          },\n          {\n            \"code\": \"193\",\n            \"display\": \"Malignant neoplasm of thyroid gland\"\n          },\n          {\n            \"code\": \"194\",\n            \"display\": \"Malignant neoplasm of other endocrine glands and related structures\"\n          },\n          {\n            \"code\": \"194.1\",\n            \"display\": \"Malignant neoplasm of parathyroid gland\"\n          },\n          {\n            \"code\": \"194.3\",\n            \"display\": \"Malignant neoplasm of pituitary gland and craniopharyngeal duct\"\n          },\n          {\n            \"code\": \"194.4\",\n            \"display\": \"Malignant neoplasm of pineal gland\"\n          },\n          {\n            \"code\": \"194.5\",\n            \"display\": \"Malignant neoplasm of carotid body\"\n          },\n          {\n            \"code\": \"194.6\",\n            \"display\": \"Malignant neoplasm of aortic body and other paraganglia\"\n          },\n          {\n            \"code\": \"194.8\",\n            \"display\": \"Malignant neoplasm of other endocrine glands and related structures\"\n          },\n          {\n            \"code\": \"194.9\",\n            \"display\": \"Malignant neoplasm of endocrine gland, site unspecified\"\n          },\n          {\n            \"code\": \"195\",\n            \"display\": \"Malignant neoplasm of other and ill-defined sites\"\n          },\n          {\n            \"code\": \"195.1\",\n            \"display\": \"Malignant neoplasm of thorax\"\n          },\n          {\n            \"code\": \"195.2\",\n            \"display\": \"Malignant neoplasm of abdomen\"\n          },\n          {\n            \"code\": \"195.3\",\n            \"display\": \"Malignant neoplasm of pelvis\"\n          },\n          {\n            \"code\": \"195.4\",\n            \"display\": \"Malignant neoplasm of upper limb\"\n          },\n          {\n            \"code\": \"195.5\",\n            \"display\": \"Malignant neoplasm of lower limb\"\n          },\n          {\n            \"code\": \"195.8\",\n            \"display\": \"Malignant neoplasm of other specified sites\"\n          },\n          {\n            \"code\": \"196\",\n            \"display\": \"Secondary and unspecified malignant neoplasm of lymph nodes\"\n          },\n          {\n            \"code\": \"196.1\",\n            \"display\": \"Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"196.2\",\n            \"display\": \"Secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"196.3\",\n            \"display\": \"Secondary and unspecified malignant neoplasm of lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"196.5\",\n            \"display\": \"Secondary and unspecified malignant neoplasm of lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"196.6\",\n            \"display\": \"Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"196.8\",\n            \"display\": \"Secondary and unspecified malignant neoplasm of lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"196.9\",\n            \"display\": \"Secondary and unspecified malignant neoplasm of lymph nodes, site unspecified\"\n          },\n          {\n            \"code\": \"197\",\n            \"display\": \"Secondary malignant neoplasm of respiratory and digestive systems\"\n          },\n          {\n            \"code\": \"197.1\",\n            \"display\": \"Secondary malignant neoplasm of mediastinum\"\n          },\n          {\n            \"code\": \"197.2\",\n            \"display\": \"Secondary malignant neoplasm of pleura\"\n          },\n          {\n            \"code\": \"197.3\",\n            \"display\": \"Secondary malignant neoplasm of other respiratory organs\"\n          },\n          {\n            \"code\": \"197.4\",\n            \"display\": \"Secondary malignant neoplasm of small intestine including duodenum\"\n          },\n          {\n            \"code\": \"197.5\",\n            \"display\": \"Secondary malignant neoplasm of large intestine and rectum\"\n          },\n          {\n            \"code\": \"197.6\",\n            \"display\": \"Secondary malignant neoplasm of retroperitoneum and peritoneum\"\n          },\n          {\n            \"code\": \"197.7\",\n            \"display\": \"Malignant neoplasm of liver, secondary\"\n          },\n          {\n            \"code\": \"197.8\",\n            \"display\": \"Secondary malignant neoplasm of other digestive organs and spleen\"\n          },\n          {\n            \"code\": \"198\",\n            \"display\": \"Secondary malignant neoplasm of other specified sites\"\n          },\n          {\n            \"code\": \"198.1\",\n            \"display\": \"Secondary malignant neoplasm of other urinary organs\"\n          },\n          {\n            \"code\": \"198.2\",\n            \"display\": \"Secondary malignant neoplasm of skin\"\n          },\n          {\n            \"code\": \"198.3\",\n            \"display\": \"Secondary malignant neoplasm of brain and spinal cord\"\n          },\n          {\n            \"code\": \"198.4\",\n            \"display\": \"Secondary malignant neoplasm of other parts of nervous system\"\n          },\n          {\n            \"code\": \"198.5\",\n            \"display\": \"Secondary malignant neoplasm of bone and bone marrow\"\n          },\n          {\n            \"code\": \"198.6\",\n            \"display\": \"Secondary malignant neoplasm of ovary\"\n          },\n          {\n            \"code\": \"198.7\",\n            \"display\": \"Secondary malignant neoplasm of adrenal gland\"\n          },\n          {\n            \"code\": \"198.81\",\n            \"display\": \"Secondary malignant neoplasm of breast\"\n          },\n          {\n            \"code\": \"198.82\",\n            \"display\": \"Secondary malignant neoplasm of genital organs\"\n          },\n          {\n            \"code\": \"198.89\",\n            \"display\": \"Secondary malignant neoplasm of other specified sites\"\n          },\n          {\n            \"code\": \"199\",\n            \"display\": \"Malignant neoplasm without specification of site\"\n          },\n          {\n            \"code\": \"199.1\",\n            \"display\": \"Other malignant neoplasm without specification of site\"\n          },\n          {\n            \"code\": \"200\",\n            \"display\": \"Lymphosarcoma and reticulosarcoma and other specified malignant tumors of lymphatic tissue\"\n          },\n          {\n            \"code\": \"200.01\",\n            \"display\": \"Reticulosarcoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"200.02\",\n            \"display\": \"Reticulosarcoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"200.03\",\n            \"display\": \"Reticulosarcoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"200.04\",\n            \"display\": \"Reticulosarcoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"200.05\",\n            \"display\": \"Reticulosarcoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"200.06\",\n            \"display\": \"Reticulosarcoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"200.07\",\n            \"display\": \"Reticulosarcoma, spleen\"\n          },\n          {\n            \"code\": \"200.08\",\n            \"display\": \"Reticulosarcoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"200.1\",\n            \"display\": \"Lymphosarcoma\"\n          },\n          {\n            \"code\": \"200.11\",\n            \"display\": \"Lymphosarcoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"200.12\",\n            \"display\": \"Lymphosarcoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"200.13\",\n            \"display\": \"Lymphosarcoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"200.14\",\n            \"display\": \"Lymphosarcoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"200.15\",\n            \"display\": \"Lymphosarcoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"200.16\",\n            \"display\": \"Lymphosarcoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"200.17\",\n            \"display\": \"Lymphosarcoma, spleen\"\n          },\n          {\n            \"code\": \"200.18\",\n            \"display\": \"Lymphosarcoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"200.2\",\n            \"display\": \"Burkitt's tumor or lymphoma\"\n          },\n          {\n            \"code\": \"200.21\",\n            \"display\": \"Burkitt's tumor or lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"200.22\",\n            \"display\": \"Burkitt's tumor or lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"200.23\",\n            \"display\": \"Burkitt's tumor or lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"200.24\",\n            \"display\": \"Burkitt's tumor or lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"200.25\",\n            \"display\": \"Burkitt's tumor or lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"200.26\",\n            \"display\": \"Burkitt's tumor or lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"200.27\",\n            \"display\": \"Burkitt's tumor or lymphoma, spleen\"\n          },\n          {\n            \"code\": \"200.28\",\n            \"display\": \"Burkitt's tumor or lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"200.3\",\n            \"display\": \"Marginal zone lymphoma\"\n          },\n          {\n            \"code\": \"200.31\",\n            \"display\": \"Marginal zone lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"200.32\",\n            \"display\": \"Marginal zone lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"200.33\",\n            \"display\": \"Marginal zone lymphoma, intraabdominal lymph nodes\"\n          },\n          {\n            \"code\": \"200.34\",\n            \"display\": \"Marginal zone lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"200.35\",\n            \"display\": \"Marginal zone lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"200.36\",\n            \"display\": \"Marginal zone lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"200.37\",\n            \"display\": \"Marginal zone lymphoma, spleen\"\n          },\n          {\n            \"code\": \"200.38\",\n            \"display\": \"Marginal zone lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"200.4\",\n            \"display\": \"Mantle cell lymphoma\"\n          },\n          {\n            \"code\": \"200.41\",\n            \"display\": \"Mantle cell lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"200.42\",\n            \"display\": \"Mantle cell lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"200.43\",\n            \"display\": \"Mantle cell lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"200.44\",\n            \"display\": \"Mantle cell lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"200.45\",\n            \"display\": \"Mantle cell lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"200.46\",\n            \"display\": \"Mantle cell lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"200.47\",\n            \"display\": \"Mantle cell lymphoma, spleen\"\n          },\n          {\n            \"code\": \"200.48\",\n            \"display\": \"Mantle cell lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"200.5\",\n            \"display\": \"Primary central nervous system lymphoma\"\n          },\n          {\n            \"code\": \"200.51\",\n            \"display\": \"Primary central nervous system lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"200.52\",\n            \"display\": \"Primary central nervous system lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"200.53\",\n            \"display\": \"Primary central nervous system lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"200.54\",\n            \"display\": \"Primary central nervous system lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"200.55\",\n            \"display\": \"Primary central nervous system lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"200.56\",\n            \"display\": \"Primary central nervous system lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"200.57\",\n            \"display\": \"Primary central nervous system lymphoma, spleen\"\n          },\n          {\n            \"code\": \"200.58\",\n            \"display\": \"Primary central nervous system lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"200.6\",\n            \"display\": \"Anaplastic large cell lymphoma\"\n          },\n          {\n            \"code\": \"200.61\",\n            \"display\": \"Anaplastic large cell lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"200.62\",\n            \"display\": \"Anaplastic large cell lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"200.63\",\n            \"display\": \"Anaplastic large cell lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"200.64\",\n            \"display\": \"Anaplastic large cell lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"200.65\",\n            \"display\": \"Anaplastic large cell lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"200.66\",\n            \"display\": \"Anaplastic large cell lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"200.67\",\n            \"display\": \"Anaplastic large cell lymphoma, spleen\"\n          },\n          {\n            \"code\": \"200.68\",\n            \"display\": \"Anaplastic large cell lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"200.7\",\n            \"display\": \"Large cell lymphoma\"\n          },\n          {\n            \"code\": \"200.71\",\n            \"display\": \"Large cell lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"200.72\",\n            \"display\": \"Large cell lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"200.73\",\n            \"display\": \"Large cell lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"200.74\",\n            \"display\": \"Large cell lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"200.75\",\n            \"display\": \"Large cell lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"200.76\",\n            \"display\": \"Large cell lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"200.77\",\n            \"display\": \"Large cell lymphoma, spleen\"\n          },\n          {\n            \"code\": \"200.78\",\n            \"display\": \"Large cell lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"200.8\",\n            \"display\": \"Other named variants of lymphosarcoma and reticulosarcoma\"\n          },\n          {\n            \"code\": \"200.81\",\n            \"display\": \"Other named variants of lymphosarcoma and reticulosarcoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"200.82\",\n            \"display\": \"Other named variants of lymphosarcoma and reticulosarcoma,intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"200.83\",\n            \"display\": \"Other named variants of lymphosarcoma and reticulosarcoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"200.84\",\n            \"display\": \"Other named variants of lymphosarcoma and reticulosarcoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"200.85\",\n            \"display\": \"Other named variants of lymphosarcoma and reticulosarcoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"200.86\",\n            \"display\": \"Other named variants of lymphosarcoma and reticulosarcoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"200.87\",\n            \"display\": \"Other named variants of lymphosarcoma and reticulosarcoma, spleen\"\n          },\n          {\n            \"code\": \"200.88\",\n            \"display\": \"Other named variants of lymphosarcoma and reticulosarcoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"201\",\n            \"display\": \"Hodgkin's disease\"\n          },\n          {\n            \"code\": \"201.01\",\n            \"display\": \"Hodgkin's paragranuloma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"201.02\",\n            \"display\": \"Hodgkin's paragranuloma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"201.03\",\n            \"display\": \"Hodgkin's paragranuloma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"201.04\",\n            \"display\": \"Hodgkin's paragranuloma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"201.05\",\n            \"display\": \"Hodgkin's paragranuloma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"201.06\",\n            \"display\": \"Hodgkin's paragranuloma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"201.07\",\n            \"display\": \"Hodgkin's paragranuloma, spleen\"\n          },\n          {\n            \"code\": \"201.08\",\n            \"display\": \"Hodgkin's paragranuloma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"201.1\",\n            \"display\": \"Hodgkin's granuloma\"\n          },\n          {\n            \"code\": \"201.11\",\n            \"display\": \"Hodgkin's granuloma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"201.12\",\n            \"display\": \"Hodgkin's granuloma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"201.13\",\n            \"display\": \"Hodgkin's granuloma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"201.14\",\n            \"display\": \"Hodgkin's granuloma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"201.15\",\n            \"display\": \"Hodgkin's granuloma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"201.16\",\n            \"display\": \"Hodgkin's granuloma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"201.17\",\n            \"display\": \"Hodgkin's granuloma, spleen\"\n          },\n          {\n            \"code\": \"201.18\",\n            \"display\": \"Hodgkin's granuloma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"201.2\",\n            \"display\": \"Hodgkin's sarcoma\"\n          },\n          {\n            \"code\": \"201.21\",\n            \"display\": \"Hodgkin's sarcoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"201.22\",\n            \"display\": \"Hodgkin's sarcoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"201.23\",\n            \"display\": \"Hodgkin's sarcoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"201.24\",\n            \"display\": \"Hodgkin's sarcoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"201.25\",\n            \"display\": \"Hodgkin's sarcoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"201.26\",\n            \"display\": \"Hodgkin's sarcoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"201.27\",\n            \"display\": \"Hodgkin's sarcoma, spleen\"\n          },\n          {\n            \"code\": \"201.28\",\n            \"display\": \"Hodgkin's sarcoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"201.4\",\n            \"display\": \"Hodgkin's disease, lymphocytic-histiocytic predominance\"\n          },\n          {\n            \"code\": \"201.41\",\n            \"display\": \"Hodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"201.42\",\n            \"display\": \"Hodgkin's disease, lymphocytic-histiocytic predominance, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"201.43\",\n            \"display\": \"Hodgkin's disease, lymphocytic-histiocytic predominance, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"201.44\",\n            \"display\": \"Hodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"201.45\",\n            \"display\": \"Hodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"201.46\",\n            \"display\": \"Hodgkin's disease, lymphocytic-histiocytic predominance, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"201.47\",\n            \"display\": \"Hodgkin's disease, lymphocytic-histiocytic predominance, spleen\"\n          },\n          {\n            \"code\": \"201.48\",\n            \"display\": \"Hodgkin's disease, lymphocytic-histiocytic predominance, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"201.5\",\n            \"display\": \"Hodgkin's disease, nodular sclerosis\"\n          },\n          {\n            \"code\": \"201.51\",\n            \"display\": \"Hodgkin's disease, nodular sclerosis, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"201.52\",\n            \"display\": \"Hodgkin's disease, nodular sclerosis, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"201.53\",\n            \"display\": \"Hodgkin's disease, nodular sclerosis, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"201.54\",\n            \"display\": \"Hodgkin's disease, nodular sclerosis, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"201.55\",\n            \"display\": \"Hodgkin's disease, nodular sclerosis, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"201.56\",\n            \"display\": \"Hodgkin's disease, nodular sclerosis, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"201.57\",\n            \"display\": \"Hodgkin's disease, nodular sclerosis, spleen\"\n          },\n          {\n            \"code\": \"201.58\",\n            \"display\": \"Hodgkin's disease, nodular sclerosis, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"201.6\",\n            \"display\": \"Hodgkin's disease, mixed cellularity\"\n          },\n          {\n            \"code\": \"201.61\",\n            \"display\": \"Hodgkin's disease, mixed cellularity, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"201.62\",\n            \"display\": \"Hodgkin's disease, mixed cellularity, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"201.63\",\n            \"display\": \"Hodgkin's disease, mixed cellularity, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"201.64\",\n            \"display\": \"Hodgkin's disease, mixed cellularity, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"201.65\",\n            \"display\": \"Hodgkin's disease, mixed cellularity, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"201.66\",\n            \"display\": \"Hodgkin's disease, mixed cellularity, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"201.67\",\n            \"display\": \"Hodgkin's disease, mixed cellularity, spleen\"\n          },\n          {\n            \"code\": \"201.68\",\n            \"display\": \"Hodgkin's disease, mixed cellularity, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"201.7\",\n            \"display\": \"Hodgkin's disease, lymphocytic depletion\"\n          },\n          {\n            \"code\": \"201.71\",\n            \"display\": \"Hodgkin's disease, lymphocytic depletion, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"201.72\",\n            \"display\": \"Hodgkin's disease, lymphocytic depletion, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"201.73\",\n            \"display\": \"Hodgkin's disease, lymphocytic depletion, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"201.74\",\n            \"display\": \"Hodgkin's disease, lymphocytic depletion, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"201.75\",\n            \"display\": \"Hodgkin's disease, lymphocytic depletion, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"201.76\",\n            \"display\": \"Hodgkin's disease, lymphocytic depletion, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"201.77\",\n            \"display\": \"Hodgkin's disease, lymphocytic depletion, spleen\"\n          },\n          {\n            \"code\": \"201.78\",\n            \"display\": \"Hodgkin's disease, lymphocytic depletion, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"201.9\",\n            \"display\": \"Hodgkin's disease, unspecified type\"\n          },\n          {\n            \"code\": \"201.91\",\n            \"display\": \"Hodgkin's disease, unspecified type, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"201.92\",\n            \"display\": \"Hodgkin's disease, unspecified type, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"201.93\",\n            \"display\": \"Hodgkin's disease, unspecified type, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"201.94\",\n            \"display\": \"Hodgkin's disease, unspecified type, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"201.95\",\n            \"display\": \"Hodgkin's disease, unspecified type, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"201.96\",\n            \"display\": \"Hodgkin's disease, unspecified type, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"201.97\",\n            \"display\": \"Hodgkin's disease, unspecified type, spleen\"\n          },\n          {\n            \"code\": \"201.98\",\n            \"display\": \"Hodgkin's disease, unspecified type, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"202\",\n            \"display\": \"Other malignant neoplasms of lymphoid and histiocytic tissue\"\n          },\n          {\n            \"code\": \"202.01\",\n            \"display\": \"Nodular lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"202.02\",\n            \"display\": \"Nodular lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"202.03\",\n            \"display\": \"Nodular lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"202.04\",\n            \"display\": \"Nodular lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"202.05\",\n            \"display\": \"Nodular lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"202.06\",\n            \"display\": \"Nodular lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"202.07\",\n            \"display\": \"Nodular lymphoma, spleen\"\n          },\n          {\n            \"code\": \"202.08\",\n            \"display\": \"Nodular lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"202.1\",\n            \"display\": \"Mycosis fungoides\"\n          },\n          {\n            \"code\": \"202.11\",\n            \"display\": \"Mycosis fungoides, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"202.12\",\n            \"display\": \"Mycosis fungoides, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"202.13\",\n            \"display\": \"Mycosis fungoides, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"202.14\",\n            \"display\": \"Mycosis fungoides, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"202.15\",\n            \"display\": \"Mycosis fungoides, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"202.16\",\n            \"display\": \"Mycosis fungoides, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"202.17\",\n            \"display\": \"Mycosis fungoides, spleen\"\n          },\n          {\n            \"code\": \"202.18\",\n            \"display\": \"Mycosis fungoides, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"202.2\",\n            \"display\": \"Sezary's disease\"\n          },\n          {\n            \"code\": \"202.21\",\n            \"display\": \"Sezary's disease, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"202.22\",\n            \"display\": \"Sezary's disease, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"202.23\",\n            \"display\": \"Sezary's disease, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"202.24\",\n            \"display\": \"Sezary's disease, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"202.25\",\n            \"display\": \"Sezary's disease, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"202.26\",\n            \"display\": \"Sezary's disease, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"202.27\",\n            \"display\": \"Sezary's disease, spleen\"\n          },\n          {\n            \"code\": \"202.28\",\n            \"display\": \"Sezary's disease, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"202.3\",\n            \"display\": \"Malignant histiocytosis\"\n          },\n          {\n            \"code\": \"202.31\",\n            \"display\": \"Malignant histiocytosis, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"202.32\",\n            \"display\": \"Malignant histiocytosis, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"202.33\",\n            \"display\": \"Malignant histiocytosis, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"202.34\",\n            \"display\": \"Malignant histiocytosis, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"202.35\",\n            \"display\": \"Malignant histiocytosis, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"202.36\",\n            \"display\": \"Malignant histiocytosis, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"202.37\",\n            \"display\": \"Malignant histiocytosis, spleen\"\n          },\n          {\n            \"code\": \"202.38\",\n            \"display\": \"Malignant histiocytosis, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"202.4\",\n            \"display\": \"Leukemic reticuloendotheliosis\"\n          },\n          {\n            \"code\": \"202.41\",\n            \"display\": \"Leukemic reticuloendotheliosis, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"202.42\",\n            \"display\": \"Leukemic reticuloendotheliosis, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"202.43\",\n            \"display\": \"Leukemic reticuloendotheliosis, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"202.44\",\n            \"display\": \"Leukemic reticuloendotheliosis, lymph nodes of axilla and upper arm\"\n          },\n          {\n            \"code\": \"202.45\",\n            \"display\": \"Leukemic reticuloendotheliosis, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"202.46\",\n            \"display\": \"Leukemic reticuloendotheliosis, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"202.47\",\n            \"display\": \"Leukemic reticuloendotheliosis, spleen\"\n          },\n          {\n            \"code\": \"202.48\",\n            \"display\": \"Leukemic reticuloendotheliosis, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"202.5\",\n            \"display\": \"Letterer-Siwe disease\"\n          },\n          {\n            \"code\": \"202.51\",\n            \"display\": \"Letterer-siwe disease, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"202.52\",\n            \"display\": \"Letterer-siwe disease, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"202.53\",\n            \"display\": \"Letterer-siwe disease, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"202.54\",\n            \"display\": \"Letterer-siwe disease, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"202.55\",\n            \"display\": \"Letterer-siwe disease, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"202.56\",\n            \"display\": \"Letterer-siwe disease, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"202.57\",\n            \"display\": \"Letterer-siwe disease, spleen\"\n          },\n          {\n            \"code\": \"202.58\",\n            \"display\": \"Letterer-siwe disease, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"202.6\",\n            \"display\": \"Malignant mast cell tumors\"\n          },\n          {\n            \"code\": \"202.61\",\n            \"display\": \"Malignant mast cell tumors, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"202.62\",\n            \"display\": \"Malignant mast cell tumors, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"202.63\",\n            \"display\": \"Malignant mast cell tumors, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"202.64\",\n            \"display\": \"Malignant mast cell tumors, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"202.65\",\n            \"display\": \"Malignant mast cell tumors, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"202.66\",\n            \"display\": \"Malignant mast cell tumors, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"202.67\",\n            \"display\": \"Malignant mast cell tumors, spleen\"\n          },\n          {\n            \"code\": \"202.68\",\n            \"display\": \"Malignant mast cell tumors, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"202.7\",\n            \"display\": \"Peripheral T-cell lymphoma\"\n          },\n          {\n            \"code\": \"202.71\",\n            \"display\": \"Peripheral T cell lymphoma, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"202.72\",\n            \"display\": \"Peripheral T cell lymphoma, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"202.73\",\n            \"display\": \"Peripheral T cell lymphoma, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"202.74\",\n            \"display\": \"Peripheral T cell lymphoma, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"202.75\",\n            \"display\": \"Peripheral T cell lymphoma, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"202.76\",\n            \"display\": \"Peripheral T cell lymphoma, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"202.77\",\n            \"display\": \"Peripheral T cell lymphoma, spleen\"\n          },\n          {\n            \"code\": \"202.78\",\n            \"display\": \"Peripheral T cell lymphoma, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"202.8\",\n            \"display\": \"Other malignant lymphomas\"\n          },\n          {\n            \"code\": \"202.81\",\n            \"display\": \"Other malignant lymphomas, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"202.82\",\n            \"display\": \"Other malignant lymphomas, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"202.83\",\n            \"display\": \"Other malignant lymphomas, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"202.84\",\n            \"display\": \"Other malignant lymphomas, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"202.85\",\n            \"display\": \"Other malignant lymphomas, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"202.86\",\n            \"display\": \"Other malignant lymphomas, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"202.87\",\n            \"display\": \"Other malignant lymphomas, spleen\"\n          },\n          {\n            \"code\": \"202.88\",\n            \"display\": \"Other malignant lymphomas, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"202.9\",\n            \"display\": \"Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue\"\n          },\n          {\n            \"code\": \"202.91\",\n            \"display\": \"Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, lymph nodes of head, face, and neck\"\n          },\n          {\n            \"code\": \"202.92\",\n            \"display\": \"Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, intrathoracic lymph nodes\"\n          },\n          {\n            \"code\": \"202.93\",\n            \"display\": \"Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, intra-abdominal lymph nodes\"\n          },\n          {\n            \"code\": \"202.94\",\n            \"display\": \"Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, lymph nodes of axilla and upper limb\"\n          },\n          {\n            \"code\": \"202.95\",\n            \"display\": \"Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, lymph nodes of inguinal region and lower limb\"\n          },\n          {\n            \"code\": \"202.96\",\n            \"display\": \"Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, intrapelvic lymph nodes\"\n          },\n          {\n            \"code\": \"202.97\",\n            \"display\": \"Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, spleen\"\n          },\n          {\n            \"code\": \"202.98\",\n            \"display\": \"Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, lymph nodes of multiple sites\"\n          },\n          {\n            \"code\": \"203\",\n            \"display\": \"Multiple myeloma and immunoproliferative neoplasms\"\n          },\n          {\n            \"code\": \"203.01\",\n            \"display\": \"Multiple myeloma, in remission\"\n          },\n          {\n            \"code\": \"203.1\",\n            \"display\": \"Plasma cell leukemia\"\n          },\n          {\n            \"code\": \"203.11\",\n            \"display\": \"Plasma cell leukemia, in remission\"\n          },\n          {\n            \"code\": \"203.8\",\n            \"display\": \"Other immunoproliferative neoplasms\"\n          },\n          {\n            \"code\": \"203.81\",\n            \"display\": \"Other immunoproliferative neoplasms, in remission\"\n          },\n          {\n            \"code\": \"204\",\n            \"display\": \"Lymphoid leukemia\"\n          },\n          {\n            \"code\": \"204.01\",\n            \"display\": \"Acute lymphoid leukemia, in remission\"\n          },\n          {\n            \"code\": \"204.1\",\n            \"display\": \"Lymphoid leukemia, chronic\"\n          },\n          {\n            \"code\": \"204.11\",\n            \"display\": \"Chronic lymphoid leukemia, in remission\"\n          },\n          {\n            \"code\": \"204.2\",\n            \"display\": \"Lymphoid leukemia, subacute\"\n          },\n          {\n            \"code\": \"204.21\",\n            \"display\": \"Subacute lymphoid leukemia, in remission\"\n          },\n          {\n            \"code\": \"204.8\",\n            \"display\": \"Other lymphoid leukemia\"\n          },\n          {\n            \"code\": \"204.81\",\n            \"display\": \"Other lymphoid leukemia, in remission\"\n          },\n          {\n            \"code\": \"204.9\",\n            \"display\": \"Unspecified lymphoid leukemia\"\n          },\n          {\n            \"code\": \"204.91\",\n            \"display\": \"Unspecified lymphoid leukemia, in remission\"\n          },\n          {\n            \"code\": \"205\",\n            \"display\": \"Myeloid leukemia\"\n          },\n          {\n            \"code\": \"205.01\",\n            \"display\": \"Acute myeloid leukemia, in remission\"\n          },\n          {\n            \"code\": \"205.1\",\n            \"display\": \"Myeloid leukemia, chronic\"\n          },\n          {\n            \"code\": \"205.11\",\n            \"display\": \"Chronic myeloid leukemia, in remission\"\n          },\n          {\n            \"code\": \"205.2\",\n            \"display\": \"Myeloid leukemia, subacute\"\n          },\n          {\n            \"code\": \"205.21\",\n            \"display\": \"Subacute myeloid leukemia,in remission\"\n          },\n          {\n            \"code\": \"205.3\",\n            \"display\": \"Myeloid sarcoma\"\n          },\n          {\n            \"code\": \"205.31\",\n            \"display\": \"Myeloid sarcoma, in remission\"\n          },\n          {\n            \"code\": \"205.8\",\n            \"display\": \"Other myeloid leukemia\"\n          },\n          {\n            \"code\": \"205.81\",\n            \"display\": \"Other myeloid leukemia, in remission\"\n          },\n          {\n            \"code\": \"205.9\",\n            \"display\": \"Unspecified myeloid leukemia\"\n          },\n          {\n            \"code\": \"205.91\",\n            \"display\": \"Unspecified myeloid leukemia, in remission\"\n          },\n          {\n            \"code\": \"206\",\n            \"display\": \"Monocytic leukemia\"\n          },\n          {\n            \"code\": \"206.01\",\n            \"display\": \"Acute monocytic leukemia,in remission\"\n          },\n          {\n            \"code\": \"206.1\",\n            \"display\": \"Monocytic leukemia, chronic\"\n          },\n          {\n            \"code\": \"206.11\",\n            \"display\": \"Chronic monocytic leukemia, in remission\"\n          },\n          {\n            \"code\": \"206.2\",\n            \"display\": \"Monocytic leukemia, subacute\"\n          },\n          {\n            \"code\": \"206.21\",\n            \"display\": \"Subacute monocytic leukemia, in remission\"\n          },\n          {\n            \"code\": \"206.8\",\n            \"display\": \"Other monocytic leukemia\"\n          },\n          {\n            \"code\": \"206.81\",\n            \"display\": \"Other monocytic leukemia, in remission\"\n          },\n          {\n            \"code\": \"206.9\",\n            \"display\": \"Unspecified monocytic leukemia\"\n          },\n          {\n            \"code\": \"206.91\",\n            \"display\": \"Unspecified monocytic leukemia, in remission\"\n          },\n          {\n            \"code\": \"207\",\n            \"display\": \"Other specified leukemia\"\n          },\n          {\n            \"code\": \"207.01\",\n            \"display\": \"Acute erythremia and erythroleukemia, in remission\"\n          },\n          {\n            \"code\": \"207.1\",\n            \"display\": \"Chronic erythremia\"\n          },\n          {\n            \"code\": \"207.11\",\n            \"display\": \"Chronic erythremia, in remission\"\n          },\n          {\n            \"code\": \"207.2\",\n            \"display\": \"Megakaryocytic leukemia\"\n          },\n          {\n            \"code\": \"207.21\",\n            \"display\": \"Megakaryocytic leukemia, in remission\"\n          },\n          {\n            \"code\": \"207.8\",\n            \"display\": \"Other specified leukemia\"\n          },\n          {\n            \"code\": \"207.81\",\n            \"display\": \"Other specified leukemia, in remission\"\n          },\n          {\n            \"code\": \"208\",\n            \"display\": \"Leukemia of unspecified cell type\"\n          },\n          {\n            \"code\": \"208.01\",\n            \"display\": \"Acute leukemia of unspecified cell type, in remission\"\n          },\n          {\n            \"code\": \"208.1\",\n            \"display\": \"Leukemia of unspecified cell type, chronic\"\n          },\n          {\n            \"code\": \"208.11\",\n            \"display\": \"Chronic leukemia of unspecified cell type, in remission\"\n          },\n          {\n            \"code\": \"208.2\",\n            \"display\": \"Leukemia of unspecified cell type, subacute\"\n          },\n          {\n            \"code\": \"208.21\",\n            \"display\": \"Subacute leukemia of unspecified cell type, in remission\"\n          },\n          {\n            \"code\": \"208.8\",\n            \"display\": \"Other leukemia of unspecified cell type\"\n          },\n          {\n            \"code\": \"208.81\",\n            \"display\": \"Other leukemia of unspecified cell type, in remission\"\n          },\n          {\n            \"code\": \"208.9\",\n            \"display\": \"Unspecified leukemia\"\n          },\n          {\n            \"code\": \"208.91\",\n            \"display\": \"Unspecified leukemia, in remission\"\n          },\n          {\n            \"code\": \"209\",\n            \"display\": \"Neuroendocrine tumors\"\n          },\n          {\n            \"code\": \"209.01\",\n            \"display\": \"Malignant carcinoid tumor of the duodenum\"\n          },\n          {\n            \"code\": \"209.02\",\n            \"display\": \"Malignant carcinoid tumor of the jejunum\"\n          },\n          {\n            \"code\": \"209.03\",\n            \"display\": \"Malignant carcinoid tumor of the ileum\"\n          },\n          {\n            \"code\": \"209.1\",\n            \"display\": \"Malignant carcinoid tumors of the appendix, large intestine, and rectum\"\n          },\n          {\n            \"code\": \"209.11\",\n            \"display\": \"Malignant carcinoid tumor of the appendix\"\n          },\n          {\n            \"code\": \"209.12\",\n            \"display\": \"Malignant carcinoid tumor of the cecum\"\n          },\n          {\n            \"code\": \"209.13\",\n            \"display\": \"Malignant carcinoid tumor of the ascending colon\"\n          },\n          {\n            \"code\": \"209.14\",\n            \"display\": \"Malignant carcinoid tumor of the transverse colon\"\n          },\n          {\n            \"code\": \"209.15\",\n            \"display\": \"Malignant carcinoid tumor of the descending colon\"\n          },\n          {\n            \"code\": \"209.16\",\n            \"display\": \"Malignant carcinoid tumor of the sigmoid colon\"\n          },\n          {\n            \"code\": \"209.17\",\n            \"display\": \"Malignant carcinoid tumor of the rectum\"\n          },\n          {\n            \"code\": \"209.2\",\n            \"display\": \"Malignant carcinoid tumors of other and unspecified sites\"\n          },\n          {\n            \"code\": \"209.21\",\n            \"display\": \"Malignant carcinoid tumor of the bronchus and lung\"\n          },\n          {\n            \"code\": \"209.22\",\n            \"display\": \"Malignant carcinoid tumor of the thymus\"\n          },\n          {\n            \"code\": \"209.23\",\n            \"display\": \"Malignant carcinoid tumor of the stomach\"\n          },\n          {\n            \"code\": \"209.24\",\n            \"display\": \"Malignant carcinoid tumor of the kidney\"\n          },\n          {\n            \"code\": \"209.25\",\n            \"display\": \"Malignant carcinoid tumor of foregut, not otherwise specified\"\n          },\n          {\n            \"code\": \"209.26\",\n            \"display\": \"Malignant carcinoid tumor of midgut, not otherwise specified\"\n          },\n          {\n            \"code\": \"209.27\",\n            \"display\": \"Malignant carcinoid tumor of hindgut, not otherwise specified\"\n          },\n          {\n            \"code\": \"209.29\",\n            \"display\": \"Malignant carcinoid tumor of other sites\"\n          },\n          {\n            \"code\": \"209.3\",\n            \"display\": \"Malignant poorly differentiated neuroendocrine tumors\"\n          },\n          {\n            \"code\": \"209.31\",\n            \"display\": \"Merkel cell carcinoma of the face\"\n          },\n          {\n            \"code\": \"209.32\",\n            \"display\": \"Merkel cell carcinoma of the scalp and neck\"\n          },\n          {\n            \"code\": \"209.33\",\n            \"display\": \"Merkel cell carcinoma of the upper limb\"\n          },\n          {\n            \"code\": \"209.34\",\n            \"display\": \"Merkel cell carcinoma of the lower limb\"\n          },\n          {\n            \"code\": \"209.35\",\n            \"display\": \"Merkel cell carcinoma of the trunk\"\n          },\n          {\n            \"code\": \"209.36\",\n            \"display\": \"Merkel cell carcinoma of other sites\"\n          },\n          {\n            \"code\": \"209.7\",\n            \"display\": \"Secondary neuroendocrine tumors\"\n          },\n          {\n            \"code\": \"209.71\",\n            \"display\": \"Secondary neuroendocrine tumor of distant lymph nodes\"\n          },\n          {\n            \"code\": \"209.72\",\n            \"display\": \"Secondary neuroendocrine tumor of liver\"\n          },\n          {\n            \"code\": \"209.73\",\n            \"display\": \"Secondary neuroendocrine tumor of bone\"\n          },\n          {\n            \"code\": \"209.74\",\n            \"display\": \"Secondary neuroendocrine tumor of peritoneum\"\n          },\n          {\n            \"code\": \"209.75\",\n            \"display\": \"Secondary Merkel cell carcinoma\"\n          },\n          {\n            \"code\": \"209.79\",\n            \"display\": \"Secondary neuroendocrine tumor of other sites\"\n          },\n          {\n            \"code\": \"238.72\",\n            \"display\": \"Low grade myelodysplastic syndrome lesions\"\n          },\n          {\n            \"code\": \"238.73\",\n            \"display\": \"High grade myelodysplastic syndrome lesions\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    },
    {
      "oid": "2.16.840.1.113883.3.464.1003.101.11.1005",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1005",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.113883.3.464.1003.101.11.1005\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T02:11:34.742+00:00\",\n    \"source\": \"#9E6EqK2Yhyn24sD4\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113883.3.464.1003.101.11.1005\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.113883.3.464.1003.101.11.1005\"\n    }\n  ],\n  \"name\": \"Office Visit\",\n  \"status\": \"active\",\n  \"publisher\": \"National Committee for Quality Assurance\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.6.12\",\n        \"version\": \"2019\",\n        \"concept\": [\n          {\n            \"code\": \"99201\",\n            \"display\": \"Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A problem focused history; A problem focused examination; Straightforward medical decision making. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are self limited or minor. Typically, 10 minutes are spent face-to-face with the patient and/or family.\"\n          },\n          {\n            \"code\": \"99202\",\n            \"display\": \"Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: An expanded problem focused history; An expanded problem focused examination; Straightforward medical decision making. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of low to moderate severity. Typically, 20 minutes are spent face-to-face with the patient and/or family.\"\n          },\n          {\n            \"code\": \"99203\",\n            \"display\": \"Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A detailed history; A detailed examination; Medical decision making of low complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate severity. Typically, 30 minutes are spent face-to-face with the patient and/or family.\"\n          },\n          {\n            \"code\": \"99204\",\n            \"display\": \"Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 45 minutes are spent face-to-face with the patient and/or family.\"\n          },\n          {\n            \"code\": \"99205\",\n            \"display\": \"Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 60 minutes are spent face-to-face with the patient and/or family.\"\n          },\n          {\n            \"code\": \"99212\",\n            \"display\": \"Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A problem focused history; A problem focused examination; Straightforward medical decision making. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are self limited or minor. Typically, 10 minutes are spent face-to-face with the patient and/or family.\"\n          },\n          {\n            \"code\": \"99213\",\n            \"display\": \"Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: An expanded problem focused history; An expanded problem focused examination; Medical decision making of low complexity. Counseling and coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of low to moderate severity. Typically, 15 minutes are spent face-to-face with the patient and/or family.\"\n          },\n          {\n            \"code\": \"99214\",\n            \"display\": \"Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A detailed history; A detailed examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 25 minutes are spent face-to-face with the patient and/or family.\"\n          },\n          {\n            \"code\": \"99215\",\n            \"display\": \"Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 40 minutes are spent face-to-face with the patient and/or family.\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    },
    {
      "oid": "2.16.840.1.113883.3.526.3.1012",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113883.3.526.3.1012",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.113883.3.526.3.1012\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T02:06:07.675+00:00\",\n    \"source\": \"#2fEfyxtxeKh3o7oG\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113883.3.526.3.1012\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.113883.3.526.3.1012\"\n    }\n  ],\n  \"name\": \"Patient Provider Interaction\",\n  \"status\": \"active\",\n  \"publisher\": \"PCPI Foundation\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.6.96\",\n        \"version\": \"2019-09\",\n        \"concept\": [\n          {\n            \"code\": \"185316007\",\n            \"display\": \"Indirect encounter (procedure)\"\n          },\n          {\n            \"code\": \"185317003\",\n            \"display\": \"Telephone encounter (procedure)\"\n          },\n          {\n            \"code\": \"185318008\",\n            \"display\": \"Third party encounter (procedure)\"\n          },\n          {\n            \"code\": \"185320006\",\n            \"display\": \"Encounter by computer link (procedure)\"\n          },\n          {\n            \"code\": \"185321005\",\n            \"display\": \"Letter encounter to patient (procedure)\"\n          },\n          {\n            \"code\": \"185349003\",\n            \"display\": \"Encounter for check up (procedure)\"\n          },\n          {\n            \"code\": \"185463005\",\n            \"display\": \"Visit out of hours (procedure)\"\n          },\n          {\n            \"code\": \"185465003\",\n            \"display\": \"Weekend visit (procedure)\"\n          },\n          {\n            \"code\": \"270424005\",\n            \"display\": \"Letter encounter from patient (procedure)\"\n          },\n          {\n            \"code\": \"270427003\",\n            \"display\": \"Patient-initiated encounter (procedure)\"\n          },\n          {\n            \"code\": \"270430005\",\n            \"display\": \"Provider-initiated encounter (procedure)\"\n          },\n          {\n            \"code\": \"308335008\",\n            \"display\": \"Patient encounter procedure (procedure)\"\n          },\n          {\n            \"code\": \"308720009\",\n            \"display\": \"Letter encounter (procedure)\"\n          },\n          {\n            \"code\": \"386473003\",\n            \"display\": \"Telephone follow-up (procedure)\"\n          },\n          {\n            \"code\": \"390906007\",\n            \"display\": \"Follow-up encounter (procedure)\"\n          },\n          {\n            \"code\": \"401267002\",\n            \"display\": \"Telephone triage encounter (procedure)\"\n          },\n          {\n            \"code\": \"401271004\",\n            \"display\": \"E-mail sent to patient (procedure)\"\n          },\n          {\n            \"code\": \"406547006\",\n            \"display\": \"Urgent follow-up (procedure)\"\n          },\n          {\n            \"code\": \"438515009\",\n            \"display\": \"E-mail encounter from caregiver (procedure)\"\n          },\n          {\n            \"code\": \"438516005\",\n            \"display\": \"E-mail encounter to caregiver (procedure)\"\n          },\n          {\n            \"code\": \"445450000\",\n            \"display\": \"Encounter by short message service text messaging (procedure)\"\n          },\n          {\n            \"code\": \"448337001\",\n            \"display\": \"Telemedicine consultation with patient (procedure)\"\n          },\n          {\n            \"code\": \"87790002\",\n            \"display\": \"Follow-up inpatient consultation visit (procedure)\"\n          },\n          {\n            \"code\": \"90526000\",\n            \"display\": \"Initial evaluation and management of healthy individual (procedure)\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    },
    {
      "oid": "2.16.840.1.113762.1.4.1116.222",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.222",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.113762.1.4.1116.222\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T02:11:39.904+00:00\",\n    \"source\": \"#WXlleiJ7Veu2dlVC\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.222\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.113762.1.4.1116.222\"\n    }\n  ],\n  \"name\": \"Aprepitant\",\n  \"status\": \"active\",\n  \"publisher\": \"American Society of Clinical Oncology\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.6.88\",\n        \"version\": \"2019-10\",\n        \"concept\": [\n          {\n            \"code\": \"1157722\",\n            \"display\": \"aprepitant Oral Product\"\n          },\n          {\n            \"code\": \"1157723\",\n            \"display\": \"aprepitant Pill\"\n          },\n          {\n            \"code\": \"358255\",\n            \"display\": \"aprepitant\"\n          },\n          {\n            \"code\": \"403810\",\n            \"display\": \"aprepitant 80 MG Oral Capsule\"\n          },\n          {\n            \"code\": \"403811\",\n            \"display\": \"aprepitant 125 MG Oral Capsule\"\n          },\n          {\n            \"code\": \"404465\",\n            \"display\": \"aprepitant 80 MG Oral Capsule [Emend]\"\n          },\n          {\n            \"code\": \"404466\",\n            \"display\": \"aprepitant 125 MG Oral Capsule [Emend]\"\n          },\n          {\n            \"code\": \"405797\",\n            \"display\": \"aprepitant 125 MG\"\n          },\n          {\n            \"code\": \"405798\",\n            \"display\": \"aprepitant Oral Capsule\"\n          },\n          {\n            \"code\": \"405799\",\n            \"display\": \"aprepitant 80 MG\"\n          },\n          {\n            \"code\": \"406015\",\n            \"display\": \"aprepitant Oral Capsule [Emend]\"\n          },\n          {\n            \"code\": \"576419\",\n            \"display\": \"aprepitant 80 MG [Emend]\"\n          },\n          {\n            \"code\": \"576420\",\n            \"display\": \"aprepitant 125 MG [Emend]\"\n          },\n          {\n            \"code\": \"644087\",\n            \"display\": \"aprepitant 40 MG\"\n          },\n          {\n            \"code\": \"644088\",\n            \"display\": \"aprepitant 40 MG Oral Capsule\"\n          },\n          {\n            \"code\": \"644277\",\n            \"display\": \"aprepitant 40 MG [Emend]\"\n          },\n          {\n            \"code\": \"644278\",\n            \"display\": \"aprepitant 40 MG Oral Capsule [Emend]\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    },
    {
      "oid": "2.16.840.1.113762.1.4.1116.167",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.167",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.113762.1.4.1116.167\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T02:11:44.644+00:00\",\n    \"source\": \"#xHTjJeVEDgCpMEHq\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.167\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.113762.1.4.1116.167\"\n    }\n  ],\n  \"name\": \"Cyclophosphamide\",\n  \"status\": \"active\",\n  \"publisher\": \"American Society of Clinical Oncology\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.6.88\",\n        \"version\": \"2019-10\",\n        \"concept\": [\n          {\n            \"code\": \"1437967\",\n            \"display\": \"Cyclophosphamide Oral Capsule\"\n          },\n          {\n            \"code\": \"1437968\",\n            \"display\": \"Cyclophosphamide 25 MG Oral Capsule\"\n          },\n          {\n            \"code\": \"1437969\",\n            \"display\": \"Cyclophosphamide 50 MG Oral Capsule\"\n          },\n          {\n            \"code\": \"197549\",\n            \"display\": \"Cyclophosphamide 25 MG Oral Tablet\"\n          },\n          {\n            \"code\": \"197550\",\n            \"display\": \"Cyclophosphamide 50 MG Oral Tablet\"\n          },\n          {\n            \"code\": \"3002\",\n            \"display\": \"Cyclophosphamide\"\n          },\n          {\n            \"code\": \"315746\",\n            \"display\": \"Cyclophosphamide 25 MG\"\n          },\n          {\n            \"code\": \"315747\",\n            \"display\": \"Cyclophosphamide 50 MG\"\n          },\n          {\n            \"code\": \"371664\",\n            \"display\": \"Cyclophosphamide Oral Tablet\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    },
    {
      "oid": "2.16.840.1.113762.1.4.1116.332",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.332",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.113762.1.4.1116.332\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T02:11:50.305+00:00\",\n    \"source\": \"#K2mDXI3Lobrzubcb\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.332\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.113762.1.4.1116.332\"\n    }\n  ],\n  \"name\": \"Daunorubicin\",\n  \"status\": \"active\",\n  \"publisher\": \"American Society of Clinical Oncology\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.6.88\",\n        \"version\": \"2019-10\",\n        \"concept\": [\n          {\n            \"code\": \"1152144\",\n            \"display\": \"Daunorubicin Injectable Product\"\n          },\n          {\n            \"code\": \"1152145\",\n            \"display\": \"Daunorubicin Liposomal Injectable Product\"\n          },\n          {\n            \"code\": \"1364321\",\n            \"display\": \"Daunorubicin citrate\"\n          },\n          {\n            \"code\": \"1732350\",\n            \"display\": \"Daunorubicin Liposomal Injection\"\n          },\n          {\n            \"code\": \"1736580\",\n            \"display\": \"Daunorubicin Injection\"\n          },\n          {\n            \"code\": \"214468\",\n            \"display\": \"Daunorubicin Liposomal\"\n          },\n          {\n            \"code\": \"221087\",\n            \"display\": \"DAUNORUBICIN CITRATE LIPOSOME\"\n          },\n          {\n            \"code\": \"309650\",\n            \"display\": \"4 ML Daunorubicin 5 MG/ML Injection\"\n          },\n          {\n            \"code\": \"3109\",\n            \"display\": \"Daunorubicin\"\n          },\n          {\n            \"code\": \"329674\",\n            \"display\": \"Daunorubicin 5 MG/ML\"\n          },\n          {\n            \"code\": \"646828\",\n            \"display\": \"Daunorubicin Liposomal 2 MG/ML\"\n          },\n          {\n            \"code\": \"646830\",\n            \"display\": \"25 ML Daunorubicin Liposomal 2 MG/ML Injection\"\n          },\n          {\n            \"code\": \"81992\",\n            \"display\": \"Daunorubicin Hydrochloride\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    },
    {
      "oid": "2.16.840.1.113762.1.4.1116.80",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.80",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.113762.1.4.1116.80\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T02:11:56.608+00:00\",\n    \"source\": \"#CjAhcRLluS0Y4n0g\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.80\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.113762.1.4.1116.80\"\n    }\n  ],\n  \"name\": \"Dexamethasone\",\n  \"status\": \"active\",\n  \"publisher\": \"American Society of Clinical Oncology\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.6.88\",\n        \"version\": \"2019-10\",\n        \"concept\": [\n          {\n            \"code\": \"105394\",\n            \"display\": \"Dexamethasone 5 MG/ML Injectable Solution\"\n          },\n          {\n            \"code\": \"1116927\",\n            \"display\": \"Dexamethasone phosphate 4 MG/ML Injectable Solution\"\n          },\n          {\n            \"code\": \"197577\",\n            \"display\": \"Dexamethasone 0.5 MG Oral Tablet\"\n          },\n          {\n            \"code\": \"197579\",\n            \"display\": \"Dexamethasone 1 MG Oral Tablet\"\n          },\n          {\n            \"code\": \"197580\",\n            \"display\": \"Dexamethasone 1.5 MG Oral Tablet\"\n          },\n          {\n            \"code\": \"197581\",\n            \"display\": \"Dexamethasone 2 MG Oral Tablet\"\n          },\n          {\n            \"code\": \"197582\",\n            \"display\": \"Dexamethasone 4 MG Oral Tablet\"\n          },\n          {\n            \"code\": \"197583\",\n            \"display\": \"Dexamethasone 6 MG Oral Tablet\"\n          },\n          {\n            \"code\": \"203705\",\n            \"display\": \"Maxidex\"\n          },\n          {\n            \"code\": \"309696\",\n            \"display\": \"Dexamethasone phosphate 10 MG/ML Injectable Solution\"\n          },\n          {\n            \"code\": \"3264\",\n            \"display\": \"Dexamethasone\"\n          },\n          {\n            \"code\": \"343033\",\n            \"display\": \"Dexamethasone 0.75 MG Oral Tablet\"\n          },\n          {\n            \"code\": \"465397\",\n            \"display\": \"Ciprofloxacin / Dexamethasone\"\n          },\n          {\n            \"code\": \"48933\",\n            \"display\": \"Dexamethasone sodium phosphate\"\n          },\n          {\n            \"code\": \"854177\",\n            \"display\": \"Dexamethasone 0.7 MG Drug Implant\"\n          },\n          {\n            \"code\": \"854178\",\n            \"display\": \"Ozurdex\"\n          },\n          {\n            \"code\": \"855602\",\n            \"display\": \"Baycadron\"\n          },\n          {\n            \"code\": \"883815\",\n            \"display\": \"Dexamethasone / Tobramycin\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    },
    {
      "oid": "2.16.840.1.113762.1.4.1116.168",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.168",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.113762.1.4.1116.168\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T02:12:00.809+00:00\",\n    \"source\": \"#kwbNC6XCoTteCe9c\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.168\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.113762.1.4.1116.168\"\n    }\n  ],\n  \"name\": \"Doxorubicin\",\n  \"status\": \"active\",\n  \"publisher\": \"American Society of Clinical Oncology\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.6.88\",\n        \"version\": \"2019-10\",\n        \"concept\": [\n          {\n            \"code\": \"1191138\",\n            \"display\": \"Doxorubicin Hydrochloride 2 MG/ML Injectable Solution\"\n          },\n          {\n            \"code\": \"1191495\",\n            \"display\": \"doxorubicin hydrochloride liposome 2 MG/ML\"\n          },\n          {\n            \"code\": \"1191496\",\n            \"display\": \"doxorubicin liposome Injectable Product\"\n          },\n          {\n            \"code\": \"1191499\",\n            \"display\": \"doxorubicin hydrochloride liposome 2 MG/ML [Doxil]\"\n          },\n          {\n            \"code\": \"1247774\",\n            \"display\": \"doxorubicin hydrochloride liposome 2 MG/ML [LipoDox]\"\n          },\n          {\n            \"code\": \"214525\",\n            \"display\": \"doxorubicin liposome\"\n          },\n          {\n            \"code\": \"3639\",\n            \"display\": \"Doxorubicin\"\n          },\n          {\n            \"code\": \"42512\",\n            \"display\": \"Adriamycin\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    },
    {
      "oid": "2.16.840.1.113762.1.4.1116.200",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.200",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.113762.1.4.1116.200\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T02:12:04.399+00:00\",\n    \"source\": \"#9bZX4lNfoXXhKYlk\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.200\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.113762.1.4.1116.200\"\n    }\n  ],\n  \"name\": \"Epirubicin\",\n  \"status\": \"active\",\n  \"publisher\": \"American Society of Clinical Oncology\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.6.88\",\n        \"version\": \"2019-10\",\n        \"concept\": [\n          {\n            \"code\": \"203213\",\n            \"display\": \"Epirubicin Hydrochloride\"\n          },\n          {\n            \"code\": \"203766\",\n            \"display\": \"Ellence\"\n          },\n          {\n            \"code\": \"3995\",\n            \"display\": \"Epirubicin\"\n          },\n          {\n            \"code\": \"836377\",\n            \"display\": \"Epirubicin Hydrochloride 2 MG/ML\"\n          },\n          {\n            \"code\": \"836379\",\n            \"display\": \"Epirubicin Hydrochloride 2 MG/ML [Ellence]\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    },
    {
      "oid": "2.16.840.1.113762.1.4.1116.82",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.82",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.113762.1.4.1116.82\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T02:12:10.061+00:00\",\n    \"source\": \"#H0oE3bcjmWg0VmHd\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.82\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.113762.1.4.1116.82\"\n    }\n  ],\n  \"name\": \"First Generation Serotonin Antagonists\",\n  \"status\": \"active\",\n  \"publisher\": \"American Society of Clinical Oncology\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.6.88\",\n        \"version\": \"2019-10\",\n        \"concept\": [\n          {\n            \"code\": \"104894\",\n            \"display\": \"Ondansetron 4 MG Disintegrating Oral Tablet\"\n          },\n          {\n            \"code\": \"104895\",\n            \"display\": \"Ondansetron 4 MG Oral Tablet [Zofran]\"\n          },\n          {\n            \"code\": \"104896\",\n            \"display\": \"Ondansetron 8 MG Oral Tablet [Zofran]\"\n          },\n          {\n            \"code\": \"104897\",\n            \"display\": \"Ondansetron 2 MG/ML Injectable Solution [Zofran]\"\n          },\n          {\n            \"code\": \"1314133\",\n            \"display\": \"2 ML Ondansetron 2 MG/ML Prefilled Syringe\"\n          },\n          {\n            \"code\": \"142149\",\n            \"display\": \"Granisetron Hydrochloride\"\n          },\n          {\n            \"code\": \"198052\",\n            \"display\": \"Ondansetron 4 MG Oral Tablet\"\n          },\n          {\n            \"code\": \"199593\",\n            \"display\": \"tropisetron 1 MG/ML Injectable Solution\"\n          },\n          {\n            \"code\": \"199594\",\n            \"display\": \"tropisetron 5 MG Oral Capsule\"\n          },\n          {\n            \"code\": \"200101\",\n            \"display\": \"dolasetron mesylate 20 MG/ML Injectable Solution\"\n          },\n          {\n            \"code\": \"203148\",\n            \"display\": \"Ondansetron Hydrochloride\"\n          },\n          {\n            \"code\": \"212447\",\n            \"display\": \"Ondansetron 0.8 MG/ML Oral Solution [Zofran]\"\n          },\n          {\n            \"code\": \"213091\",\n            \"display\": \"Dolasetron 50 MG Oral Tablet [Anzemet]\"\n          },\n          {\n            \"code\": \"213092\",\n            \"display\": \"Dolasetron 100 MG Oral Tablet [Anzemet]\"\n          },\n          {\n            \"code\": \"213093\",\n            \"display\": \"dolasetron mesylate 20 MG/ML Injectable Solution [Anzemet]\"\n          },\n          {\n            \"code\": \"215357\",\n            \"display\": \"Anzemet\"\n          },\n          {\n            \"code\": \"240912\",\n            \"display\": \"Granisetron 1 MG/ML Injectable Solution\"\n          },\n          {\n            \"code\": \"250535\",\n            \"display\": \"Granisetron 2 MG Oral Tablet\"\n          },\n          {\n            \"code\": \"250587\",\n            \"display\": \"Ondansetron 16 MG Rectal Suppository\"\n          },\n          {\n            \"code\": \"251426\",\n            \"display\": \"Granisetron 0.2 MG/ML Oral Solution\"\n          },\n          {\n            \"code\": \"26225\",\n            \"display\": \"Ondansetron\"\n          },\n          {\n            \"code\": \"26237\",\n            \"display\": \"Granisetron\"\n          },\n          {\n            \"code\": \"27392\",\n            \"display\": \"tropisetron\"\n          },\n          {\n            \"code\": \"283504\",\n            \"display\": \"Ondansetron 2 MG/ML Injectable Solution\"\n          },\n          {\n            \"code\": \"29398\",\n            \"display\": \"dolasetron mesylate\"\n          },\n          {\n            \"code\": \"310006\",\n            \"display\": \"Dolasetron 100 MG Oral Tablet\"\n          },\n          {\n            \"code\": \"310007\",\n            \"display\": \"Dolasetron 50 MG Oral Tablet\"\n          },\n          {\n            \"code\": \"310599\",\n            \"display\": \"Granisetron 1 MG Oral Tablet\"\n          },\n          {\n            \"code\": \"312083\",\n            \"display\": \"50 ML Ondansetron 0.64 MG/ML Injection\"\n          },\n          {\n            \"code\": \"312084\",\n            \"display\": \"Ondansetron 24 MG Oral Tablet\"\n          },\n          {\n            \"code\": \"312085\",\n            \"display\": \"Ondansetron 0.8 MG/ML Oral Solution\"\n          },\n          {\n            \"code\": \"312086\",\n            \"display\": \"Ondansetron 8 MG Oral Tablet\"\n          },\n          {\n            \"code\": \"312087\",\n            \"display\": \"Ondansetron 8 MG Disintegrating Oral Tablet\"\n          },\n          {\n            \"code\": \"328343\",\n            \"display\": \"Granisetron 1 MG/ML\"\n          },\n          {\n            \"code\": \"328344\",\n            \"display\": \"Granisetron 1 MG\"\n          },\n          {\n            \"code\": \"328448\",\n            \"display\": \"Ondansetron 2 MG/ML\"\n          },\n          {\n            \"code\": \"328449\",\n            \"display\": \"Ondansetron 0.64 MG/ML\"\n          },\n          {\n            \"code\": \"328450\",\n            \"display\": \"Ondansetron 4 MG\"\n          },\n          {\n            \"code\": \"328451\",\n            \"display\": \"Ondansetron 8 MG\"\n          },\n          {\n            \"code\": \"329712\",\n            \"display\": \"Dolasetron 50 MG\"\n          },\n          {\n            \"code\": \"330073\",\n            \"display\": \"Ondansetron 0.8 MG/ML\"\n          },\n          {\n            \"code\": \"330388\",\n            \"display\": \"Ondansetron 24 MG\"\n          },\n          {\n            \"code\": \"330683\",\n            \"display\": \"Dolasetron 100 MG\"\n          },\n          {\n            \"code\": \"333411\",\n            \"display\": \"tropisetron 1 MG/ML\"\n          },\n          {\n            \"code\": \"333745\",\n            \"display\": \"tropisetron 5 MG\"\n          },\n          {\n            \"code\": \"334912\",\n            \"display\": \"Granisetron 0.2 MG/ML\"\n          },\n          {\n            \"code\": \"334913\",\n            \"display\": \"Granisetron 2 MG\"\n          },\n          {\n            \"code\": \"337375\",\n            \"display\": \"Ondansetron 16 MG\"\n          },\n          {\n            \"code\": \"401714\",\n            \"display\": \"Dolasetron 200 MG Oral Tablet\"\n          },\n          {\n            \"code\": \"402385\",\n            \"display\": \"Dolasetron 200 MG\"\n          },\n          {\n            \"code\": \"543217\",\n            \"display\": \"Granisetron 0.1 MG/ML\"\n          },\n          {\n            \"code\": \"543218\",\n            \"display\": \"1 ML Granisetron 0.1 MG/ML Injection\"\n          },\n          {\n            \"code\": \"563812\",\n            \"display\": \"Ondansetron 4 MG [Zofran]\"\n          },\n          {\n            \"code\": \"563813\",\n            \"display\": \"Ondansetron 8 MG [Zofran]\"\n          },\n          {\n            \"code\": \"563814\",\n            \"display\": \"Ondansetron 2 MG/ML [Zofran]\"\n          },\n          {\n            \"code\": \"565198\",\n            \"display\": \"Ondansetron 0.8 MG/ML [Zofran]\"\n          },\n          {\n            \"code\": \"573020\",\n            \"display\": \"Dolasetron 50 MG [Anzemet]\"\n          },\n          {\n            \"code\": \"573021\",\n            \"display\": \"Dolasetron 100 MG [Anzemet]\"\n          },\n          {\n            \"code\": \"66981\",\n            \"display\": \"Zofran\"\n          },\n          {\n            \"code\": \"68091\",\n            \"display\": \"Dolasetron\"\n          },\n          {\n            \"code\": \"692695\",\n            \"display\": \"Ondansetron 16 MG Oral Tablet\"\n          },\n          {\n            \"code\": \"807264\",\n            \"display\": \"Sancuso\"\n          },\n          {\n            \"code\": \"825004\",\n            \"display\": \"Granisetron 0.129 MG/HR [Sancuso]\"\n          },\n          {\n            \"code\": \"876690\",\n            \"display\": \"Ondansetron 4 MG Disintegrating Oral Tablet [Zofran]\"\n          },\n          {\n            \"code\": \"876693\",\n            \"display\": \"Ondansetron 8 MG Disintegrating Oral Tablet [Zofran]\"\n          },\n          {\n            \"code\": \"998028\",\n            \"display\": \"Ondansetron 8 MG Oral Strip\"\n          },\n          {\n            \"code\": \"998029\",\n            \"display\": \"Zuplenz\"\n          },\n          {\n            \"code\": \"998030\",\n            \"display\": \"Ondansetron 8 MG [Zuplenz]\"\n          },\n          {\n            \"code\": \"998032\",\n            \"display\": \"Ondansetron 8 MG Oral Strip [Zuplenz]\"\n          },\n          {\n            \"code\": \"998033\",\n            \"display\": \"Ondansetron 4 MG Oral Strip\"\n          },\n          {\n            \"code\": \"998034\",\n            \"display\": \"Ondansetron 4 MG [Zuplenz]\"\n          },\n          {\n            \"code\": \"998035\",\n            \"display\": \"Ondansetron 4 MG Oral Strip [Zuplenz]\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    },
    {
      "oid": "2.16.840.1.113762.1.4.1116.223",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.223",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.113762.1.4.1116.223\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T02:12:13.538+00:00\",\n    \"source\": \"#U8wqzRM46nUQIz1m\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.223\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.113762.1.4.1116.223\"\n    }\n  ],\n  \"name\": \"Fosaprepitant\",\n  \"status\": \"active\",\n  \"publisher\": \"American Society of Clinical Oncology\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.6.88\",\n        \"version\": \"2019-10\",\n        \"concept\": [\n          {\n            \"code\": \"1731071\",\n            \"display\": \"fosaprepitant\"\n          },\n          {\n            \"code\": \"357280\",\n            \"display\": \"Emend\"\n          },\n          {\n            \"code\": \"754763\",\n            \"display\": \"Fosaprepitant dimeglumine\"\n          },\n          {\n            \"code\": \"759503\",\n            \"display\": \"Emend Injection\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    },
    {
      "oid": "2.16.840.1.113762.1.4.1116.331",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.331",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.113762.1.4.1116.331\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T02:12:15.981+00:00\",\n    \"source\": \"#kricSPEuBFvOCwrL\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.331\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.113762.1.4.1116.331\"\n    }\n  ],\n  \"name\": \"High Emetigenic Risk Chemotherapy\",\n  \"status\": \"active\",\n  \"publisher\": \"American Society of Clinical Oncology\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.6.88\",\n        \"version\": \"2019-10\",\n        \"concept\": [\n          {\n            \"code\": \"1007452\",\n            \"display\": \"Mechlorethamine / Quinine / Terpin hydrate\"\n          },\n          {\n            \"code\": \"1008398\",\n            \"display\": \"Mechlorethamine / Terpin hydrate\"\n          },\n          {\n            \"code\": \"10114\",\n            \"display\": \"Streptozocin\"\n          },\n          {\n            \"code\": \"155036\",\n            \"display\": \"Mechlorethamine hydrochloride\"\n          },\n          {\n            \"code\": \"202856\",\n            \"display\": \"Platinol\"\n          },\n          {\n            \"code\": \"203599\",\n            \"display\": \"Cosmegen\"\n          },\n          {\n            \"code\": \"2105\",\n            \"display\": \"Carmustine\"\n          },\n          {\n            \"code\": \"217357\",\n            \"display\": \"Gliadel\"\n          },\n          {\n            \"code\": \"220991\",\n            \"display\": \"Zanosar\"\n          },\n          {\n            \"code\": \"2555\",\n            \"display\": \"Cisplatin\"\n          },\n          {\n            \"code\": \"281544\",\n            \"display\": \"Mustargen\"\n          },\n          {\n            \"code\": \"3098\",\n            \"display\": \"Dacarbazine\"\n          },\n          {\n            \"code\": \"3100\",\n            \"display\": \"Dactinomycin\"\n          },\n          {\n            \"code\": \"6674\",\n            \"display\": \"Mechlorethamine\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    },
    {
      "oid": "2.16.840.1.113762.1.4.1116.199",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.199",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.113762.1.4.1116.199\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T02:12:18.562+00:00\",\n    \"source\": \"#RC4jk0zYGltUNnm7\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.199\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.113762.1.4.1116.199\"\n    }\n  ],\n  \"name\": \"Idarubicin\",\n  \"status\": \"active\",\n  \"publisher\": \"American Society of Clinical Oncology\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.6.88\",\n        \"version\": \"2019-10\",\n        \"concept\": [\n          {\n            \"code\": \"5650\",\n            \"display\": \"Idarubicin\"\n          },\n          {\n            \"code\": \"82124\",\n            \"display\": \"Idarubicin Hydrochloride\"\n          },\n          {\n            \"code\": \"996151\",\n            \"display\": \"Idarubicin Hydrochloride 1 MG/ML\"\n          },\n          {\n            \"code\": \"996153\",\n            \"display\": \"Idarubicin Hydrochloride 1 MG/ML [Idamycin]\"\n          },\n          {\n            \"code\": \"996155\",\n            \"display\": \"Idarubicin Hydrochloride 10 MG\"\n          },\n          {\n            \"code\": \"996156\",\n            \"display\": \"Idarubicin Hydrochloride 10 MG Oral Capsule\"\n          },\n          {\n            \"code\": \"996157\",\n            \"display\": \"Idarubicin Hydrochloride 25 MG\"\n          },\n          {\n            \"code\": \"996158\",\n            \"display\": \"Idarubicin Hydrochloride 25 MG Oral Capsule\"\n          },\n          {\n            \"code\": \"996159\",\n            \"display\": \"Idarubicin Hydrochloride 5 MG\"\n          },\n          {\n            \"code\": \"996160\",\n            \"display\": \"Idarubicin Hydrochloride 5 MG Oral Capsule\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    },
    {
      "oid": "2.16.840.1.113762.1.4.1116.334",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.334",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.113762.1.4.1116.334\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T02:12:21.325+00:00\",\n    \"source\": \"#DNd6xQXDu18z3c6j\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.334\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.113762.1.4.1116.334\"\n    }\n  ],\n  \"name\": \"NEPA Netupitant Palonosetron\",\n  \"status\": \"active\",\n  \"publisher\": \"American Society of Clinical Oncology\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.6.88\",\n        \"version\": \"2019-10\",\n        \"concept\": [\n          {\n            \"code\": \"1552339\",\n            \"display\": \"netupitant / palonosetron Oral Product\"\n          },\n          {\n            \"code\": \"1552340\",\n            \"display\": \"netupitant / palonosetron Pill\"\n          },\n          {\n            \"code\": \"1552341\",\n            \"display\": \"netupitant / palonosetron Oral Capsule\"\n          },\n          {\n            \"code\": \"1552342\",\n            \"display\": \"netupitant / palonosetron\"\n          },\n          {\n            \"code\": \"1552343\",\n            \"display\": \"netupitant 300 MG / palonosetron 0.5 MG Oral Capsule\"\n          },\n          {\n            \"code\": \"1552344\",\n            \"display\": \"Akynzeo\"\n          },\n          {\n            \"code\": \"1552345\",\n            \"display\": \"netupitant 300 MG / palonosetron 0.5 MG [Akynzeo]\"\n          },\n          {\n            \"code\": \"1552346\",\n            \"display\": \"netupitant / palonosetron Oral Capsule [Akynzeo]\"\n          },\n          {\n            \"code\": \"1552347\",\n            \"display\": \"Akynzeo Oral Product\"\n          },\n          {\n            \"code\": \"1552348\",\n            \"display\": \"Akynzeo Pill\"\n          },\n          {\n            \"code\": \"1552349\",\n            \"display\": \"netupitant 300 MG / palonosetron 0.5 MG Oral Capsule [Akynzeo]\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    },
    {
      "oid": "2.16.840.1.113762.1.4.1116.335",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.335",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.113762.1.4.1116.335\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T02:12:24.034+00:00\",\n    \"source\": \"#HRAdtrE0zkcGh7XD\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.335\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.113762.1.4.1116.335\"\n    }\n  ],\n  \"name\": \"Netupitant\",\n  \"status\": \"active\",\n  \"publisher\": \"American Society of Clinical Oncology\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.6.88\",\n        \"version\": \"2019-10\",\n        \"concept\": [\n          {\n            \"code\": \"1552337\",\n            \"display\": \"netupitant\"\n          },\n          {\n            \"code\": \"1552338\",\n            \"display\": \"netupitant 300 MG\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    },
    {
      "oid": "2.16.840.1.113762.1.4.1116.81",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.81",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.113762.1.4.1116.81\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T02:12:26.945+00:00\",\n    \"source\": \"#Oue58yHosTN2KcWE\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113762.1.4.1116.81\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.113762.1.4.1116.81\"\n    }\n  ],\n  \"name\": \"Palonosetron\",\n  \"status\": \"active\",\n  \"publisher\": \"American Society of Clinical Oncology\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.6.88\",\n        \"version\": \"2019-10\",\n        \"concept\": [\n          {\n            \"code\": \"1160714\",\n            \"display\": \"palonosetron Injectable Product\"\n          },\n          {\n            \"code\": \"1552339\",\n            \"display\": \"netupitant / palonosetron Oral Product\"\n          },\n          {\n            \"code\": \"1552340\",\n            \"display\": \"netupitant / palonosetron Pill\"\n          },\n          {\n            \"code\": \"1552341\",\n            \"display\": \"netupitant / palonosetron Oral Capsule\"\n          },\n          {\n            \"code\": \"1552342\",\n            \"display\": \"netupitant / palonosetron\"\n          },\n          {\n            \"code\": \"1552343\",\n            \"display\": \"netupitant 300 MG / palonosetron 0.5 MG Oral Capsule\"\n          },\n          {\n            \"code\": \"1552345\",\n            \"display\": \"netupitant 300 MG / palonosetron 0.5 MG [Akynzeo]\"\n          },\n          {\n            \"code\": \"1552349\",\n            \"display\": \"netupitant 300 MG / palonosetron 0.5 MG Oral Capsule [Akynzeo]\"\n          },\n          {\n            \"code\": \"397405\",\n            \"display\": \"Palonosetron hydrochloride\"\n          },\n          {\n            \"code\": \"405781\",\n            \"display\": \"palonosetron 0.05 MG/ML\"\n          },\n          {\n            \"code\": \"576528\",\n            \"display\": \"palonosetron 0.05 MG/ML [Aloxi]\"\n          },\n          {\n            \"code\": \"70561\",\n            \"display\": \"palonosetron\"\n          },\n          {\n            \"code\": \"805446\",\n            \"display\": \"palonosetron 0.5 MG\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    },
    {
      "oid": "2.16.840.1.113883.3.526.2.313",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113883.3.526.2.313",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.113883.3.526.2.313\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T02:12:29.621+00:00\",\n    \"source\": \"#KtzGtQCGISFukweX\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113883.3.526.2.313\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.113883.3.526.2.313\"\n    }\n  ],\n  \"name\": \"Medical Reason\",\n  \"status\": \"active\",\n  \"publisher\": \"PCPI Foundation\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.6.96\",\n        \"version\": \"2019-09\",\n        \"concept\": [\n          {\n            \"code\": \"183932001\",\n            \"display\": \"Procedure contraindicated (situation)\"\n          },\n          {\n            \"code\": \"183964008\",\n            \"display\": \"Treatment not indicated (situation)\"\n          },\n          {\n            \"code\": \"183966005\",\n            \"display\": \"Drug treatment not indicated (situation)\"\n          },\n          {\n            \"code\": \"216952002\",\n            \"display\": \"Failure in dosage (event)\"\n          },\n          {\n            \"code\": \"266721009\",\n            \"display\": \"Absent response to treatment (situation)\"\n          },\n          {\n            \"code\": \"269191009\",\n            \"display\": \"Late effect of medical and surgical care complication (disorder)\"\n          },\n          {\n            \"code\": \"274512008\",\n            \"display\": \"Drug therapy discontinued (situation)\"\n          },\n          {\n            \"code\": \"31438003\",\n            \"display\": \"Drug resistance (disorder)\"\n          },\n          {\n            \"code\": \"35688006\",\n            \"display\": \"Complication of medical care (disorder)\"\n          },\n          {\n            \"code\": \"371133007\",\n            \"display\": \"Treatment modification (procedure)\"\n          },\n          {\n            \"code\": \"397745006\",\n            \"display\": \"Medical contraindication (finding)\"\n          },\n          {\n            \"code\": \"407563006\",\n            \"display\": \"Treatment not tolerated (situation)\"\n          },\n          {\n            \"code\": \"410534003\",\n            \"display\": \"Not indicated (qualifier value)\"\n          },\n          {\n            \"code\": \"410536001\",\n            \"display\": \"Contraindicated (qualifier value)\"\n          },\n          {\n            \"code\": \"416098002\",\n            \"display\": \"Allergy to drug (finding)\"\n          },\n          {\n            \"code\": \"416406003\",\n            \"display\": \"Procedure discontinued (situation)\"\n          },\n          {\n            \"code\": \"428119001\",\n            \"display\": \"Procedure not indicated (situation)\"\n          },\n          {\n            \"code\": \"445528004\",\n            \"display\": \"Treatment changed (situation)\"\n          },\n          {\n            \"code\": \"59037007\",\n            \"display\": \"Intolerance to drug (finding)\"\n          },\n          {\n            \"code\": \"62014003\",\n            \"display\": \"Adverse reaction caused by drug (disorder)\"\n          },\n          {\n            \"code\": \"79899007\",\n            \"display\": \"Drug interaction (finding)\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    },
    {
      "oid": "2.16.840.1.113883.3.526.2.311",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113883.3.526.2.311",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.113883.3.526.2.311\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T02:12:31.845+00:00\",\n    \"source\": \"#B5vO5S8YYLmSmwnB\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113883.3.526.2.311\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.113883.3.526.2.311\"\n    }\n  ],\n  \"name\": \"Patient Reason\",\n  \"status\": \"active\",\n  \"publisher\": \"PCPI Foundation\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.6.96\",\n        \"version\": \"2019-09\",\n        \"concept\": [\n          {\n            \"code\": \"105480006\",\n            \"display\": \"Refusal of treatment by patient (situation)\"\n          },\n          {\n            \"code\": \"160932005\",\n            \"display\": \"Financial problem (finding)\"\n          },\n          {\n            \"code\": \"160934006\",\n            \"display\": \"Financial circumstances change (finding)\"\n          },\n          {\n            \"code\": \"182890002\",\n            \"display\": \"Patient requests alternative treatment (finding)\"\n          },\n          {\n            \"code\": \"182895007\",\n            \"display\": \"Drug declined by patient (situation)\"\n          },\n          {\n            \"code\": \"182897004\",\n            \"display\": \"Drug declined by patient - side effects (situation)\"\n          },\n          {\n            \"code\": \"182900006\",\n            \"display\": \"Drug declined by patient - patient beliefs (situation)\"\n          },\n          {\n            \"code\": \"182902003\",\n            \"display\": \"Drug declined by patient - cannot pay script (situation)\"\n          },\n          {\n            \"code\": \"183944003\",\n            \"display\": \"Procedure refused (situation)\"\n          },\n          {\n            \"code\": \"183945002\",\n            \"display\": \"Procedure refused for religious reason (situation)\"\n          },\n          {\n            \"code\": \"184081006\",\n            \"display\": \"Patient has moved away (finding)\"\n          },\n          {\n            \"code\": \"185479006\",\n            \"display\": \"Patient dissatisfied with result (finding)\"\n          },\n          {\n            \"code\": \"185481008\",\n            \"display\": \"Dissatisfied with doctor (finding)\"\n          },\n          {\n            \"code\": \"224187001\",\n            \"display\": \"Variable income (finding)\"\n          },\n          {\n            \"code\": \"225928004\",\n            \"display\": \"Patient self-discharge against medical advice (procedure)\"\n          },\n          {\n            \"code\": \"266710000\",\n            \"display\": \"Drugs not taken/completed (situation)\"\n          },\n          {\n            \"code\": \"266966009\",\n            \"display\": \"Family illness (situation)\"\n          },\n          {\n            \"code\": \"275694009\",\n            \"display\": \"Patient defaulted from follow-up (finding)\"\n          },\n          {\n            \"code\": \"275936005\",\n            \"display\": \"Patient noncompliance - general (situation)\"\n          },\n          {\n            \"code\": \"281399006\",\n            \"display\": \"Did not attend (finding)\"\n          },\n          {\n            \"code\": \"310343007\",\n            \"display\": \"Further opinion sought (finding)\"\n          },\n          {\n            \"code\": \"373787003\",\n            \"display\": \"Treatment delay - patient choice (finding)\"\n          },\n          {\n            \"code\": \"406149000\",\n            \"display\": \"Medication refused (situation)\"\n          },\n          {\n            \"code\": \"408367005\",\n            \"display\": \"Patient forgets to take medication (finding)\"\n          },\n          {\n            \"code\": \"413310006\",\n            \"display\": \"Patient non-compliant - refused access to services (situation)\"\n          },\n          {\n            \"code\": \"413311005\",\n            \"display\": \"Patient non-compliant - refused intervention / support (situation)\"\n          },\n          {\n            \"code\": \"413312003\",\n            \"display\": \"Patient non-compliant - refused service (situation)\"\n          },\n          {\n            \"code\": \"416432009\",\n            \"display\": \"Procedure not wanted (situation)\"\n          },\n          {\n            \"code\": \"423656007\",\n            \"display\": \"Income insufficient to buy necessities (finding)\"\n          },\n          {\n            \"code\": \"424739004\",\n            \"display\": \"Income sufficient to buy only necessities (finding)\"\n          },\n          {\n            \"code\": \"443390004\",\n            \"display\": \"Refused (qualifier value)\"\n          },\n          {\n            \"code\": \"713247000\",\n            \"display\": \"Procedure discontinued by patient (situation)\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    },
    {
      "oid": "2.16.840.1.113883.3.526.2.310",
      "reason": "Exists",
      "success": true,
      "link": "http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113883.3.526.2.310",
      "json": "{\n  \"resourceType\": \"ValueSet\",\n  \"id\": \"2.16.840.1.113883.3.526.2.310\",\n  \"meta\": {\n    \"versionId\": \"1\",\n    \"lastUpdated\": \"2020-02-22T02:12:35.389+00:00\",\n    \"source\": \"#q8IlCJGbZHjHKdkA\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/ValueSet/2.16.840.1.113883.3.526.2.310\",\n  \"identifier\": [\n    {\n      \"system\": \"urn:ietf:rfc:3986\",\n      \"value\": \"2.16.840.1.113883.3.526.2.310\"\n    }\n  ],\n  \"name\": \"System Reason\",\n  \"status\": \"active\",\n  \"publisher\": \"PCPI Foundation\",\n  \"compose\": {\n    \"include\": [\n      {\n        \"system\": \"2.16.840.1.113883.6.96\",\n        \"version\": \"2019-09\",\n        \"concept\": [\n          {\n            \"code\": \"107724000\",\n            \"display\": \"Patient transfer (procedure)\"\n          },\n          {\n            \"code\": \"182856006\",\n            \"display\": \"Drug not available - out of stock (finding)\"\n          },\n          {\n            \"code\": \"182857002\",\n            \"display\": \"Drug not available-off market (finding)\"\n          },\n          {\n            \"code\": \"185335007\",\n            \"display\": \"Appointment canceled by hospital (finding)\"\n          },\n          {\n            \"code\": \"224194003\",\n            \"display\": \"Not entitled to benefits (finding)\"\n          },\n          {\n            \"code\": \"224198000\",\n            \"display\": \"Delay in receiving benefits (finding)\"\n          },\n          {\n            \"code\": \"224199008\",\n            \"display\": \"Loss of benefits (finding)\"\n          },\n          {\n            \"code\": \"242990004\",\n            \"display\": \"Drug not available for administration (event)\"\n          },\n          {\n            \"code\": \"266756008\",\n            \"display\": \"Medical care unavailable (situation)\"\n          },\n          {\n            \"code\": \"270459005\",\n            \"display\": \"Patient on waiting list (finding)\"\n          },\n          {\n            \"code\": \"309017000\",\n            \"display\": \"Referred to doctor (finding)\"\n          },\n          {\n            \"code\": \"309846006\",\n            \"display\": \"Treatment not available (situation)\"\n          },\n          {\n            \"code\": \"419808006\",\n            \"display\": \"Finding related to health insurance issues (finding)\"\n          },\n          {\n            \"code\": \"424553001\",\n            \"display\": \"Uninsured medical expenses (finding)\"\n          }\n        ]\n      }\n    ]\n  }\n}",
      "valueSetFhirValidationResults": []
    }
  ],
  "measureConversionResults": {
    "measureResults": [],
    "measureConversionType": null,
    "measureFhirValidationResults": [
      {
        "severity": "ERROR",
        "locationField": "Measure.group[0].population[0]",
        "errorDescription": "Profile http://hl7.org/fhir/StructureDefinition/Measure, Element 'Measure.group[0].population[0].criteria': minimum required = 1, but only found 0"
      },
      {
        "severity": "ERROR",
        "locationField": "Measure.group[0].population[1]",
        "errorDescription": "Profile http://hl7.org/fhir/StructureDefinition/Measure, Element 'Measure.group[0].population[1].criteria': minimum required = 1, but only found 0"
      },
      {
        "severity": "ERROR",
        "locationField": "Measure.group[0].population[2]",
        "errorDescription": "Profile http://hl7.org/fhir/StructureDefinition/Measure, Element 'Measure.group[0].population[2].criteria': minimum required = 1, but only found 0"
      },
      {
        "severity": "ERROR",
        "locationField": "Measure.group[0].population[3]",
        "errorDescription": "Profile http://hl7.org/fhir/StructureDefinition/Measure, Element 'Measure.group[0].population[3].criteria': minimum required = 1, but only found 0"
      }
    ],
    "reason": "New",
    "success": null,
    "link": null,
    "fhirMeasureJson": "{\n  \"resourceType\": \"Measure\",\n  \"id\": \"40280382649c54c30164b3e14334084e\",\n  \"text\": {\n    \"status\": \"generated\",\n    \"div\": \"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html lang="en">
 <head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
  <title>JEK_AT_Antiemetic Therapy Prescribed for Highly Emetogenic Chemotherapy Risk</title>
  <style type="text/css">
body {
	color: rgb(26, 26, 26);
	background-color: rgb(255,255,255);
	font-family: Verdana, Tahoma, sans-serif;
	font-size: 11px;
    overflow-y: auto;
}



h1 {
	font-size: 12pt;
	font-weight: bold;
}

h2 {
	font-size: 11pt;
	font-weight: bold;
}

h3 {
	font-size: 10pt;
	font-weight: bold;
}

h4 {
	font-size: 8pt;
	font-weight: bold;
}





tr {
	background-color: rgb(224,224,224);
}

td {
	padding: 0.1cm 0.2cm;
	vertical-align: top;
}



a {
	/*color: rgb(0, 0, 255);
	background-color: rgb(255,255,255);*/
}

table { 
 line-height: 10pt; 
 width: 80%; 
 font-size: 11px; 
 }

/*div {
	width: 80%;
}*/

.list-unstyled {
    list-style-type: none;
}

.list-unstyled li {
    padding-top: 5px;
}

.list-header {
    font-size: 12px;
    color: rgb(0, 0, 238);
}

.list-header:hover {
    text-decoration: underline;
}

.code {
    font-family: Consolas,Menlo,Monaco,Lucida Console,Liberation Mono,DejaVu Sans Mono,Bitstream Vera Sans Mono,Courier New,monospace,sans-serif;
    color:black;
    font-size: 12px;
}

.p-l-10 {
    padding-left: 10px;
}

.section {
    font-size: 10pt;
    margin-top: 1em;
    margin-bottom: 1em;
    margin-right: 0.5em;
    font-weight: 700;
    display: inline-block;
}

.cql-keyword-new {
    color: rgb(0, 0, 255);
    font-weight: 700;
}

.cql-class, .cql-object {
    color: rgb(25, 127, 157);
}

.cql_keyword {
    color: rgb(127, 0, 85);
    font-weight: 700;
}
.cql_function {
    color: rgb(127, 0, 85);
    font-weight: 700;
}
.cql_attribute {
    color: rgb(127, 0, 85);
    font-weight: 700;
}
.cql_string {
    color: rgb(42, 0, 255);
}
.cql_identifier .cql_function {
    color: rgb(60, 76, 114);
}
hr.style13 {
	height: 10px;
	border: 0;
	box-shadow: 0 10px 10px -10px #8c8b8b inset;
}


.treeview:hover input ~ label:before,
.treeview.hover input ~ label:before {
  opacity: 1.0;
  -webkit-transition-duration: 0.5s;
  -moz-transition-duration: 0.5s;
  -ms-transition-duration: 0.5s;
  -o-transition-duration: 0.5s;
  transition-duration: 0.5s;
}

.treeview ul {
  -webkit-transition-duration: 1s;
  -moz-transition-duration: 1s;
  -ms-transition-duration: 1s;
  -o-transition-duration: 1s;
  transition-duration: 1s;
  -webkit-transition-timing-function: ease;
  -moz-transition-timing-function: ease;
  -ms-transition-timing-function: ease;
  -o-transition-timing-function: ease;
  transition-timing-function: ease;
  list-style: none;
  padding-left: 1em;
}
.treeview ul li span {
  -webkit-transition-property: color;
  -moz-transition-property: color;
  -ms-transition-property: color;
  -o-transition-property: color;
  transition-property: color;
  -webkit-transition-duration: 1s;
  -moz-transition-duration: 1s;
  -ms-transition-duration: 1s;
  -o-transition-duration: 1s;
  transition-duration: 1s;
  
}

.treeview input {
  display: none;
}

.treeview input[type=checkbox]:checked ~ ul {
  display: none;  
}

.treeview input[type=checkbox] ~ ul {
  max-height: 100%;
  margin-right: 20%;
  opacity: 1;  
}

.treeview input ~ label {
  cursor: pointer;
}
.treeview input ~ label:before {
  content: '';
  width: 0;
  height: 0;
  position: absolute;
  margin-left: -1em;
  margin-top: 0.25em;
  border-width: 4px;
  border-style: solid;
  border-top-color: transparent;
  border-right-color: rgb(0, 0, 238);
  border-bottom-color: rgb(0, 0, 238);
  border-left-color: transparent;
  opacity: 0.0;
  -webkit-transition-property: opacity;
  -moz-transition-property: opacity;
  -ms-transition-property: opacity;
  -o-transition-property: opacity;
  transition-property: opacity;
  -webkit-transition-duration: 1s;
  -moz-transition-duration: 1s;
  -ms-transition-duration: 1s;
  -o-transition-duration: 1s;
  transition-duration: 1s;
}
.treeview input:checked ~ label:before {
  margin-left: -0.8em;
  border-width: 5px;
  border-top-color: transparent;
  border-right-color: transparent;
  border-bottom-color: transparent;
  border-left-color: rgb(0, 0, 238);
}




.h1center {
	font-size: 12pt;
	font-weight: bold;
	text-align: center;
	width: 80%;
}

.header_table{
	border: 1pt inset rgb(0,0,0);
}

.narr_table {
	width: 100%;
}

.narr_tr {
	background-color: rgb(225,225,225);
}

pre {
 overflow: auto; /* Use horizontal scroller if needed; for Firefox 2, not needed in Firefox 3 */
 white-space: pre-wrap; /* css-3 */
 white-space: -moz-pre-wrap !important; /* Mozilla, since 1999 */
 white-space: -pre-wrap; /* Opera 4-6 */
 white-space: -o-pre-wrap; /* Opera 7 */
 word-wrap: break-word; /* Internet Explorer 5.5+ */
 font-family: Verdana, Tahoma, sans-serif;
 font-size: 11px;
 text-align:left;
 margin: 0px 0px 0px 0px;
 padding:0px 0px 0px 0px;
}
.narr_th {
	background-color: rgb(201,201,201);
}

.td_label{
	font-weight: bold;
	color: white;
}

.hll { background-color: #ffffcc }
.c { color: #408080; font-style: italic } /* Comment */
.err { border: 1px solid #FF0000 } /* Error */
.k { color: #008000; font-weight: bold } /* Keyword */
.o { color: #666666 } /* Operator */
.cm { color: #408080; font-style: italic } /* Comment.Multiline */
.cp { color: #BC7A00 } /* Comment.Preproc */
.c1 { color: #408080; font-style: italic } /* Comment.Single */
.cs { color: #408080; font-style: italic } /* Comment.Special */
.gd { color: #A00000 } /* Generic.Deleted */
.ge { font-style: italic } /* Generic.Emph */
.gr { color: #FF0000 } /* Generic.Error */
.gh { color: #000080; font-weight: bold } /* Generic.Heading */
.gi { color: #00A000 } /* Generic.Inserted */
.go { color: #888888 } /* Generic.Output */
.gp { color: #000080; font-weight: bold } /* Generic.Prompt */
.gs { font-weight: bold } /* Generic.Strong */
.gu { color: #800080; font-weight: bold } /* Generic.Subheading */
.gt { color: #0044DD } /* Generic.Traceback */
.kc { color: #008000; font-weight: bold } /* Keyword.Constant */
.kd { color: #008000; font-weight: bold } /* Keyword.Declaration */
.kn { color: #008000; font-weight: bold } /* Keyword.Namespace */
.kp { color: #008000 } /* Keyword.Pseudo */
.kr { color: #008000; font-weight: bold } /* Keyword.Reserved */
.kt { color: #B00040 } /* Keyword.Type */
.m { color: #666666 } /* Literal.Number */
.s { color: #BA2121 } /* Literal.String */
.na { color: #7D9029 } /* Name.Attribute */
.nb { color: #008000 } /* Name.Builtin */
.nc { color: #0000FF; font-weight: bold } /* Name.Class */
.no { color: #880000 } /* Name.Constant */
.nd { color: #AA22FF } /* Name.Decorator */
.ni { color: #999999; font-weight: bold } /* Name.Entity */
.ne { color: #D2413A; font-weight: bold } /* Name.Exception */
.nf { color: #0000FF } /* Name.Function */
.nl { color: #A0A000 } /* Name.Label */
.nn { color: #0000FF; font-weight: bold } /* Name.Namespace */
.nt { color: #008000; font-weight: bold } /* Name.Tag */
.nv { color: #19177C } /* Name.Variable */
.ow { color: #AA22FF; font-weight: bold } /* Operator.Word */
.w { color: #bbbbbb } /* Text.Whitespace */
.mf { color: #666666 } /* Literal.Number.Float */
.mh { color: #666666 } /* Literal.Number.Hex */
.mi { color: #666666 } /* Literal.Number.Integer */
.mo { color: #666666 } /* Literal.Number.Oct */
.sb { color: #BA2121 } /* Literal.String.Backtick */
.sc { color: #BA2121 } /* Literal.String.Char */
.sd { color: #BA2121; font-style: italic } /* Literal.String.Doc */
.s2 { color: #BA2121 } /* Literal.String.Double */
.se { color: #BB6622; font-weight: bold } /* Literal.String.Escape */
.sh { color: #BA2121 } /* Literal.String.Heredoc */
.si { color: #BB6688; font-weight: bold } /* Literal.String.Interpol */
.sx { color: #008000 } /* Literal.String.Other */
.sr { color: #BB6688 } /* Literal.String.Regex */
.s1 { color: #BA2121 } /* Literal.String.Single */
.ss { color: #19177C } /* Literal.String.Symbol */
.bp { color: #008000 } /* Name.Builtin.Pseudo */
.vc { color: #19177C } /* Name.Variable.Class */
.vg { color: #19177C } /* Name.Variable.Global */
.vi { color: #19177C } /* Name.Variable.Instance */
.il { color: #666666 } /* Literal.Number.Integer.Long */

#nn-text
{
    text-align: center;
    text-align: center;
    color:lightgrey;
    font-size:40px;
}

.cql-definition-body {
	width:950px;
	display: block;
	word-wrap: break-word;
}li {  padding-left: 15px;}	</style>
 </head>
 <body>
  <table class="header_table">
   <tbody>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">eCQM Title</span></td>
     <td style="width:80%" colspan="3"><h1 style="font-size:10px">JEK_AT_Antiemetic Therapy Prescribed for Highly Emetogenic Chemotherapy Risk</h1></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">eCQM Identifier (Measure Authoring Tool)</span></td>
     <td style="width:30%"> </td>
     <td style="background-color:#656565; width:20%"><span class="td_label">eCQM Version number</span></td>
     <td style="width:30%">1.0.000</td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">NQF Number</span></td>
     <td style="width:30%">Not Applicable</td>
     <td style="background-color:#656565; width:20%"><span class="td_label">GUID</span></td>
     <td>acb1d0a2-3ac0-4024-a51c-2a26ded3bfea</td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Measurement Period</span></td>
     <td style="width:80%" colspan="3">January 1, 20XX through December 31, 20XX</td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Measure Steward</span></td>
     <td style="width:80%" colspan="3">American Society of Clinical Oncology</td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Measure Developer</span></td>
     <td style="width:80%" colspan="3">American Society of Clinical Oncology</td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Endorsed By</span></td>
     <td style="width:80%" colspan="3">None</td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Description</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Percentage of patients who were prescribed antiemetic therapy for highly emetogenic risk chemotherapy.</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Copyright</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>American Society of Clinical Oncology, 2015</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Disclaimer</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre> </pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Measure Scoring</span></td>
     <td style="width:80%" colspan="3">Proportion</td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Measure Type</span></td>
     <td style="width:80%" colspan="3">Process</td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Stratification</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre> </pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Risk Adjustment</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre> </pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Rate Aggregation</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre> </pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Rationale</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Antiemetic treatment for patients who receive combination chemotherapy should be determined according to the agent with the greatest degree of emetic risk.</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Clinical Recommendation Statement</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Patients who are prescribed a highly emetic risk chemotherapy regimen should also receive recommended antiemetics to control nausea and vomiting.</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Improvement Notation</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Higher scores represent higher quality</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Reference</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Antiemetics:  American Society of Clinical Oncology Clinical Practice Guideline Update Ethan Basch, 
JCO Nov 1, 2011:4189-4198 http://jco.ascopubs.org/content/29/31/4189.full?sid=780ad973-7019-417b-8047-8c896c3df0e5

NCCN Clinical Practice Guidelines in Oncolog. AntiemesisV.1.2014
http://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf
 
NICCQ Measure G-3A2. IF a patient ever receives highly emetogenic chemotherapy THEN the patient should receive potent anti-emetic therapy (e.g. 5HT blockade). (Adapted)
http://jco.ascopubs.org/cgi/content/abstract/24/4/626

http://ascopubs.org/doi/pdf/10.1200/JCO.2015.64.3635</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Definition</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>High-risk emetigenic agents include: Carmustine, Cisplatin, Cyclophosphamide ? 1,500 mg/m2, Dacarbazine, Dactinomycin, Mechlorethamine, Streptozotocin. Moderate risk emetigenic agents include: Azacitidine, Alemtuzumab, Bendamustine, Carboplatin, Clofarabine, Cyclophosphamide  1,000 mg/m2, Daunorubicin, Doxorubicin, Epirubicin, Idarubicin, Ifosfamide, Irinotecan and Oxaliplatin</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Guidance</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Antiemetigenic therapy should be prescribed within 7 days of high or moderate risk emetic chemotherapy.</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Transmission Format</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre> </pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Initial Population</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre> </pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Denominator</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Patient received high emetic risk chemotherapy.</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Denominator Exclusions</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Chemotherapy was not administered or administered but not overseen by practice at any time.</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Numerator</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Palonosetron or first generation 5-HT3 is prescribed on or before the chemotherapy initiation date, and dexamethasone is prescribed on or before the chemotherapy initiation date, and Aprepitant/fosaprepitant/netupitant was prescribed on or before the chemotherapy initiation date; or the patient received alternative treatment according to a clinical trial protocol.</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Numerator Exclusions</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre> </pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Denominator Exceptions</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre>Patient declined, contraindication or other clinical exclusion documented.</pre>
      </div></td>
    </tr>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Supplemental Data Elements</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre> </pre>
      </div></td>
    </tr>
   </tbody>
  </table>
  <h2><a name="toc">Table of Contents</a></h2>
  <ul style="padding-left: 50px;">
   <li><a href="#d1e405">Population Criteria</a></li>
   <li><a href="#d1e649">Definitions</a></li>
   <li><a href="#d1e650">Functions</a></li>
   <li><a href="#d1e555">Terminology</a></li>
   <li><a href="#d1e647">Data Criteria (QDM Data Elements)</a></li>
   <li><a href="#d1e767">Supplemental Data Elements</a></li>
   <li><a href="#d1e879">Risk Adjustment Variables</a></li>
  </ul>
  <div style="float:left; background:teal; height:3px; width:80%"></div>
  <pre><br></pre>
  <h3><a name="d1e405" href="#toc">Population Criteria</a></h3>
  <div>
   <ul style="list-style:none;padding-left:10px;">
    <li class="list-unstyled" style="list-style:none;padding-left:0px;">
     <div class="treeview hover p-l-10">
      <ul class="list-unstyled">
       <li class="list-unstyled"><input type="checkbox" id="test-initialPopulation_319"><label for="test-initialPopulation_319" class="list-header"><strong>Initial Population</strong></label>
        <ul class="code">
         <li class="list-unstyled">
          <div class="treeview hover p-l-10">
           <ul>
            <li style="padding-left: 0px;">
             <div>
              <pre class="cql-definition-body">Count("Office Visits")&gt;= 2
	and "First Cancer Dx" is not null</pre>
             </div></li>
           </ul>&nbsp;
          </div></li>
        </ul></li>
      </ul>
     </div></li>
    <li class="list-unstyled" style="list-style:none;padding-left:0px;">
     <div class="treeview hover p-l-10">
      <ul class="list-unstyled">
       <li class="list-unstyled"><input type="checkbox" id="test-denominator_148"><label for="test-denominator_148" class="list-header"><strong>Denominator</strong></label>
        <ul class="code">
         <li class="list-unstyled">
          <div class="treeview hover p-l-10">
           <ul>
            <li style="padding-left: 0px;">
             <div>
              <pre class="cql-definition-body">"Initial Population"
	and ( exists "Cyclophosphamide Administered after First Cancer Dx"
			and exists "Specific Mod Risk Chemo Administered after First Cancer Dx"
	)
	or exists "High Emetic Risk Chemo Administered after First Cancer Dx"</pre>
             </div></li>
           </ul>&nbsp;
          </div></li>
        </ul></li>
      </ul>
     </div></li>
    <li class="list-unstyled" style="list-style:none;padding-left:0px;">
     <div class="treeview hover p-l-10">
      <ul class="list-unstyled">
       <li class="list-unstyled"><input type="checkbox" id="test-denominatorExclusions_473"><label for="test-denominatorExclusions_473" class="list-header"><strong>Denominator Exclusions</strong></label>
        <ul class="code">
         <li>
          <div id="test-None_905">
           <strong class="cql-class">None</strong>
          </div></li>
        </ul></li>
      </ul>
     </div></li>
    <li class="list-unstyled" style="list-style:none;padding-left:0px;">
     <div class="treeview hover p-l-10">
      <ul class="list-unstyled">
       <li class="list-unstyled"><input type="checkbox" id="test-numerator_711"><label for="test-numerator_711" class="list-header"><strong>Numerator</strong></label>
        <ul class="code">
         <li class="list-unstyled">
          <div class="treeview hover p-l-10">
           <ul>
            <li style="padding-left: 0px;">
             <div>
              <pre class="cql-definition-body">exists "Clinical Trial Participant within 7 days after start of High Emetic Risk Combo Chemotherapy"
	or exists "Clinical Trial Participant before start of High Emetic Risk Combo Chemotherapy"
	or ( ( exists "Dexamethasone administered or ordered within 7 days after Combo High Risk Chemo"
				or exists "Dexamethasone administered or ordered before Combo High Risk Chemo"
		)
			and ( exists "Palonosetron administered or ordered within 7 days after Combo High Risk Chemo"
					or exists "Palonosetron administered or ordered before Combo High Risk Chemo"
			)
			or ( ( exists "Aprepitant, Fosaprepitant or Netupitant  administered or ordered within 7 days after Combo High Risk Chemo"
						or exists "Aprepitant, Fosaprepitant or Netupitant  administered or ordered before Combo High Risk Chemo"
				)
					and ( exists "First Gen Serotonin Antagonists or Palonosetron administered or ordered within 7 days after Combo High Risk Chemo"
							or exists "First Gen Serotonin Antagonists or Palonosetron administered or ordered before Combo High Risk Chemo"
					)
			)
	)</pre>
             </div></li>
           </ul>&nbsp;
          </div></li>
        </ul></li>
      </ul>
     </div></li>
    <li class="list-unstyled" style="list-style:none;padding-left:0px;">
     <div class="treeview hover p-l-10">
      <ul class="list-unstyled">
       <li class="list-unstyled"><input type="checkbox" id="test-numeratorExclusions_483"><label for="test-numeratorExclusions_483" class="list-header"><strong>Numerator Exclusions</strong></label>
        <ul class="code">
         <li>
          <div id="test-None_95">
           <strong class="cql-class">None</strong>
          </div></li>
        </ul></li>
      </ul>
     </div></li>
    <li class="list-unstyled" style="list-style:none;padding-left:0px;">
     <div class="treeview hover p-l-10">
      <ul class="list-unstyled">
       <li class="list-unstyled"><input type="checkbox" id="test-denominatorExceptions_825"><label for="test-denominatorExceptions_825" class="list-header"><strong>Denominator Exceptions</strong></label>
        <ul class="code">
         <li class="list-unstyled">
          <div class="treeview hover p-l-10">
           <ul>
            <li style="padding-left: 0px;">
             <div>
              <pre class="cql-definition-body">exists "Reasons for Not prescribing or Ordering First Gen Serotonin Antagonists, Aprepitant, Fosprepitant or Netupitant"</pre>
             </div></li>
           </ul>&nbsp;
          </div></li>
        </ul></li>
      </ul>
     </div></li>
    <li class="list-unstyled" style="list-style:none;padding-left:0px;">
     <div class="treeview hover p-l-10">
      <ul class="list-unstyled">
       <li class="list-unstyled"><input type="checkbox" id="test-stratum_918"><label for="test-stratum_918" class="list-header"><strong>Stratification</strong></label>
        <ul class="code">
         <li>
          <div id="test-None_846">
           <strong class="cql-class">None</strong>
          </div></li>
        </ul></li>
      </ul>
     </div></li>
   </ul>
  </div>
  <h3><a name="d1e649" href="#toc">Definitions</a></h3>
  <div>
   <ul style="list-style:none;padding-left: 10px;">
    <li class="list-unstyled" style="list-style:none;">
     <div>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-Actionability_274">
         <label for="test-Actionability_274" class="list-header"><strong> Actionability</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">true</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-Actionability_End_Date_307">
         <label for="test-Actionability_End_Date_307" class="list-header"><strong> Actionability End Date</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">"Actionability Start Date" + 7 days</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-Actionability_Start_Date_594">
         <label for="test-Actionability_Start_Date_594" class="list-header"><strong> Actionability Start Date</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">First("Combination High Emetic Risk Chemotherapy administered after First Cancer Dx".relevantPeriod.low)</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-Aprepitant,_Fosaprepitant_or_Netupitant__administered_or_ordered_before_Combo_High_Risk_Chemo_922">
         <label for="test-Aprepitant,_Fosaprepitant_or_Netupitant__administered_or_ordered_before_Combo_High_Risk_Chemo_922" class="list-header"><strong> Aprepitant, Fosaprepitant or Netupitant administered or ordered before Combo High Risk Chemo</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">( ["Medication, Administered": "Aprepitant"]
	union ["Medication, Administered": "Fosaprepitant"]
	union ["Medication, Administered": "Netupitant"]
	union ["Medication, Order": "Aprepitant"]
	union ["Medication, Order": "Fosaprepitant"]
	union ["Medication, Order": "Netupitant"] ) MedAdmin
	with "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx" ComboChemo
		such that MedAdmin.relevantPeriod starts before start of ComboChemo.relevantPeriod</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-Aprepitant,_Fosaprepitant_or_Netupitant__administered_or_ordered_within_7_days_after_Combo_High_Risk_Chemo_329">
         <label for="test-Aprepitant,_Fosaprepitant_or_Netupitant__administered_or_ordered_within_7_days_after_Combo_High_Risk_Chemo_329" class="list-header"><strong> Aprepitant, Fosaprepitant or Netupitant administered or ordered within 7 days after Combo High Risk Chemo</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">( ["Medication, Administered": "Aprepitant"]
	union ["Medication, Administered": "Fosaprepitant"]
	union ["Medication, Administered": "Netupitant"]
	union ["Medication, Order": "Aprepitant"]
	union ["Medication, Order": "Fosaprepitant"]
	union ["Medication, Order": "Netupitant"] ) MedAdmin
	with "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx" ComboChemo
		such that MedAdmin.relevantPeriod starts 7 days or less after start of ComboChemo.relevantPeriod</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-Clinical_Trial_Participant_before_start_of_High_Emetic_Risk_Combo_Chemotherapy_894">
         <label for="test-Clinical_Trial_Participant_before_start_of_High_Emetic_Risk_Combo_Chemotherapy_894" class="list-header"><strong> Clinical Trial Participant before start of High Emetic Risk Combo Chemotherapy</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">( ["Care Goal": "Clinical Trial Participant"] ) Trial
	with "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx" ComboChemo
		such that Trial.relevantPeriod starts before start of ComboChemo.relevantPeriod</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-Clinical_Trial_Participant_within_7_days_after_start_of_High_Emetic_Risk_Combo_Chemotherapy_288">
         <label for="test-Clinical_Trial_Participant_within_7_days_after_start_of_High_Emetic_Risk_Combo_Chemotherapy_288" class="list-header"><strong> Clinical Trial Participant within 7 days after start of High Emetic Risk Combo Chemotherapy</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">( ["Care Goal": "Clinical Trial Participant"] ) Trial
	with "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx" ComboChemo
		such that Trial.relevantPeriod starts 7 days or less after start of ComboChemo.relevantPeriod</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-Combination_High_Emetic_Risk_Chemotherapy_administered_after_First_Cancer_Dx_310">
         <label for="test-Combination_High_Emetic_Risk_Chemotherapy_administered_after_First_Cancer_Dx_310" class="list-header"><strong> Combination High Emetic Risk Chemotherapy administered after First Cancer Dx</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">"High Risk Cyclophosphamide Administered after First Cancer Dx"
	union "High Emetic Risk Chemo Administered after First Cancer Dx"</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-Cyclophosphamide_Administered_after_First_Cancer_Dx_160">
         <label for="test-Cyclophosphamide_Administered_after_First_Cancer_Dx_160" class="list-header"><strong> Cyclophosphamide Administered after First Cancer Dx</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">["Medication, Administered": "Cyclophosphamide"] MedAdmin
	with "First Cancer Dx" Dx
		such that MedAdmin.relevantPeriod starts after start of Dx.prevalencePeriod</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-Denominator_531">
         <label for="test-Denominator_531" class="list-header"><strong> Denominator</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">"Initial Population"
	and ( exists "Cyclophosphamide Administered after First Cancer Dx"
			and exists "Specific Mod Risk Chemo Administered after First Cancer Dx"
	)
	or exists "High Emetic Risk Chemo Administered after First Cancer Dx"</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-Denominator_Exceptions_308">
         <label for="test-Denominator_Exceptions_308" class="list-header"><strong> Denominator Exceptions</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">exists "Reasons for Not prescribing or Ordering First Gen Serotonin Antagonists, Aprepitant, Fosprepitant or Netupitant"</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-Dexamethasone_administered_or_ordered_before_Combo_High_Risk_Chemo_692">
         <label for="test-Dexamethasone_administered_or_ordered_before_Combo_High_Risk_Chemo_692" class="list-header"><strong> Dexamethasone administered or ordered before Combo High Risk Chemo</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">( ["Medication, Administered": "Dexamethasone"]
	union ["Medication, Order": "Dexamethasone"] ) MedAdmin
	with "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx" ComboChemo
		such that MedAdmin.relevantPeriod starts before start of ComboChemo.relevantPeriod</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-Dexamethasone_administered_or_ordered_within_7_days_after_Combo_High_Risk_Chemo_25">
         <label for="test-Dexamethasone_administered_or_ordered_within_7_days_after_Combo_High_Risk_Chemo_25" class="list-header"><strong> Dexamethasone administered or ordered within 7 days after Combo High Risk Chemo</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">( ["Medication, Administered": "Dexamethasone"]
	union ["Medication, Order": "Dexamethasone"] ) MedAdmin
	with "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx" ComboChemo
		such that MedAdmin.relevantPeriod starts 7 days or less after start of ComboChemo.relevantPeriod</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-First_Cancer_Dx_688">
         <label for="test-First_Cancer_Dx_688" class="list-header"><strong> First Cancer Dx</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">First(((["Diagnosis": "Cancer"])Dx
		where Dx.prevalencePeriod starts during "Measurement Period")DD
		sort by start of prevalencePeriod
)</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-First_Gen_Serotonin_Antagonists_or_Palonosetron_administered_or_ordered_before_Combo_High_Risk_Chemo_992">
         <label for="test-First_Gen_Serotonin_Antagonists_or_Palonosetron_administered_or_ordered_before_Combo_High_Risk_Chemo_992" class="list-header"><strong> First Gen Serotonin Antagonists or Palonosetron administered or ordered before Combo High Risk Chemo</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">( ["Medication, Administered": "First Generation Serotonin Antagonists"]
	union ["Medication, Administered": "Palonosetron"]
	union ["Medication, Order": "First Generation Serotonin Antagonists"]
	union ["Medication, Order": "Palonosetron"] ) MedAdmin
	with "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx" ComboChemo
		such that MedAdmin.relevantPeriod starts before start of ComboChemo.relevantPeriod</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-First_Gen_Serotonin_Antagonists_or_Palonosetron_administered_or_ordered_within_7_days_after_Combo_High_Risk_Chemo_644">
         <label for="test-First_Gen_Serotonin_Antagonists_or_Palonosetron_administered_or_ordered_within_7_days_after_Combo_High_Risk_Chemo_644" class="list-header"><strong> First Gen Serotonin Antagonists or Palonosetron administered or ordered within 7 days after Combo High Risk Chemo</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">( ["Medication, Administered": "First Generation Serotonin Antagonists"]
	union ["Medication, Administered": "Palonosetron"]
	union ["Medication, Order": "First Generation Serotonin Antagonists"]
	union ["Medication, Order": "Palonosetron"] ) MedAdmin
	with "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx" ComboChemo
		such that MedAdmin.relevantPeriod starts 7 days or less after start of ComboChemo.relevantPeriod</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-High_Emetic_Risk_Chemo_Administered_after_First_Cancer_Dx_134">
         <label for="test-High_Emetic_Risk_Chemo_Administered_after_First_Cancer_Dx_134" class="list-header"><strong> High Emetic Risk Chemo Administered after First Cancer Dx</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">["Medication, Administered": "High Emetigenic Risk Chemotherapy"] MedAdmin
	with "First Cancer Dx" Dx
		such that MedAdmin.relevantPeriod starts after start of Dx.prevalencePeriod</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-High_Risk_Cyclophosphamide_Administered_after_First_Cancer_Dx_607">
         <label for="test-High_Risk_Cyclophosphamide_Administered_after_First_Cancer_Dx_607" class="list-header"><strong> High Risk Cyclophosphamide Administered after First Cancer Dx</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">"Cyclophosphamide Administered after First Cancer Dx"
	union "Specific Mod Risk Chemo Administered after First Cancer Dx"</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-Initial_Population_427">
         <label for="test-Initial_Population_427" class="list-header"><strong> Initial Population</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">Count("Office Visits")&gt;= 2
	and "First Cancer Dx" is not null</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-Numerator_475">
         <label for="test-Numerator_475" class="list-header"><strong> Numerator</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">exists "Clinical Trial Participant within 7 days after start of High Emetic Risk Combo Chemotherapy"
	or exists "Clinical Trial Participant before start of High Emetic Risk Combo Chemotherapy"
	or ( ( exists "Dexamethasone administered or ordered within 7 days after Combo High Risk Chemo"
				or exists "Dexamethasone administered or ordered before Combo High Risk Chemo"
		)
			and ( exists "Palonosetron administered or ordered within 7 days after Combo High Risk Chemo"
					or exists "Palonosetron administered or ordered before Combo High Risk Chemo"
			)
			or ( ( exists "Aprepitant, Fosaprepitant or Netupitant  administered or ordered within 7 days after Combo High Risk Chemo"
						or exists "Aprepitant, Fosaprepitant or Netupitant  administered or ordered before Combo High Risk Chemo"
				)
					and ( exists "First Gen Serotonin Antagonists or Palonosetron administered or ordered within 7 days after Combo High Risk Chemo"
							or exists "First Gen Serotonin Antagonists or Palonosetron administered or ordered before Combo High Risk Chemo"
					)
			)
	)</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-Office_Visits_475">
         <label for="test-Office_Visits_475" class="list-header"><strong> Office Visits</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">( ["Encounter, Performed": "Office Visit"]
	union ["Encounter, Performed": "Patient Provider Interaction"] ) Enc
	where Enc.relevantPeriod starts during "Measurement Period"</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-Palonosetron_administered_or_ordered_before_Combo_High_Risk_Chemo_461">
         <label for="test-Palonosetron_administered_or_ordered_before_Combo_High_Risk_Chemo_461" class="list-header"><strong> Palonosetron administered or ordered before Combo High Risk Chemo</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">( ["Medication, Administered": "NEPA Netupitant Palonosetron"]
	union ["Medication, Order": "NEPA Netupitant Palonosetron"] ) MedAdmin
	with "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx" ComboChemo
		such that MedAdmin.relevantPeriod starts before start of ComboChemo.relevantPeriod</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-Palonosetron_administered_or_ordered_within_7_days_after_Combo_High_Risk_Chemo_786">
         <label for="test-Palonosetron_administered_or_ordered_within_7_days_after_Combo_High_Risk_Chemo_786" class="list-header"><strong> Palonosetron administered or ordered within 7 days after Combo High Risk Chemo</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">( ["Medication, Administered": "NEPA Netupitant Palonosetron"]
	union ["Medication, Order": "NEPA Netupitant Palonosetron"] ) MedAdmin
	with "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx" ComboChemo
		such that MedAdmin.relevantPeriod starts 7 days or less after start of ComboChemo.relevantPeriod</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-Reasons_for_Not_prescribing_or_Ordering_First_Gen_Serotonin_Antagonists,_Aprepitant,_Fosprepitant_or_Netupitant_458">
         <label for="test-Reasons_for_Not_prescribing_or_Ordering_First_Gen_Serotonin_Antagonists,_Aprepitant,_Fosprepitant_or_Netupitant_458" class="list-header"><strong> Reasons for Not prescribing or Ordering First Gen Serotonin Antagonists, Aprepitant, Fosprepitant or Netupitant</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">( ["Medication, Administered": "First Generation Serotonin Antagonists"]
	union ["Medication, Administered": "Aprepitant"]
	union ["Medication, Administered": "Fosaprepitant"]
	union ["Medication, Administered": "Netupitant"]
	union ["Medication, Order": "First Generation Serotonin Antagonists"]
	union ["Medication, Order": "Aprepitant"]
	union ["Medication, Order": "Fosaprepitant"]
	union ["Medication, Order": "Netupitant"] ) MedNotOrdered
	where MedNotOrdered.negationRationale in "Medical Reason"
		or MedNotOrdered.negationRationale in "Patient Reason"
		or MedNotOrdered.negationRationale in "System Reason"
			and MedNotOrdered.relevantPeriod starts during "Measurement Period"</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-SDE_Ethnicity_274">
         <label for="test-SDE_Ethnicity_274" class="list-header"><strong> SDE Ethnicity</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">["Patient Characteristic Ethnicity": "Ethnicity"]</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-SDE_Payer_684">
         <label for="test-SDE_Payer_684" class="list-header"><strong> SDE Payer</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">["Patient Characteristic Payer": "Payer"]</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-SDE_Race_530">
         <label for="test-SDE_Race_530" class="list-header"><strong> SDE Race</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">["Patient Characteristic Race": "Race"]</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-SDE_Sex_82">
         <label for="test-SDE_Sex_82" class="list-header"><strong> SDE Sex</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">["Patient Characteristic Sex": "ONC Administrative Sex"] </pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
      <ul class="list-unstyled" style="list-style:none;padding-left:0;">
       <li class="list-unstyled">
        <div class="treeview hover p-l-10">
         <input type="checkbox" id="test-Specific_Mod_Risk_Chemo_Administered_after_First_Cancer_Dx_935">
         <label for="test-Specific_Mod_Risk_Chemo_Administered_after_First_Cancer_Dx_935" class="list-header"><strong> Specific Mod Risk Chemo Administered after First Cancer Dx</strong></label>
         <ul class="code" style="margin-right: 20%; opacity: 1;">
          <li class="list-unstyled">
           <div>
            <ul style="padding-left: 0px;">
             <li style="padding-left: 0px;" class="list-unstyled">
              <div>
               <pre class="cql-definition-body">( ["Medication, Administered": "Doxorubicin"]
	union ["Medication, Administered": "Epirubicin"]
	union ["Medication, Administered": "Idarubicin"]
	union ["Medication, Administered": "Daunorubicin"] ) MedAdmin
	with "First Cancer Dx" Dx
		such that MedAdmin.relevantPeriod starts after start of Dx.prevalencePeriod</pre>
              </div></li>
            </ul>&nbsp;
           </div></li>
         </ul>
        </div></li>
      </ul>
     </div></li>
   </ul>
  </div>
  <h3><a name="d1e650" href="#toc">Functions</a></h3>
  <div>
   <ul style="list-style:none;padding-left: 10px;">
    <li class="list-unstyled" style="list-style:none;">
     <div></div></li>
    <li>None</li>
   </ul>
  </div>
  <h3><a name="d1e555" href="#toc">Terminology</a></h3>
  <div>
   <ul style="padding-left: 50px;">
    <li>valueset "Aprepitant" (2.16.840.1.113762.1.4.1116.222)</li>
    <li>valueset "Cancer" (2.16.840.1.113762.1.4.1116.231)</li>
    <li>valueset "Clinical Trial Participant" (2.16.840.1.113762.1.4.1116.150)</li>
    <li>valueset "Cyclophosphamide" (2.16.840.1.113762.1.4.1116.167)</li>
    <li>valueset "Daunorubicin" (2.16.840.1.113762.1.4.1116.332)</li>
    <li>valueset "Dexamethasone" (2.16.840.1.113762.1.4.1116.80)</li>
    <li>valueset "Doxorubicin" (2.16.840.1.113762.1.4.1116.168)</li>
    <li>valueset "Epirubicin" (2.16.840.1.113762.1.4.1116.200)</li>
    <li>valueset "Ethnicity" (2.16.840.1.114222.4.11.837)</li>
    <li>valueset "First Generation Serotonin Antagonists" (2.16.840.1.113762.1.4.1116.82)</li>
    <li>valueset "Fosaprepitant" (2.16.840.1.113762.1.4.1116.223)</li>
    <li>valueset "High Emetigenic Risk Chemotherapy" (2.16.840.1.113762.1.4.1116.331)</li>
    <li>valueset "Idarubicin" (2.16.840.1.113762.1.4.1116.199)</li>
    <li>valueset "Medical Reason" (2.16.840.1.113883.3.526.2.313)</li>
    <li>valueset "NEPA Netupitant Palonosetron" (2.16.840.1.113762.1.4.1116.334)</li>
    <li>valueset "Netupitant" (2.16.840.1.113762.1.4.1116.335)</li>
    <li>valueset "Office Visit" (2.16.840.1.113883.3.464.1003.101.11.1005)</li>
    <li>valueset "ONC Administrative Sex" (2.16.840.1.113762.1.4.1)</li>
    <li>valueset "Palonosetron" (2.16.840.1.113762.1.4.1116.81)</li>
    <li>valueset "Patient Provider Interaction" (2.16.840.1.113883.3.526.3.1012)</li>
    <li>valueset "Patient Reason" (2.16.840.1.113883.3.526.2.311)</li>
    <li>valueset "Payer" (2.16.840.1.114222.4.11.3591)</li>
    <li>valueset "Race" (2.16.840.1.114222.4.11.836)</li>
    <li>valueset "System Reason" (2.16.840.1.113883.3.526.2.310)</li>
   </ul>
  </div>
  <h3><a name="d1e647" href="#toc">Data Criteria (QDM Data Elements)</a></h3>
  <ul style="padding-left: 50px;">
   <li style="width:80%">"Care Goal: Clinical Trial Participant" using "Clinical Trial Participant (2.16.840.1.113762.1.4.1116.150)"</li>
   <li style="width:80%">"Diagnosis: Cancer" using "Cancer (2.16.840.1.113762.1.4.1116.231)"</li>
   <li style="width:80%">"Encounter, Performed: Office Visit" using "Office Visit (2.16.840.1.113883.3.464.1003.101.11.1005)"</li>
   <li style="width:80%">"Encounter, Performed: Patient Provider Interaction" using "Patient Provider Interaction (2.16.840.1.113883.3.526.3.1012)"</li>
   <li style="width:80%">"Medication, Administered: Aprepitant" using "Aprepitant (2.16.840.1.113762.1.4.1116.222)"</li>
   <li style="width:80%">"Medication, Administered: Cyclophosphamide" using "Cyclophosphamide (2.16.840.1.113762.1.4.1116.167)"</li>
   <li style="width:80%">"Medication, Administered: Daunorubicin" using "Daunorubicin (2.16.840.1.113762.1.4.1116.332)"</li>
   <li style="width:80%">"Medication, Administered: Dexamethasone" using "Dexamethasone (2.16.840.1.113762.1.4.1116.80)"</li>
   <li style="width:80%">"Medication, Administered: Doxorubicin" using "Doxorubicin (2.16.840.1.113762.1.4.1116.168)"</li>
   <li style="width:80%">"Medication, Administered: Epirubicin" using "Epirubicin (2.16.840.1.113762.1.4.1116.200)"</li>
   <li style="width:80%">"Medication, Administered: First Generation Serotonin Antagonists" using "First Generation Serotonin Antagonists (2.16.840.1.113762.1.4.1116.82)"</li>
   <li style="width:80%">"Medication, Administered: Fosaprepitant" using "Fosaprepitant (2.16.840.1.113762.1.4.1116.223)"</li>
   <li style="width:80%">"Medication, Administered: High Emetigenic Risk Chemotherapy" using "High Emetigenic Risk Chemotherapy (2.16.840.1.113762.1.4.1116.331)"</li>
   <li style="width:80%">"Medication, Administered: Idarubicin" using "Idarubicin (2.16.840.1.113762.1.4.1116.199)"</li>
   <li style="width:80%">"Medication, Administered: NEPA Netupitant Palonosetron" using "NEPA Netupitant Palonosetron (2.16.840.1.113762.1.4.1116.334)"</li>
   <li style="width:80%">"Medication, Administered: Netupitant" using "Netupitant (2.16.840.1.113762.1.4.1116.335)"</li>
   <li style="width:80%">"Medication, Administered: Palonosetron" using "Palonosetron (2.16.840.1.113762.1.4.1116.81)"</li>
   <li style="width:80%">"Medication, Order: Aprepitant" using "Aprepitant (2.16.840.1.113762.1.4.1116.222)"</li>
   <li style="width:80%">"Medication, Order: Dexamethasone" using "Dexamethasone (2.16.840.1.113762.1.4.1116.80)"</li>
   <li style="width:80%">"Medication, Order: First Generation Serotonin Antagonists" using "First Generation Serotonin Antagonists (2.16.840.1.113762.1.4.1116.82)"</li>
   <li style="width:80%">"Medication, Order: Fosaprepitant" using "Fosaprepitant (2.16.840.1.113762.1.4.1116.223)"</li>
   <li style="width:80%">"Medication, Order: NEPA Netupitant Palonosetron" using "NEPA Netupitant Palonosetron (2.16.840.1.113762.1.4.1116.334)"</li>
   <li style="width:80%">"Medication, Order: Netupitant" using "Netupitant (2.16.840.1.113762.1.4.1116.335)"</li>
   <li style="width:80%">"Medication, Order: Palonosetron" using "Palonosetron (2.16.840.1.113762.1.4.1116.81)"</li>
   <li style="width:80%">"Patient Characteristic Ethnicity: Ethnicity" using "Ethnicity (2.16.840.1.114222.4.11.837)"</li>
   <li style="width:80%">"Patient Characteristic Payer: Payer" using "Payer (2.16.840.1.114222.4.11.3591)"</li>
   <li style="width:80%">"Patient Characteristic Race: Race" using "Race (2.16.840.1.114222.4.11.836)"</li>
   <li style="width:80%">"Patient Characteristic Sex: ONC Administrative Sex" using "ONC Administrative Sex (2.16.840.1.113762.1.4.1)"</li>
  </ul>
  <h3><a name="d1e767" href="#toc">Supplemental Data Elements</a></h3>
  <div>
   <ul style="list-style:none;padding-left: 25px;">
    <li class="list-unstyled">
     <div class="treeview hover p-l-10">
      <input type="checkbox" id="test-Actionability_47">
      <label for="test-Actionability_47" class="list-header"><strong> Actionability</strong></label>
      <ul class="code" style="margin-right: 20%; opacity: 1;">
       <li class="list-unstyled">
        <div>
         <ul style="padding-left: 0px;">
          <li style="padding-left: 0px;" class="list-unstyled">
           <div>
            <pre class="cql-definition-body">true</pre>
           </div></li>
         </ul>&nbsp;
        </div></li>
      </ul>
     </div></li>
    <li class="list-unstyled">
     <div class="treeview hover p-l-10">
      <input type="checkbox" id="test-Actionability_End_Date_849">
      <label for="test-Actionability_End_Date_849" class="list-header"><strong> Actionability End Date</strong></label>
      <ul class="code" style="margin-right: 20%; opacity: 1;">
       <li class="list-unstyled">
        <div>
         <ul style="padding-left: 0px;">
          <li style="padding-left: 0px;" class="list-unstyled">
           <div>
            <pre class="cql-definition-body">"Actionability Start Date" + 7 days</pre>
           </div></li>
         </ul>&nbsp;
        </div></li>
      </ul>
     </div></li>
    <li class="list-unstyled">
     <div class="treeview hover p-l-10">
      <input type="checkbox" id="test-Actionability_Start_Date_515">
      <label for="test-Actionability_Start_Date_515" class="list-header"><strong> Actionability Start Date</strong></label>
      <ul class="code" style="margin-right: 20%; opacity: 1;">
       <li class="list-unstyled">
        <div>
         <ul style="padding-left: 0px;">
          <li style="padding-left: 0px;" class="list-unstyled">
           <div>
            <pre class="cql-definition-body">First("Combination High Emetic Risk Chemotherapy administered after First Cancer Dx".relevantPeriod.low)</pre>
           </div></li>
         </ul>&nbsp;
        </div></li>
      </ul>
     </div></li>
    <li class="list-unstyled">
     <div class="treeview hover p-l-10">
      <input type="checkbox" id="test-SDE_Ethnicity_389">
      <label for="test-SDE_Ethnicity_389" class="list-header"><strong> SDE Ethnicity</strong></label>
      <ul class="code" style="margin-right: 20%; opacity: 1;">
       <li class="list-unstyled">
        <div>
         <ul style="padding-left: 0px;">
          <li style="padding-left: 0px;" class="list-unstyled">
           <div>
            <pre class="cql-definition-body">["Patient Characteristic Ethnicity": "Ethnicity"]</pre>
           </div></li>
         </ul>&nbsp;
        </div></li>
      </ul>
     </div></li>
    <li class="list-unstyled">
     <div class="treeview hover p-l-10">
      <input type="checkbox" id="test-SDE_Payer_95">
      <label for="test-SDE_Payer_95" class="list-header"><strong> SDE Payer</strong></label>
      <ul class="code" style="margin-right: 20%; opacity: 1;">
       <li class="list-unstyled">
        <div>
         <ul style="padding-left: 0px;">
          <li style="padding-left: 0px;" class="list-unstyled">
           <div>
            <pre class="cql-definition-body">["Patient Characteristic Payer": "Payer"]</pre>
           </div></li>
         </ul>&nbsp;
        </div></li>
      </ul>
     </div></li>
    <li class="list-unstyled">
     <div class="treeview hover p-l-10">
      <input type="checkbox" id="test-SDE_Race_910">
      <label for="test-SDE_Race_910" class="list-header"><strong> SDE Race</strong></label>
      <ul class="code" style="margin-right: 20%; opacity: 1;">
       <li class="list-unstyled">
        <div>
         <ul style="padding-left: 0px;">
          <li style="padding-left: 0px;" class="list-unstyled">
           <div>
            <pre class="cql-definition-body">["Patient Characteristic Race": "Race"]</pre>
           </div></li>
         </ul>&nbsp;
        </div></li>
      </ul>
     </div></li>
    <li class="list-unstyled">
     <div class="treeview hover p-l-10">
      <input type="checkbox" id="test-SDE_Sex_270">
      <label for="test-SDE_Sex_270" class="list-header"><strong> SDE Sex</strong></label>
      <ul class="code" style="margin-right: 20%; opacity: 1;">
       <li class="list-unstyled">
        <div>
         <ul style="padding-left: 0px;">
          <li style="padding-left: 0px;" class="list-unstyled">
           <div>
            <pre class="cql-definition-body">["Patient Characteristic Sex": "ONC Administrative Sex"] </pre>
           </div></li>
         </ul>&nbsp;
        </div></li>
      </ul>
     </div></li>
   </ul>
  </div>
  <h3><a name="d1e879" href="#toc">Risk Adjustment Variables</a></h3>
  <div>
   <ul style="list-style:none;padding-left: 25px;">
    <li>None</li>
   </ul>
  </div>
  <div style="float:left; background:teal; height:3px; width:80%"></div>
  <pre><br></pre>
  <table class="header_table">
   <tbody>
    <tr>
     <td style="background-color:#656565; width:20%"><span class="td_label">Measure Set</span></td>
     <td style="width:80%" colspan="3">
      <div style="width:660px;overflow-x:hidden;overflow-y:auto">
       <pre> </pre>
      </div></td>
    </tr>
   </tbody>
  </table>
 </body>
</html></div>\"\n  },\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/Measure/40280382649c54c30164b3e14334084e\",\n  \"version\": \"v1.0.0\",\n  \"name\": \"JEK_AT_Antiemetic Therapy Prescribed for Highly Emetogenic Chemotherapy Risk\",\n  \"title\": \"High Antiemetic QCP SMT27 CQL\",\n  \"status\": \"active\",\n  \"experimental\": false,\n  \"publisher\": \"American Society of Clinical Oncology\",\n  \"contact\": [\n    {\n      \"telecom\": [\n        {\n          \"system\": \"url\",\n          \"value\": \"https://cms.gov\"\n        }\n      ]\n    }\n  ],\n  \"description\": \"Percentage of patients who were prescribed antiemetic therapy for highly emetogenic risk chemotherapy.\",\n  \"useContext\": [\n    {\n      \"code\": {\n        \"code\": \"program\"\n      },\n      \"valueCodeableConcept\": {\n        \"text\": \"eligible-provider\"\n      }\n    }\n  ],\n  \"jurisdiction\": [\n    {\n      \"coding\": [\n        {\n          \"system\": \"urn:iso:std:iso:3166\",\n          \"code\": \"US\"\n        }\n      ]\n    }\n  ],\n  \"purpose\": \"Unknown\",\n  \"copyright\": \"American Society of Clinical Oncology, 2015\",\n  \"approvalDate\": \"2018-12-20\",\n  \"effectivePeriod\": {\n    \"start\": \"1969-12-31T17:00:00-07:00\",\n    \"end\": \"1969-12-31T17:00:00-07:00\"\n  },\n  \"topic\": [\n    {\n      \"coding\": [\n        {\n          \"system\": \"http://loinc.org\",\n          \"code\": \"57024-2\",\n          \"display\": \"Health Quality Measure Document\"\n        }\n      ]\n    }\n  ],\n  \"relatedArtifact\": [\n    {\n      \"type\": \"citation\",\n      \"citation\": \"Antiemetics:  American Society of Clinical Oncology Clinical Practice Guideline Update Ethan Basch, \\nJCO Nov 1, 2011:4189-4198 http://jco.ascopubs.org/content/29/31/4189.full?sid=780ad973-7019-417b-8047-8c896c3df0e5\\n\\nNCCN Clinical Practice Guidelines in Oncolog. AntiemesisV.1.2014\\nhttp://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf\\n \\nNICCQ Measure G-3A2. IF a patient ever receives highly emetogenic chemotherapy THEN the patient should receive potent anti-emetic therapy (e.g. 5HT blockade). (Adapted)\\nhttp://jco.ascopubs.org/cgi/content/abstract/24/4/626\\n\\nhttp://ascopubs.org/doi/pdf/10.1200/JCO.2015.64.3635\"\n    }\n  ],\n  \"scoring\": {\n    \"coding\": [\n      {\n        \"system\": \"http://hl7.org/fhir/measure-scoring\",\n        \"code\": \"Proportion\"\n      }\n    ]\n  },\n  \"type\": [\n    {\n      \"coding\": [\n        {\n          \"system\": \"http://hl7.org/fhir/measure-type\",\n          \"code\": \"process\"\n        }\n      ]\n    }\n  ],\n  \"rationale\": \"Antiemetic treatment for patients who receive combination chemotherapy should be determined according to the agent with the greatest degree of emetic risk.\",\n  \"clinicalRecommendationStatement\": \"Patients who are prescribed a highly emetic risk chemotherapy regimen should also receive recommended antiemetics to control nausea and vomiting.\",\n  \"guidance\": \"Antiemetigenic therapy should be prescribed within 7 days of high or moderate risk emetic chemotherapy.\",\n  \"group\": [\n    {\n      \"population\": [\n        {\n          \"code\": {\n            \"coding\": [\n              {\n                \"system\": \"http://terminology.hl7.org/CodeSystem/measure-population\",\n                \"code\": \"initialPopulation\",\n                \"display\": \"Initial Population 1\"\n              }\n            ]\n          }\n        },\n        {\n          \"code\": {\n            \"coding\": [\n              {\n                \"system\": \"http://terminology.hl7.org/CodeSystem/measure-population\",\n                \"code\": \"denominator\",\n                \"display\": \"Denominator 1\"\n              }\n            ]\n          }\n        },\n        {\n          \"code\": {\n            \"coding\": [\n              {\n                \"system\": \"http://terminology.hl7.org/CodeSystem/measure-population\",\n                \"code\": \"denominatorExceptions\",\n                \"display\": \"Denominator Exceptions 1\"\n              }\n            ]\n          }\n        },\n        {\n          \"code\": {\n            \"coding\": [\n              {\n                \"system\": \"http://terminology.hl7.org/CodeSystem/measure-population\",\n                \"code\": \"numerator\",\n                \"display\": \"Numerator 1\"\n              }\n            ]\n          }\n        }\n      ]\n    }\n  ],\n  \"supplementalData\": [\n    {\n      \"code\": {\n        \"text\": \"actionability\"\n      },\n      \"usage\": [\n        {\n          \"coding\": [\n            {\n              \"system\": \"http://hl7.org/fhir/measure-data-usage\",\n              \"code\": \"supplemental-data\"\n            }\n          ]\n        }\n      ],\n      \"criteria\": {\n        \"language\": \"text/cql\",\n        \"expression\": \"Actionability\"\n      }\n    },\n    {\n      \"code\": {\n        \"text\": \"actionability-end-date\"\n      },\n      \"usage\": [\n        {\n          \"coding\": [\n            {\n              \"system\": \"http://hl7.org/fhir/measure-data-usage\",\n              \"code\": \"supplemental-data\"\n            }\n          ]\n        }\n      ],\n      \"criteria\": {\n        \"language\": \"text/cql\",\n        \"expression\": \"Actionability End Date\"\n      }\n    },\n    {\n      \"code\": {\n        \"text\": \"actionability-start-date\"\n      },\n      \"usage\": [\n        {\n          \"coding\": [\n            {\n              \"system\": \"http://hl7.org/fhir/measure-data-usage\",\n              \"code\": \"supplemental-data\"\n            }\n          ]\n        }\n      ],\n      \"criteria\": {\n        \"language\": \"text/cql\",\n        \"expression\": \"Actionability Start Date\"\n      }\n    },\n    {\n      \"code\": {\n        \"text\": \"sde-ethnicity\"\n      },\n      \"usage\": [\n        {\n          \"coding\": [\n            {\n              \"system\": \"http://hl7.org/fhir/measure-data-usage\",\n              \"code\": \"supplemental-data\"\n            }\n          ]\n        }\n      ],\n      \"criteria\": {\n        \"language\": \"text/cql\",\n        \"expression\": \"SDE Ethnicity\"\n      }\n    },\n    {\n      \"code\": {\n        \"text\": \"sde-payer\"\n      },\n      \"usage\": [\n        {\n          \"coding\": [\n            {\n              \"system\": \"http://hl7.org/fhir/measure-data-usage\",\n              \"code\": \"supplemental-data\"\n            }\n          ]\n        }\n      ],\n      \"criteria\": {\n        \"language\": \"text/cql\",\n        \"expression\": \"SDE Payer\"\n      }\n    },\n    {\n      \"code\": {\n        \"text\": \"sde-race\"\n      },\n      \"usage\": [\n        {\n          \"coding\": [\n            {\n              \"system\": \"http://hl7.org/fhir/measure-data-usage\",\n              \"code\": \"supplemental-data\"\n            }\n          ]\n        }\n      ],\n      \"criteria\": {\n        \"language\": \"text/cql\",\n        \"expression\": \"SDE Race\"\n      }\n    },\n    {\n      \"code\": {\n        \"text\": \"sde-sex\"\n      },\n      \"usage\": [\n        {\n          \"coding\": [\n            {\n              \"system\": \"http://hl7.org/fhir/measure-data-usage\",\n              \"code\": \"supplemental-data\"\n            }\n          ]\n        }\n      ],\n      \"criteria\": {\n        \"language\": \"text/cql\",\n        \"expression\": \"SDE Sex\"\n      }\n    }\n  ]\n}"
  },
  "libraryConversionResults": [
    {
      "matId": "40280382678f73560167cc6fffca0afe",
      "name": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk",
      "version": "1.000",
      "reason": "Not Found in Hapi",
      "success": false,
      "link": null,
      "fhirLibraryJson": "{\n  \"resourceType\": \"Library\",\n  \"id\": \"40280382678f73560167cc6fffca0afe\",\n  \"url\": \"http://localhost:6060/hapi-fhir-jpaserver/fhir/Library/40280382678f73560167cc6fffca0afe\",\n  \"version\": \"1.000\",\n  \"name\": \"JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk\",\n  \"status\": \"active\",\n  \"type\": {\n    \"coding\": [\n      {\n        \"system\": \"http://hl7.org/fhir/codesystem-library-type.html\",\n        \"code\": \"logic-library\"\n      }\n    ]\n  },\n  \"date\": \"2020-02-25T11:03:31-07:00\",\n  \"approvalDate\": \"2018-12-20\",\n  \"content\": [\n    {\n      \"contentType\": \"application/elm+xml\",\n      \"data\": \"{
  "library" : {
    "identifier" : {
      "id" : "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk",
      "version" : "1.0.000"
    },
    "schemaIdentifier" : {
      "id" : "urn:hl7-org:elm",
      "version" : "r1"
    },
    "usings" : {
      "def" : [ {
        "localIdentifier" : "System",
        "uri" : "urn:hl7-org:elm-types:r1"
      }, {
        "localId" : "1",
        "locator" : "3:1-3:23",
        "localIdentifier" : "QDM",
        "uri" : "urn:healthit-gov:qdm:v5_4",
        "version" : "5.4"
      } ]
    },
    "parameters" : {
      "def" : [ {
        "localId" : "34",
        "locator" : "36:1-36:49",
        "name" : "Measurement Period",
        "accessLevel" : "Public",
        "parameterTypeSpecifier" : {
          "localId" : "33",
          "locator" : "36:32-36:49",
          "type" : "IntervalTypeSpecifier",
          "pointType" : {
            "localId" : "32",
            "locator" : "36:41-36:48",
            "name" : "{urn:hl7-org:elm-types:r1}DateTime",
            "type" : "NamedTypeSpecifier"
          }
        }
      } ]
    },
    "codeSystems" : {
      "def" : [ {
        "localId" : "2",
        "locator" : "5:1-5:51",
        "name" : "LOINC",
        "id" : "urn:oid:2.16.840.1.113883.6.1",
        "accessLevel" : "Public"
      }, {
        "localId" : "3",
        "locator" : "6:1-6:55",
        "name" : "SNOMEDCT",
        "id" : "urn:oid:2.16.840.1.113883.6.96",
        "accessLevel" : "Public"
      } ]
    },
    "valueSets" : {
      "def" : [ {
        "localId" : "4",
        "locator" : "8:1-8:63",
        "name" : "Aprepitant",
        "id" : "urn:oid:2.16.840.1.113762.1.4.1116.222",
        "accessLevel" : "Public"
      }, {
        "localId" : "5",
        "locator" : "9:1-9:59",
        "name" : "Cancer",
        "id" : "urn:oid:2.16.840.1.113762.1.4.1116.231",
        "accessLevel" : "Public"
      }, {
        "localId" : "6",
        "locator" : "10:1-10:79",
        "name" : "Clinical Trial Participant",
        "id" : "urn:oid:2.16.840.1.113762.1.4.1116.150",
        "accessLevel" : "Public"
      }, {
        "localId" : "7",
        "locator" : "11:1-11:69",
        "name" : "Cyclophosphamide",
        "id" : "urn:oid:2.16.840.1.113762.1.4.1116.167",
        "accessLevel" : "Public"
      }, {
        "localId" : "8",
        "locator" : "12:1-12:65",
        "name" : "Daunorubicin",
        "id" : "urn:oid:2.16.840.1.113762.1.4.1116.332",
        "accessLevel" : "Public"
      }, {
        "localId" : "9",
        "locator" : "13:1-13:65",
        "name" : "Dexamethasone",
        "id" : "urn:oid:2.16.840.1.113762.1.4.1116.80",
        "accessLevel" : "Public"
      }, {
        "localId" : "10",
        "locator" : "14:1-14:64",
        "name" : "Doxorubicin",
        "id" : "urn:oid:2.16.840.1.113762.1.4.1116.168",
        "accessLevel" : "Public"
      }, {
        "localId" : "11",
        "locator" : "15:1-15:63",
        "name" : "Epirubicin",
        "id" : "urn:oid:2.16.840.1.113762.1.4.1116.200",
        "accessLevel" : "Public"
      }, {
        "localId" : "12",
        "locator" : "16:1-16:58",
        "name" : "Ethnicity",
        "id" : "urn:oid:2.16.840.1.114222.4.11.837",
        "accessLevel" : "Public"
      }, {
        "localId" : "13",
        "locator" : "17:1-17:90",
        "name" : "First Generation Serotonin Antagonists",
        "id" : "urn:oid:2.16.840.1.113762.1.4.1116.82",
        "accessLevel" : "Public"
      }, {
        "localId" : "14",
        "locator" : "18:1-18:66",
        "name" : "Fosaprepitant",
        "id" : "urn:oid:2.16.840.1.113762.1.4.1116.223",
        "accessLevel" : "Public"
      }, {
        "localId" : "15",
        "locator" : "19:1-19:86",
        "name" : "High Emetigenic Risk Chemotherapy",
        "id" : "urn:oid:2.16.840.1.113762.1.4.1116.331",
        "accessLevel" : "Public"
      }, {
        "localId" : "16",
        "locator" : "20:1-20:63",
        "name" : "Idarubicin",
        "id" : "urn:oid:2.16.840.1.113762.1.4.1116.199",
        "accessLevel" : "Public"
      }, {
        "localId" : "17",
        "locator" : "21:1-21:66",
        "name" : "Medical Reason",
        "id" : "urn:oid:2.16.840.1.113883.3.526.2.313",
        "accessLevel" : "Public"
      }, {
        "localId" : "18",
        "locator" : "22:1-22:81",
        "name" : "NEPA Netupitant Palonosetron",
        "id" : "urn:oid:2.16.840.1.113762.1.4.1116.334",
        "accessLevel" : "Public"
      }, {
        "localId" : "19",
        "locator" : "23:1-23:63",
        "name" : "Netupitant",
        "id" : "urn:oid:2.16.840.1.113762.1.4.1116.335",
        "accessLevel" : "Public"
      }, {
        "localId" : "20",
        "locator" : "24:1-24:75",
        "name" : "Office Visit",
        "id" : "urn:oid:2.16.840.1.113883.3.464.1003.101.11.1005",
        "accessLevel" : "Public"
      }, {
        "localId" : "21",
        "locator" : "25:1-25:68",
        "name" : "ONC Administrative Sex",
        "id" : "urn:oid:2.16.840.1.113762.1.4.1",
        "accessLevel" : "Public"
      }, {
        "localId" : "22",
        "locator" : "26:1-26:64",
        "name" : "Palonosetron",
        "id" : "urn:oid:2.16.840.1.113762.1.4.1116.81",
        "accessLevel" : "Public"
      }, {
        "localId" : "23",
        "locator" : "27:1-27:81",
        "name" : "Patient Provider Interaction",
        "id" : "urn:oid:2.16.840.1.113883.3.526.3.1012",
        "accessLevel" : "Public"
      }, {
        "localId" : "24",
        "locator" : "28:1-28:66",
        "name" : "Patient Reason",
        "id" : "urn:oid:2.16.840.1.113883.3.526.2.311",
        "accessLevel" : "Public"
      }, {
        "localId" : "25",
        "locator" : "29:1-29:55",
        "name" : "Payer",
        "id" : "urn:oid:2.16.840.1.114222.4.11.3591",
        "accessLevel" : "Public"
      }, {
        "localId" : "26",
        "locator" : "30:1-30:53",
        "name" : "Race",
        "id" : "urn:oid:2.16.840.1.114222.4.11.836",
        "accessLevel" : "Public"
      }, {
        "localId" : "27",
        "locator" : "31:1-31:65",
        "name" : "System Reason",
        "id" : "urn:oid:2.16.840.1.113883.3.526.2.310",
        "accessLevel" : "Public"
      } ]
    },
    "codes" : {
      "def" : [ {
        "localId" : "29",
        "locator" : "33:1-33:60",
        "name" : "Birthdate",
        "id" : "21112-8",
        "display" : "Birthdate",
        "accessLevel" : "Public",
        "codeSystem" : {
          "localId" : "28",
          "locator" : "33:34-33:40",
          "name" : "LOINC"
        }
      }, {
        "localId" : "31",
        "locator" : "34:1-34:55",
        "name" : "Dead",
        "id" : "419099009",
        "display" : "Dead",
        "accessLevel" : "Public",
        "codeSystem" : {
          "localId" : "30",
          "locator" : "34:31-34:40",
          "name" : "SNOMEDCT"
        }
      } ]
    },
    "statements" : {
      "def" : [ {
        "locator" : "38:1-38:15",
        "name" : "Patient",
        "context" : "Patient",
        "expression" : {
          "type" : "SingletonFrom",
          "operand" : {
            "locator" : "38:1-38:15",
            "dataType" : "{urn:healthit-gov:qdm:v5_4}Patient",
            "templateId" : "Patient",
            "type" : "Retrieve"
          }
        }
      }, {
        "localId" : "36",
        "locator" : "40:1-41:51",
        "name" : "SDE Ethnicity",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "36",
            "s" : [ {
              "value" : [ "define ", "\"SDE Ethnicity\"", ":\n  " ]
            }, {
              "r" : "35",
              "s" : [ {
                "value" : [ "[", "\"Patient Characteristic Ethnicity\"", ": " ]
              }, {
                "s" : [ {
                  "value" : [ "\"Ethnicity\"" ]
                } ]
              }, {
                "value" : [ "]" ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "35",
          "locator" : "41:3-41:51",
          "dataType" : "{urn:healthit-gov:qdm:v5_4}PatientCharacteristicEthnicity",
          "codeProperty" : "code",
          "type" : "Retrieve",
          "codes" : {
            "locator" : "41:40-41:50",
            "name" : "Ethnicity",
            "type" : "ValueSetRef"
          }
        }
      }, {
        "localId" : "38",
        "locator" : "43:1-44:43",
        "name" : "SDE Payer",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "38",
            "s" : [ {
              "value" : [ "define ", "\"SDE Payer\"", ":\n  " ]
            }, {
              "r" : "37",
              "s" : [ {
                "value" : [ "[", "\"Patient Characteristic Payer\"", ": " ]
              }, {
                "s" : [ {
                  "value" : [ "\"Payer\"" ]
                } ]
              }, {
                "value" : [ "]" ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "37",
          "locator" : "44:3-44:43",
          "dataType" : "{urn:healthit-gov:qdm:v5_4}PatientCharacteristicPayer",
          "codeProperty" : "code",
          "type" : "Retrieve",
          "codes" : {
            "locator" : "44:36-44:42",
            "name" : "Payer",
            "type" : "ValueSetRef"
          }
        }
      }, {
        "localId" : "40",
        "locator" : "46:1-47:41",
        "name" : "SDE Race",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "40",
            "s" : [ {
              "value" : [ "define ", "\"SDE Race\"", ":\n  " ]
            }, {
              "r" : "39",
              "s" : [ {
                "value" : [ "[", "\"Patient Characteristic Race\"", ": " ]
              }, {
                "s" : [ {
                  "value" : [ "\"Race\"" ]
                } ]
              }, {
                "value" : [ "]" ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "39",
          "locator" : "47:3-47:41",
          "dataType" : "{urn:healthit-gov:qdm:v5_4}PatientCharacteristicRace",
          "codeProperty" : "code",
          "type" : "Retrieve",
          "codes" : {
            "locator" : "47:35-47:40",
            "name" : "Race",
            "type" : "ValueSetRef"
          }
        }
      }, {
        "localId" : "42",
        "locator" : "49:1-50:58",
        "name" : "SDE Sex",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "42",
            "s" : [ {
              "value" : [ "define ", "\"SDE Sex\"", ":\n  " ]
            }, {
              "r" : "41",
              "s" : [ {
                "value" : [ "[", "\"Patient Characteristic Sex\"", ": " ]
              }, {
                "s" : [ {
                  "value" : [ "\"ONC Administrative Sex\"" ]
                } ]
              }, {
                "value" : [ "]" ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "41",
          "locator" : "50:3-50:58",
          "dataType" : "{urn:healthit-gov:qdm:v5_4}PatientCharacteristicSex",
          "codeProperty" : "code",
          "type" : "Retrieve",
          "codes" : {
            "locator" : "50:34-50:57",
            "name" : "ONC Administrative Sex",
            "type" : "ValueSetRef"
          }
        }
      }, {
        "localId" : "52",
        "locator" : "52:1-55:62",
        "name" : "Office Visits",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "52",
            "s" : [ {
              "value" : [ "define ", "\"Office Visits\"", ":\n  " ]
            }, {
              "r" : "51",
              "s" : [ {
                "s" : [ {
                  "r" : "46",
                  "s" : [ {
                    "r" : "45",
                    "s" : [ {
                      "value" : [ "( " ]
                    }, {
                      "r" : "45",
                      "s" : [ {
                        "r" : "43",
                        "s" : [ {
                          "value" : [ "[", "\"Encounter, Performed\"", ": " ]
                        }, {
                          "s" : [ {
                            "value" : [ "\"Office Visit\"" ]
                          } ]
                        }, {
                          "value" : [ "]" ]
                        } ]
                      }, {
                        "value" : [ "\n  \tunion " ]
                      }, {
                        "r" : "44",
                        "s" : [ {
                          "value" : [ "[", "\"Encounter, Performed\"", ": " ]
                        }, {
                          "s" : [ {
                            "value" : [ "\"Patient Provider Interaction\"" ]
                          } ]
                        }, {
                          "value" : [ "]" ]
                        } ]
                      } ]
                    }, {
                      "value" : [ " )" ]
                    } ]
                  }, {
                    "value" : [ " ", "Enc" ]
                  } ]
                } ]
              }, {
                "value" : [ "\n  \t" ]
              }, {
                "r" : "50",
                "s" : [ {
                  "value" : [ "where " ]
                }, {
                  "r" : "50",
                  "s" : [ {
                    "r" : "48",
                    "s" : [ {
                      "r" : "47",
                      "s" : [ {
                        "value" : [ "Enc" ]
                      } ]
                    }, {
                      "value" : [ "." ]
                    }, {
                      "r" : "48",
                      "s" : [ {
                        "value" : [ "relevantPeriod" ]
                      } ]
                    } ]
                  }, {
                    "r" : "50",
                    "value" : [ " ", "starts during", " " ]
                  }, {
                    "r" : "49",
                    "s" : [ {
                      "value" : [ "\"Measurement Period\"" ]
                    } ]
                  } ]
                } ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "51",
          "locator" : "53:3-55:62",
          "type" : "Query",
          "source" : [ {
            "localId" : "46",
            "locator" : "53:3-54:71",
            "alias" : "Enc",
            "expression" : {
              "localId" : "45",
              "locator" : "53:3-54:67",
              "type" : "Union",
              "operand" : [ {
                "localId" : "43",
                "locator" : "53:5-53:44",
                "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveEncounterPerformed",
                "templateId" : "PositiveEncounterPerformed",
                "codeProperty" : "code",
                "type" : "Retrieve",
                "codes" : {
                  "locator" : "53:30-53:43",
                  "name" : "Office Visit",
                  "type" : "ValueSetRef"
                }
              }, {
                "localId" : "44",
                "locator" : "54:10-54:65",
                "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveEncounterPerformed",
                "templateId" : "PositiveEncounterPerformed",
                "codeProperty" : "code",
                "type" : "Retrieve",
                "codes" : {
                  "locator" : "54:35-54:64",
                  "name" : "Patient Provider Interaction",
                  "type" : "ValueSetRef"
                }
              } ]
            }
          } ],
          "relationship" : [ ],
          "where" : {
            "localId" : "50",
            "locator" : "55:4-55:62",
            "type" : "In",
            "operand" : [ {
              "locator" : "55:29-55:34",
              "type" : "Start",
              "operand" : {
                "localId" : "48",
                "locator" : "55:10-55:27",
                "path" : "relevantPeriod",
                "scope" : "Enc",
                "type" : "Property"
              }
            }, {
              "localId" : "49",
              "locator" : "55:43-55:62",
              "name" : "Measurement Period",
              "type" : "ParameterRef"
            } ]
          }
        }
      }, {
        "localId" : "69",
        "locator" : "208:1-212:3",
        "name" : "First Cancer Dx",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "69",
            "s" : [ {
              "value" : [ "define ", "\"First Cancer Dx\"", ":\n  " ]
            }, {
              "r" : "68",
              "s" : [ {
                "value" : [ "First", "(" ]
              }, {
                "r" : "67",
                "s" : [ {
                  "s" : [ {
                    "r" : "62",
                    "s" : [ {
                      "r" : "61",
                      "s" : [ {
                        "value" : [ "(" ]
                      }, {
                        "r" : "61",
                        "s" : [ {
                          "s" : [ {
                            "r" : "56",
                            "s" : [ {
                              "r" : "55",
                              "s" : [ {
                                "value" : [ "(" ]
                              }, {
                                "r" : "55",
                                "s" : [ {
                                  "value" : [ "[", "\"Diagnosis\"", ": " ]
                                }, {
                                  "s" : [ {
                                    "value" : [ "\"Cancer\"" ]
                                  } ]
                                }, {
                                  "value" : [ "]" ]
                                } ]
                              }, {
                                "value" : [ ")" ]
                              } ]
                            }, {
                              "value" : [ "Dx" ]
                            } ]
                          } ]
                        }, {
                          "value" : [ "\n  \t\t" ]
                        }, {
                          "r" : "60",
                          "s" : [ {
                            "value" : [ "where " ]
                          }, {
                            "r" : "60",
                            "s" : [ {
                              "r" : "58",
                              "s" : [ {
                                "r" : "57",
                                "s" : [ {
                                  "value" : [ "Dx" ]
                                } ]
                              }, {
                                "value" : [ "." ]
                              }, {
                                "r" : "58",
                                "s" : [ {
                                  "value" : [ "prevalencePeriod" ]
                                } ]
                              } ]
                            }, {
                              "r" : "60",
                              "value" : [ " ", "starts during", " " ]
                            }, {
                              "r" : "59",
                              "s" : [ {
                                "value" : [ "\"Measurement Period\"" ]
                              } ]
                            } ]
                          } ]
                        } ]
                      }, {
                        "value" : [ ")" ]
                      } ]
                    }, {
                      "value" : [ "DD" ]
                    } ]
                  } ]
                }, {
                  "value" : [ "\n  \t\t" ]
                }, {
                  "r" : "66",
                  "s" : [ {
                    "value" : [ "sort by " ]
                  }, {
                    "r" : "65",
                    "s" : [ {
                      "r" : "64",
                      "s" : [ {
                        "value" : [ "start of " ]
                      }, {
                        "r" : "63",
                        "s" : [ {
                          "value" : [ "prevalencePeriod" ]
                        } ]
                      } ]
                    } ]
                  } ]
                } ]
              }, {
                "value" : [ "\n  )" ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "68",
          "locator" : "209:3-212:3",
          "type" : "First",
          "source" : {
            "localId" : "67",
            "locator" : "209:9-211:37",
            "type" : "Query",
            "source" : [ {
              "localId" : "62",
              "locator" : "209:9-210:67",
              "alias" : "DD",
              "expression" : {
                "localId" : "61",
                "locator" : "209:9-210:65",
                "type" : "Query",
                "source" : [ {
                  "localId" : "56",
                  "locator" : "209:10-209:36",
                  "alias" : "Dx",
                  "expression" : {
                    "localId" : "55",
                    "locator" : "209:10-209:34",
                    "dataType" : "{urn:healthit-gov:qdm:v5_4}Diagnosis",
                    "codeProperty" : "code",
                    "type" : "Retrieve",
                    "codes" : {
                      "locator" : "209:25-209:32",
                      "name" : "Cancer",
                      "type" : "ValueSetRef"
                    }
                  }
                } ],
                "relationship" : [ ],
                "where" : {
                  "localId" : "60",
                  "locator" : "210:5-210:64",
                  "type" : "In",
                  "operand" : [ {
                    "locator" : "210:31-210:36",
                    "type" : "Start",
                    "operand" : {
                      "localId" : "58",
                      "locator" : "210:11-210:29",
                      "path" : "prevalencePeriod",
                      "scope" : "Dx",
                      "type" : "Property"
                    }
                  }, {
                    "localId" : "59",
                    "locator" : "210:45-210:64",
                    "name" : "Measurement Period",
                    "type" : "ParameterRef"
                  } ]
                }
              }
            } ],
            "relationship" : [ ],
            "sort" : {
              "localId" : "66",
              "locator" : "211:5-211:37",
              "by" : [ {
                "localId" : "65",
                "locator" : "211:13-211:37",
                "direction" : "asc",
                "type" : "ByExpression",
                "expression" : {
                  "localId" : "64",
                  "locator" : "211:13-211:37",
                  "type" : "Start",
                  "operand" : {
                    "localId" : "63",
                    "locator" : "211:22-211:37",
                    "name" : "prevalencePeriod",
                    "type" : "IdentifierRef"
                  }
                }
              } ]
            }
          }
        }
      }, {
        "localId" : "80",
        "locator" : "57:1-60:79",
        "name" : "Cyclophosphamide Administered after First Cancer Dx",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "80",
            "s" : [ {
              "value" : [ "define ", "\"Cyclophosphamide Administered after First Cancer Dx\"", ":\n  " ]
            }, {
              "r" : "79",
              "s" : [ {
                "s" : [ {
                  "r" : "54",
                  "s" : [ {
                    "r" : "53",
                    "s" : [ {
                      "r" : "53",
                      "s" : [ {
                        "value" : [ "[", "\"Medication, Administered\"", ": " ]
                      }, {
                        "s" : [ {
                          "value" : [ "\"Cyclophosphamide\"" ]
                        } ]
                      }, {
                        "value" : [ "]" ]
                      } ]
                    } ]
                  }, {
                    "value" : [ " ", "MedAdmin" ]
                  } ]
                } ]
              }, {
                "value" : [ "\n  \t" ]
              }, {
                "r" : "78",
                "s" : [ {
                  "value" : [ "with " ]
                }, {
                  "r" : "71",
                  "s" : [ {
                    "r" : "70",
                    "s" : [ {
                      "s" : [ {
                        "value" : [ "\"First Cancer Dx\"" ]
                      } ]
                    } ]
                  }, {
                    "value" : [ " ", "Dx" ]
                  } ]
                }, {
                  "value" : [ "\n  \t\tsuch that " ]
                }, {
                  "r" : "77",
                  "s" : [ {
                    "r" : "73",
                    "s" : [ {
                      "r" : "72",
                      "s" : [ {
                        "value" : [ "MedAdmin" ]
                      } ]
                    }, {
                      "value" : [ "." ]
                    }, {
                      "r" : "73",
                      "s" : [ {
                        "value" : [ "relevantPeriod" ]
                      } ]
                    } ]
                  }, {
                    "r" : "77",
                    "value" : [ " ", "starts after", " " ]
                  }, {
                    "r" : "76",
                    "s" : [ {
                      "value" : [ "start of " ]
                    }, {
                      "r" : "75",
                      "s" : [ {
                        "r" : "74",
                        "s" : [ {
                          "value" : [ "Dx" ]
                        } ]
                      }, {
                        "value" : [ "." ]
                      }, {
                        "r" : "75",
                        "s" : [ {
                          "value" : [ "prevalencePeriod" ]
                        } ]
                      } ]
                    } ]
                  } ]
                } ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "79",
          "locator" : "58:3-60:79",
          "type" : "Query",
          "source" : [ {
            "localId" : "54",
            "locator" : "58:3-58:59",
            "alias" : "MedAdmin",
            "expression" : {
              "localId" : "53",
              "locator" : "58:3-58:50",
              "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
              "templateId" : "PositiveMedicationAdministered",
              "codeProperty" : "code",
              "type" : "Retrieve",
              "codes" : {
                "locator" : "58:32-58:49",
                "name" : "Cyclophosphamide",
                "type" : "ValueSetRef"
              }
            }
          } ],
          "relationship" : [ {
            "localId" : "78",
            "locator" : "59:4-60:79",
            "alias" : "Dx",
            "type" : "With",
            "expression" : {
              "localId" : "70",
              "locator" : "59:9-59:25",
              "name" : "First Cancer Dx",
              "type" : "ExpressionRef"
            },
            "suchThat" : {
              "localId" : "77",
              "locator" : "60:15-60:79",
              "type" : "After",
              "operand" : [ {
                "locator" : "60:39-60:44",
                "type" : "Start",
                "operand" : {
                  "localId" : "73",
                  "locator" : "60:15-60:37",
                  "path" : "relevantPeriod",
                  "scope" : "MedAdmin",
                  "type" : "Property"
                }
              }, {
                "localId" : "76",
                "locator" : "60:52-60:79",
                "type" : "Start",
                "operand" : {
                  "localId" : "75",
                  "locator" : "60:61-60:79",
                  "path" : "prevalencePeriod",
                  "scope" : "Dx",
                  "type" : "Property"
                }
              } ]
            }
          } ]
        }
      }, {
        "localId" : "88",
        "locator" : "62:1-64:36",
        "name" : "Initial Population",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "88",
            "s" : [ {
              "value" : [ "define ", "\"Initial Population\"", ":\n  " ]
            }, {
              "r" : "87",
              "s" : [ {
                "r" : "84",
                "s" : [ {
                  "r" : "82",
                  "s" : [ {
                    "value" : [ "Count", "(" ]
                  }, {
                    "r" : "81",
                    "s" : [ {
                      "value" : [ "\"Office Visits\"" ]
                    } ]
                  }, {
                    "value" : [ ")" ]
                  } ]
                }, {
                  "r" : "83",
                  "value" : [ ">=", " ", "2" ]
                } ]
              }, {
                "value" : [ "\n  \tand " ]
              }, {
                "r" : "86",
                "s" : [ {
                  "r" : "85",
                  "s" : [ {
                    "value" : [ "\"First Cancer Dx\"" ]
                  } ]
                }, {
                  "value" : [ " is not null" ]
                } ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "87",
          "locator" : "63:3-64:36",
          "type" : "And",
          "operand" : [ {
            "localId" : "84",
            "locator" : "63:3-63:28",
            "type" : "GreaterOrEqual",
            "operand" : [ {
              "localId" : "82",
              "locator" : "63:3-63:24",
              "type" : "Count",
              "source" : {
                "localId" : "81",
                "locator" : "63:9-63:23",
                "name" : "Office Visits",
                "type" : "ExpressionRef"
              }
            }, {
              "localId" : "83",
              "locator" : "63:28",
              "valueType" : "{urn:hl7-org:elm-types:r1}Integer",
              "value" : "2",
              "type" : "Literal"
            } ]
          }, {
            "localId" : "86",
            "locator" : "64:8-64:36",
            "type" : "Not",
            "operand" : {
              "locator" : "64:8-64:36",
              "type" : "IsNull",
              "operand" : {
                "localId" : "85",
                "locator" : "64:8-64:24",
                "name" : "First Cancer Dx",
                "type" : "ExpressionRef"
              }
            }
          } ]
        }
      }, {
        "localId" : "101",
        "locator" : "66:1-69:79",
        "name" : "High Emetic Risk Chemo Administered after First Cancer Dx",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "101",
            "s" : [ {
              "value" : [ "define ", "\"High Emetic Risk Chemo Administered after First Cancer Dx\"", ":\n  " ]
            }, {
              "r" : "100",
              "s" : [ {
                "s" : [ {
                  "r" : "90",
                  "s" : [ {
                    "r" : "89",
                    "s" : [ {
                      "r" : "89",
                      "s" : [ {
                        "value" : [ "[", "\"Medication, Administered\"", ": " ]
                      }, {
                        "s" : [ {
                          "value" : [ "\"High Emetigenic Risk Chemotherapy\"" ]
                        } ]
                      }, {
                        "value" : [ "]" ]
                      } ]
                    } ]
                  }, {
                    "value" : [ " ", "MedAdmin" ]
                  } ]
                } ]
              }, {
                "value" : [ "\n  \t" ]
              }, {
                "r" : "99",
                "s" : [ {
                  "value" : [ "with " ]
                }, {
                  "r" : "92",
                  "s" : [ {
                    "r" : "91",
                    "s" : [ {
                      "s" : [ {
                        "value" : [ "\"First Cancer Dx\"" ]
                      } ]
                    } ]
                  }, {
                    "value" : [ " ", "Dx" ]
                  } ]
                }, {
                  "value" : [ "\n  \t\tsuch that " ]
                }, {
                  "r" : "98",
                  "s" : [ {
                    "r" : "94",
                    "s" : [ {
                      "r" : "93",
                      "s" : [ {
                        "value" : [ "MedAdmin" ]
                      } ]
                    }, {
                      "value" : [ "." ]
                    }, {
                      "r" : "94",
                      "s" : [ {
                        "value" : [ "relevantPeriod" ]
                      } ]
                    } ]
                  }, {
                    "r" : "98",
                    "value" : [ " ", "starts after", " " ]
                  }, {
                    "r" : "97",
                    "s" : [ {
                      "value" : [ "start of " ]
                    }, {
                      "r" : "96",
                      "s" : [ {
                        "r" : "95",
                        "s" : [ {
                          "value" : [ "Dx" ]
                        } ]
                      }, {
                        "value" : [ "." ]
                      }, {
                        "r" : "96",
                        "s" : [ {
                          "value" : [ "prevalencePeriod" ]
                        } ]
                      } ]
                    } ]
                  } ]
                } ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "100",
          "locator" : "67:3-69:79",
          "type" : "Query",
          "source" : [ {
            "localId" : "90",
            "locator" : "67:3-67:76",
            "alias" : "MedAdmin",
            "expression" : {
              "localId" : "89",
              "locator" : "67:3-67:67",
              "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
              "templateId" : "PositiveMedicationAdministered",
              "codeProperty" : "code",
              "type" : "Retrieve",
              "codes" : {
                "locator" : "67:32-67:66",
                "name" : "High Emetigenic Risk Chemotherapy",
                "type" : "ValueSetRef"
              }
            }
          } ],
          "relationship" : [ {
            "localId" : "99",
            "locator" : "68:4-69:79",
            "alias" : "Dx",
            "type" : "With",
            "expression" : {
              "localId" : "91",
              "locator" : "68:9-68:25",
              "name" : "First Cancer Dx",
              "type" : "ExpressionRef"
            },
            "suchThat" : {
              "localId" : "98",
              "locator" : "69:15-69:79",
              "type" : "After",
              "operand" : [ {
                "locator" : "69:39-69:44",
                "type" : "Start",
                "operand" : {
                  "localId" : "94",
                  "locator" : "69:15-69:37",
                  "path" : "relevantPeriod",
                  "scope" : "MedAdmin",
                  "type" : "Property"
                }
              }, {
                "localId" : "97",
                "locator" : "69:52-69:79",
                "type" : "Start",
                "operand" : {
                  "localId" : "96",
                  "locator" : "69:61-69:79",
                  "path" : "prevalencePeriod",
                  "scope" : "Dx",
                  "type" : "Property"
                }
              } ]
            }
          } ]
        }
      }, {
        "localId" : "120",
        "locator" : "71:1-77:79",
        "name" : "Specific Mod Risk Chemo Administered after First Cancer Dx",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "120",
            "s" : [ {
              "value" : [ "define ", "\"Specific Mod Risk Chemo Administered after First Cancer Dx\"", ":\n  " ]
            }, {
              "r" : "119",
              "s" : [ {
                "s" : [ {
                  "r" : "109",
                  "s" : [ {
                    "r" : "108",
                    "s" : [ {
                      "value" : [ "( " ]
                    }, {
                      "r" : "108",
                      "s" : [ {
                        "r" : "106",
                        "s" : [ {
                          "r" : "104",
                          "s" : [ {
                            "r" : "102",
                            "s" : [ {
                              "value" : [ "[", "\"Medication, Administered\"", ": " ]
                            }, {
                              "s" : [ {
                                "value" : [ "\"Doxorubicin\"" ]
                              } ]
                            }, {
                              "value" : [ "]" ]
                            } ]
                          }, {
                            "value" : [ "\n  \tunion " ]
                          }, {
                            "r" : "103",
                            "s" : [ {
                              "value" : [ "[", "\"Medication, Administered\"", ": " ]
                            }, {
                              "s" : [ {
                                "value" : [ "\"Epirubicin\"" ]
                              } ]
                            }, {
                              "value" : [ "]" ]
                            } ]
                          } ]
                        }, {
                          "value" : [ "\n  \tunion " ]
                        }, {
                          "r" : "105",
                          "s" : [ {
                            "value" : [ "[", "\"Medication, Administered\"", ": " ]
                          }, {
                            "s" : [ {
                              "value" : [ "\"Idarubicin\"" ]
                            } ]
                          }, {
                            "value" : [ "]" ]
                          } ]
                        } ]
                      }, {
                        "value" : [ "\n  \tunion " ]
                      }, {
                        "r" : "107",
                        "s" : [ {
                          "value" : [ "[", "\"Medication, Administered\"", ": " ]
                        }, {
                          "s" : [ {
                            "value" : [ "\"Daunorubicin\"" ]
                          } ]
                        }, {
                          "value" : [ "]" ]
                        } ]
                      } ]
                    }, {
                      "value" : [ " )" ]
                    } ]
                  }, {
                    "value" : [ " ", "MedAdmin" ]
                  } ]
                } ]
              }, {
                "value" : [ "\n  \t" ]
              }, {
                "r" : "118",
                "s" : [ {
                  "value" : [ "with " ]
                }, {
                  "r" : "111",
                  "s" : [ {
                    "r" : "110",
                    "s" : [ {
                      "s" : [ {
                        "value" : [ "\"First Cancer Dx\"" ]
                      } ]
                    } ]
                  }, {
                    "value" : [ " ", "Dx" ]
                  } ]
                }, {
                  "value" : [ "\n  \t\tsuch that " ]
                }, {
                  "r" : "117",
                  "s" : [ {
                    "r" : "113",
                    "s" : [ {
                      "r" : "112",
                      "s" : [ {
                        "value" : [ "MedAdmin" ]
                      } ]
                    }, {
                      "value" : [ "." ]
                    }, {
                      "r" : "113",
                      "s" : [ {
                        "value" : [ "relevantPeriod" ]
                      } ]
                    } ]
                  }, {
                    "r" : "117",
                    "value" : [ " ", "starts after", " " ]
                  }, {
                    "r" : "116",
                    "s" : [ {
                      "value" : [ "start of " ]
                    }, {
                      "r" : "115",
                      "s" : [ {
                        "r" : "114",
                        "s" : [ {
                          "value" : [ "Dx" ]
                        } ]
                      }, {
                        "value" : [ "." ]
                      }, {
                        "r" : "115",
                        "s" : [ {
                          "value" : [ "prevalencePeriod" ]
                        } ]
                      } ]
                    } ]
                  } ]
                } ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "119",
          "locator" : "72:3-77:79",
          "type" : "Query",
          "source" : [ {
            "localId" : "109",
            "locator" : "72:3-75:64",
            "alias" : "MedAdmin",
            "expression" : {
              "localId" : "108",
              "locator" : "72:3-75:55",
              "type" : "Union",
              "operand" : [ {
                "localId" : "104",
                "locator" : "72:5-73:51",
                "type" : "Union",
                "operand" : [ {
                  "localId" : "102",
                  "locator" : "72:5-72:47",
                  "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                  "templateId" : "PositiveMedicationAdministered",
                  "codeProperty" : "code",
                  "type" : "Retrieve",
                  "codes" : {
                    "locator" : "72:34-72:46",
                    "name" : "Doxorubicin",
                    "type" : "ValueSetRef"
                  }
                }, {
                  "localId" : "103",
                  "locator" : "73:10-73:51",
                  "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                  "templateId" : "PositiveMedicationAdministered",
                  "codeProperty" : "code",
                  "type" : "Retrieve",
                  "codes" : {
                    "locator" : "73:39-73:50",
                    "name" : "Epirubicin",
                    "type" : "ValueSetRef"
                  }
                } ]
              }, {
                "type" : "Union",
                "operand" : [ {
                  "localId" : "105",
                  "locator" : "74:10-74:51",
                  "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                  "templateId" : "PositiveMedicationAdministered",
                  "codeProperty" : "code",
                  "type" : "Retrieve",
                  "codes" : {
                    "locator" : "74:39-74:50",
                    "name" : "Idarubicin",
                    "type" : "ValueSetRef"
                  }
                }, {
                  "localId" : "107",
                  "locator" : "75:10-75:53",
                  "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                  "templateId" : "PositiveMedicationAdministered",
                  "codeProperty" : "code",
                  "type" : "Retrieve",
                  "codes" : {
                    "locator" : "75:39-75:52",
                    "name" : "Daunorubicin",
                    "type" : "ValueSetRef"
                  }
                } ]
              } ]
            }
          } ],
          "relationship" : [ {
            "localId" : "118",
            "locator" : "76:4-77:79",
            "alias" : "Dx",
            "type" : "With",
            "expression" : {
              "localId" : "110",
              "locator" : "76:9-76:25",
              "name" : "First Cancer Dx",
              "type" : "ExpressionRef"
            },
            "suchThat" : {
              "localId" : "117",
              "locator" : "77:15-77:79",
              "type" : "After",
              "operand" : [ {
                "locator" : "77:39-77:44",
                "type" : "Start",
                "operand" : {
                  "localId" : "113",
                  "locator" : "77:15-77:37",
                  "path" : "relevantPeriod",
                  "scope" : "MedAdmin",
                  "type" : "Property"
                }
              }, {
                "localId" : "116",
                "locator" : "77:52-77:79",
                "type" : "Start",
                "operand" : {
                  "localId" : "115",
                  "locator" : "77:61-77:79",
                  "path" : "prevalencePeriod",
                  "scope" : "Dx",
                  "type" : "Property"
                }
              } ]
            }
          } ]
        }
      }, {
        "localId" : "126",
        "locator" : "188:1-190:69",
        "name" : "High Risk Cyclophosphamide Administered after First Cancer Dx",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "126",
            "s" : [ {
              "value" : [ "define ", "\"High Risk Cyclophosphamide Administered after First Cancer Dx\"", ":\n  " ]
            }, {
              "r" : "125",
              "s" : [ {
                "r" : "123",
                "s" : [ {
                  "value" : [ "\"Cyclophosphamide Administered after First Cancer Dx\"" ]
                } ]
              }, {
                "value" : [ "\n  \tunion " ]
              }, {
                "r" : "124",
                "s" : [ {
                  "value" : [ "\"Specific Mod Risk Chemo Administered after First Cancer Dx\"" ]
                } ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "125",
          "locator" : "189:3-190:69",
          "type" : "Union",
          "operand" : [ {
            "localId" : "123",
            "locator" : "189:3-189:55",
            "name" : "Cyclophosphamide Administered after First Cancer Dx",
            "type" : "ExpressionRef"
          }, {
            "localId" : "124",
            "locator" : "190:10-190:69",
            "name" : "Specific Mod Risk Chemo Administered after First Cancer Dx",
            "type" : "ExpressionRef"
          } ]
        }
      }, {
        "localId" : "130",
        "locator" : "184:1-186:68",
        "name" : "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "130",
            "s" : [ {
              "value" : [ "define ", "\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\"", ":\n  " ]
            }, {
              "r" : "129",
              "s" : [ {
                "r" : "127",
                "s" : [ {
                  "value" : [ "\"High Risk Cyclophosphamide Administered after First Cancer Dx\"" ]
                } ]
              }, {
                "value" : [ "\n  \tunion " ]
              }, {
                "r" : "128",
                "s" : [ {
                  "value" : [ "\"High Emetic Risk Chemo Administered after First Cancer Dx\"" ]
                } ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "129",
          "locator" : "185:3-186:68",
          "type" : "Union",
          "operand" : [ {
            "localId" : "127",
            "locator" : "185:3-185:65",
            "name" : "High Risk Cyclophosphamide Administered after First Cancer Dx",
            "type" : "ExpressionRef"
          }, {
            "localId" : "128",
            "locator" : "186:10-186:68",
            "name" : "High Emetic Risk Chemo Administered after First Cancer Dx",
            "type" : "ExpressionRef"
          } ]
        }
      }, {
        "localId" : "141",
        "locator" : "79:1-82:83",
        "name" : "Clinical Trial Participant before start of High Emetic Risk Combo Chemotherapy",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "141",
            "s" : [ {
              "value" : [ "define ", "\"Clinical Trial Participant before start of High Emetic Risk Combo Chemotherapy\"", ":\n  " ]
            }, {
              "r" : "140",
              "s" : [ {
                "s" : [ {
                  "r" : "122",
                  "s" : [ {
                    "r" : "121",
                    "s" : [ {
                      "value" : [ "( " ]
                    }, {
                      "r" : "121",
                      "s" : [ {
                        "value" : [ "[", "\"Care Goal\"", ": " ]
                      }, {
                        "s" : [ {
                          "value" : [ "\"Clinical Trial Participant\"" ]
                        } ]
                      }, {
                        "value" : [ "]" ]
                      } ]
                    }, {
                      "value" : [ " )" ]
                    } ]
                  }, {
                    "value" : [ " ", "Trial" ]
                  } ]
                } ]
              }, {
                "value" : [ "\n  \t" ]
              }, {
                "r" : "139",
                "s" : [ {
                  "value" : [ "with " ]
                }, {
                  "r" : "132",
                  "s" : [ {
                    "r" : "131",
                    "s" : [ {
                      "s" : [ {
                        "value" : [ "\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\"" ]
                      } ]
                    } ]
                  }, {
                    "value" : [ " ", "ComboChemo" ]
                  } ]
                }, {
                  "value" : [ "\n  \t\tsuch that " ]
                }, {
                  "r" : "138",
                  "s" : [ {
                    "r" : "134",
                    "s" : [ {
                      "r" : "133",
                      "s" : [ {
                        "value" : [ "Trial" ]
                      } ]
                    }, {
                      "value" : [ "." ]
                    }, {
                      "r" : "134",
                      "s" : [ {
                        "value" : [ "relevantPeriod" ]
                      } ]
                    } ]
                  }, {
                    "r" : "138",
                    "value" : [ " ", "starts before", " " ]
                  }, {
                    "r" : "137",
                    "s" : [ {
                      "value" : [ "start of " ]
                    }, {
                      "r" : "136",
                      "s" : [ {
                        "r" : "135",
                        "s" : [ {
                          "value" : [ "ComboChemo" ]
                        } ]
                      }, {
                        "value" : [ "." ]
                      }, {
                        "r" : "136",
                        "s" : [ {
                          "value" : [ "relevantPeriod" ]
                        } ]
                      } ]
                    } ]
                  } ]
                } ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "140",
          "locator" : "80:3-82:83",
          "type" : "Query",
          "source" : [ {
            "localId" : "122",
            "locator" : "80:3-80:55",
            "alias" : "Trial",
            "expression" : {
              "localId" : "121",
              "locator" : "80:3-80:49",
              "dataType" : "{urn:healthit-gov:qdm:v5_4}CareGoal",
              "codeProperty" : "code",
              "type" : "Retrieve",
              "codes" : {
                "locator" : "80:19-80:46",
                "name" : "Clinical Trial Participant",
                "type" : "ValueSetRef"
              }
            }
          } ],
          "relationship" : [ {
            "localId" : "139",
            "locator" : "81:4-82:83",
            "alias" : "ComboChemo",
            "type" : "With",
            "expression" : {
              "localId" : "131",
              "locator" : "81:9-81:86",
              "name" : "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx",
              "type" : "ExpressionRef"
            },
            "suchThat" : {
              "localId" : "138",
              "locator" : "82:15-82:83",
              "type" : "Before",
              "operand" : [ {
                "locator" : "82:36-82:41",
                "type" : "Start",
                "operand" : {
                  "localId" : "134",
                  "locator" : "82:15-82:34",
                  "path" : "relevantPeriod",
                  "scope" : "Trial",
                  "type" : "Property"
                }
              }, {
                "localId" : "137",
                "locator" : "82:50-82:83",
                "type" : "Start",
                "operand" : {
                  "localId" : "136",
                  "locator" : "82:59-82:83",
                  "path" : "relevantPeriod",
                  "scope" : "ComboChemo",
                  "type" : "Property"
                }
              } ]
            }
          } ]
        }
      }, {
        "localId" : "155",
        "locator" : "84:1-87:97",
        "name" : "Clinical Trial Participant within 7 days after start of High Emetic Risk Combo Chemotherapy",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "155",
            "s" : [ {
              "value" : [ "define ", "\"Clinical Trial Participant within 7 days after start of High Emetic Risk Combo Chemotherapy\"", ":\n  " ]
            }, {
              "r" : "154",
              "s" : [ {
                "s" : [ {
                  "r" : "143",
                  "s" : [ {
                    "r" : "142",
                    "s" : [ {
                      "value" : [ "( " ]
                    }, {
                      "r" : "142",
                      "s" : [ {
                        "value" : [ "[", "\"Care Goal\"", ": " ]
                      }, {
                        "s" : [ {
                          "value" : [ "\"Clinical Trial Participant\"" ]
                        } ]
                      }, {
                        "value" : [ "]" ]
                      } ]
                    }, {
                      "value" : [ " )" ]
                    } ]
                  }, {
                    "value" : [ " ", "Trial" ]
                  } ]
                } ]
              }, {
                "value" : [ "\n  \t" ]
              }, {
                "r" : "153",
                "s" : [ {
                  "value" : [ "with " ]
                }, {
                  "r" : "145",
                  "s" : [ {
                    "r" : "144",
                    "s" : [ {
                      "s" : [ {
                        "value" : [ "\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\"" ]
                      } ]
                    } ]
                  }, {
                    "value" : [ " ", "ComboChemo" ]
                  } ]
                }, {
                  "value" : [ "\n  \t\tsuch that " ]
                }, {
                  "r" : "152",
                  "s" : [ {
                    "r" : "147",
                    "s" : [ {
                      "r" : "146",
                      "s" : [ {
                        "value" : [ "Trial" ]
                      } ]
                    }, {
                      "value" : [ "." ]
                    }, {
                      "r" : "147",
                      "s" : [ {
                        "value" : [ "relevantPeriod" ]
                      } ]
                    } ]
                  }, {
                    "value" : [ " " ]
                  }, {
                    "r" : "152",
                    "s" : [ {
                      "value" : [ "starts " ]
                    }, {
                      "r" : "151",
                      "s" : [ {
                        "value" : [ "7 ", "days" ]
                      } ]
                    }, {
                      "value" : [ " or less after" ]
                    } ]
                  }, {
                    "value" : [ " " ]
                  }, {
                    "r" : "150",
                    "s" : [ {
                      "value" : [ "start of " ]
                    }, {
                      "r" : "149",
                      "s" : [ {
                        "r" : "148",
                        "s" : [ {
                          "value" : [ "ComboChemo" ]
                        } ]
                      }, {
                        "value" : [ "." ]
                      }, {
                        "r" : "149",
                        "s" : [ {
                          "value" : [ "relevantPeriod" ]
                        } ]
                      } ]
                    } ]
                  } ]
                } ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "154",
          "locator" : "85:3-87:97",
          "type" : "Query",
          "source" : [ {
            "localId" : "143",
            "locator" : "85:3-85:55",
            "alias" : "Trial",
            "expression" : {
              "localId" : "142",
              "locator" : "85:3-85:49",
              "dataType" : "{urn:healthit-gov:qdm:v5_4}CareGoal",
              "codeProperty" : "code",
              "type" : "Retrieve",
              "codes" : {
                "locator" : "85:19-85:46",
                "name" : "Clinical Trial Participant",
                "type" : "ValueSetRef"
              }
            }
          } ],
          "relationship" : [ {
            "localId" : "153",
            "locator" : "86:4-87:97",
            "alias" : "ComboChemo",
            "type" : "With",
            "expression" : {
              "localId" : "144",
              "locator" : "86:9-86:86",
              "name" : "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx",
              "type" : "ExpressionRef"
            },
            "suchThat" : {
              "localId" : "152",
              "locator" : "87:15-87:97",
              "type" : "And",
              "operand" : [ {
                "locator" : "87:43-87:56",
                "type" : "In",
                "operand" : [ {
                  "locator" : "87:36-87:41",
                  "type" : "Start",
                  "operand" : {
                    "localId" : "147",
                    "locator" : "87:15-87:34",
                    "path" : "relevantPeriod",
                    "scope" : "Trial",
                    "type" : "Property"
                  }
                }, {
                  "locator" : "87:43-87:56",
                  "lowClosed" : false,
                  "highClosed" : true,
                  "type" : "Interval",
                  "low" : {
                    "localId" : "150",
                    "locator" : "87:64-87:97",
                    "type" : "Start",
                    "operand" : {
                      "localId" : "149",
                      "locator" : "87:73-87:97",
                      "path" : "relevantPeriod",
                      "scope" : "ComboChemo",
                      "type" : "Property"
                    }
                  },
                  "high" : {
                    "locator" : "87:64-87:97",
                    "type" : "Add",
                    "operand" : [ {
                      "localId" : "150",
                      "locator" : "87:64-87:97",
                      "type" : "Start",
                      "operand" : {
                        "localId" : "149",
                        "locator" : "87:73-87:97",
                        "path" : "relevantPeriod",
                        "scope" : "ComboChemo",
                        "type" : "Property"
                      }
                    }, {
                      "localId" : "151",
                      "locator" : "87:43-87:48",
                      "value" : 7,
                      "unit" : "days",
                      "type" : "Quantity"
                    } ]
                  }
                } ]
              }, {
                "locator" : "87:43-87:56",
                "type" : "Not",
                "operand" : {
                  "locator" : "87:43-87:56",
                  "type" : "IsNull",
                  "operand" : {
                    "localId" : "150",
                    "locator" : "87:64-87:97",
                    "type" : "Start",
                    "operand" : {
                      "localId" : "149",
                      "locator" : "87:73-87:97",
                      "path" : "relevantPeriod",
                      "scope" : "ComboChemo",
                      "type" : "Property"
                    }
                  }
                }
              } ]
            }
          } ]
        }
      }, {
        "localId" : "171",
        "locator" : "89:1-93:100",
        "name" : "Dexamethasone administered or ordered within 7 days after Combo High Risk Chemo",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "171",
            "s" : [ {
              "value" : [ "define ", "\"Dexamethasone administered or ordered within 7 days after Combo High Risk Chemo\"", ":\n  " ]
            }, {
              "r" : "170",
              "s" : [ {
                "s" : [ {
                  "r" : "159",
                  "s" : [ {
                    "r" : "158",
                    "s" : [ {
                      "value" : [ "( " ]
                    }, {
                      "r" : "158",
                      "s" : [ {
                        "r" : "156",
                        "s" : [ {
                          "value" : [ "[", "\"Medication, Administered\"", ": " ]
                        }, {
                          "s" : [ {
                            "value" : [ "\"Dexamethasone\"" ]
                          } ]
                        }, {
                          "value" : [ "]" ]
                        } ]
                      }, {
                        "value" : [ "\n  \tunion " ]
                      }, {
                        "r" : "157",
                        "s" : [ {
                          "value" : [ "[", "\"Medication, Order\"", ": " ]
                        }, {
                          "s" : [ {
                            "value" : [ "\"Dexamethasone\"" ]
                          } ]
                        }, {
                          "value" : [ "]" ]
                        } ]
                      } ]
                    }, {
                      "value" : [ " )" ]
                    } ]
                  }, {
                    "value" : [ " ", "MedAdmin" ]
                  } ]
                } ]
              }, {
                "value" : [ "\n  \t" ]
              }, {
                "r" : "169",
                "s" : [ {
                  "value" : [ "with " ]
                }, {
                  "r" : "161",
                  "s" : [ {
                    "r" : "160",
                    "s" : [ {
                      "s" : [ {
                        "value" : [ "\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\"" ]
                      } ]
                    } ]
                  }, {
                    "value" : [ " ", "ComboChemo" ]
                  } ]
                }, {
                  "value" : [ "\n  \t\tsuch that " ]
                }, {
                  "r" : "168",
                  "s" : [ {
                    "r" : "163",
                    "s" : [ {
                      "r" : "162",
                      "s" : [ {
                        "value" : [ "MedAdmin" ]
                      } ]
                    }, {
                      "value" : [ "." ]
                    }, {
                      "r" : "163",
                      "s" : [ {
                        "value" : [ "relevantPeriod" ]
                      } ]
                    } ]
                  }, {
                    "value" : [ " " ]
                  }, {
                    "r" : "168",
                    "s" : [ {
                      "value" : [ "starts " ]
                    }, {
                      "r" : "167",
                      "s" : [ {
                        "value" : [ "7 ", "days" ]
                      } ]
                    }, {
                      "value" : [ " or less after" ]
                    } ]
                  }, {
                    "value" : [ " " ]
                  }, {
                    "r" : "166",
                    "s" : [ {
                      "value" : [ "start of " ]
                    }, {
                      "r" : "165",
                      "s" : [ {
                        "r" : "164",
                        "s" : [ {
                          "value" : [ "ComboChemo" ]
                        } ]
                      }, {
                        "value" : [ "." ]
                      }, {
                        "r" : "165",
                        "s" : [ {
                          "value" : [ "relevantPeriod" ]
                        } ]
                      } ]
                    } ]
                  } ]
                } ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "170",
          "locator" : "90:3-93:100",
          "type" : "Query",
          "source" : [ {
            "localId" : "159",
            "locator" : "90:3-91:58",
            "alias" : "MedAdmin",
            "expression" : {
              "localId" : "158",
              "locator" : "90:3-91:49",
              "type" : "Union",
              "operand" : [ {
                "type" : "As",
                "operand" : {
                  "localId" : "156",
                  "locator" : "90:5-90:49",
                  "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                  "templateId" : "PositiveMedicationAdministered",
                  "codeProperty" : "code",
                  "type" : "Retrieve",
                  "codes" : {
                    "locator" : "90:34-90:48",
                    "name" : "Dexamethasone",
                    "type" : "ValueSetRef"
                  }
                },
                "asTypeSpecifier" : {
                  "type" : "ListTypeSpecifier",
                  "elementType" : {
                    "type" : "ChoiceTypeSpecifier",
                    "choice" : [ {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                      "type" : "NamedTypeSpecifier"
                    }, {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                      "type" : "NamedTypeSpecifier"
                    } ]
                  }
                }
              }, {
                "type" : "As",
                "operand" : {
                  "localId" : "157",
                  "locator" : "91:10-91:47",
                  "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                  "templateId" : "PositiveMedicationOrder",
                  "codeProperty" : "code",
                  "type" : "Retrieve",
                  "codes" : {
                    "locator" : "91:32-91:46",
                    "name" : "Dexamethasone",
                    "type" : "ValueSetRef"
                  }
                },
                "asTypeSpecifier" : {
                  "type" : "ListTypeSpecifier",
                  "elementType" : {
                    "type" : "ChoiceTypeSpecifier",
                    "choice" : [ {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                      "type" : "NamedTypeSpecifier"
                    }, {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                      "type" : "NamedTypeSpecifier"
                    } ]
                  }
                }
              } ]
            }
          } ],
          "relationship" : [ {
            "localId" : "169",
            "locator" : "92:4-93:100",
            "alias" : "ComboChemo",
            "type" : "With",
            "expression" : {
              "localId" : "160",
              "locator" : "92:9-92:86",
              "name" : "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx",
              "type" : "ExpressionRef"
            },
            "suchThat" : {
              "localId" : "168",
              "locator" : "93:15-93:100",
              "type" : "And",
              "operand" : [ {
                "locator" : "93:46-93:59",
                "type" : "In",
                "operand" : [ {
                  "locator" : "93:39-93:44",
                  "type" : "Start",
                  "operand" : {
                    "localId" : "163",
                    "locator" : "93:15-93:37",
                    "path" : "relevantPeriod",
                    "scope" : "MedAdmin",
                    "type" : "Property"
                  }
                }, {
                  "locator" : "93:46-93:59",
                  "lowClosed" : false,
                  "highClosed" : true,
                  "type" : "Interval",
                  "low" : {
                    "localId" : "166",
                    "locator" : "93:67-93:100",
                    "type" : "Start",
                    "operand" : {
                      "localId" : "165",
                      "locator" : "93:76-93:100",
                      "path" : "relevantPeriod",
                      "scope" : "ComboChemo",
                      "type" : "Property"
                    }
                  },
                  "high" : {
                    "locator" : "93:67-93:100",
                    "type" : "Add",
                    "operand" : [ {
                      "localId" : "166",
                      "locator" : "93:67-93:100",
                      "type" : "Start",
                      "operand" : {
                        "localId" : "165",
                        "locator" : "93:76-93:100",
                        "path" : "relevantPeriod",
                        "scope" : "ComboChemo",
                        "type" : "Property"
                      }
                    }, {
                      "localId" : "167",
                      "locator" : "93:46-93:51",
                      "value" : 7,
                      "unit" : "days",
                      "type" : "Quantity"
                    } ]
                  }
                } ]
              }, {
                "locator" : "93:46-93:59",
                "type" : "Not",
                "operand" : {
                  "locator" : "93:46-93:59",
                  "type" : "IsNull",
                  "operand" : {
                    "localId" : "166",
                    "locator" : "93:67-93:100",
                    "type" : "Start",
                    "operand" : {
                      "localId" : "165",
                      "locator" : "93:76-93:100",
                      "path" : "relevantPeriod",
                      "scope" : "ComboChemo",
                      "type" : "Property"
                    }
                  }
                }
              } ]
            }
          } ]
        }
      }, {
        "localId" : "186",
        "locator" : "95:1-99:86",
        "name" : "Dexamethasone administered or ordered before Combo High Risk Chemo",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "186",
            "s" : [ {
              "value" : [ "define ", "\"Dexamethasone administered or ordered before Combo High Risk Chemo\"", ":\n  " ]
            }, {
              "r" : "185",
              "s" : [ {
                "s" : [ {
                  "r" : "175",
                  "s" : [ {
                    "r" : "174",
                    "s" : [ {
                      "value" : [ "( " ]
                    }, {
                      "r" : "174",
                      "s" : [ {
                        "r" : "172",
                        "s" : [ {
                          "value" : [ "[", "\"Medication, Administered\"", ": " ]
                        }, {
                          "s" : [ {
                            "value" : [ "\"Dexamethasone\"" ]
                          } ]
                        }, {
                          "value" : [ "]" ]
                        } ]
                      }, {
                        "value" : [ "\n  \tunion " ]
                      }, {
                        "r" : "173",
                        "s" : [ {
                          "value" : [ "[", "\"Medication, Order\"", ": " ]
                        }, {
                          "s" : [ {
                            "value" : [ "\"Dexamethasone\"" ]
                          } ]
                        }, {
                          "value" : [ "]" ]
                        } ]
                      } ]
                    }, {
                      "value" : [ " )" ]
                    } ]
                  }, {
                    "value" : [ " ", "MedAdmin" ]
                  } ]
                } ]
              }, {
                "value" : [ "\n  \t" ]
              }, {
                "r" : "184",
                "s" : [ {
                  "value" : [ "with " ]
                }, {
                  "r" : "177",
                  "s" : [ {
                    "r" : "176",
                    "s" : [ {
                      "s" : [ {
                        "value" : [ "\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\"" ]
                      } ]
                    } ]
                  }, {
                    "value" : [ " ", "ComboChemo" ]
                  } ]
                }, {
                  "value" : [ "\n  \t\tsuch that " ]
                }, {
                  "r" : "183",
                  "s" : [ {
                    "r" : "179",
                    "s" : [ {
                      "r" : "178",
                      "s" : [ {
                        "value" : [ "MedAdmin" ]
                      } ]
                    }, {
                      "value" : [ "." ]
                    }, {
                      "r" : "179",
                      "s" : [ {
                        "value" : [ "relevantPeriod" ]
                      } ]
                    } ]
                  }, {
                    "r" : "183",
                    "value" : [ " ", "starts before", " " ]
                  }, {
                    "r" : "182",
                    "s" : [ {
                      "value" : [ "start of " ]
                    }, {
                      "r" : "181",
                      "s" : [ {
                        "r" : "180",
                        "s" : [ {
                          "value" : [ "ComboChemo" ]
                        } ]
                      }, {
                        "value" : [ "." ]
                      }, {
                        "r" : "181",
                        "s" : [ {
                          "value" : [ "relevantPeriod" ]
                        } ]
                      } ]
                    } ]
                  } ]
                } ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "185",
          "locator" : "96:3-99:86",
          "type" : "Query",
          "source" : [ {
            "localId" : "175",
            "locator" : "96:3-97:58",
            "alias" : "MedAdmin",
            "expression" : {
              "localId" : "174",
              "locator" : "96:3-97:49",
              "type" : "Union",
              "operand" : [ {
                "type" : "As",
                "operand" : {
                  "localId" : "172",
                  "locator" : "96:5-96:49",
                  "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                  "templateId" : "PositiveMedicationAdministered",
                  "codeProperty" : "code",
                  "type" : "Retrieve",
                  "codes" : {
                    "locator" : "96:34-96:48",
                    "name" : "Dexamethasone",
                    "type" : "ValueSetRef"
                  }
                },
                "asTypeSpecifier" : {
                  "type" : "ListTypeSpecifier",
                  "elementType" : {
                    "type" : "ChoiceTypeSpecifier",
                    "choice" : [ {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                      "type" : "NamedTypeSpecifier"
                    }, {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                      "type" : "NamedTypeSpecifier"
                    } ]
                  }
                }
              }, {
                "type" : "As",
                "operand" : {
                  "localId" : "173",
                  "locator" : "97:10-97:47",
                  "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                  "templateId" : "PositiveMedicationOrder",
                  "codeProperty" : "code",
                  "type" : "Retrieve",
                  "codes" : {
                    "locator" : "97:32-97:46",
                    "name" : "Dexamethasone",
                    "type" : "ValueSetRef"
                  }
                },
                "asTypeSpecifier" : {
                  "type" : "ListTypeSpecifier",
                  "elementType" : {
                    "type" : "ChoiceTypeSpecifier",
                    "choice" : [ {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                      "type" : "NamedTypeSpecifier"
                    }, {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                      "type" : "NamedTypeSpecifier"
                    } ]
                  }
                }
              } ]
            }
          } ],
          "relationship" : [ {
            "localId" : "184",
            "locator" : "98:4-99:86",
            "alias" : "ComboChemo",
            "type" : "With",
            "expression" : {
              "localId" : "176",
              "locator" : "98:9-98:86",
              "name" : "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx",
              "type" : "ExpressionRef"
            },
            "suchThat" : {
              "localId" : "183",
              "locator" : "99:15-99:86",
              "type" : "Before",
              "operand" : [ {
                "locator" : "99:39-99:44",
                "type" : "Start",
                "operand" : {
                  "localId" : "179",
                  "locator" : "99:15-99:37",
                  "path" : "relevantPeriod",
                  "scope" : "MedAdmin",
                  "type" : "Property"
                }
              }, {
                "localId" : "182",
                "locator" : "99:53-99:86",
                "type" : "Start",
                "operand" : {
                  "localId" : "181",
                  "locator" : "99:62-99:86",
                  "path" : "relevantPeriod",
                  "scope" : "ComboChemo",
                  "type" : "Property"
                }
              } ]
            }
          } ]
        }
      }, {
        "localId" : "201",
        "locator" : "101:1-105:86",
        "name" : "Palonosetron administered or ordered before Combo High Risk Chemo",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "201",
            "s" : [ {
              "value" : [ "define ", "\"Palonosetron administered or ordered before Combo High Risk Chemo\"", ":\n  " ]
            }, {
              "r" : "200",
              "s" : [ {
                "s" : [ {
                  "r" : "190",
                  "s" : [ {
                    "r" : "189",
                    "s" : [ {
                      "value" : [ "( " ]
                    }, {
                      "r" : "189",
                      "s" : [ {
                        "r" : "187",
                        "s" : [ {
                          "value" : [ "[", "\"Medication, Administered\"", ": " ]
                        }, {
                          "s" : [ {
                            "value" : [ "\"NEPA Netupitant Palonosetron\"" ]
                          } ]
                        }, {
                          "value" : [ "]" ]
                        } ]
                      }, {
                        "value" : [ "\n  \tunion " ]
                      }, {
                        "r" : "188",
                        "s" : [ {
                          "value" : [ "[", "\"Medication, Order\"", ": " ]
                        }, {
                          "s" : [ {
                            "value" : [ "\"NEPA Netupitant Palonosetron\"" ]
                          } ]
                        }, {
                          "value" : [ "]" ]
                        } ]
                      } ]
                    }, {
                      "value" : [ " )" ]
                    } ]
                  }, {
                    "value" : [ " ", "MedAdmin" ]
                  } ]
                } ]
              }, {
                "value" : [ "\n  \t" ]
              }, {
                "r" : "199",
                "s" : [ {
                  "value" : [ "with " ]
                }, {
                  "r" : "192",
                  "s" : [ {
                    "r" : "191",
                    "s" : [ {
                      "s" : [ {
                        "value" : [ "\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\"" ]
                      } ]
                    } ]
                  }, {
                    "value" : [ " ", "ComboChemo" ]
                  } ]
                }, {
                  "value" : [ "\n  \t\tsuch that " ]
                }, {
                  "r" : "198",
                  "s" : [ {
                    "r" : "194",
                    "s" : [ {
                      "r" : "193",
                      "s" : [ {
                        "value" : [ "MedAdmin" ]
                      } ]
                    }, {
                      "value" : [ "." ]
                    }, {
                      "r" : "194",
                      "s" : [ {
                        "value" : [ "relevantPeriod" ]
                      } ]
                    } ]
                  }, {
                    "r" : "198",
                    "value" : [ " ", "starts before", " " ]
                  }, {
                    "r" : "197",
                    "s" : [ {
                      "value" : [ "start of " ]
                    }, {
                      "r" : "196",
                      "s" : [ {
                        "r" : "195",
                        "s" : [ {
                          "value" : [ "ComboChemo" ]
                        } ]
                      }, {
                        "value" : [ "." ]
                      }, {
                        "r" : "196",
                        "s" : [ {
                          "value" : [ "relevantPeriod" ]
                        } ]
                      } ]
                    } ]
                  } ]
                } ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "200",
          "locator" : "102:3-105:86",
          "type" : "Query",
          "source" : [ {
            "localId" : "190",
            "locator" : "102:3-103:73",
            "alias" : "MedAdmin",
            "expression" : {
              "localId" : "189",
              "locator" : "102:3-103:64",
              "type" : "Union",
              "operand" : [ {
                "type" : "As",
                "operand" : {
                  "localId" : "187",
                  "locator" : "102:5-102:64",
                  "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                  "templateId" : "PositiveMedicationAdministered",
                  "codeProperty" : "code",
                  "type" : "Retrieve",
                  "codes" : {
                    "locator" : "102:34-102:63",
                    "name" : "NEPA Netupitant Palonosetron",
                    "type" : "ValueSetRef"
                  }
                },
                "asTypeSpecifier" : {
                  "type" : "ListTypeSpecifier",
                  "elementType" : {
                    "type" : "ChoiceTypeSpecifier",
                    "choice" : [ {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                      "type" : "NamedTypeSpecifier"
                    }, {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                      "type" : "NamedTypeSpecifier"
                    } ]
                  }
                }
              }, {
                "type" : "As",
                "operand" : {
                  "localId" : "188",
                  "locator" : "103:10-103:62",
                  "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                  "templateId" : "PositiveMedicationOrder",
                  "codeProperty" : "code",
                  "type" : "Retrieve",
                  "codes" : {
                    "locator" : "103:32-103:61",
                    "name" : "NEPA Netupitant Palonosetron",
                    "type" : "ValueSetRef"
                  }
                },
                "asTypeSpecifier" : {
                  "type" : "ListTypeSpecifier",
                  "elementType" : {
                    "type" : "ChoiceTypeSpecifier",
                    "choice" : [ {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                      "type" : "NamedTypeSpecifier"
                    }, {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                      "type" : "NamedTypeSpecifier"
                    } ]
                  }
                }
              } ]
            }
          } ],
          "relationship" : [ {
            "localId" : "199",
            "locator" : "104:4-105:86",
            "alias" : "ComboChemo",
            "type" : "With",
            "expression" : {
              "localId" : "191",
              "locator" : "104:9-104:86",
              "name" : "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx",
              "type" : "ExpressionRef"
            },
            "suchThat" : {
              "localId" : "198",
              "locator" : "105:15-105:86",
              "type" : "Before",
              "operand" : [ {
                "locator" : "105:39-105:44",
                "type" : "Start",
                "operand" : {
                  "localId" : "194",
                  "locator" : "105:15-105:37",
                  "path" : "relevantPeriod",
                  "scope" : "MedAdmin",
                  "type" : "Property"
                }
              }, {
                "localId" : "197",
                "locator" : "105:53-105:86",
                "type" : "Start",
                "operand" : {
                  "localId" : "196",
                  "locator" : "105:62-105:86",
                  "path" : "relevantPeriod",
                  "scope" : "ComboChemo",
                  "type" : "Property"
                }
              } ]
            }
          } ]
        }
      }, {
        "localId" : "217",
        "locator" : "107:1-111:100",
        "name" : "Palonosetron administered or ordered within 7 days after Combo High Risk Chemo",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "217",
            "s" : [ {
              "value" : [ "define ", "\"Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\"", ":\n  " ]
            }, {
              "r" : "216",
              "s" : [ {
                "s" : [ {
                  "r" : "205",
                  "s" : [ {
                    "r" : "204",
                    "s" : [ {
                      "value" : [ "( " ]
                    }, {
                      "r" : "204",
                      "s" : [ {
                        "r" : "202",
                        "s" : [ {
                          "value" : [ "[", "\"Medication, Administered\"", ": " ]
                        }, {
                          "s" : [ {
                            "value" : [ "\"NEPA Netupitant Palonosetron\"" ]
                          } ]
                        }, {
                          "value" : [ "]" ]
                        } ]
                      }, {
                        "value" : [ "\n  \tunion " ]
                      }, {
                        "r" : "203",
                        "s" : [ {
                          "value" : [ "[", "\"Medication, Order\"", ": " ]
                        }, {
                          "s" : [ {
                            "value" : [ "\"NEPA Netupitant Palonosetron\"" ]
                          } ]
                        }, {
                          "value" : [ "]" ]
                        } ]
                      } ]
                    }, {
                      "value" : [ " )" ]
                    } ]
                  }, {
                    "value" : [ " ", "MedAdmin" ]
                  } ]
                } ]
              }, {
                "value" : [ "\n  \t" ]
              }, {
                "r" : "215",
                "s" : [ {
                  "value" : [ "with " ]
                }, {
                  "r" : "207",
                  "s" : [ {
                    "r" : "206",
                    "s" : [ {
                      "s" : [ {
                        "value" : [ "\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\"" ]
                      } ]
                    } ]
                  }, {
                    "value" : [ " ", "ComboChemo" ]
                  } ]
                }, {
                  "value" : [ "\n  \t\tsuch that " ]
                }, {
                  "r" : "214",
                  "s" : [ {
                    "r" : "209",
                    "s" : [ {
                      "r" : "208",
                      "s" : [ {
                        "value" : [ "MedAdmin" ]
                      } ]
                    }, {
                      "value" : [ "." ]
                    }, {
                      "r" : "209",
                      "s" : [ {
                        "value" : [ "relevantPeriod" ]
                      } ]
                    } ]
                  }, {
                    "value" : [ " " ]
                  }, {
                    "r" : "214",
                    "s" : [ {
                      "value" : [ "starts " ]
                    }, {
                      "r" : "213",
                      "s" : [ {
                        "value" : [ "7 ", "days" ]
                      } ]
                    }, {
                      "value" : [ " or less after" ]
                    } ]
                  }, {
                    "value" : [ " " ]
                  }, {
                    "r" : "212",
                    "s" : [ {
                      "value" : [ "start of " ]
                    }, {
                      "r" : "211",
                      "s" : [ {
                        "r" : "210",
                        "s" : [ {
                          "value" : [ "ComboChemo" ]
                        } ]
                      }, {
                        "value" : [ "." ]
                      }, {
                        "r" : "211",
                        "s" : [ {
                          "value" : [ "relevantPeriod" ]
                        } ]
                      } ]
                    } ]
                  } ]
                } ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "216",
          "locator" : "108:3-111:100",
          "type" : "Query",
          "source" : [ {
            "localId" : "205",
            "locator" : "108:3-109:73",
            "alias" : "MedAdmin",
            "expression" : {
              "localId" : "204",
              "locator" : "108:3-109:64",
              "type" : "Union",
              "operand" : [ {
                "type" : "As",
                "operand" : {
                  "localId" : "202",
                  "locator" : "108:5-108:64",
                  "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                  "templateId" : "PositiveMedicationAdministered",
                  "codeProperty" : "code",
                  "type" : "Retrieve",
                  "codes" : {
                    "locator" : "108:34-108:63",
                    "name" : "NEPA Netupitant Palonosetron",
                    "type" : "ValueSetRef"
                  }
                },
                "asTypeSpecifier" : {
                  "type" : "ListTypeSpecifier",
                  "elementType" : {
                    "type" : "ChoiceTypeSpecifier",
                    "choice" : [ {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                      "type" : "NamedTypeSpecifier"
                    }, {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                      "type" : "NamedTypeSpecifier"
                    } ]
                  }
                }
              }, {
                "type" : "As",
                "operand" : {
                  "localId" : "203",
                  "locator" : "109:10-109:62",
                  "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                  "templateId" : "PositiveMedicationOrder",
                  "codeProperty" : "code",
                  "type" : "Retrieve",
                  "codes" : {
                    "locator" : "109:32-109:61",
                    "name" : "NEPA Netupitant Palonosetron",
                    "type" : "ValueSetRef"
                  }
                },
                "asTypeSpecifier" : {
                  "type" : "ListTypeSpecifier",
                  "elementType" : {
                    "type" : "ChoiceTypeSpecifier",
                    "choice" : [ {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                      "type" : "NamedTypeSpecifier"
                    }, {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                      "type" : "NamedTypeSpecifier"
                    } ]
                  }
                }
              } ]
            }
          } ],
          "relationship" : [ {
            "localId" : "215",
            "locator" : "110:4-111:100",
            "alias" : "ComboChemo",
            "type" : "With",
            "expression" : {
              "localId" : "206",
              "locator" : "110:9-110:86",
              "name" : "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx",
              "type" : "ExpressionRef"
            },
            "suchThat" : {
              "localId" : "214",
              "locator" : "111:15-111:100",
              "type" : "And",
              "operand" : [ {
                "locator" : "111:46-111:59",
                "type" : "In",
                "operand" : [ {
                  "locator" : "111:39-111:44",
                  "type" : "Start",
                  "operand" : {
                    "localId" : "209",
                    "locator" : "111:15-111:37",
                    "path" : "relevantPeriod",
                    "scope" : "MedAdmin",
                    "type" : "Property"
                  }
                }, {
                  "locator" : "111:46-111:59",
                  "lowClosed" : false,
                  "highClosed" : true,
                  "type" : "Interval",
                  "low" : {
                    "localId" : "212",
                    "locator" : "111:67-111:100",
                    "type" : "Start",
                    "operand" : {
                      "localId" : "211",
                      "locator" : "111:76-111:100",
                      "path" : "relevantPeriod",
                      "scope" : "ComboChemo",
                      "type" : "Property"
                    }
                  },
                  "high" : {
                    "locator" : "111:67-111:100",
                    "type" : "Add",
                    "operand" : [ {
                      "localId" : "212",
                      "locator" : "111:67-111:100",
                      "type" : "Start",
                      "operand" : {
                        "localId" : "211",
                        "locator" : "111:76-111:100",
                        "path" : "relevantPeriod",
                        "scope" : "ComboChemo",
                        "type" : "Property"
                      }
                    }, {
                      "localId" : "213",
                      "locator" : "111:46-111:51",
                      "value" : 7,
                      "unit" : "days",
                      "type" : "Quantity"
                    } ]
                  }
                } ]
              }, {
                "locator" : "111:46-111:59",
                "type" : "Not",
                "operand" : {
                  "locator" : "111:46-111:59",
                  "type" : "IsNull",
                  "operand" : {
                    "localId" : "212",
                    "locator" : "111:67-111:100",
                    "type" : "Start",
                    "operand" : {
                      "localId" : "211",
                      "locator" : "111:76-111:100",
                      "path" : "relevantPeriod",
                      "scope" : "ComboChemo",
                      "type" : "Property"
                    }
                  }
                }
              } ]
            }
          } ]
        }
      }, {
        "localId" : "237",
        "locator" : "113:1-119:100",
        "name" : "First Gen Serotonin Antagonists or Palonosetron administered or ordered within 7 days after Combo High Risk Chemo",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "237",
            "s" : [ {
              "value" : [ "define ", "\"First Gen Serotonin Antagonists or Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\"", ":\n  " ]
            }, {
              "r" : "236",
              "s" : [ {
                "s" : [ {
                  "r" : "225",
                  "s" : [ {
                    "r" : "224",
                    "s" : [ {
                      "value" : [ "( " ]
                    }, {
                      "r" : "224",
                      "s" : [ {
                        "r" : "222",
                        "s" : [ {
                          "r" : "220",
                          "s" : [ {
                            "r" : "218",
                            "s" : [ {
                              "value" : [ "[", "\"Medication, Administered\"", ": " ]
                            }, {
                              "s" : [ {
                                "value" : [ "\"First Generation Serotonin Antagonists\"" ]
                              } ]
                            }, {
                              "value" : [ "]" ]
                            } ]
                          }, {
                            "value" : [ "\n  \tunion " ]
                          }, {
                            "r" : "219",
                            "s" : [ {
                              "value" : [ "[", "\"Medication, Administered\"", ": " ]
                            }, {
                              "s" : [ {
                                "value" : [ "\"Palonosetron\"" ]
                              } ]
                            }, {
                              "value" : [ "]" ]
                            } ]
                          } ]
                        }, {
                          "value" : [ "\n  \tunion " ]
                        }, {
                          "r" : "221",
                          "s" : [ {
                            "value" : [ "[", "\"Medication, Order\"", ": " ]
                          }, {
                            "s" : [ {
                              "value" : [ "\"First Generation Serotonin Antagonists\"" ]
                            } ]
                          }, {
                            "value" : [ "]" ]
                          } ]
                        } ]
                      }, {
                        "value" : [ "\n  \tunion " ]
                      }, {
                        "r" : "223",
                        "s" : [ {
                          "value" : [ "[", "\"Medication, Order\"", ": " ]
                        }, {
                          "s" : [ {
                            "value" : [ "\"Palonosetron\"" ]
                          } ]
                        }, {
                          "value" : [ "]" ]
                        } ]
                      } ]
                    }, {
                      "value" : [ " )" ]
                    } ]
                  }, {
                    "value" : [ " ", "MedAdmin" ]
                  } ]
                } ]
              }, {
                "value" : [ "\n  \t" ]
              }, {
                "r" : "235",
                "s" : [ {
                  "value" : [ "with " ]
                }, {
                  "r" : "227",
                  "s" : [ {
                    "r" : "226",
                    "s" : [ {
                      "s" : [ {
                        "value" : [ "\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\"" ]
                      } ]
                    } ]
                  }, {
                    "value" : [ " ", "ComboChemo" ]
                  } ]
                }, {
                  "value" : [ "\n  \t\tsuch that " ]
                }, {
                  "r" : "234",
                  "s" : [ {
                    "r" : "229",
                    "s" : [ {
                      "r" : "228",
                      "s" : [ {
                        "value" : [ "MedAdmin" ]
                      } ]
                    }, {
                      "value" : [ "." ]
                    }, {
                      "r" : "229",
                      "s" : [ {
                        "value" : [ "relevantPeriod" ]
                      } ]
                    } ]
                  }, {
                    "value" : [ " " ]
                  }, {
                    "r" : "234",
                    "s" : [ {
                      "value" : [ "starts " ]
                    }, {
                      "r" : "233",
                      "s" : [ {
                        "value" : [ "7 ", "days" ]
                      } ]
                    }, {
                      "value" : [ " or less after" ]
                    } ]
                  }, {
                    "value" : [ " " ]
                  }, {
                    "r" : "232",
                    "s" : [ {
                      "value" : [ "start of " ]
                    }, {
                      "r" : "231",
                      "s" : [ {
                        "r" : "230",
                        "s" : [ {
                          "value" : [ "ComboChemo" ]
                        } ]
                      }, {
                        "value" : [ "." ]
                      }, {
                        "r" : "231",
                        "s" : [ {
                          "value" : [ "relevantPeriod" ]
                        } ]
                      } ]
                    } ]
                  } ]
                } ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "236",
          "locator" : "114:3-119:100",
          "type" : "Query",
          "source" : [ {
            "localId" : "225",
            "locator" : "114:3-117:57",
            "alias" : "MedAdmin",
            "expression" : {
              "localId" : "224",
              "locator" : "114:3-117:48",
              "type" : "Union",
              "operand" : [ {
                "type" : "As",
                "operand" : {
                  "localId" : "222",
                  "locator" : "114:5-116:72",
                  "type" : "Union",
                  "operand" : [ {
                    "type" : "As",
                    "operand" : {
                      "localId" : "220",
                      "locator" : "114:5-115:53",
                      "type" : "Union",
                      "operand" : [ {
                        "localId" : "218",
                        "locator" : "114:5-114:74",
                        "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                        "templateId" : "PositiveMedicationAdministered",
                        "codeProperty" : "code",
                        "type" : "Retrieve",
                        "codes" : {
                          "locator" : "114:34-114:73",
                          "name" : "First Generation Serotonin Antagonists",
                          "type" : "ValueSetRef"
                        }
                      }, {
                        "localId" : "219",
                        "locator" : "115:10-115:53",
                        "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                        "templateId" : "PositiveMedicationAdministered",
                        "codeProperty" : "code",
                        "type" : "Retrieve",
                        "codes" : {
                          "locator" : "115:39-115:52",
                          "name" : "Palonosetron",
                          "type" : "ValueSetRef"
                        }
                      } ]
                    },
                    "asTypeSpecifier" : {
                      "type" : "ListTypeSpecifier",
                      "elementType" : {
                        "type" : "ChoiceTypeSpecifier",
                        "choice" : [ {
                          "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                          "type" : "NamedTypeSpecifier"
                        }, {
                          "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                          "type" : "NamedTypeSpecifier"
                        } ]
                      }
                    }
                  }, {
                    "type" : "As",
                    "operand" : {
                      "localId" : "221",
                      "locator" : "116:10-116:72",
                      "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                      "templateId" : "PositiveMedicationOrder",
                      "codeProperty" : "code",
                      "type" : "Retrieve",
                      "codes" : {
                        "locator" : "116:32-116:71",
                        "name" : "First Generation Serotonin Antagonists",
                        "type" : "ValueSetRef"
                      }
                    },
                    "asTypeSpecifier" : {
                      "type" : "ListTypeSpecifier",
                      "elementType" : {
                        "type" : "ChoiceTypeSpecifier",
                        "choice" : [ {
                          "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                          "type" : "NamedTypeSpecifier"
                        }, {
                          "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                          "type" : "NamedTypeSpecifier"
                        } ]
                      }
                    }
                  } ]
                },
                "asTypeSpecifier" : {
                  "type" : "ListTypeSpecifier",
                  "elementType" : {
                    "type" : "ChoiceTypeSpecifier",
                    "choice" : [ {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                      "type" : "NamedTypeSpecifier"
                    }, {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                      "type" : "NamedTypeSpecifier"
                    } ]
                  }
                }
              }, {
                "type" : "As",
                "operand" : {
                  "localId" : "223",
                  "locator" : "117:10-117:46",
                  "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                  "templateId" : "PositiveMedicationOrder",
                  "codeProperty" : "code",
                  "type" : "Retrieve",
                  "codes" : {
                    "locator" : "117:32-117:45",
                    "name" : "Palonosetron",
                    "type" : "ValueSetRef"
                  }
                },
                "asTypeSpecifier" : {
                  "type" : "ListTypeSpecifier",
                  "elementType" : {
                    "type" : "ChoiceTypeSpecifier",
                    "choice" : [ {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                      "type" : "NamedTypeSpecifier"
                    }, {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                      "type" : "NamedTypeSpecifier"
                    } ]
                  }
                }
              } ]
            }
          } ],
          "relationship" : [ {
            "localId" : "235",
            "locator" : "118:4-119:100",
            "alias" : "ComboChemo",
            "type" : "With",
            "expression" : {
              "localId" : "226",
              "locator" : "118:9-118:86",
              "name" : "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx",
              "type" : "ExpressionRef"
            },
            "suchThat" : {
              "localId" : "234",
              "locator" : "119:15-119:100",
              "type" : "And",
              "operand" : [ {
                "locator" : "119:46-119:59",
                "type" : "In",
                "operand" : [ {
                  "locator" : "119:39-119:44",
                  "type" : "Start",
                  "operand" : {
                    "localId" : "229",
                    "locator" : "119:15-119:37",
                    "path" : "relevantPeriod",
                    "scope" : "MedAdmin",
                    "type" : "Property"
                  }
                }, {
                  "locator" : "119:46-119:59",
                  "lowClosed" : false,
                  "highClosed" : true,
                  "type" : "Interval",
                  "low" : {
                    "localId" : "232",
                    "locator" : "119:67-119:100",
                    "type" : "Start",
                    "operand" : {
                      "localId" : "231",
                      "locator" : "119:76-119:100",
                      "path" : "relevantPeriod",
                      "scope" : "ComboChemo",
                      "type" : "Property"
                    }
                  },
                  "high" : {
                    "locator" : "119:67-119:100",
                    "type" : "Add",
                    "operand" : [ {
                      "localId" : "232",
                      "locator" : "119:67-119:100",
                      "type" : "Start",
                      "operand" : {
                        "localId" : "231",
                        "locator" : "119:76-119:100",
                        "path" : "relevantPeriod",
                        "scope" : "ComboChemo",
                        "type" : "Property"
                      }
                    }, {
                      "localId" : "233",
                      "locator" : "119:46-119:51",
                      "value" : 7,
                      "unit" : "days",
                      "type" : "Quantity"
                    } ]
                  }
                } ]
              }, {
                "locator" : "119:46-119:59",
                "type" : "Not",
                "operand" : {
                  "locator" : "119:46-119:59",
                  "type" : "IsNull",
                  "operand" : {
                    "localId" : "232",
                    "locator" : "119:67-119:100",
                    "type" : "Start",
                    "operand" : {
                      "localId" : "231",
                      "locator" : "119:76-119:100",
                      "path" : "relevantPeriod",
                      "scope" : "ComboChemo",
                      "type" : "Property"
                    }
                  }
                }
              } ]
            }
          } ]
        }
      }, {
        "localId" : "256",
        "locator" : "121:1-127:86",
        "name" : "First Gen Serotonin Antagonists or Palonosetron administered or ordered before Combo High Risk Chemo",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "256",
            "s" : [ {
              "value" : [ "define ", "\"First Gen Serotonin Antagonists or Palonosetron administered or ordered before Combo High Risk Chemo\"", ":\n  " ]
            }, {
              "r" : "255",
              "s" : [ {
                "s" : [ {
                  "r" : "245",
                  "s" : [ {
                    "r" : "244",
                    "s" : [ {
                      "value" : [ "( " ]
                    }, {
                      "r" : "244",
                      "s" : [ {
                        "r" : "242",
                        "s" : [ {
                          "r" : "240",
                          "s" : [ {
                            "r" : "238",
                            "s" : [ {
                              "value" : [ "[", "\"Medication, Administered\"", ": " ]
                            }, {
                              "s" : [ {
                                "value" : [ "\"First Generation Serotonin Antagonists\"" ]
                              } ]
                            }, {
                              "value" : [ "]" ]
                            } ]
                          }, {
                            "value" : [ "\n  \tunion " ]
                          }, {
                            "r" : "239",
                            "s" : [ {
                              "value" : [ "[", "\"Medication, Administered\"", ": " ]
                            }, {
                              "s" : [ {
                                "value" : [ "\"Palonosetron\"" ]
                              } ]
                            }, {
                              "value" : [ "]" ]
                            } ]
                          } ]
                        }, {
                          "value" : [ "\n  \tunion " ]
                        }, {
                          "r" : "241",
                          "s" : [ {
                            "value" : [ "[", "\"Medication, Order\"", ": " ]
                          }, {
                            "s" : [ {
                              "value" : [ "\"First Generation Serotonin Antagonists\"" ]
                            } ]
                          }, {
                            "value" : [ "]" ]
                          } ]
                        } ]
                      }, {
                        "value" : [ "\n  \tunion " ]
                      }, {
                        "r" : "243",
                        "s" : [ {
                          "value" : [ "[", "\"Medication, Order\"", ": " ]
                        }, {
                          "s" : [ {
                            "value" : [ "\"Palonosetron\"" ]
                          } ]
                        }, {
                          "value" : [ "]" ]
                        } ]
                      } ]
                    }, {
                      "value" : [ " )" ]
                    } ]
                  }, {
                    "value" : [ " ", "MedAdmin" ]
                  } ]
                } ]
              }, {
                "value" : [ "\n  \t" ]
              }, {
                "r" : "254",
                "s" : [ {
                  "value" : [ "with " ]
                }, {
                  "r" : "247",
                  "s" : [ {
                    "r" : "246",
                    "s" : [ {
                      "s" : [ {
                        "value" : [ "\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\"" ]
                      } ]
                    } ]
                  }, {
                    "value" : [ " ", "ComboChemo" ]
                  } ]
                }, {
                  "value" : [ "\n  \t\tsuch that " ]
                }, {
                  "r" : "253",
                  "s" : [ {
                    "r" : "249",
                    "s" : [ {
                      "r" : "248",
                      "s" : [ {
                        "value" : [ "MedAdmin" ]
                      } ]
                    }, {
                      "value" : [ "." ]
                    }, {
                      "r" : "249",
                      "s" : [ {
                        "value" : [ "relevantPeriod" ]
                      } ]
                    } ]
                  }, {
                    "r" : "253",
                    "value" : [ " ", "starts before", " " ]
                  }, {
                    "r" : "252",
                    "s" : [ {
                      "value" : [ "start of " ]
                    }, {
                      "r" : "251",
                      "s" : [ {
                        "r" : "250",
                        "s" : [ {
                          "value" : [ "ComboChemo" ]
                        } ]
                      }, {
                        "value" : [ "." ]
                      }, {
                        "r" : "251",
                        "s" : [ {
                          "value" : [ "relevantPeriod" ]
                        } ]
                      } ]
                    } ]
                  } ]
                } ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "255",
          "locator" : "122:3-127:86",
          "type" : "Query",
          "source" : [ {
            "localId" : "245",
            "locator" : "122:3-125:57",
            "alias" : "MedAdmin",
            "expression" : {
              "localId" : "244",
              "locator" : "122:3-125:48",
              "type" : "Union",
              "operand" : [ {
                "type" : "As",
                "operand" : {
                  "localId" : "242",
                  "locator" : "122:5-124:72",
                  "type" : "Union",
                  "operand" : [ {
                    "type" : "As",
                    "operand" : {
                      "localId" : "240",
                      "locator" : "122:5-123:53",
                      "type" : "Union",
                      "operand" : [ {
                        "localId" : "238",
                        "locator" : "122:5-122:74",
                        "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                        "templateId" : "PositiveMedicationAdministered",
                        "codeProperty" : "code",
                        "type" : "Retrieve",
                        "codes" : {
                          "locator" : "122:34-122:73",
                          "name" : "First Generation Serotonin Antagonists",
                          "type" : "ValueSetRef"
                        }
                      }, {
                        "localId" : "239",
                        "locator" : "123:10-123:53",
                        "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                        "templateId" : "PositiveMedicationAdministered",
                        "codeProperty" : "code",
                        "type" : "Retrieve",
                        "codes" : {
                          "locator" : "123:39-123:52",
                          "name" : "Palonosetron",
                          "type" : "ValueSetRef"
                        }
                      } ]
                    },
                    "asTypeSpecifier" : {
                      "type" : "ListTypeSpecifier",
                      "elementType" : {
                        "type" : "ChoiceTypeSpecifier",
                        "choice" : [ {
                          "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                          "type" : "NamedTypeSpecifier"
                        }, {
                          "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                          "type" : "NamedTypeSpecifier"
                        } ]
                      }
                    }
                  }, {
                    "type" : "As",
                    "operand" : {
                      "localId" : "241",
                      "locator" : "124:10-124:72",
                      "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                      "templateId" : "PositiveMedicationOrder",
                      "codeProperty" : "code",
                      "type" : "Retrieve",
                      "codes" : {
                        "locator" : "124:32-124:71",
                        "name" : "First Generation Serotonin Antagonists",
                        "type" : "ValueSetRef"
                      }
                    },
                    "asTypeSpecifier" : {
                      "type" : "ListTypeSpecifier",
                      "elementType" : {
                        "type" : "ChoiceTypeSpecifier",
                        "choice" : [ {
                          "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                          "type" : "NamedTypeSpecifier"
                        }, {
                          "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                          "type" : "NamedTypeSpecifier"
                        } ]
                      }
                    }
                  } ]
                },
                "asTypeSpecifier" : {
                  "type" : "ListTypeSpecifier",
                  "elementType" : {
                    "type" : "ChoiceTypeSpecifier",
                    "choice" : [ {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                      "type" : "NamedTypeSpecifier"
                    }, {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                      "type" : "NamedTypeSpecifier"
                    } ]
                  }
                }
              }, {
                "type" : "As",
                "operand" : {
                  "localId" : "243",
                  "locator" : "125:10-125:46",
                  "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                  "templateId" : "PositiveMedicationOrder",
                  "codeProperty" : "code",
                  "type" : "Retrieve",
                  "codes" : {
                    "locator" : "125:32-125:45",
                    "name" : "Palonosetron",
                    "type" : "ValueSetRef"
                  }
                },
                "asTypeSpecifier" : {
                  "type" : "ListTypeSpecifier",
                  "elementType" : {
                    "type" : "ChoiceTypeSpecifier",
                    "choice" : [ {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                      "type" : "NamedTypeSpecifier"
                    }, {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                      "type" : "NamedTypeSpecifier"
                    } ]
                  }
                }
              } ]
            }
          } ],
          "relationship" : [ {
            "localId" : "254",
            "locator" : "126:4-127:86",
            "alias" : "ComboChemo",
            "type" : "With",
            "expression" : {
              "localId" : "246",
              "locator" : "126:9-126:86",
              "name" : "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx",
              "type" : "ExpressionRef"
            },
            "suchThat" : {
              "localId" : "253",
              "locator" : "127:15-127:86",
              "type" : "Before",
              "operand" : [ {
                "locator" : "127:39-127:44",
                "type" : "Start",
                "operand" : {
                  "localId" : "249",
                  "locator" : "127:15-127:37",
                  "path" : "relevantPeriod",
                  "scope" : "MedAdmin",
                  "type" : "Property"
                }
              }, {
                "localId" : "252",
                "locator" : "127:53-127:86",
                "type" : "Start",
                "operand" : {
                  "localId" : "251",
                  "locator" : "127:62-127:86",
                  "path" : "relevantPeriod",
                  "scope" : "ComboChemo",
                  "type" : "Property"
                }
              } ]
            }
          } ]
        }
      }, {
        "localId" : "293",
        "locator" : "132:1-144:72",
        "name" : "Reasons for Not prescribing or Ordering First Gen Serotonin Antagonists, Aprepitant, Fosprepitant or Netupitant",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "293",
            "s" : [ {
              "value" : [ "define ", "\"Reasons for Not prescribing or Ordering First Gen Serotonin Antagonists, Aprepitant, Fosprepitant or Netupitant\"", ":\n  " ]
            }, {
              "r" : "292",
              "s" : [ {
                "s" : [ {
                  "r" : "272",
                  "s" : [ {
                    "r" : "271",
                    "s" : [ {
                      "value" : [ "( " ]
                    }, {
                      "r" : "271",
                      "s" : [ {
                        "r" : "269",
                        "s" : [ {
                          "r" : "267",
                          "s" : [ {
                            "r" : "265",
                            "s" : [ {
                              "r" : "263",
                              "s" : [ {
                                "r" : "261",
                                "s" : [ {
                                  "r" : "259",
                                  "s" : [ {
                                    "r" : "257",
                                    "s" : [ {
                                      "value" : [ "[", "\"Medication, Administered\"", ": " ]
                                    }, {
                                      "s" : [ {
                                        "value" : [ "\"First Generation Serotonin Antagonists\"" ]
                                      } ]
                                    }, {
                                      "value" : [ "]" ]
                                    } ]
                                  }, {
                                    "value" : [ "\n  \tunion " ]
                                  }, {
                                    "r" : "258",
                                    "s" : [ {
                                      "value" : [ "[", "\"Medication, Administered\"", ": " ]
                                    }, {
                                      "s" : [ {
                                        "value" : [ "\"Aprepitant\"" ]
                                      } ]
                                    }, {
                                      "value" : [ "]" ]
                                    } ]
                                  } ]
                                }, {
                                  "value" : [ "\n  \tunion " ]
                                }, {
                                  "r" : "260",
                                  "s" : [ {
                                    "value" : [ "[", "\"Medication, Administered\"", ": " ]
                                  }, {
                                    "s" : [ {
                                      "value" : [ "\"Fosaprepitant\"" ]
                                    } ]
                                  }, {
                                    "value" : [ "]" ]
                                  } ]
                                } ]
                              }, {
                                "value" : [ "\n  \tunion " ]
                              }, {
                                "r" : "262",
                                "s" : [ {
                                  "value" : [ "[", "\"Medication, Administered\"", ": " ]
                                }, {
                                  "s" : [ {
                                    "value" : [ "\"Netupitant\"" ]
                                  } ]
                                }, {
                                  "value" : [ "]" ]
                                } ]
                              } ]
                            }, {
                              "value" : [ "\n  \tunion " ]
                            }, {
                              "r" : "264",
                              "s" : [ {
                                "value" : [ "[", "\"Medication, Order\"", ": " ]
                              }, {
                                "s" : [ {
                                  "value" : [ "\"First Generation Serotonin Antagonists\"" ]
                                } ]
                              }, {
                                "value" : [ "]" ]
                              } ]
                            } ]
                          }, {
                            "value" : [ "\n  \tunion " ]
                          }, {
                            "r" : "266",
                            "s" : [ {
                              "value" : [ "[", "\"Medication, Order\"", ": " ]
                            }, {
                              "s" : [ {
                                "value" : [ "\"Aprepitant\"" ]
                              } ]
                            }, {
                              "value" : [ "]" ]
                            } ]
                          } ]
                        }, {
                          "value" : [ "\n  \tunion " ]
                        }, {
                          "r" : "268",
                          "s" : [ {
                            "value" : [ "[", "\"Medication, Order\"", ": " ]
                          }, {
                            "s" : [ {
                              "value" : [ "\"Fosaprepitant\"" ]
                            } ]
                          }, {
                            "value" : [ "]" ]
                          } ]
                        } ]
                      }, {
                        "value" : [ "\n  \tunion " ]
                      }, {
                        "r" : "270",
                        "s" : [ {
                          "value" : [ "[", "\"Medication, Order\"", ": " ]
                        }, {
                          "s" : [ {
                            "value" : [ "\"Netupitant\"" ]
                          } ]
                        }, {
                          "value" : [ "]" ]
                        } ]
                      } ]
                    }, {
                      "value" : [ " )" ]
                    } ]
                  }, {
                    "value" : [ " ", "MedNotOrdered" ]
                  } ]
                } ]
              }, {
                "value" : [ "\n  \t" ]
              }, {
                "r" : "291",
                "s" : [ {
                  "value" : [ "where " ]
                }, {
                  "r" : "291",
                  "s" : [ {
                    "r" : "281",
                    "s" : [ {
                      "r" : "276",
                      "s" : [ {
                        "r" : "274",
                        "s" : [ {
                          "r" : "273",
                          "s" : [ {
                            "value" : [ "MedNotOrdered" ]
                          } ]
                        }, {
                          "value" : [ "." ]
                        }, {
                          "r" : "274",
                          "s" : [ {
                            "value" : [ "negationRationale" ]
                          } ]
                        } ]
                      }, {
                        "value" : [ " in " ]
                      }, {
                        "r" : "275",
                        "s" : [ {
                          "value" : [ "\"Medical Reason\"" ]
                        } ]
                      } ]
                    }, {
                      "value" : [ "\n  \t\tor " ]
                    }, {
                      "r" : "280",
                      "s" : [ {
                        "r" : "278",
                        "s" : [ {
                          "r" : "277",
                          "s" : [ {
                            "value" : [ "MedNotOrdered" ]
                          } ]
                        }, {
                          "value" : [ "." ]
                        }, {
                          "r" : "278",
                          "s" : [ {
                            "value" : [ "negationRationale" ]
                          } ]
                        } ]
                      }, {
                        "value" : [ " in " ]
                      }, {
                        "r" : "279",
                        "s" : [ {
                          "value" : [ "\"Patient Reason\"" ]
                        } ]
                      } ]
                    } ]
                  }, {
                    "value" : [ "\n  \t\tor " ]
                  }, {
                    "r" : "290",
                    "s" : [ {
                      "r" : "285",
                      "s" : [ {
                        "r" : "283",
                        "s" : [ {
                          "r" : "282",
                          "s" : [ {
                            "value" : [ "MedNotOrdered" ]
                          } ]
                        }, {
                          "value" : [ "." ]
                        }, {
                          "r" : "283",
                          "s" : [ {
                            "value" : [ "negationRationale" ]
                          } ]
                        } ]
                      }, {
                        "value" : [ " in " ]
                      }, {
                        "r" : "284",
                        "s" : [ {
                          "value" : [ "\"System Reason\"" ]
                        } ]
                      } ]
                    }, {
                      "value" : [ "\n  \t\t\tand " ]
                    }, {
                      "r" : "289",
                      "s" : [ {
                        "r" : "287",
                        "s" : [ {
                          "r" : "286",
                          "s" : [ {
                            "value" : [ "MedNotOrdered" ]
                          } ]
                        }, {
                          "value" : [ "." ]
                        }, {
                          "r" : "287",
                          "s" : [ {
                            "value" : [ "relevantPeriod" ]
                          } ]
                        } ]
                      }, {
                        "r" : "289",
                        "value" : [ " ", "starts during", " " ]
                      }, {
                        "r" : "288",
                        "s" : [ {
                          "value" : [ "\"Measurement Period\"" ]
                        } ]
                      } ]
                    } ]
                  } ]
                } ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "292",
          "locator" : "133:3-144:72",
          "type" : "Query",
          "source" : [ {
            "localId" : "272",
            "locator" : "133:3-140:60",
            "alias" : "MedNotOrdered",
            "expression" : {
              "localId" : "271",
              "locator" : "133:3-140:46",
              "type" : "Union",
              "operand" : [ {
                "type" : "As",
                "operand" : {
                  "localId" : "269",
                  "locator" : "133:5-139:47",
                  "type" : "Union",
                  "operand" : [ {
                    "type" : "As",
                    "operand" : {
                      "localId" : "267",
                      "locator" : "133:5-138:44",
                      "type" : "Union",
                      "operand" : [ {
                        "type" : "As",
                        "operand" : {
                          "localId" : "265",
                          "locator" : "133:5-137:72",
                          "type" : "Union",
                          "operand" : [ {
                            "type" : "As",
                            "operand" : {
                              "localId" : "263",
                              "locator" : "133:5-136:51",
                              "type" : "Union",
                              "operand" : [ {
                                "localId" : "259",
                                "locator" : "133:5-134:51",
                                "type" : "Union",
                                "operand" : [ {
                                  "localId" : "257",
                                  "locator" : "133:5-133:74",
                                  "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                                  "templateId" : "PositiveMedicationAdministered",
                                  "codeProperty" : "code",
                                  "type" : "Retrieve",
                                  "codes" : {
                                    "locator" : "133:34-133:73",
                                    "name" : "First Generation Serotonin Antagonists",
                                    "type" : "ValueSetRef"
                                  }
                                }, {
                                  "localId" : "258",
                                  "locator" : "134:10-134:51",
                                  "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                                  "templateId" : "PositiveMedicationAdministered",
                                  "codeProperty" : "code",
                                  "type" : "Retrieve",
                                  "codes" : {
                                    "locator" : "134:39-134:50",
                                    "name" : "Aprepitant",
                                    "type" : "ValueSetRef"
                                  }
                                } ]
                              }, {
                                "type" : "Union",
                                "operand" : [ {
                                  "localId" : "260",
                                  "locator" : "135:10-135:54",
                                  "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                                  "templateId" : "PositiveMedicationAdministered",
                                  "codeProperty" : "code",
                                  "type" : "Retrieve",
                                  "codes" : {
                                    "locator" : "135:39-135:53",
                                    "name" : "Fosaprepitant",
                                    "type" : "ValueSetRef"
                                  }
                                }, {
                                  "localId" : "262",
                                  "locator" : "136:10-136:51",
                                  "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                                  "templateId" : "PositiveMedicationAdministered",
                                  "codeProperty" : "code",
                                  "type" : "Retrieve",
                                  "codes" : {
                                    "locator" : "136:39-136:50",
                                    "name" : "Netupitant",
                                    "type" : "ValueSetRef"
                                  }
                                } ]
                              } ]
                            },
                            "asTypeSpecifier" : {
                              "type" : "ListTypeSpecifier",
                              "elementType" : {
                                "type" : "ChoiceTypeSpecifier",
                                "choice" : [ {
                                  "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                                  "type" : "NamedTypeSpecifier"
                                }, {
                                  "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                                  "type" : "NamedTypeSpecifier"
                                } ]
                              }
                            }
                          }, {
                            "type" : "As",
                            "operand" : {
                              "localId" : "264",
                              "locator" : "137:10-137:72",
                              "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                              "templateId" : "PositiveMedicationOrder",
                              "codeProperty" : "code",
                              "type" : "Retrieve",
                              "codes" : {
                                "locator" : "137:32-137:71",
                                "name" : "First Generation Serotonin Antagonists",
                                "type" : "ValueSetRef"
                              }
                            },
                            "asTypeSpecifier" : {
                              "type" : "ListTypeSpecifier",
                              "elementType" : {
                                "type" : "ChoiceTypeSpecifier",
                                "choice" : [ {
                                  "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                                  "type" : "NamedTypeSpecifier"
                                }, {
                                  "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                                  "type" : "NamedTypeSpecifier"
                                } ]
                              }
                            }
                          } ]
                        },
                        "asTypeSpecifier" : {
                          "type" : "ListTypeSpecifier",
                          "elementType" : {
                            "type" : "ChoiceTypeSpecifier",
                            "choice" : [ {
                              "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                              "type" : "NamedTypeSpecifier"
                            }, {
                              "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                              "type" : "NamedTypeSpecifier"
                            } ]
                          }
                        }
                      }, {
                        "type" : "As",
                        "operand" : {
                          "localId" : "266",
                          "locator" : "138:10-138:44",
                          "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                          "templateId" : "PositiveMedicationOrder",
                          "codeProperty" : "code",
                          "type" : "Retrieve",
                          "codes" : {
                            "locator" : "138:32-138:43",
                            "name" : "Aprepitant",
                            "type" : "ValueSetRef"
                          }
                        },
                        "asTypeSpecifier" : {
                          "type" : "ListTypeSpecifier",
                          "elementType" : {
                            "type" : "ChoiceTypeSpecifier",
                            "choice" : [ {
                              "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                              "type" : "NamedTypeSpecifier"
                            }, {
                              "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                              "type" : "NamedTypeSpecifier"
                            } ]
                          }
                        }
                      } ]
                    },
                    "asTypeSpecifier" : {
                      "type" : "ListTypeSpecifier",
                      "elementType" : {
                        "type" : "ChoiceTypeSpecifier",
                        "choice" : [ {
                          "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                          "type" : "NamedTypeSpecifier"
                        }, {
                          "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                          "type" : "NamedTypeSpecifier"
                        } ]
                      }
                    }
                  }, {
                    "type" : "As",
                    "operand" : {
                      "localId" : "268",
                      "locator" : "139:10-139:47",
                      "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                      "templateId" : "PositiveMedicationOrder",
                      "codeProperty" : "code",
                      "type" : "Retrieve",
                      "codes" : {
                        "locator" : "139:32-139:46",
                        "name" : "Fosaprepitant",
                        "type" : "ValueSetRef"
                      }
                    },
                    "asTypeSpecifier" : {
                      "type" : "ListTypeSpecifier",
                      "elementType" : {
                        "type" : "ChoiceTypeSpecifier",
                        "choice" : [ {
                          "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                          "type" : "NamedTypeSpecifier"
                        }, {
                          "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                          "type" : "NamedTypeSpecifier"
                        } ]
                      }
                    }
                  } ]
                },
                "asTypeSpecifier" : {
                  "type" : "ListTypeSpecifier",
                  "elementType" : {
                    "type" : "ChoiceTypeSpecifier",
                    "choice" : [ {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                      "type" : "NamedTypeSpecifier"
                    }, {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                      "type" : "NamedTypeSpecifier"
                    } ]
                  }
                }
              }, {
                "type" : "As",
                "operand" : {
                  "localId" : "270",
                  "locator" : "140:10-140:44",
                  "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                  "templateId" : "PositiveMedicationOrder",
                  "codeProperty" : "code",
                  "type" : "Retrieve",
                  "codes" : {
                    "locator" : "140:32-140:43",
                    "name" : "Netupitant",
                    "type" : "ValueSetRef"
                  }
                },
                "asTypeSpecifier" : {
                  "type" : "ListTypeSpecifier",
                  "elementType" : {
                    "type" : "ChoiceTypeSpecifier",
                    "choice" : [ {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                      "type" : "NamedTypeSpecifier"
                    }, {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                      "type" : "NamedTypeSpecifier"
                    } ]
                  }
                }
              } ]
            }
          } ],
          "relationship" : [ ],
          "where" : {
            "localId" : "291",
            "locator" : "141:4-144:72",
            "type" : "Or",
            "operand" : [ {
              "localId" : "281",
              "locator" : "141:10-142:58",
              "type" : "Or",
              "operand" : [ {
                "localId" : "276",
                "locator" : "141:10-141:60",
                "type" : "InValueSet",
                "code" : {
                  "localId" : "274",
                  "locator" : "141:10-141:40",
                  "path" : "negationRationale",
                  "scope" : "MedNotOrdered",
                  "type" : "Property"
                },
                "valueset" : {
                  "localId" : "275",
                  "locator" : "141:45-141:60",
                  "name" : "Medical Reason"
                }
              }, {
                "localId" : "280",
                "locator" : "142:8-142:58",
                "type" : "InValueSet",
                "code" : {
                  "localId" : "278",
                  "locator" : "142:8-142:38",
                  "path" : "negationRationale",
                  "scope" : "MedNotOrdered",
                  "type" : "Property"
                },
                "valueset" : {
                  "localId" : "279",
                  "locator" : "142:43-142:58",
                  "name" : "Patient Reason"
                }
              } ]
            }, {
              "localId" : "290",
              "locator" : "143:8-144:72",
              "type" : "And",
              "operand" : [ {
                "localId" : "285",
                "locator" : "143:8-143:57",
                "type" : "InValueSet",
                "code" : {
                  "localId" : "283",
                  "locator" : "143:8-143:38",
                  "path" : "negationRationale",
                  "scope" : "MedNotOrdered",
                  "type" : "Property"
                },
                "valueset" : {
                  "localId" : "284",
                  "locator" : "143:43-143:57",
                  "name" : "System Reason"
                }
              }, {
                "localId" : "289",
                "locator" : "144:10-144:72",
                "type" : "In",
                "operand" : [ {
                  "locator" : "144:39-144:44",
                  "type" : "Start",
                  "operand" : {
                    "localId" : "287",
                    "locator" : "144:10-144:37",
                    "path" : "relevantPeriod",
                    "scope" : "MedNotOrdered",
                    "type" : "Property"
                  }
                }, {
                  "localId" : "288",
                  "locator" : "144:53-144:72",
                  "name" : "Measurement Period",
                  "type" : "ParameterRef"
                } ]
              } ]
            } ]
          }
        }
      }, {
        "localId" : "296",
        "locator" : "129:1-130:122",
        "name" : "Denominator Exceptions",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "296",
            "s" : [ {
              "value" : [ "define ", "\"Denominator Exceptions\"", ":\n  " ]
            }, {
              "r" : "295",
              "s" : [ {
                "value" : [ "exists " ]
              }, {
                "r" : "294",
                "s" : [ {
                  "value" : [ "\"Reasons for Not prescribing or Ordering First Gen Serotonin Antagonists, Aprepitant, Fosprepitant or Netupitant\"" ]
                } ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "295",
          "locator" : "130:3-130:122",
          "type" : "Exists",
          "operand" : {
            "localId" : "294",
            "locator" : "130:10-130:122",
            "name" : "Reasons for Not prescribing or Ordering First Gen Serotonin Antagonists, Aprepitant, Fosprepitant or Netupitant",
            "type" : "ExpressionRef"
          }
        }
      }, {
        "localId" : "319",
        "locator" : "146:1-154:86",
        "name" : "Aprepitant, Fosaprepitant or Netupitant  administered or ordered before Combo High Risk Chemo",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "319",
            "s" : [ {
              "value" : [ "define ", "\"Aprepitant, Fosaprepitant or Netupitant  administered or ordered before Combo High Risk Chemo\"", ":\n  " ]
            }, {
              "r" : "318",
              "s" : [ {
                "s" : [ {
                  "r" : "308",
                  "s" : [ {
                    "r" : "307",
                    "s" : [ {
                      "value" : [ "( " ]
                    }, {
                      "r" : "307",
                      "s" : [ {
                        "r" : "305",
                        "s" : [ {
                          "r" : "303",
                          "s" : [ {
                            "r" : "301",
                            "s" : [ {
                              "r" : "299",
                              "s" : [ {
                                "r" : "297",
                                "s" : [ {
                                  "value" : [ "[", "\"Medication, Administered\"", ": " ]
                                }, {
                                  "s" : [ {
                                    "value" : [ "\"Aprepitant\"" ]
                                  } ]
                                }, {
                                  "value" : [ "]" ]
                                } ]
                              }, {
                                "value" : [ "\n  \tunion " ]
                              }, {
                                "r" : "298",
                                "s" : [ {
                                  "value" : [ "[", "\"Medication, Administered\"", ": " ]
                                }, {
                                  "s" : [ {
                                    "value" : [ "\"Fosaprepitant\"" ]
                                  } ]
                                }, {
                                  "value" : [ "]" ]
                                } ]
                              } ]
                            }, {
                              "value" : [ "\n  \tunion " ]
                            }, {
                              "r" : "300",
                              "s" : [ {
                                "value" : [ "[", "\"Medication, Administered\"", ": " ]
                              }, {
                                "s" : [ {
                                  "value" : [ "\"Netupitant\"" ]
                                } ]
                              }, {
                                "value" : [ "]" ]
                              } ]
                            } ]
                          }, {
                            "value" : [ "\n  \tunion " ]
                          }, {
                            "r" : "302",
                            "s" : [ {
                              "value" : [ "[", "\"Medication, Order\"", ": " ]
                            }, {
                              "s" : [ {
                                "value" : [ "\"Aprepitant\"" ]
                              } ]
                            }, {
                              "value" : [ "]" ]
                            } ]
                          } ]
                        }, {
                          "value" : [ "\n  \tunion " ]
                        }, {
                          "r" : "304",
                          "s" : [ {
                            "value" : [ "[", "\"Medication, Order\"", ": " ]
                          }, {
                            "s" : [ {
                              "value" : [ "\"Fosaprepitant\"" ]
                            } ]
                          }, {
                            "value" : [ "]" ]
                          } ]
                        } ]
                      }, {
                        "value" : [ "\n  \tunion " ]
                      }, {
                        "r" : "306",
                        "s" : [ {
                          "value" : [ "[", "\"Medication, Order\"", ": " ]
                        }, {
                          "s" : [ {
                            "value" : [ "\"Netupitant\"" ]
                          } ]
                        }, {
                          "value" : [ "]" ]
                        } ]
                      } ]
                    }, {
                      "value" : [ " )" ]
                    } ]
                  }, {
                    "value" : [ " ", "MedAdmin" ]
                  } ]
                } ]
              }, {
                "value" : [ "\n  \t" ]
              }, {
                "r" : "317",
                "s" : [ {
                  "value" : [ "with " ]
                }, {
                  "r" : "310",
                  "s" : [ {
                    "r" : "309",
                    "s" : [ {
                      "s" : [ {
                        "value" : [ "\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\"" ]
                      } ]
                    } ]
                  }, {
                    "value" : [ " ", "ComboChemo" ]
                  } ]
                }, {
                  "value" : [ "\n  \t\tsuch that " ]
                }, {
                  "r" : "316",
                  "s" : [ {
                    "r" : "312",
                    "s" : [ {
                      "r" : "311",
                      "s" : [ {
                        "value" : [ "MedAdmin" ]
                      } ]
                    }, {
                      "value" : [ "." ]
                    }, {
                      "r" : "312",
                      "s" : [ {
                        "value" : [ "relevantPeriod" ]
                      } ]
                    } ]
                  }, {
                    "r" : "316",
                    "value" : [ " ", "starts before", " " ]
                  }, {
                    "r" : "315",
                    "s" : [ {
                      "value" : [ "start of " ]
                    }, {
                      "r" : "314",
                      "s" : [ {
                        "r" : "313",
                        "s" : [ {
                          "value" : [ "ComboChemo" ]
                        } ]
                      }, {
                        "value" : [ "." ]
                      }, {
                        "r" : "314",
                        "s" : [ {
                          "value" : [ "relevantPeriod" ]
                        } ]
                      } ]
                    } ]
                  } ]
                } ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "318",
          "locator" : "147:3-154:86",
          "type" : "Query",
          "source" : [ {
            "localId" : "308",
            "locator" : "147:3-152:55",
            "alias" : "MedAdmin",
            "expression" : {
              "localId" : "307",
              "locator" : "147:3-152:46",
              "type" : "Union",
              "operand" : [ {
                "type" : "As",
                "operand" : {
                  "localId" : "305",
                  "locator" : "147:5-151:47",
                  "type" : "Union",
                  "operand" : [ {
                    "type" : "As",
                    "operand" : {
                      "localId" : "303",
                      "locator" : "147:5-150:44",
                      "type" : "Union",
                      "operand" : [ {
                        "type" : "As",
                        "operand" : {
                          "localId" : "299",
                          "locator" : "147:5-148:54",
                          "type" : "Union",
                          "operand" : [ {
                            "localId" : "297",
                            "locator" : "147:5-147:46",
                            "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                            "templateId" : "PositiveMedicationAdministered",
                            "codeProperty" : "code",
                            "type" : "Retrieve",
                            "codes" : {
                              "locator" : "147:34-147:45",
                              "name" : "Aprepitant",
                              "type" : "ValueSetRef"
                            }
                          }, {
                            "localId" : "298",
                            "locator" : "148:10-148:54",
                            "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                            "templateId" : "PositiveMedicationAdministered",
                            "codeProperty" : "code",
                            "type" : "Retrieve",
                            "codes" : {
                              "locator" : "148:39-148:53",
                              "name" : "Fosaprepitant",
                              "type" : "ValueSetRef"
                            }
                          } ]
                        },
                        "asTypeSpecifier" : {
                          "type" : "ListTypeSpecifier",
                          "elementType" : {
                            "type" : "ChoiceTypeSpecifier",
                            "choice" : [ {
                              "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                              "type" : "NamedTypeSpecifier"
                            }, {
                              "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                              "type" : "NamedTypeSpecifier"
                            } ]
                          }
                        }
                      }, {
                        "type" : "As",
                        "operand" : {
                          "type" : "Union",
                          "operand" : [ {
                            "type" : "As",
                            "operand" : {
                              "localId" : "300",
                              "locator" : "149:10-149:51",
                              "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                              "templateId" : "PositiveMedicationAdministered",
                              "codeProperty" : "code",
                              "type" : "Retrieve",
                              "codes" : {
                                "locator" : "149:39-149:50",
                                "name" : "Netupitant",
                                "type" : "ValueSetRef"
                              }
                            },
                            "asTypeSpecifier" : {
                              "type" : "ListTypeSpecifier",
                              "elementType" : {
                                "type" : "ChoiceTypeSpecifier",
                                "choice" : [ {
                                  "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                                  "type" : "NamedTypeSpecifier"
                                }, {
                                  "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                                  "type" : "NamedTypeSpecifier"
                                } ]
                              }
                            }
                          }, {
                            "type" : "As",
                            "operand" : {
                              "localId" : "302",
                              "locator" : "150:10-150:44",
                              "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                              "templateId" : "PositiveMedicationOrder",
                              "codeProperty" : "code",
                              "type" : "Retrieve",
                              "codes" : {
                                "locator" : "150:32-150:43",
                                "name" : "Aprepitant",
                                "type" : "ValueSetRef"
                              }
                            },
                            "asTypeSpecifier" : {
                              "type" : "ListTypeSpecifier",
                              "elementType" : {
                                "type" : "ChoiceTypeSpecifier",
                                "choice" : [ {
                                  "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                                  "type" : "NamedTypeSpecifier"
                                }, {
                                  "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                                  "type" : "NamedTypeSpecifier"
                                } ]
                              }
                            }
                          } ]
                        },
                        "asTypeSpecifier" : {
                          "type" : "ListTypeSpecifier",
                          "elementType" : {
                            "type" : "ChoiceTypeSpecifier",
                            "choice" : [ {
                              "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                              "type" : "NamedTypeSpecifier"
                            }, {
                              "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                              "type" : "NamedTypeSpecifier"
                            } ]
                          }
                        }
                      } ]
                    },
                    "asTypeSpecifier" : {
                      "type" : "ListTypeSpecifier",
                      "elementType" : {
                        "type" : "ChoiceTypeSpecifier",
                        "choice" : [ {
                          "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                          "type" : "NamedTypeSpecifier"
                        }, {
                          "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                          "type" : "NamedTypeSpecifier"
                        } ]
                      }
                    }
                  }, {
                    "type" : "As",
                    "operand" : {
                      "localId" : "304",
                      "locator" : "151:10-151:47",
                      "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                      "templateId" : "PositiveMedicationOrder",
                      "codeProperty" : "code",
                      "type" : "Retrieve",
                      "codes" : {
                        "locator" : "151:32-151:46",
                        "name" : "Fosaprepitant",
                        "type" : "ValueSetRef"
                      }
                    },
                    "asTypeSpecifier" : {
                      "type" : "ListTypeSpecifier",
                      "elementType" : {
                        "type" : "ChoiceTypeSpecifier",
                        "choice" : [ {
                          "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                          "type" : "NamedTypeSpecifier"
                        }, {
                          "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                          "type" : "NamedTypeSpecifier"
                        } ]
                      }
                    }
                  } ]
                },
                "asTypeSpecifier" : {
                  "type" : "ListTypeSpecifier",
                  "elementType" : {
                    "type" : "ChoiceTypeSpecifier",
                    "choice" : [ {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                      "type" : "NamedTypeSpecifier"
                    }, {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                      "type" : "NamedTypeSpecifier"
                    } ]
                  }
                }
              }, {
                "type" : "As",
                "operand" : {
                  "localId" : "306",
                  "locator" : "152:10-152:44",
                  "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                  "templateId" : "PositiveMedicationOrder",
                  "codeProperty" : "code",
                  "type" : "Retrieve",
                  "codes" : {
                    "locator" : "152:32-152:43",
                    "name" : "Netupitant",
                    "type" : "ValueSetRef"
                  }
                },
                "asTypeSpecifier" : {
                  "type" : "ListTypeSpecifier",
                  "elementType" : {
                    "type" : "ChoiceTypeSpecifier",
                    "choice" : [ {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                      "type" : "NamedTypeSpecifier"
                    }, {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                      "type" : "NamedTypeSpecifier"
                    } ]
                  }
                }
              } ]
            }
          } ],
          "relationship" : [ {
            "localId" : "317",
            "locator" : "153:4-154:86",
            "alias" : "ComboChemo",
            "type" : "With",
            "expression" : {
              "localId" : "309",
              "locator" : "153:9-153:86",
              "name" : "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx",
              "type" : "ExpressionRef"
            },
            "suchThat" : {
              "localId" : "316",
              "locator" : "154:15-154:86",
              "type" : "Before",
              "operand" : [ {
                "locator" : "154:39-154:44",
                "type" : "Start",
                "operand" : {
                  "localId" : "312",
                  "locator" : "154:15-154:37",
                  "path" : "relevantPeriod",
                  "scope" : "MedAdmin",
                  "type" : "Property"
                }
              }, {
                "localId" : "315",
                "locator" : "154:53-154:86",
                "type" : "Start",
                "operand" : {
                  "localId" : "314",
                  "locator" : "154:62-154:86",
                  "path" : "relevantPeriod",
                  "scope" : "ComboChemo",
                  "type" : "Property"
                }
              } ]
            }
          } ]
        }
      }, {
        "localId" : "343",
        "locator" : "156:1-164:100",
        "name" : "Aprepitant, Fosaprepitant or Netupitant  administered or ordered within 7 days after Combo High Risk Chemo",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "343",
            "s" : [ {
              "value" : [ "define ", "\"Aprepitant, Fosaprepitant or Netupitant  administered or ordered within 7 days after Combo High Risk Chemo\"", ":\n  " ]
            }, {
              "r" : "342",
              "s" : [ {
                "s" : [ {
                  "r" : "331",
                  "s" : [ {
                    "r" : "330",
                    "s" : [ {
                      "value" : [ "( " ]
                    }, {
                      "r" : "330",
                      "s" : [ {
                        "r" : "328",
                        "s" : [ {
                          "r" : "326",
                          "s" : [ {
                            "r" : "324",
                            "s" : [ {
                              "r" : "322",
                              "s" : [ {
                                "r" : "320",
                                "s" : [ {
                                  "value" : [ "[", "\"Medication, Administered\"", ": " ]
                                }, {
                                  "s" : [ {
                                    "value" : [ "\"Aprepitant\"" ]
                                  } ]
                                }, {
                                  "value" : [ "]" ]
                                } ]
                              }, {
                                "value" : [ "\n  \tunion " ]
                              }, {
                                "r" : "321",
                                "s" : [ {
                                  "value" : [ "[", "\"Medication, Administered\"", ": " ]
                                }, {
                                  "s" : [ {
                                    "value" : [ "\"Fosaprepitant\"" ]
                                  } ]
                                }, {
                                  "value" : [ "]" ]
                                } ]
                              } ]
                            }, {
                              "value" : [ "\n  \tunion " ]
                            }, {
                              "r" : "323",
                              "s" : [ {
                                "value" : [ "[", "\"Medication, Administered\"", ": " ]
                              }, {
                                "s" : [ {
                                  "value" : [ "\"Netupitant\"" ]
                                } ]
                              }, {
                                "value" : [ "]" ]
                              } ]
                            } ]
                          }, {
                            "value" : [ "\n  \tunion " ]
                          }, {
                            "r" : "325",
                            "s" : [ {
                              "value" : [ "[", "\"Medication, Order\"", ": " ]
                            }, {
                              "s" : [ {
                                "value" : [ "\"Aprepitant\"" ]
                              } ]
                            }, {
                              "value" : [ "]" ]
                            } ]
                          } ]
                        }, {
                          "value" : [ "\n  \tunion " ]
                        }, {
                          "r" : "327",
                          "s" : [ {
                            "value" : [ "[", "\"Medication, Order\"", ": " ]
                          }, {
                            "s" : [ {
                              "value" : [ "\"Fosaprepitant\"" ]
                            } ]
                          }, {
                            "value" : [ "]" ]
                          } ]
                        } ]
                      }, {
                        "value" : [ "\n  \tunion " ]
                      }, {
                        "r" : "329",
                        "s" : [ {
                          "value" : [ "[", "\"Medication, Order\"", ": " ]
                        }, {
                          "s" : [ {
                            "value" : [ "\"Netupitant\"" ]
                          } ]
                        }, {
                          "value" : [ "]" ]
                        } ]
                      } ]
                    }, {
                      "value" : [ " )" ]
                    } ]
                  }, {
                    "value" : [ " ", "MedAdmin" ]
                  } ]
                } ]
              }, {
                "value" : [ "\n  \t" ]
              }, {
                "r" : "341",
                "s" : [ {
                  "value" : [ "with " ]
                }, {
                  "r" : "333",
                  "s" : [ {
                    "r" : "332",
                    "s" : [ {
                      "s" : [ {
                        "value" : [ "\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\"" ]
                      } ]
                    } ]
                  }, {
                    "value" : [ " ", "ComboChemo" ]
                  } ]
                }, {
                  "value" : [ "\n  \t\tsuch that " ]
                }, {
                  "r" : "340",
                  "s" : [ {
                    "r" : "335",
                    "s" : [ {
                      "r" : "334",
                      "s" : [ {
                        "value" : [ "MedAdmin" ]
                      } ]
                    }, {
                      "value" : [ "." ]
                    }, {
                      "r" : "335",
                      "s" : [ {
                        "value" : [ "relevantPeriod" ]
                      } ]
                    } ]
                  }, {
                    "value" : [ " " ]
                  }, {
                    "r" : "340",
                    "s" : [ {
                      "value" : [ "starts " ]
                    }, {
                      "r" : "339",
                      "s" : [ {
                        "value" : [ "7 ", "days" ]
                      } ]
                    }, {
                      "value" : [ " or less after" ]
                    } ]
                  }, {
                    "value" : [ " " ]
                  }, {
                    "r" : "338",
                    "s" : [ {
                      "value" : [ "start of " ]
                    }, {
                      "r" : "337",
                      "s" : [ {
                        "r" : "336",
                        "s" : [ {
                          "value" : [ "ComboChemo" ]
                        } ]
                      }, {
                        "value" : [ "." ]
                      }, {
                        "r" : "337",
                        "s" : [ {
                          "value" : [ "relevantPeriod" ]
                        } ]
                      } ]
                    } ]
                  } ]
                } ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "342",
          "locator" : "157:3-164:100",
          "type" : "Query",
          "source" : [ {
            "localId" : "331",
            "locator" : "157:3-162:55",
            "alias" : "MedAdmin",
            "expression" : {
              "localId" : "330",
              "locator" : "157:3-162:46",
              "type" : "Union",
              "operand" : [ {
                "type" : "As",
                "operand" : {
                  "localId" : "328",
                  "locator" : "157:5-161:47",
                  "type" : "Union",
                  "operand" : [ {
                    "type" : "As",
                    "operand" : {
                      "localId" : "326",
                      "locator" : "157:5-160:44",
                      "type" : "Union",
                      "operand" : [ {
                        "type" : "As",
                        "operand" : {
                          "localId" : "322",
                          "locator" : "157:5-158:54",
                          "type" : "Union",
                          "operand" : [ {
                            "localId" : "320",
                            "locator" : "157:5-157:46",
                            "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                            "templateId" : "PositiveMedicationAdministered",
                            "codeProperty" : "code",
                            "type" : "Retrieve",
                            "codes" : {
                              "locator" : "157:34-157:45",
                              "name" : "Aprepitant",
                              "type" : "ValueSetRef"
                            }
                          }, {
                            "localId" : "321",
                            "locator" : "158:10-158:54",
                            "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                            "templateId" : "PositiveMedicationAdministered",
                            "codeProperty" : "code",
                            "type" : "Retrieve",
                            "codes" : {
                              "locator" : "158:39-158:53",
                              "name" : "Fosaprepitant",
                              "type" : "ValueSetRef"
                            }
                          } ]
                        },
                        "asTypeSpecifier" : {
                          "type" : "ListTypeSpecifier",
                          "elementType" : {
                            "type" : "ChoiceTypeSpecifier",
                            "choice" : [ {
                              "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                              "type" : "NamedTypeSpecifier"
                            }, {
                              "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                              "type" : "NamedTypeSpecifier"
                            } ]
                          }
                        }
                      }, {
                        "type" : "As",
                        "operand" : {
                          "type" : "Union",
                          "operand" : [ {
                            "type" : "As",
                            "operand" : {
                              "localId" : "323",
                              "locator" : "159:10-159:51",
                              "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                              "templateId" : "PositiveMedicationAdministered",
                              "codeProperty" : "code",
                              "type" : "Retrieve",
                              "codes" : {
                                "locator" : "159:39-159:50",
                                "name" : "Netupitant",
                                "type" : "ValueSetRef"
                              }
                            },
                            "asTypeSpecifier" : {
                              "type" : "ListTypeSpecifier",
                              "elementType" : {
                                "type" : "ChoiceTypeSpecifier",
                                "choice" : [ {
                                  "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                                  "type" : "NamedTypeSpecifier"
                                }, {
                                  "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                                  "type" : "NamedTypeSpecifier"
                                } ]
                              }
                            }
                          }, {
                            "type" : "As",
                            "operand" : {
                              "localId" : "325",
                              "locator" : "160:10-160:44",
                              "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                              "templateId" : "PositiveMedicationOrder",
                              "codeProperty" : "code",
                              "type" : "Retrieve",
                              "codes" : {
                                "locator" : "160:32-160:43",
                                "name" : "Aprepitant",
                                "type" : "ValueSetRef"
                              }
                            },
                            "asTypeSpecifier" : {
                              "type" : "ListTypeSpecifier",
                              "elementType" : {
                                "type" : "ChoiceTypeSpecifier",
                                "choice" : [ {
                                  "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                                  "type" : "NamedTypeSpecifier"
                                }, {
                                  "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                                  "type" : "NamedTypeSpecifier"
                                } ]
                              }
                            }
                          } ]
                        },
                        "asTypeSpecifier" : {
                          "type" : "ListTypeSpecifier",
                          "elementType" : {
                            "type" : "ChoiceTypeSpecifier",
                            "choice" : [ {
                              "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                              "type" : "NamedTypeSpecifier"
                            }, {
                              "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                              "type" : "NamedTypeSpecifier"
                            } ]
                          }
                        }
                      } ]
                    },
                    "asTypeSpecifier" : {
                      "type" : "ListTypeSpecifier",
                      "elementType" : {
                        "type" : "ChoiceTypeSpecifier",
                        "choice" : [ {
                          "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                          "type" : "NamedTypeSpecifier"
                        }, {
                          "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                          "type" : "NamedTypeSpecifier"
                        } ]
                      }
                    }
                  }, {
                    "type" : "As",
                    "operand" : {
                      "localId" : "327",
                      "locator" : "161:10-161:47",
                      "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                      "templateId" : "PositiveMedicationOrder",
                      "codeProperty" : "code",
                      "type" : "Retrieve",
                      "codes" : {
                        "locator" : "161:32-161:46",
                        "name" : "Fosaprepitant",
                        "type" : "ValueSetRef"
                      }
                    },
                    "asTypeSpecifier" : {
                      "type" : "ListTypeSpecifier",
                      "elementType" : {
                        "type" : "ChoiceTypeSpecifier",
                        "choice" : [ {
                          "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                          "type" : "NamedTypeSpecifier"
                        }, {
                          "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                          "type" : "NamedTypeSpecifier"
                        } ]
                      }
                    }
                  } ]
                },
                "asTypeSpecifier" : {
                  "type" : "ListTypeSpecifier",
                  "elementType" : {
                    "type" : "ChoiceTypeSpecifier",
                    "choice" : [ {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                      "type" : "NamedTypeSpecifier"
                    }, {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                      "type" : "NamedTypeSpecifier"
                    } ]
                  }
                }
              }, {
                "type" : "As",
                "operand" : {
                  "localId" : "329",
                  "locator" : "162:10-162:44",
                  "dataType" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                  "templateId" : "PositiveMedicationOrder",
                  "codeProperty" : "code",
                  "type" : "Retrieve",
                  "codes" : {
                    "locator" : "162:32-162:43",
                    "name" : "Netupitant",
                    "type" : "ValueSetRef"
                  }
                },
                "asTypeSpecifier" : {
                  "type" : "ListTypeSpecifier",
                  "elementType" : {
                    "type" : "ChoiceTypeSpecifier",
                    "choice" : [ {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder",
                      "type" : "NamedTypeSpecifier"
                    }, {
                      "name" : "{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered",
                      "type" : "NamedTypeSpecifier"
                    } ]
                  }
                }
              } ]
            }
          } ],
          "relationship" : [ {
            "localId" : "341",
            "locator" : "163:4-164:100",
            "alias" : "ComboChemo",
            "type" : "With",
            "expression" : {
              "localId" : "332",
              "locator" : "163:9-163:86",
              "name" : "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx",
              "type" : "ExpressionRef"
            },
            "suchThat" : {
              "localId" : "340",
              "locator" : "164:15-164:100",
              "type" : "And",
              "operand" : [ {
                "locator" : "164:46-164:59",
                "type" : "In",
                "operand" : [ {
                  "locator" : "164:39-164:44",
                  "type" : "Start",
                  "operand" : {
                    "localId" : "335",
                    "locator" : "164:15-164:37",
                    "path" : "relevantPeriod",
                    "scope" : "MedAdmin",
                    "type" : "Property"
                  }
                }, {
                  "locator" : "164:46-164:59",
                  "lowClosed" : false,
                  "highClosed" : true,
                  "type" : "Interval",
                  "low" : {
                    "localId" : "338",
                    "locator" : "164:67-164:100",
                    "type" : "Start",
                    "operand" : {
                      "localId" : "337",
                      "locator" : "164:76-164:100",
                      "path" : "relevantPeriod",
                      "scope" : "ComboChemo",
                      "type" : "Property"
                    }
                  },
                  "high" : {
                    "locator" : "164:67-164:100",
                    "type" : "Add",
                    "operand" : [ {
                      "localId" : "338",
                      "locator" : "164:67-164:100",
                      "type" : "Start",
                      "operand" : {
                        "localId" : "337",
                        "locator" : "164:76-164:100",
                        "path" : "relevantPeriod",
                        "scope" : "ComboChemo",
                        "type" : "Property"
                      }
                    }, {
                      "localId" : "339",
                      "locator" : "164:46-164:51",
                      "value" : 7,
                      "unit" : "days",
                      "type" : "Quantity"
                    } ]
                  }
                } ]
              }, {
                "locator" : "164:46-164:59",
                "type" : "Not",
                "operand" : {
                  "locator" : "164:46-164:59",
                  "type" : "IsNull",
                  "operand" : {
                    "localId" : "338",
                    "locator" : "164:67-164:100",
                    "type" : "Start",
                    "operand" : {
                      "localId" : "337",
                      "locator" : "164:76-164:100",
                      "path" : "relevantPeriod",
                      "scope" : "ComboChemo",
                      "type" : "Property"
                    }
                  }
                }
              } ]
            }
          } ]
        }
      }, {
        "localId" : "373",
        "locator" : "166:1-182:4",
        "name" : "Numerator",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "373",
            "s" : [ {
              "value" : [ "define ", "\"Numerator\"", ":\n  " ]
            }, {
              "r" : "372",
              "s" : [ {
                "r" : "348",
                "s" : [ {
                  "r" : "345",
                  "s" : [ {
                    "value" : [ "exists " ]
                  }, {
                    "r" : "344",
                    "s" : [ {
                      "value" : [ "\"Clinical Trial Participant within 7 days after start of High Emetic Risk Combo Chemotherapy\"" ]
                    } ]
                  } ]
                }, {
                  "value" : [ "\n  \tor " ]
                }, {
                  "r" : "347",
                  "s" : [ {
                    "value" : [ "exists " ]
                  }, {
                    "r" : "346",
                    "s" : [ {
                      "value" : [ "\"Clinical Trial Participant before start of High Emetic Risk Combo Chemotherapy\"" ]
                    } ]
                  } ]
                } ]
              }, {
                "value" : [ "\n  \tor " ]
              }, {
                "r" : "371",
                "s" : [ {
                  "value" : [ "( " ]
                }, {
                  "r" : "371",
                  "s" : [ {
                    "r" : "359",
                    "s" : [ {
                      "r" : "353",
                      "s" : [ {
                        "value" : [ "( " ]
                      }, {
                        "r" : "353",
                        "s" : [ {
                          "r" : "350",
                          "s" : [ {
                            "value" : [ "exists " ]
                          }, {
                            "r" : "349",
                            "s" : [ {
                              "value" : [ "\"Dexamethasone administered or ordered within 7 days after Combo High Risk Chemo\"" ]
                            } ]
                          } ]
                        }, {
                          "value" : [ "\n  \t\t\t\tor " ]
                        }, {
                          "r" : "352",
                          "s" : [ {
                            "value" : [ "exists " ]
                          }, {
                            "r" : "351",
                            "s" : [ {
                              "value" : [ "\"Dexamethasone administered or ordered before Combo High Risk Chemo\"" ]
                            } ]
                          } ]
                        } ]
                      }, {
                        "value" : [ "\n  \t\t)" ]
                      } ]
                    }, {
                      "value" : [ "\n  \t\t\tand " ]
                    }, {
                      "r" : "358",
                      "s" : [ {
                        "value" : [ "( " ]
                      }, {
                        "r" : "358",
                        "s" : [ {
                          "r" : "355",
                          "s" : [ {
                            "value" : [ "exists " ]
                          }, {
                            "r" : "354",
                            "s" : [ {
                              "value" : [ "\"Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\"" ]
                            } ]
                          } ]
                        }, {
                          "value" : [ "\n  \t\t\t\t\tor " ]
                        }, {
                          "r" : "357",
                          "s" : [ {
                            "value" : [ "exists " ]
                          }, {
                            "r" : "356",
                            "s" : [ {
                              "value" : [ "\"Palonosetron administered or ordered before Combo High Risk Chemo\"" ]
                            } ]
                          } ]
                        } ]
                      }, {
                        "value" : [ "\n  \t\t\t)" ]
                      } ]
                    } ]
                  }, {
                    "value" : [ "\n  \t\t\tor " ]
                  }, {
                    "r" : "370",
                    "s" : [ {
                      "value" : [ "( " ]
                    }, {
                      "r" : "370",
                      "s" : [ {
                        "r" : "364",
                        "s" : [ {
                          "value" : [ "( " ]
                        }, {
                          "r" : "364",
                          "s" : [ {
                            "r" : "361",
                            "s" : [ {
                              "value" : [ "exists " ]
                            }, {
                              "r" : "360",
                              "s" : [ {
                                "value" : [ "\"Aprepitant, Fosaprepitant or Netupitant  administered or ordered within 7 days after Combo High Risk Chemo\"" ]
                              } ]
                            } ]
                          }, {
                            "value" : [ "\n  \t\t\t\t\t\tor " ]
                          }, {
                            "r" : "363",
                            "s" : [ {
                              "value" : [ "exists " ]
                            }, {
                              "r" : "362",
                              "s" : [ {
                                "value" : [ "\"Aprepitant, Fosaprepitant or Netupitant  administered or ordered before Combo High Risk Chemo\"" ]
                              } ]
                            } ]
                          } ]
                        }, {
                          "value" : [ "\n  \t\t\t\t)" ]
                        } ]
                      }, {
                        "value" : [ "\n  \t\t\t\t\tand " ]
                      }, {
                        "r" : "369",
                        "s" : [ {
                          "value" : [ "( " ]
                        }, {
                          "r" : "369",
                          "s" : [ {
                            "r" : "366",
                            "s" : [ {
                              "value" : [ "exists " ]
                            }, {
                              "r" : "365",
                              "s" : [ {
                                "value" : [ "\"First Gen Serotonin Antagonists or Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\"" ]
                              } ]
                            } ]
                          }, {
                            "value" : [ "\n  \t\t\t\t\t\t\tor " ]
                          }, {
                            "r" : "368",
                            "s" : [ {
                              "value" : [ "exists " ]
                            }, {
                              "r" : "367",
                              "s" : [ {
                                "value" : [ "\"First Gen Serotonin Antagonists or Palonosetron administered or ordered before Combo High Risk Chemo\"" ]
                              } ]
                            } ]
                          } ]
                        }, {
                          "value" : [ "\n  \t\t\t\t\t)" ]
                        } ]
                      } ]
                    }, {
                      "value" : [ "\n  \t\t\t)" ]
                    } ]
                  } ]
                }, {
                  "value" : [ "\n  \t)" ]
                } ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "372",
          "locator" : "167:3-182:4",
          "type" : "Or",
          "operand" : [ {
            "localId" : "348",
            "locator" : "167:3-168:93",
            "type" : "Or",
            "operand" : [ {
              "localId" : "345",
              "locator" : "167:3-167:102",
              "type" : "Exists",
              "operand" : {
                "localId" : "344",
                "locator" : "167:10-167:102",
                "name" : "Clinical Trial Participant within 7 days after start of High Emetic Risk Combo Chemotherapy",
                "type" : "ExpressionRef"
              }
            }, {
              "localId" : "347",
              "locator" : "168:7-168:93",
              "type" : "Exists",
              "operand" : {
                "localId" : "346",
                "locator" : "168:14-168:93",
                "name" : "Clinical Trial Participant before start of High Emetic Risk Combo Chemotherapy",
                "type" : "ExpressionRef"
              }
            } ]
          }, {
            "localId" : "371",
            "locator" : "169:7-182:4",
            "type" : "Or",
            "operand" : [ {
              "localId" : "359",
              "locator" : "169:9-174:6",
              "type" : "And",
              "operand" : [ {
                "localId" : "353",
                "locator" : "169:9-171:5",
                "type" : "Or",
                "operand" : [ {
                  "localId" : "350",
                  "locator" : "169:11-169:98",
                  "type" : "Exists",
                  "operand" : {
                    "localId" : "349",
                    "locator" : "169:18-169:98",
                    "name" : "Dexamethasone administered or ordered within 7 days after Combo High Risk Chemo",
                    "type" : "ExpressionRef"
                  }
                }, {
                  "localId" : "352",
                  "locator" : "170:10-170:84",
                  "type" : "Exists",
                  "operand" : {
                    "localId" : "351",
                    "locator" : "170:17-170:84",
                    "name" : "Dexamethasone administered or ordered before Combo High Risk Chemo",
                    "type" : "ExpressionRef"
                  }
                } ]
              }, {
                "localId" : "358",
                "locator" : "172:10-174:6",
                "type" : "Or",
                "operand" : [ {
                  "localId" : "355",
                  "locator" : "172:12-172:98",
                  "type" : "Exists",
                  "operand" : {
                    "localId" : "354",
                    "locator" : "172:19-172:98",
                    "name" : "Palonosetron administered or ordered within 7 days after Combo High Risk Chemo",
                    "type" : "ExpressionRef"
                  }
                }, {
                  "localId" : "357",
                  "locator" : "173:11-173:84",
                  "type" : "Exists",
                  "operand" : {
                    "localId" : "356",
                    "locator" : "173:18-173:84",
                    "name" : "Palonosetron administered or ordered before Combo High Risk Chemo",
                    "type" : "ExpressionRef"
                  }
                } ]
              } ]
            }, {
              "localId" : "370",
              "locator" : "175:9-181:6",
              "type" : "And",
              "operand" : [ {
                "localId" : "364",
                "locator" : "175:11-177:7",
                "type" : "Or",
                "operand" : [ {
                  "localId" : "361",
                  "locator" : "175:13-175:127",
                  "type" : "Exists",
                  "operand" : {
                    "localId" : "360",
                    "locator" : "175:20-175:127",
                    "name" : "Aprepitant, Fosaprepitant or Netupitant  administered or ordered within 7 days after Combo High Risk Chemo",
                    "type" : "ExpressionRef"
                  }
                }, {
                  "localId" : "363",
                  "locator" : "176:12-176:113",
                  "type" : "Exists",
                  "operand" : {
                    "localId" : "362",
                    "locator" : "176:19-176:113",
                    "name" : "Aprepitant, Fosaprepitant or Netupitant  administered or ordered before Combo High Risk Chemo",
                    "type" : "ExpressionRef"
                  }
                } ]
              }, {
                "localId" : "369",
                "locator" : "178:12-180:8",
                "type" : "Or",
                "operand" : [ {
                  "localId" : "366",
                  "locator" : "178:14-178:135",
                  "type" : "Exists",
                  "operand" : {
                    "localId" : "365",
                    "locator" : "178:21-178:135",
                    "name" : "First Gen Serotonin Antagonists or Palonosetron administered or ordered within 7 days after Combo High Risk Chemo",
                    "type" : "ExpressionRef"
                  }
                }, {
                  "localId" : "368",
                  "locator" : "179:13-179:121",
                  "type" : "Exists",
                  "operand" : {
                    "localId" : "367",
                    "locator" : "179:20-179:121",
                    "name" : "First Gen Serotonin Antagonists or Palonosetron administered or ordered before Combo High Risk Chemo",
                    "type" : "ExpressionRef"
                  }
                } ]
              } ]
            } ]
          } ]
        }
      }, {
        "localId" : "384",
        "locator" : "192:1-197:72",
        "name" : "Denominator",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "384",
            "s" : [ {
              "value" : [ "define ", "\"Denominator\"", ":\n  " ]
            }, {
              "r" : "383",
              "s" : [ {
                "r" : "380",
                "s" : [ {
                  "r" : "374",
                  "s" : [ {
                    "value" : [ "\"Initial Population\"" ]
                  } ]
                }, {
                  "value" : [ "\n  \tand " ]
                }, {
                  "r" : "379",
                  "s" : [ {
                    "value" : [ "( " ]
                  }, {
                    "r" : "379",
                    "s" : [ {
                      "r" : "376",
                      "s" : [ {
                        "value" : [ "exists " ]
                      }, {
                        "r" : "375",
                        "s" : [ {
                          "value" : [ "\"Cyclophosphamide Administered after First Cancer Dx\"" ]
                        } ]
                      } ]
                    }, {
                      "value" : [ "\n  \t\t\tand " ]
                    }, {
                      "r" : "378",
                      "s" : [ {
                        "value" : [ "exists " ]
                      }, {
                        "r" : "377",
                        "s" : [ {
                          "value" : [ "\"Specific Mod Risk Chemo Administered after First Cancer Dx\"" ]
                        } ]
                      } ]
                    } ]
                  }, {
                    "value" : [ "\n  \t)" ]
                  } ]
                } ]
              }, {
                "value" : [ "\n  \tor " ]
              }, {
                "r" : "382",
                "s" : [ {
                  "value" : [ "exists " ]
                }, {
                  "r" : "381",
                  "s" : [ {
                    "value" : [ "\"High Emetic Risk Chemo Administered after First Cancer Dx\"" ]
                  } ]
                } ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "383",
          "locator" : "193:3-197:72",
          "type" : "Or",
          "operand" : [ {
            "localId" : "380",
            "locator" : "193:3-196:4",
            "type" : "And",
            "operand" : [ {
              "localId" : "374",
              "locator" : "193:3-193:22",
              "name" : "Initial Population",
              "type" : "ExpressionRef"
            }, {
              "localId" : "379",
              "locator" : "194:8-196:4",
              "type" : "And",
              "operand" : [ {
                "localId" : "376",
                "locator" : "194:10-194:69",
                "type" : "Exists",
                "operand" : {
                  "localId" : "375",
                  "locator" : "194:17-194:69",
                  "name" : "Cyclophosphamide Administered after First Cancer Dx",
                  "type" : "ExpressionRef"
                }
              }, {
                "localId" : "378",
                "locator" : "195:10-195:76",
                "type" : "Exists",
                "operand" : {
                  "localId" : "377",
                  "locator" : "195:17-195:76",
                  "name" : "Specific Mod Risk Chemo Administered after First Cancer Dx",
                  "type" : "ExpressionRef"
                }
              } ]
            } ]
          }, {
            "localId" : "382",
            "locator" : "197:7-197:72",
            "type" : "Exists",
            "operand" : {
              "localId" : "381",
              "locator" : "197:14-197:72",
              "name" : "High Emetic Risk Chemo Administered after First Cancer Dx",
              "type" : "ExpressionRef"
            }
          } ]
        }
      }, {
        "localId" : "386",
        "locator" : "199:1-200:6",
        "name" : "Actionability",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "386",
            "s" : [ {
              "r" : "385",
              "value" : [ "define ", "\"Actionability\"", ":\n  ", "true" ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "385",
          "locator" : "200:3-200:6",
          "valueType" : "{urn:hl7-org:elm-types:r1}Boolean",
          "value" : "true",
          "type" : "Literal"
        }
      }, {
        "localId" : "391",
        "locator" : "202:1-203:106",
        "name" : "Actionability Start Date",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "391",
            "s" : [ {
              "value" : [ "define ", "\"Actionability Start Date\"", ":\n  " ]
            }, {
              "r" : "390",
              "s" : [ {
                "value" : [ "First", "(" ]
              }, {
                "r" : "389",
                "s" : [ {
                  "r" : "388",
                  "s" : [ {
                    "r" : "387",
                    "s" : [ {
                      "value" : [ "\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\"" ]
                    } ]
                  }, {
                    "value" : [ "." ]
                  }, {
                    "r" : "388",
                    "s" : [ {
                      "value" : [ "relevantPeriod" ]
                    } ]
                  } ]
                }, {
                  "value" : [ "." ]
                }, {
                  "r" : "389",
                  "s" : [ {
                    "value" : [ "low" ]
                  } ]
                } ]
              }, {
                "value" : [ ")" ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "390",
          "locator" : "203:3-203:106",
          "type" : "First",
          "source" : {
            "localId" : "389",
            "locator" : "203:9-203:105",
            "type" : "Query",
            "source" : [ {
              "alias" : "$this",
              "expression" : {
                "localId" : "388",
                "locator" : "203:9-203:101",
                "type" : "Query",
                "source" : [ {
                  "alias" : "$this",
                  "expression" : {
                    "localId" : "387",
                    "locator" : "203:9-203:86",
                    "name" : "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx",
                    "type" : "ExpressionRef"
                  }
                } ],
                "where" : {
                  "type" : "Not",
                  "operand" : {
                    "type" : "IsNull",
                    "operand" : {
                      "path" : "relevantPeriod",
                      "type" : "Property",
                      "source" : {
                        "name" : "$this",
                        "type" : "AliasRef"
                      }
                    }
                  }
                },
                "return" : {
                  "expression" : {
                    "path" : "relevantPeriod",
                    "type" : "Property",
                    "source" : {
                      "name" : "$this",
                      "type" : "AliasRef"
                    }
                  }
                }
              }
            } ],
            "where" : {
              "type" : "Not",
              "operand" : {
                "type" : "IsNull",
                "operand" : {
                  "path" : "low",
                  "type" : "Property",
                  "source" : {
                    "name" : "$this",
                    "type" : "AliasRef"
                  }
                }
              }
            },
            "return" : {
              "expression" : {
                "path" : "low",
                "type" : "Property",
                "source" : {
                  "name" : "$this",
                  "type" : "AliasRef"
                }
              }
            }
          }
        }
      }, {
        "localId" : "395",
        "locator" : "205:1-206:37",
        "name" : "Actionability End Date",
        "context" : "Patient",
        "accessLevel" : "Public",
        "annotation" : [ {
          "type" : "Annotation",
          "s" : {
            "r" : "395",
            "s" : [ {
              "value" : [ "define ", "\"Actionability End Date\"", ":\n  " ]
            }, {
              "r" : "394",
              "s" : [ {
                "r" : "392",
                "s" : [ {
                  "value" : [ "\"Actionability Start Date\"" ]
                } ]
              }, {
                "value" : [ " + " ]
              }, {
                "r" : "393",
                "s" : [ {
                  "value" : [ "7 ", "days" ]
                } ]
              } ]
            } ]
          }
        } ],
        "expression" : {
          "localId" : "394",
          "locator" : "206:3-206:37",
          "type" : "Add",
          "operand" : [ {
            "localId" : "392",
            "locator" : "206:3-206:28",
            "name" : "Actionability Start Date",
            "type" : "ExpressionRef"
          }, {
            "localId" : "393",
            "locator" : "206:32-206:37",
            "value" : 7,
            "unit" : "days",
            "type" : "Quantity"
          } ]
        }
      } ]
    }
  }
}\"\n    },\n    {\n      \"contentType\": \"text/cql\",\n      \"data\": \"library JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk version '1.0.000'

using QDM version '5.4'

codesystem "LOINC": 'urn:oid:2.16.840.1.113883.6.1' 
codesystem "SNOMEDCT": 'urn:oid:2.16.840.1.113883.6.96' 

valueset "Aprepitant": 'urn:oid:2.16.840.1.113762.1.4.1116.222' 
valueset "Cancer": 'urn:oid:2.16.840.1.113762.1.4.1116.231' 
valueset "Clinical Trial Participant": 'urn:oid:2.16.840.1.113762.1.4.1116.150' 
valueset "Cyclophosphamide": 'urn:oid:2.16.840.1.113762.1.4.1116.167' 
valueset "Daunorubicin": 'urn:oid:2.16.840.1.113762.1.4.1116.332' 
valueset "Dexamethasone": 'urn:oid:2.16.840.1.113762.1.4.1116.80' 
valueset "Doxorubicin": 'urn:oid:2.16.840.1.113762.1.4.1116.168' 
valueset "Epirubicin": 'urn:oid:2.16.840.1.113762.1.4.1116.200' 
valueset "Ethnicity": 'urn:oid:2.16.840.1.114222.4.11.837' 
valueset "First Generation Serotonin Antagonists": 'urn:oid:2.16.840.1.113762.1.4.1116.82' 
valueset "Fosaprepitant": 'urn:oid:2.16.840.1.113762.1.4.1116.223' 
valueset "High Emetigenic Risk Chemotherapy": 'urn:oid:2.16.840.1.113762.1.4.1116.331' 
valueset "Idarubicin": 'urn:oid:2.16.840.1.113762.1.4.1116.199' 
valueset "Medical Reason": 'urn:oid:2.16.840.1.113883.3.526.2.313' 
valueset "NEPA Netupitant Palonosetron": 'urn:oid:2.16.840.1.113762.1.4.1116.334' 
valueset "Netupitant": 'urn:oid:2.16.840.1.113762.1.4.1116.335' 
valueset "Office Visit": 'urn:oid:2.16.840.1.113883.3.464.1003.101.11.1005' 
valueset "ONC Administrative Sex": 'urn:oid:2.16.840.1.113762.1.4.1' 
valueset "Palonosetron": 'urn:oid:2.16.840.1.113762.1.4.1116.81' 
valueset "Patient Provider Interaction": 'urn:oid:2.16.840.1.113883.3.526.3.1012' 
valueset "Patient Reason": 'urn:oid:2.16.840.1.113883.3.526.2.311' 
valueset "Payer": 'urn:oid:2.16.840.1.114222.4.11.3591' 
valueset "Race": 'urn:oid:2.16.840.1.114222.4.11.836' 
valueset "System Reason": 'urn:oid:2.16.840.1.113883.3.526.2.310' 

code "Birthdate": '21112-8' from "LOINC" display 'Birthdate'
code "Dead": '419099009' from "SNOMEDCT" display 'Dead'

parameter "Measurement Period" Interval<DateTime>

context Patient

define "SDE Ethnicity":
  ["Patient Characteristic Ethnicity": "Ethnicity"]

define "SDE Payer":
  ["Patient Characteristic Payer": "Payer"]

define "SDE Race":
  ["Patient Characteristic Race": "Race"]

define "SDE Sex":
  ["Patient Characteristic Sex": "ONC Administrative Sex"]

define "Office Visits":
  ( ["Encounter, Performed": "Office Visit"]
  	union ["Encounter, Performed": "Patient Provider Interaction"] ) Enc
  	where Enc.relevantPeriod starts during "Measurement Period"

define "Cyclophosphamide Administered after First Cancer Dx":
  ["Medication, Administered": "Cyclophosphamide"] MedAdmin
  	with "First Cancer Dx" Dx
  		such that MedAdmin.relevantPeriod starts after start of Dx.prevalencePeriod

define "Initial Population":
  Count("Office Visits")>= 2
  	and "First Cancer Dx" is not null

define "High Emetic Risk Chemo Administered after First Cancer Dx":
  ["Medication, Administered": "High Emetigenic Risk Chemotherapy"] MedAdmin
  	with "First Cancer Dx" Dx
  		such that MedAdmin.relevantPeriod starts after start of Dx.prevalencePeriod

define "Specific Mod Risk Chemo Administered after First Cancer Dx":
  ( ["Medication, Administered": "Doxorubicin"]
  	union ["Medication, Administered": "Epirubicin"]
  	union ["Medication, Administered": "Idarubicin"]
  	union ["Medication, Administered": "Daunorubicin"] ) MedAdmin
  	with "First Cancer Dx" Dx
  		such that MedAdmin.relevantPeriod starts after start of Dx.prevalencePeriod

define "Clinical Trial Participant before start of High Emetic Risk Combo Chemotherapy":
  ( ["Care Goal": "Clinical Trial Participant"] ) Trial
  	with "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx" ComboChemo
  		such that Trial.relevantPeriod starts before start of ComboChemo.relevantPeriod

define "Clinical Trial Participant within 7 days after start of High Emetic Risk Combo Chemotherapy":
  ( ["Care Goal": "Clinical Trial Participant"] ) Trial
  	with "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx" ComboChemo
  		such that Trial.relevantPeriod starts 7 days or less after start of ComboChemo.relevantPeriod

define "Dexamethasone administered or ordered within 7 days after Combo High Risk Chemo":
  ( ["Medication, Administered": "Dexamethasone"]
  	union ["Medication, Order": "Dexamethasone"] ) MedAdmin
  	with "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx" ComboChemo
  		such that MedAdmin.relevantPeriod starts 7 days or less after start of ComboChemo.relevantPeriod

define "Dexamethasone administered or ordered before Combo High Risk Chemo":
  ( ["Medication, Administered": "Dexamethasone"]
  	union ["Medication, Order": "Dexamethasone"] ) MedAdmin
  	with "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx" ComboChemo
  		such that MedAdmin.relevantPeriod starts before start of ComboChemo.relevantPeriod

define "Palonosetron administered or ordered before Combo High Risk Chemo":
  ( ["Medication, Administered": "NEPA Netupitant Palonosetron"]
  	union ["Medication, Order": "NEPA Netupitant Palonosetron"] ) MedAdmin
  	with "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx" ComboChemo
  		such that MedAdmin.relevantPeriod starts before start of ComboChemo.relevantPeriod

define "Palonosetron administered or ordered within 7 days after Combo High Risk Chemo":
  ( ["Medication, Administered": "NEPA Netupitant Palonosetron"]
  	union ["Medication, Order": "NEPA Netupitant Palonosetron"] ) MedAdmin
  	with "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx" ComboChemo
  		such that MedAdmin.relevantPeriod starts 7 days or less after start of ComboChemo.relevantPeriod

define "First Gen Serotonin Antagonists or Palonosetron administered or ordered within 7 days after Combo High Risk Chemo":
  ( ["Medication, Administered": "First Generation Serotonin Antagonists"]
  	union ["Medication, Administered": "Palonosetron"]
  	union ["Medication, Order": "First Generation Serotonin Antagonists"]
  	union ["Medication, Order": "Palonosetron"] ) MedAdmin
  	with "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx" ComboChemo
  		such that MedAdmin.relevantPeriod starts 7 days or less after start of ComboChemo.relevantPeriod

define "First Gen Serotonin Antagonists or Palonosetron administered or ordered before Combo High Risk Chemo":
  ( ["Medication, Administered": "First Generation Serotonin Antagonists"]
  	union ["Medication, Administered": "Palonosetron"]
  	union ["Medication, Order": "First Generation Serotonin Antagonists"]
  	union ["Medication, Order": "Palonosetron"] ) MedAdmin
  	with "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx" ComboChemo
  		such that MedAdmin.relevantPeriod starts before start of ComboChemo.relevantPeriod

define "Denominator Exceptions":
  exists "Reasons for Not prescribing or Ordering First Gen Serotonin Antagonists, Aprepitant, Fosprepitant or Netupitant"

define "Reasons for Not prescribing or Ordering First Gen Serotonin Antagonists, Aprepitant, Fosprepitant or Netupitant":
  ( ["Medication, Administered": "First Generation Serotonin Antagonists"]
  	union ["Medication, Administered": "Aprepitant"]
  	union ["Medication, Administered": "Fosaprepitant"]
  	union ["Medication, Administered": "Netupitant"]
  	union ["Medication, Order": "First Generation Serotonin Antagonists"]
  	union ["Medication, Order": "Aprepitant"]
  	union ["Medication, Order": "Fosaprepitant"]
  	union ["Medication, Order": "Netupitant"] ) MedNotOrdered
  	where MedNotOrdered.negationRationale in "Medical Reason"
  		or MedNotOrdered.negationRationale in "Patient Reason"
  		or MedNotOrdered.negationRationale in "System Reason"
  			and MedNotOrdered.relevantPeriod starts during "Measurement Period"

define "Aprepitant, Fosaprepitant or Netupitant  administered or ordered before Combo High Risk Chemo":
  ( ["Medication, Administered": "Aprepitant"]
  	union ["Medication, Administered": "Fosaprepitant"]
  	union ["Medication, Administered": "Netupitant"]
  	union ["Medication, Order": "Aprepitant"]
  	union ["Medication, Order": "Fosaprepitant"]
  	union ["Medication, Order": "Netupitant"] ) MedAdmin
  	with "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx" ComboChemo
  		such that MedAdmin.relevantPeriod starts before start of ComboChemo.relevantPeriod

define "Aprepitant, Fosaprepitant or Netupitant  administered or ordered within 7 days after Combo High Risk Chemo":
  ( ["Medication, Administered": "Aprepitant"]
  	union ["Medication, Administered": "Fosaprepitant"]
  	union ["Medication, Administered": "Netupitant"]
  	union ["Medication, Order": "Aprepitant"]
  	union ["Medication, Order": "Fosaprepitant"]
  	union ["Medication, Order": "Netupitant"] ) MedAdmin
  	with "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx" ComboChemo
  		such that MedAdmin.relevantPeriod starts 7 days or less after start of ComboChemo.relevantPeriod

define "Numerator":
  exists "Clinical Trial Participant within 7 days after start of High Emetic Risk Combo Chemotherapy"
  	or exists "Clinical Trial Participant before start of High Emetic Risk Combo Chemotherapy"
  	or ( ( exists "Dexamethasone administered or ordered within 7 days after Combo High Risk Chemo"
  				or exists "Dexamethasone administered or ordered before Combo High Risk Chemo"
  		)
  			and ( exists "Palonosetron administered or ordered within 7 days after Combo High Risk Chemo"
  					or exists "Palonosetron administered or ordered before Combo High Risk Chemo"
  			)
  			or ( ( exists "Aprepitant, Fosaprepitant or Netupitant  administered or ordered within 7 days after Combo High Risk Chemo"
  						or exists "Aprepitant, Fosaprepitant or Netupitant  administered or ordered before Combo High Risk Chemo"
  				)
  					and ( exists "First Gen Serotonin Antagonists or Palonosetron administered or ordered within 7 days after Combo High Risk Chemo"
  							or exists "First Gen Serotonin Antagonists or Palonosetron administered or ordered before Combo High Risk Chemo"
  					)
  			)
  	)

define "Combination High Emetic Risk Chemotherapy administered after First Cancer Dx":
  "High Risk Cyclophosphamide Administered after First Cancer Dx"
  	union "High Emetic Risk Chemo Administered after First Cancer Dx"

define "High Risk Cyclophosphamide Administered after First Cancer Dx":
  "Cyclophosphamide Administered after First Cancer Dx"
  	union "Specific Mod Risk Chemo Administered after First Cancer Dx"

define "Denominator":
  "Initial Population"
  	and ( exists "Cyclophosphamide Administered after First Cancer Dx"
  			and exists "Specific Mod Risk Chemo Administered after First Cancer Dx"
  	)
  	or exists "High Emetic Risk Chemo Administered after First Cancer Dx"

define "Actionability":
  true

define "Actionability Start Date":
  First("Combination High Emetic Risk Chemotherapy administered after First Cancer Dx".relevantPeriod.low)

define "Actionability End Date":
  "Actionability Start Date" + 7 days

define "First Cancer Dx":
  First(((["Diagnosis": "Cancer"])Dx
  		where Dx.prevalencePeriod starts during "Measurement Period")DD
  		sort by start of prevalencePeriod
  )

\"\n    }\n  ]\n}",
      "libraryFhirValidationResults": [],
      "cqlConversionResult": {
        "type": null,
        "result": false,
        "errors": [
          "CQl-Fhir conversion produced 161 cqlConversionErrors errors.",
          "CQl-Fir conversion produced 47 matCqlConversionExceptions (errorExceptions) errors."
        ],
        "cql": "library JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk version '1.0.000'\n\nusing QDM version '5.4'\n\ncodesystem \"LOINC\": 'urn:oid:2.16.840.1.113883.6.1' \ncodesystem \"SNOMEDCT\": 'urn:oid:2.16.840.1.113883.6.96' \n\nvalueset \"Aprepitant\": 'urn:oid:2.16.840.1.113762.1.4.1116.222' \nvalueset \"Cancer\": 'urn:oid:2.16.840.1.113762.1.4.1116.231' \nvalueset \"Clinical Trial Participant\": 'urn:oid:2.16.840.1.113762.1.4.1116.150' \nvalueset \"Cyclophosphamide\": 'urn:oid:2.16.840.1.113762.1.4.1116.167' \nvalueset \"Daunorubicin\": 'urn:oid:2.16.840.1.113762.1.4.1116.332' \nvalueset \"Dexamethasone\": 'urn:oid:2.16.840.1.113762.1.4.1116.80' \nvalueset \"Doxorubicin\": 'urn:oid:2.16.840.1.113762.1.4.1116.168' \nvalueset \"Epirubicin\": 'urn:oid:2.16.840.1.113762.1.4.1116.200' \nvalueset \"Ethnicity\": 'urn:oid:2.16.840.1.114222.4.11.837' \nvalueset \"First Generation Serotonin Antagonists\": 'urn:oid:2.16.840.1.113762.1.4.1116.82' \nvalueset \"Fosaprepitant\": 'urn:oid:2.16.840.1.113762.1.4.1116.223' \nvalueset \"High Emetigenic Risk Chemotherapy\": 'urn:oid:2.16.840.1.113762.1.4.1116.331' \nvalueset \"Idarubicin\": 'urn:oid:2.16.840.1.113762.1.4.1116.199' \nvalueset \"Medical Reason\": 'urn:oid:2.16.840.1.113883.3.526.2.313' \nvalueset \"NEPA Netupitant Palonosetron\": 'urn:oid:2.16.840.1.113762.1.4.1116.334' \nvalueset \"Netupitant\": 'urn:oid:2.16.840.1.113762.1.4.1116.335' \nvalueset \"Office Visit\": 'urn:oid:2.16.840.1.113883.3.464.1003.101.11.1005' \nvalueset \"ONC Administrative Sex\": 'urn:oid:2.16.840.1.113762.1.4.1' \nvalueset \"Palonosetron\": 'urn:oid:2.16.840.1.113762.1.4.1116.81' \nvalueset \"Patient Provider Interaction\": 'urn:oid:2.16.840.1.113883.3.526.3.1012' \nvalueset \"Patient Reason\": 'urn:oid:2.16.840.1.113883.3.526.2.311' \nvalueset \"Payer\": 'urn:oid:2.16.840.1.114222.4.11.3591' \nvalueset \"Race\": 'urn:oid:2.16.840.1.114222.4.11.836' \nvalueset \"System Reason\": 'urn:oid:2.16.840.1.113883.3.526.2.310' \n\ncode \"Birthdate\": '21112-8' from \"LOINC\" display 'Birthdate'\ncode \"Dead\": '419099009' from \"SNOMEDCT\" display 'Dead'\n\nparameter \"Measurement Period\" Interval<DateTime>\n\ncontext Patient\n\ndefine \"SDE Ethnicity\":\n  [\"Patient Characteristic Ethnicity\": \"Ethnicity\"]\n\ndefine \"SDE Payer\":\n  [\"Patient Characteristic Payer\": \"Payer\"]\n\ndefine \"SDE Race\":\n  [\"Patient Characteristic Race\": \"Race\"]\n\ndefine \"SDE Sex\":\n  [\"Patient Characteristic Sex\": \"ONC Administrative Sex\"]\n\ndefine \"Office Visits\":\n  ( [\"Encounter, Performed\": \"Office Visit\"]\n  \tunion [\"Encounter, Performed\": \"Patient Provider Interaction\"] ) Enc\n  \twhere Enc.relevantPeriod starts during \"Measurement Period\"\n\ndefine \"Cyclophosphamide Administered after First Cancer Dx\":\n  [\"Medication, Administered\": \"Cyclophosphamide\"] MedAdmin\n  \twith \"First Cancer Dx\" Dx\n  \t\tsuch that MedAdmin.relevantPeriod starts after start of Dx.prevalencePeriod\n\ndefine \"Initial Population\":\n  Count(\"Office Visits\")>= 2\n  \tand \"First Cancer Dx\" is not null\n\ndefine \"High Emetic Risk Chemo Administered after First Cancer Dx\":\n  [\"Medication, Administered\": \"High Emetigenic Risk Chemotherapy\"] MedAdmin\n  \twith \"First Cancer Dx\" Dx\n  \t\tsuch that MedAdmin.relevantPeriod starts after start of Dx.prevalencePeriod\n\ndefine \"Specific Mod Risk Chemo Administered after First Cancer Dx\":\n  ( [\"Medication, Administered\": \"Doxorubicin\"]\n  \tunion [\"Medication, Administered\": \"Epirubicin\"]\n  \tunion [\"Medication, Administered\": \"Idarubicin\"]\n  \tunion [\"Medication, Administered\": \"Daunorubicin\"] ) MedAdmin\n  \twith \"First Cancer Dx\" Dx\n  \t\tsuch that MedAdmin.relevantPeriod starts after start of Dx.prevalencePeriod\n\ndefine \"Clinical Trial Participant before start of High Emetic Risk Combo Chemotherapy\":\n  ( [\"Care Goal\": \"Clinical Trial Participant\"] ) Trial\n  \twith \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\" ComboChemo\n  \t\tsuch that Trial.relevantPeriod starts before start of ComboChemo.relevantPeriod\n\ndefine \"Clinical Trial Participant within 7 days after start of High Emetic Risk Combo Chemotherapy\":\n  ( [\"Care Goal\": \"Clinical Trial Participant\"] ) Trial\n  \twith \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\" ComboChemo\n  \t\tsuch that Trial.relevantPeriod starts 7 days or less after start of ComboChemo.relevantPeriod\n\ndefine \"Dexamethasone administered or ordered within 7 days after Combo High Risk Chemo\":\n  ( [\"Medication, Administered\": \"Dexamethasone\"]\n  \tunion [\"Medication, Order\": \"Dexamethasone\"] ) MedAdmin\n  \twith \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\" ComboChemo\n  \t\tsuch that MedAdmin.relevantPeriod starts 7 days or less after start of ComboChemo.relevantPeriod\n\ndefine \"Dexamethasone administered or ordered before Combo High Risk Chemo\":\n  ( [\"Medication, Administered\": \"Dexamethasone\"]\n  \tunion [\"Medication, Order\": \"Dexamethasone\"] ) MedAdmin\n  \twith \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\" ComboChemo\n  \t\tsuch that MedAdmin.relevantPeriod starts before start of ComboChemo.relevantPeriod\n\ndefine \"Palonosetron administered or ordered before Combo High Risk Chemo\":\n  ( [\"Medication, Administered\": \"NEPA Netupitant Palonosetron\"]\n  \tunion [\"Medication, Order\": \"NEPA Netupitant Palonosetron\"] ) MedAdmin\n  \twith \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\" ComboChemo\n  \t\tsuch that MedAdmin.relevantPeriod starts before start of ComboChemo.relevantPeriod\n\ndefine \"Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\":\n  ( [\"Medication, Administered\": \"NEPA Netupitant Palonosetron\"]\n  \tunion [\"Medication, Order\": \"NEPA Netupitant Palonosetron\"] ) MedAdmin\n  \twith \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\" ComboChemo\n  \t\tsuch that MedAdmin.relevantPeriod starts 7 days or less after start of ComboChemo.relevantPeriod\n\ndefine \"First Gen Serotonin Antagonists or Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\":\n  ( [\"Medication, Administered\": \"First Generation Serotonin Antagonists\"]\n  \tunion [\"Medication, Administered\": \"Palonosetron\"]\n  \tunion [\"Medication, Order\": \"First Generation Serotonin Antagonists\"]\n  \tunion [\"Medication, Order\": \"Palonosetron\"] ) MedAdmin\n  \twith \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\" ComboChemo\n  \t\tsuch that MedAdmin.relevantPeriod starts 7 days or less after start of ComboChemo.relevantPeriod\n\ndefine \"First Gen Serotonin Antagonists or Palonosetron administered or ordered before Combo High Risk Chemo\":\n  ( [\"Medication, Administered\": \"First Generation Serotonin Antagonists\"]\n  \tunion [\"Medication, Administered\": \"Palonosetron\"]\n  \tunion [\"Medication, Order\": \"First Generation Serotonin Antagonists\"]\n  \tunion [\"Medication, Order\": \"Palonosetron\"] ) MedAdmin\n  \twith \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\" ComboChemo\n  \t\tsuch that MedAdmin.relevantPeriod starts before start of ComboChemo.relevantPeriod\n\ndefine \"Denominator Exceptions\":\n  exists \"Reasons for Not prescribing or Ordering First Gen Serotonin Antagonists, Aprepitant, Fosprepitant or Netupitant\"\n\ndefine \"Reasons for Not prescribing or Ordering First Gen Serotonin Antagonists, Aprepitant, Fosprepitant or Netupitant\":\n  ( [\"Medication, Administered\": \"First Generation Serotonin Antagonists\"]\n  \tunion [\"Medication, Administered\": \"Aprepitant\"]\n  \tunion [\"Medication, Administered\": \"Fosaprepitant\"]\n  \tunion [\"Medication, Administered\": \"Netupitant\"]\n  \tunion [\"Medication, Order\": \"First Generation Serotonin Antagonists\"]\n  \tunion [\"Medication, Order\": \"Aprepitant\"]\n  \tunion [\"Medication, Order\": \"Fosaprepitant\"]\n  \tunion [\"Medication, Order\": \"Netupitant\"] ) MedNotOrdered\n  \twhere MedNotOrdered.negationRationale in \"Medical Reason\"\n  \t\tor MedNotOrdered.negationRationale in \"Patient Reason\"\n  \t\tor MedNotOrdered.negationRationale in \"System Reason\"\n  \t\t\tand MedNotOrdered.relevantPeriod starts during \"Measurement Period\"\n\ndefine \"Aprepitant, Fosaprepitant or Netupitant  administered or ordered before Combo High Risk Chemo\":\n  ( [\"Medication, Administered\": \"Aprepitant\"]\n  \tunion [\"Medication, Administered\": \"Fosaprepitant\"]\n  \tunion [\"Medication, Administered\": \"Netupitant\"]\n  \tunion [\"Medication, Order\": \"Aprepitant\"]\n  \tunion [\"Medication, Order\": \"Fosaprepitant\"]\n  \tunion [\"Medication, Order\": \"Netupitant\"] ) MedAdmin\n  \twith \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\" ComboChemo\n  \t\tsuch that MedAdmin.relevantPeriod starts before start of ComboChemo.relevantPeriod\n\ndefine \"Aprepitant, Fosaprepitant or Netupitant  administered or ordered within 7 days after Combo High Risk Chemo\":\n  ( [\"Medication, Administered\": \"Aprepitant\"]\n  \tunion [\"Medication, Administered\": \"Fosaprepitant\"]\n  \tunion [\"Medication, Administered\": \"Netupitant\"]\n  \tunion [\"Medication, Order\": \"Aprepitant\"]\n  \tunion [\"Medication, Order\": \"Fosaprepitant\"]\n  \tunion [\"Medication, Order\": \"Netupitant\"] ) MedAdmin\n  \twith \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\" ComboChemo\n  \t\tsuch that MedAdmin.relevantPeriod starts 7 days or less after start of ComboChemo.relevantPeriod\n\ndefine \"Numerator\":\n  exists \"Clinical Trial Participant within 7 days after start of High Emetic Risk Combo Chemotherapy\"\n  \tor exists \"Clinical Trial Participant before start of High Emetic Risk Combo Chemotherapy\"\n  \tor ( ( exists \"Dexamethasone administered or ordered within 7 days after Combo High Risk Chemo\"\n  \t\t\t\tor exists \"Dexamethasone administered or ordered before Combo High Risk Chemo\"\n  \t\t)\n  \t\t\tand ( exists \"Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\"\n  \t\t\t\t\tor exists \"Palonosetron administered or ordered before Combo High Risk Chemo\"\n  \t\t\t)\n  \t\t\tor ( ( exists \"Aprepitant, Fosaprepitant or Netupitant  administered or ordered within 7 days after Combo High Risk Chemo\"\n  \t\t\t\t\t\tor exists \"Aprepitant, Fosaprepitant or Netupitant  administered or ordered before Combo High Risk Chemo\"\n  \t\t\t\t)\n  \t\t\t\t\tand ( exists \"First Gen Serotonin Antagonists or Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\"\n  \t\t\t\t\t\t\tor exists \"First Gen Serotonin Antagonists or Palonosetron administered or ordered before Combo High Risk Chemo\"\n  \t\t\t\t\t)\n  \t\t\t)\n  \t)\n\ndefine \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\":\n  \"High Risk Cyclophosphamide Administered after First Cancer Dx\"\n  \tunion \"High Emetic Risk Chemo Administered after First Cancer Dx\"\n\ndefine \"High Risk Cyclophosphamide Administered after First Cancer Dx\":\n  \"Cyclophosphamide Administered after First Cancer Dx\"\n  \tunion \"Specific Mod Risk Chemo Administered after First Cancer Dx\"\n\ndefine \"Denominator\":\n  \"Initial Population\"\n  \tand ( exists \"Cyclophosphamide Administered after First Cancer Dx\"\n  \t\t\tand exists \"Specific Mod Risk Chemo Administered after First Cancer Dx\"\n  \t)\n  \tor exists \"High Emetic Risk Chemo Administered after First Cancer Dx\"\n\ndefine \"Actionability\":\n  true\n\ndefine \"Actionability Start Date\":\n  First(\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\".relevantPeriod.low)\n\ndefine \"Actionability End Date\":\n  \"Actionability Start Date\" + 7 days\n\ndefine \"First Cancer Dx\":\n  First((([\"Diagnosis\": \"Cancer\"])Dx\n  \t\twhere Dx.prevalencePeriod starts during \"Measurement Period\")DD\n  \t\tsort by start of prevalencePeriod\n  )\n\n",
        "elm": "{\n  \"library\" : {\n    \"identifier\" : {\n      \"id\" : \"JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk\",\n      \"version\" : \"1.0.000\"\n    },\n    \"schemaIdentifier\" : {\n      \"id\" : \"urn:hl7-org:elm\",\n      \"version\" : \"r1\"\n    },\n    \"usings\" : {\n      \"def\" : [ {\n        \"localIdentifier\" : \"System\",\n        \"uri\" : \"urn:hl7-org:elm-types:r1\"\n      }, {\n        \"localId\" : \"1\",\n        \"locator\" : \"3:1-3:23\",\n        \"localIdentifier\" : \"QDM\",\n        \"uri\" : \"urn:healthit-gov:qdm:v5_4\",\n        \"version\" : \"5.4\"\n      } ]\n    },\n    \"parameters\" : {\n      \"def\" : [ {\n        \"localId\" : \"34\",\n        \"locator\" : \"36:1-36:49\",\n        \"name\" : \"Measurement Period\",\n        \"accessLevel\" : \"Public\",\n        \"parameterTypeSpecifier\" : {\n          \"localId\" : \"33\",\n          \"locator\" : \"36:32-36:49\",\n          \"type\" : \"IntervalTypeSpecifier\",\n          \"pointType\" : {\n            \"localId\" : \"32\",\n            \"locator\" : \"36:41-36:48\",\n            \"name\" : \"{urn:hl7-org:elm-types:r1}DateTime\",\n            \"type\" : \"NamedTypeSpecifier\"\n          }\n        }\n      } ]\n    },\n    \"codeSystems\" : {\n      \"def\" : [ {\n        \"localId\" : \"2\",\n        \"locator\" : \"5:1-5:51\",\n        \"name\" : \"LOINC\",\n        \"id\" : \"urn:oid:2.16.840.1.113883.6.1\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"3\",\n        \"locator\" : \"6:1-6:55\",\n        \"name\" : \"SNOMEDCT\",\n        \"id\" : \"urn:oid:2.16.840.1.113883.6.96\",\n        \"accessLevel\" : \"Public\"\n      } ]\n    },\n    \"valueSets\" : {\n      \"def\" : [ {\n        \"localId\" : \"4\",\n        \"locator\" : \"8:1-8:63\",\n        \"name\" : \"Aprepitant\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.222\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"5\",\n        \"locator\" : \"9:1-9:59\",\n        \"name\" : \"Cancer\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.231\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"6\",\n        \"locator\" : \"10:1-10:79\",\n        \"name\" : \"Clinical Trial Participant\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.150\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"7\",\n        \"locator\" : \"11:1-11:69\",\n        \"name\" : \"Cyclophosphamide\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.167\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"8\",\n        \"locator\" : \"12:1-12:65\",\n        \"name\" : \"Daunorubicin\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.332\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"9\",\n        \"locator\" : \"13:1-13:65\",\n        \"name\" : \"Dexamethasone\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.80\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"10\",\n        \"locator\" : \"14:1-14:64\",\n        \"name\" : \"Doxorubicin\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.168\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"11\",\n        \"locator\" : \"15:1-15:63\",\n        \"name\" : \"Epirubicin\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.200\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"12\",\n        \"locator\" : \"16:1-16:58\",\n        \"name\" : \"Ethnicity\",\n        \"id\" : \"urn:oid:2.16.840.1.114222.4.11.837\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"13\",\n        \"locator\" : \"17:1-17:90\",\n        \"name\" : \"First Generation Serotonin Antagonists\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.82\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"14\",\n        \"locator\" : \"18:1-18:66\",\n        \"name\" : \"Fosaprepitant\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.223\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"15\",\n        \"locator\" : \"19:1-19:86\",\n        \"name\" : \"High Emetigenic Risk Chemotherapy\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.331\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"16\",\n        \"locator\" : \"20:1-20:63\",\n        \"name\" : \"Idarubicin\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.199\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"17\",\n        \"locator\" : \"21:1-21:66\",\n        \"name\" : \"Medical Reason\",\n        \"id\" : \"urn:oid:2.16.840.1.113883.3.526.2.313\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"18\",\n        \"locator\" : \"22:1-22:81\",\n        \"name\" : \"NEPA Netupitant Palonosetron\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.334\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"19\",\n        \"locator\" : \"23:1-23:63\",\n        \"name\" : \"Netupitant\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.335\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"20\",\n        \"locator\" : \"24:1-24:75\",\n        \"name\" : \"Office Visit\",\n        \"id\" : \"urn:oid:2.16.840.1.113883.3.464.1003.101.11.1005\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"21\",\n        \"locator\" : \"25:1-25:68\",\n        \"name\" : \"ONC Administrative Sex\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"22\",\n        \"locator\" : \"26:1-26:64\",\n        \"name\" : \"Palonosetron\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.81\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"23\",\n        \"locator\" : \"27:1-27:81\",\n        \"name\" : \"Patient Provider Interaction\",\n        \"id\" : \"urn:oid:2.16.840.1.113883.3.526.3.1012\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"24\",\n        \"locator\" : \"28:1-28:66\",\n        \"name\" : \"Patient Reason\",\n        \"id\" : \"urn:oid:2.16.840.1.113883.3.526.2.311\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"25\",\n        \"locator\" : \"29:1-29:55\",\n        \"name\" : \"Payer\",\n        \"id\" : \"urn:oid:2.16.840.1.114222.4.11.3591\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"26\",\n        \"locator\" : \"30:1-30:53\",\n        \"name\" : \"Race\",\n        \"id\" : \"urn:oid:2.16.840.1.114222.4.11.836\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"27\",\n        \"locator\" : \"31:1-31:65\",\n        \"name\" : \"System Reason\",\n        \"id\" : \"urn:oid:2.16.840.1.113883.3.526.2.310\",\n        \"accessLevel\" : \"Public\"\n      } ]\n    },\n    \"codes\" : {\n      \"def\" : [ {\n        \"localId\" : \"29\",\n        \"locator\" : \"33:1-33:60\",\n        \"name\" : \"Birthdate\",\n        \"id\" : \"21112-8\",\n        \"display\" : \"Birthdate\",\n        \"accessLevel\" : \"Public\",\n        \"codeSystem\" : {\n          \"localId\" : \"28\",\n          \"locator\" : \"33:34-33:40\",\n          \"name\" : \"LOINC\"\n        }\n      }, {\n        \"localId\" : \"31\",\n        \"locator\" : \"34:1-34:55\",\n        \"name\" : \"Dead\",\n        \"id\" : \"419099009\",\n        \"display\" : \"Dead\",\n        \"accessLevel\" : \"Public\",\n        \"codeSystem\" : {\n          \"localId\" : \"30\",\n          \"locator\" : \"34:31-34:40\",\n          \"name\" : \"SNOMEDCT\"\n        }\n      } ]\n    },\n    \"statements\" : {\n      \"def\" : [ {\n        \"locator\" : \"38:1-38:15\",\n        \"name\" : \"Patient\",\n        \"context\" : \"Patient\",\n        \"expression\" : {\n          \"type\" : \"SingletonFrom\",\n          \"operand\" : {\n            \"locator\" : \"38:1-38:15\",\n            \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}Patient\",\n            \"templateId\" : \"Patient\",\n            \"type\" : \"Retrieve\"\n          }\n        }\n      }, {\n        \"localId\" : \"36\",\n        \"locator\" : \"40:1-41:51\",\n        \"name\" : \"SDE Ethnicity\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"36\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"SDE Ethnicity\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"35\",\n              \"s\" : [ {\n                \"value\" : [ \"[\", \"\\\"Patient Characteristic Ethnicity\\\"\", \": \" ]\n              }, {\n                \"s\" : [ {\n                  \"value\" : [ \"\\\"Ethnicity\\\"\" ]\n                } ]\n              }, {\n                \"value\" : [ \"]\" ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"35\",\n          \"locator\" : \"41:3-41:51\",\n          \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PatientCharacteristicEthnicity\",\n          \"codeProperty\" : \"code\",\n          \"type\" : \"Retrieve\",\n          \"codes\" : {\n            \"locator\" : \"41:40-41:50\",\n            \"name\" : \"Ethnicity\",\n            \"type\" : \"ValueSetRef\"\n          }\n        }\n      }, {\n        \"localId\" : \"38\",\n        \"locator\" : \"43:1-44:43\",\n        \"name\" : \"SDE Payer\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"38\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"SDE Payer\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"37\",\n              \"s\" : [ {\n                \"value\" : [ \"[\", \"\\\"Patient Characteristic Payer\\\"\", \": \" ]\n              }, {\n                \"s\" : [ {\n                  \"value\" : [ \"\\\"Payer\\\"\" ]\n                } ]\n              }, {\n                \"value\" : [ \"]\" ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"37\",\n          \"locator\" : \"44:3-44:43\",\n          \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PatientCharacteristicPayer\",\n          \"codeProperty\" : \"code\",\n          \"type\" : \"Retrieve\",\n          \"codes\" : {\n            \"locator\" : \"44:36-44:42\",\n            \"name\" : \"Payer\",\n            \"type\" : \"ValueSetRef\"\n          }\n        }\n      }, {\n        \"localId\" : \"40\",\n        \"locator\" : \"46:1-47:41\",\n        \"name\" : \"SDE Race\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"40\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"SDE Race\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"39\",\n              \"s\" : [ {\n                \"value\" : [ \"[\", \"\\\"Patient Characteristic Race\\\"\", \": \" ]\n              }, {\n                \"s\" : [ {\n                  \"value\" : [ \"\\\"Race\\\"\" ]\n                } ]\n              }, {\n                \"value\" : [ \"]\" ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"39\",\n          \"locator\" : \"47:3-47:41\",\n          \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PatientCharacteristicRace\",\n          \"codeProperty\" : \"code\",\n          \"type\" : \"Retrieve\",\n          \"codes\" : {\n            \"locator\" : \"47:35-47:40\",\n            \"name\" : \"Race\",\n            \"type\" : \"ValueSetRef\"\n          }\n        }\n      }, {\n        \"localId\" : \"42\",\n        \"locator\" : \"49:1-50:58\",\n        \"name\" : \"SDE Sex\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"42\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"SDE Sex\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"41\",\n              \"s\" : [ {\n                \"value\" : [ \"[\", \"\\\"Patient Characteristic Sex\\\"\", \": \" ]\n              }, {\n                \"s\" : [ {\n                  \"value\" : [ \"\\\"ONC Administrative Sex\\\"\" ]\n                } ]\n              }, {\n                \"value\" : [ \"]\" ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"41\",\n          \"locator\" : \"50:3-50:58\",\n          \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PatientCharacteristicSex\",\n          \"codeProperty\" : \"code\",\n          \"type\" : \"Retrieve\",\n          \"codes\" : {\n            \"locator\" : \"50:34-50:57\",\n            \"name\" : \"ONC Administrative Sex\",\n            \"type\" : \"ValueSetRef\"\n          }\n        }\n      }, {\n        \"localId\" : \"52\",\n        \"locator\" : \"52:1-55:62\",\n        \"name\" : \"Office Visits\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"52\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Office Visits\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"51\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"46\",\n                  \"s\" : [ {\n                    \"r\" : \"45\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"45\",\n                      \"s\" : [ {\n                        \"r\" : \"43\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"Encounter, Performed\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Office Visit\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\tunion \" ]\n                      }, {\n                        \"r\" : \"44\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"Encounter, Performed\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Patient Provider Interaction\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"Enc\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"50\",\n                \"s\" : [ {\n                  \"value\" : [ \"where \" ]\n                }, {\n                  \"r\" : \"50\",\n                  \"s\" : [ {\n                    \"r\" : \"48\",\n                    \"s\" : [ {\n                      \"r\" : \"47\",\n                      \"s\" : [ {\n                        \"value\" : [ \"Enc\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"48\",\n                      \"s\" : [ {\n                        \"value\" : [ \"relevantPeriod\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"r\" : \"50\",\n                    \"value\" : [ \" \", \"starts during\", \" \" ]\n                  }, {\n                    \"r\" : \"49\",\n                    \"s\" : [ {\n                      \"value\" : [ \"\\\"Measurement Period\\\"\" ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"51\",\n          \"locator\" : \"53:3-55:62\",\n          \"type\" : \"Query\",\n          \"source\" : [ {\n            \"localId\" : \"46\",\n            \"locator\" : \"53:3-54:71\",\n            \"alias\" : \"Enc\",\n            \"expression\" : {\n              \"localId\" : \"45\",\n              \"locator\" : \"53:3-54:67\",\n              \"type\" : \"Union\",\n              \"operand\" : [ {\n                \"localId\" : \"43\",\n                \"locator\" : \"53:5-53:44\",\n                \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveEncounterPerformed\",\n                \"templateId\" : \"PositiveEncounterPerformed\",\n                \"codeProperty\" : \"code\",\n                \"type\" : \"Retrieve\",\n                \"codes\" : {\n                  \"locator\" : \"53:30-53:43\",\n                  \"name\" : \"Office Visit\",\n                  \"type\" : \"ValueSetRef\"\n                }\n              }, {\n                \"localId\" : \"44\",\n                \"locator\" : \"54:10-54:65\",\n                \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveEncounterPerformed\",\n                \"templateId\" : \"PositiveEncounterPerformed\",\n                \"codeProperty\" : \"code\",\n                \"type\" : \"Retrieve\",\n                \"codes\" : {\n                  \"locator\" : \"54:35-54:64\",\n                  \"name\" : \"Patient Provider Interaction\",\n                  \"type\" : \"ValueSetRef\"\n                }\n              } ]\n            }\n          } ],\n          \"relationship\" : [ ],\n          \"where\" : {\n            \"localId\" : \"50\",\n            \"locator\" : \"55:4-55:62\",\n            \"type\" : \"In\",\n            \"operand\" : [ {\n              \"locator\" : \"55:29-55:34\",\n              \"type\" : \"Start\",\n              \"operand\" : {\n                \"localId\" : \"48\",\n                \"locator\" : \"55:10-55:27\",\n                \"path\" : \"relevantPeriod\",\n                \"scope\" : \"Enc\",\n                \"type\" : \"Property\"\n              }\n            }, {\n              \"localId\" : \"49\",\n              \"locator\" : \"55:43-55:62\",\n              \"name\" : \"Measurement Period\",\n              \"type\" : \"ParameterRef\"\n            } ]\n          }\n        }\n      }, {\n        \"localId\" : \"69\",\n        \"locator\" : \"208:1-212:3\",\n        \"name\" : \"First Cancer Dx\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"69\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"First Cancer Dx\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"68\",\n              \"s\" : [ {\n                \"value\" : [ \"First\", \"(\" ]\n              }, {\n                \"r\" : \"67\",\n                \"s\" : [ {\n                  \"s\" : [ {\n                    \"r\" : \"62\",\n                    \"s\" : [ {\n                      \"r\" : \"61\",\n                      \"s\" : [ {\n                        \"value\" : [ \"(\" ]\n                      }, {\n                        \"r\" : \"61\",\n                        \"s\" : [ {\n                          \"s\" : [ {\n                            \"r\" : \"56\",\n                            \"s\" : [ {\n                              \"r\" : \"55\",\n                              \"s\" : [ {\n                                \"value\" : [ \"(\" ]\n                              }, {\n                                \"r\" : \"55\",\n                                \"s\" : [ {\n                                  \"value\" : [ \"[\", \"\\\"Diagnosis\\\"\", \": \" ]\n                                }, {\n                                  \"s\" : [ {\n                                    \"value\" : [ \"\\\"Cancer\\\"\" ]\n                                  } ]\n                                }, {\n                                  \"value\" : [ \"]\" ]\n                                } ]\n                              }, {\n                                \"value\" : [ \")\" ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"Dx\" ]\n                            } ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"\\n  \\t\\t\" ]\n                        }, {\n                          \"r\" : \"60\",\n                          \"s\" : [ {\n                            \"value\" : [ \"where \" ]\n                          }, {\n                            \"r\" : \"60\",\n                            \"s\" : [ {\n                              \"r\" : \"58\",\n                              \"s\" : [ {\n                                \"r\" : \"57\",\n                                \"s\" : [ {\n                                  \"value\" : [ \"Dx\" ]\n                                } ]\n                              }, {\n                                \"value\" : [ \".\" ]\n                              }, {\n                                \"r\" : \"58\",\n                                \"s\" : [ {\n                                  \"value\" : [ \"prevalencePeriod\" ]\n                                } ]\n                              } ]\n                            }, {\n                              \"r\" : \"60\",\n                              \"value\" : [ \" \", \"starts during\", \" \" ]\n                            }, {\n                              \"r\" : \"59\",\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"Measurement Period\\\"\" ]\n                              } ]\n                            } ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \")\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \"DD\" ]\n                    } ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\t\" ]\n                }, {\n                  \"r\" : \"66\",\n                  \"s\" : [ {\n                    \"value\" : [ \"sort by \" ]\n                  }, {\n                    \"r\" : \"65\",\n                    \"s\" : [ {\n                      \"r\" : \"64\",\n                      \"s\" : [ {\n                        \"value\" : [ \"start of \" ]\n                      }, {\n                        \"r\" : \"63\",\n                        \"s\" : [ {\n                          \"value\" : [ \"prevalencePeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  )\" ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"68\",\n          \"locator\" : \"209:3-212:3\",\n          \"type\" : \"First\",\n          \"source\" : {\n            \"localId\" : \"67\",\n            \"locator\" : \"209:9-211:37\",\n            \"type\" : \"Query\",\n            \"source\" : [ {\n              \"localId\" : \"62\",\n              \"locator\" : \"209:9-210:67\",\n              \"alias\" : \"DD\",\n              \"expression\" : {\n                \"localId\" : \"61\",\n                \"locator\" : \"209:9-210:65\",\n                \"type\" : \"Query\",\n                \"source\" : [ {\n                  \"localId\" : \"56\",\n                  \"locator\" : \"209:10-209:36\",\n                  \"alias\" : \"Dx\",\n                  \"expression\" : {\n                    \"localId\" : \"55\",\n                    \"locator\" : \"209:10-209:34\",\n                    \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}Diagnosis\",\n                    \"codeProperty\" : \"code\",\n                    \"type\" : \"Retrieve\",\n                    \"codes\" : {\n                      \"locator\" : \"209:25-209:32\",\n                      \"name\" : \"Cancer\",\n                      \"type\" : \"ValueSetRef\"\n                    }\n                  }\n                } ],\n                \"relationship\" : [ ],\n                \"where\" : {\n                  \"localId\" : \"60\",\n                  \"locator\" : \"210:5-210:64\",\n                  \"type\" : \"In\",\n                  \"operand\" : [ {\n                    \"locator\" : \"210:31-210:36\",\n                    \"type\" : \"Start\",\n                    \"operand\" : {\n                      \"localId\" : \"58\",\n                      \"locator\" : \"210:11-210:29\",\n                      \"path\" : \"prevalencePeriod\",\n                      \"scope\" : \"Dx\",\n                      \"type\" : \"Property\"\n                    }\n                  }, {\n                    \"localId\" : \"59\",\n                    \"locator\" : \"210:45-210:64\",\n                    \"name\" : \"Measurement Period\",\n                    \"type\" : \"ParameterRef\"\n                  } ]\n                }\n              }\n            } ],\n            \"relationship\" : [ ],\n            \"sort\" : {\n              \"localId\" : \"66\",\n              \"locator\" : \"211:5-211:37\",\n              \"by\" : [ {\n                \"localId\" : \"65\",\n                \"locator\" : \"211:13-211:37\",\n                \"direction\" : \"asc\",\n                \"type\" : \"ByExpression\",\n                \"expression\" : {\n                  \"localId\" : \"64\",\n                  \"locator\" : \"211:13-211:37\",\n                  \"type\" : \"Start\",\n                  \"operand\" : {\n                    \"localId\" : \"63\",\n                    \"locator\" : \"211:22-211:37\",\n                    \"name\" : \"prevalencePeriod\",\n                    \"type\" : \"IdentifierRef\"\n                  }\n                }\n              } ]\n            }\n          }\n        }\n      }, {\n        \"localId\" : \"80\",\n        \"locator\" : \"57:1-60:79\",\n        \"name\" : \"Cyclophosphamide Administered after First Cancer Dx\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"80\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Cyclophosphamide Administered after First Cancer Dx\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"79\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"54\",\n                  \"s\" : [ {\n                    \"r\" : \"53\",\n                    \"s\" : [ {\n                      \"r\" : \"53\",\n                      \"s\" : [ {\n                        \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                      }, {\n                        \"s\" : [ {\n                          \"value\" : [ \"\\\"Cyclophosphamide\\\"\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"]\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedAdmin\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"78\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"71\",\n                  \"s\" : [ {\n                    \"r\" : \"70\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"Dx\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"77\",\n                  \"s\" : [ {\n                    \"r\" : \"73\",\n                    \"s\" : [ {\n                      \"r\" : \"72\",\n                      \"s\" : [ {\n                        \"value\" : [ \"MedAdmin\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"73\",\n                      \"s\" : [ {\n                        \"value\" : [ \"relevantPeriod\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"r\" : \"77\",\n                    \"value\" : [ \" \", \"starts after\", \" \" ]\n                  }, {\n                    \"r\" : \"76\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"75\",\n                      \"s\" : [ {\n                        \"r\" : \"74\",\n                        \"s\" : [ {\n                          \"value\" : [ \"Dx\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"75\",\n                        \"s\" : [ {\n                          \"value\" : [ \"prevalencePeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"79\",\n          \"locator\" : \"58:3-60:79\",\n          \"type\" : \"Query\",\n          \"source\" : [ {\n            \"localId\" : \"54\",\n            \"locator\" : \"58:3-58:59\",\n            \"alias\" : \"MedAdmin\",\n            \"expression\" : {\n              \"localId\" : \"53\",\n              \"locator\" : \"58:3-58:50\",\n              \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n              \"templateId\" : \"PositiveMedicationAdministered\",\n              \"codeProperty\" : \"code\",\n              \"type\" : \"Retrieve\",\n              \"codes\" : {\n                \"locator\" : \"58:32-58:49\",\n                \"name\" : \"Cyclophosphamide\",\n                \"type\" : \"ValueSetRef\"\n              }\n            }\n          } ],\n          \"relationship\" : [ {\n            \"localId\" : \"78\",\n            \"locator\" : \"59:4-60:79\",\n            \"alias\" : \"Dx\",\n            \"type\" : \"With\",\n            \"expression\" : {\n              \"localId\" : \"70\",\n              \"locator\" : \"59:9-59:25\",\n              \"name\" : \"First Cancer Dx\",\n              \"type\" : \"ExpressionRef\"\n            },\n            \"suchThat\" : {\n              \"localId\" : \"77\",\n              \"locator\" : \"60:15-60:79\",\n              \"type\" : \"After\",\n              \"operand\" : [ {\n                \"locator\" : \"60:39-60:44\",\n                \"type\" : \"Start\",\n                \"operand\" : {\n                  \"localId\" : \"73\",\n                  \"locator\" : \"60:15-60:37\",\n                  \"path\" : \"relevantPeriod\",\n                  \"scope\" : \"MedAdmin\",\n                  \"type\" : \"Property\"\n                }\n              }, {\n                \"localId\" : \"76\",\n                \"locator\" : \"60:52-60:79\",\n                \"type\" : \"Start\",\n                \"operand\" : {\n                  \"localId\" : \"75\",\n                  \"locator\" : \"60:61-60:79\",\n                  \"path\" : \"prevalencePeriod\",\n                  \"scope\" : \"Dx\",\n                  \"type\" : \"Property\"\n                }\n              } ]\n            }\n          } ]\n        }\n      }, {\n        \"localId\" : \"88\",\n        \"locator\" : \"62:1-64:36\",\n        \"name\" : \"Initial Population\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"88\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Initial Population\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"87\",\n              \"s\" : [ {\n                \"r\" : \"84\",\n                \"s\" : [ {\n                  \"r\" : \"82\",\n                  \"s\" : [ {\n                    \"value\" : [ \"Count\", \"(\" ]\n                  }, {\n                    \"r\" : \"81\",\n                    \"s\" : [ {\n                      \"value\" : [ \"\\\"Office Visits\\\"\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \")\" ]\n                  } ]\n                }, {\n                  \"r\" : \"83\",\n                  \"value\" : [ \">=\", \" \", \"2\" ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\tand \" ]\n              }, {\n                \"r\" : \"86\",\n                \"s\" : [ {\n                  \"r\" : \"85\",\n                  \"s\" : [ {\n                    \"value\" : [ \"\\\"First Cancer Dx\\\"\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \" is not null\" ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"87\",\n          \"locator\" : \"63:3-64:36\",\n          \"type\" : \"And\",\n          \"operand\" : [ {\n            \"localId\" : \"84\",\n            \"locator\" : \"63:3-63:28\",\n            \"type\" : \"GreaterOrEqual\",\n            \"operand\" : [ {\n              \"localId\" : \"82\",\n              \"locator\" : \"63:3-63:24\",\n              \"type\" : \"Count\",\n              \"source\" : {\n                \"localId\" : \"81\",\n                \"locator\" : \"63:9-63:23\",\n                \"name\" : \"Office Visits\",\n                \"type\" : \"ExpressionRef\"\n              }\n            }, {\n              \"localId\" : \"83\",\n              \"locator\" : \"63:28\",\n              \"valueType\" : \"{urn:hl7-org:elm-types:r1}Integer\",\n              \"value\" : \"2\",\n              \"type\" : \"Literal\"\n            } ]\n          }, {\n            \"localId\" : \"86\",\n            \"locator\" : \"64:8-64:36\",\n            \"type\" : \"Not\",\n            \"operand\" : {\n              \"locator\" : \"64:8-64:36\",\n              \"type\" : \"IsNull\",\n              \"operand\" : {\n                \"localId\" : \"85\",\n                \"locator\" : \"64:8-64:24\",\n                \"name\" : \"First Cancer Dx\",\n                \"type\" : \"ExpressionRef\"\n              }\n            }\n          } ]\n        }\n      }, {\n        \"localId\" : \"101\",\n        \"locator\" : \"66:1-69:79\",\n        \"name\" : \"High Emetic Risk Chemo Administered after First Cancer Dx\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"101\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"High Emetic Risk Chemo Administered after First Cancer Dx\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"100\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"90\",\n                  \"s\" : [ {\n                    \"r\" : \"89\",\n                    \"s\" : [ {\n                      \"r\" : \"89\",\n                      \"s\" : [ {\n                        \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                      }, {\n                        \"s\" : [ {\n                          \"value\" : [ \"\\\"High Emetigenic Risk Chemotherapy\\\"\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"]\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedAdmin\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"99\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"92\",\n                  \"s\" : [ {\n                    \"r\" : \"91\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"Dx\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"98\",\n                  \"s\" : [ {\n                    \"r\" : \"94\",\n                    \"s\" : [ {\n                      \"r\" : \"93\",\n                      \"s\" : [ {\n                        \"value\" : [ \"MedAdmin\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"94\",\n                      \"s\" : [ {\n                        \"value\" : [ \"relevantPeriod\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"r\" : \"98\",\n                    \"value\" : [ \" \", \"starts after\", \" \" ]\n                  }, {\n                    \"r\" : \"97\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"96\",\n                      \"s\" : [ {\n                        \"r\" : \"95\",\n                        \"s\" : [ {\n                          \"value\" : [ \"Dx\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"96\",\n                        \"s\" : [ {\n                          \"value\" : [ \"prevalencePeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"100\",\n          \"locator\" : \"67:3-69:79\",\n          \"type\" : \"Query\",\n          \"source\" : [ {\n            \"localId\" : \"90\",\n            \"locator\" : \"67:3-67:76\",\n            \"alias\" : \"MedAdmin\",\n            \"expression\" : {\n              \"localId\" : \"89\",\n              \"locator\" : \"67:3-67:67\",\n              \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n              \"templateId\" : \"PositiveMedicationAdministered\",\n              \"codeProperty\" : \"code\",\n              \"type\" : \"Retrieve\",\n              \"codes\" : {\n                \"locator\" : \"67:32-67:66\",\n                \"name\" : \"High Emetigenic Risk Chemotherapy\",\n                \"type\" : \"ValueSetRef\"\n              }\n            }\n          } ],\n          \"relationship\" : [ {\n            \"localId\" : \"99\",\n            \"locator\" : \"68:4-69:79\",\n            \"alias\" : \"Dx\",\n            \"type\" : \"With\",\n            \"expression\" : {\n              \"localId\" : \"91\",\n              \"locator\" : \"68:9-68:25\",\n              \"name\" : \"First Cancer Dx\",\n              \"type\" : \"ExpressionRef\"\n            },\n            \"suchThat\" : {\n              \"localId\" : \"98\",\n              \"locator\" : \"69:15-69:79\",\n              \"type\" : \"After\",\n              \"operand\" : [ {\n                \"locator\" : \"69:39-69:44\",\n                \"type\" : \"Start\",\n                \"operand\" : {\n                  \"localId\" : \"94\",\n                  \"locator\" : \"69:15-69:37\",\n                  \"path\" : \"relevantPeriod\",\n                  \"scope\" : \"MedAdmin\",\n                  \"type\" : \"Property\"\n                }\n              }, {\n                \"localId\" : \"97\",\n                \"locator\" : \"69:52-69:79\",\n                \"type\" : \"Start\",\n                \"operand\" : {\n                  \"localId\" : \"96\",\n                  \"locator\" : \"69:61-69:79\",\n                  \"path\" : \"prevalencePeriod\",\n                  \"scope\" : \"Dx\",\n                  \"type\" : \"Property\"\n                }\n              } ]\n            }\n          } ]\n        }\n      }, {\n        \"localId\" : \"120\",\n        \"locator\" : \"71:1-77:79\",\n        \"name\" : \"Specific Mod Risk Chemo Administered after First Cancer Dx\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"120\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Specific Mod Risk Chemo Administered after First Cancer Dx\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"119\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"109\",\n                  \"s\" : [ {\n                    \"r\" : \"108\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"108\",\n                      \"s\" : [ {\n                        \"r\" : \"106\",\n                        \"s\" : [ {\n                          \"r\" : \"104\",\n                          \"s\" : [ {\n                            \"r\" : \"102\",\n                            \"s\" : [ {\n                              \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                            }, {\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"Doxorubicin\\\"\" ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"]\" ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"\\n  \\tunion \" ]\n                          }, {\n                            \"r\" : \"103\",\n                            \"s\" : [ {\n                              \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                            }, {\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"Epirubicin\\\"\" ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"]\" ]\n                            } ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"\\n  \\tunion \" ]\n                        }, {\n                          \"r\" : \"105\",\n                          \"s\" : [ {\n                            \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                          }, {\n                            \"s\" : [ {\n                              \"value\" : [ \"\\\"Idarubicin\\\"\" ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"]\" ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\tunion \" ]\n                      }, {\n                        \"r\" : \"107\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Daunorubicin\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedAdmin\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"118\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"111\",\n                  \"s\" : [ {\n                    \"r\" : \"110\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"Dx\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"117\",\n                  \"s\" : [ {\n                    \"r\" : \"113\",\n                    \"s\" : [ {\n                      \"r\" : \"112\",\n                      \"s\" : [ {\n                        \"value\" : [ \"MedAdmin\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"113\",\n                      \"s\" : [ {\n                        \"value\" : [ \"relevantPeriod\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"r\" : \"117\",\n                    \"value\" : [ \" \", \"starts after\", \" \" ]\n                  }, {\n                    \"r\" : \"116\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"115\",\n                      \"s\" : [ {\n                        \"r\" : \"114\",\n                        \"s\" : [ {\n                          \"value\" : [ \"Dx\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"115\",\n                        \"s\" : [ {\n                          \"value\" : [ \"prevalencePeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"119\",\n          \"locator\" : \"72:3-77:79\",\n          \"type\" : \"Query\",\n          \"source\" : [ {\n            \"localId\" : \"109\",\n            \"locator\" : \"72:3-75:64\",\n            \"alias\" : \"MedAdmin\",\n            \"expression\" : {\n              \"localId\" : \"108\",\n              \"locator\" : \"72:3-75:55\",\n              \"type\" : \"Union\",\n              \"operand\" : [ {\n                \"localId\" : \"104\",\n                \"locator\" : \"72:5-73:51\",\n                \"type\" : \"Union\",\n                \"operand\" : [ {\n                  \"localId\" : \"102\",\n                  \"locator\" : \"72:5-72:47\",\n                  \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                  \"templateId\" : \"PositiveMedicationAdministered\",\n                  \"codeProperty\" : \"code\",\n                  \"type\" : \"Retrieve\",\n                  \"codes\" : {\n                    \"locator\" : \"72:34-72:46\",\n                    \"name\" : \"Doxorubicin\",\n                    \"type\" : \"ValueSetRef\"\n                  }\n                }, {\n                  \"localId\" : \"103\",\n                  \"locator\" : \"73:10-73:51\",\n                  \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                  \"templateId\" : \"PositiveMedicationAdministered\",\n                  \"codeProperty\" : \"code\",\n                  \"type\" : \"Retrieve\",\n                  \"codes\" : {\n                    \"locator\" : \"73:39-73:50\",\n                    \"name\" : \"Epirubicin\",\n                    \"type\" : \"ValueSetRef\"\n                  }\n                } ]\n              }, {\n                \"type\" : \"Union\",\n                \"operand\" : [ {\n                  \"localId\" : \"105\",\n                  \"locator\" : \"74:10-74:51\",\n                  \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                  \"templateId\" : \"PositiveMedicationAdministered\",\n                  \"codeProperty\" : \"code\",\n                  \"type\" : \"Retrieve\",\n                  \"codes\" : {\n                    \"locator\" : \"74:39-74:50\",\n                    \"name\" : \"Idarubicin\",\n                    \"type\" : \"ValueSetRef\"\n                  }\n                }, {\n                  \"localId\" : \"107\",\n                  \"locator\" : \"75:10-75:53\",\n                  \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                  \"templateId\" : \"PositiveMedicationAdministered\",\n                  \"codeProperty\" : \"code\",\n                  \"type\" : \"Retrieve\",\n                  \"codes\" : {\n                    \"locator\" : \"75:39-75:52\",\n                    \"name\" : \"Daunorubicin\",\n                    \"type\" : \"ValueSetRef\"\n                  }\n                } ]\n              } ]\n            }\n          } ],\n          \"relationship\" : [ {\n            \"localId\" : \"118\",\n            \"locator\" : \"76:4-77:79\",\n            \"alias\" : \"Dx\",\n            \"type\" : \"With\",\n            \"expression\" : {\n              \"localId\" : \"110\",\n              \"locator\" : \"76:9-76:25\",\n              \"name\" : \"First Cancer Dx\",\n              \"type\" : \"ExpressionRef\"\n            },\n            \"suchThat\" : {\n              \"localId\" : \"117\",\n              \"locator\" : \"77:15-77:79\",\n              \"type\" : \"After\",\n              \"operand\" : [ {\n                \"locator\" : \"77:39-77:44\",\n                \"type\" : \"Start\",\n                \"operand\" : {\n                  \"localId\" : \"113\",\n                  \"locator\" : \"77:15-77:37\",\n                  \"path\" : \"relevantPeriod\",\n                  \"scope\" : \"MedAdmin\",\n                  \"type\" : \"Property\"\n                }\n              }, {\n                \"localId\" : \"116\",\n                \"locator\" : \"77:52-77:79\",\n                \"type\" : \"Start\",\n                \"operand\" : {\n                  \"localId\" : \"115\",\n                  \"locator\" : \"77:61-77:79\",\n                  \"path\" : \"prevalencePeriod\",\n                  \"scope\" : \"Dx\",\n                  \"type\" : \"Property\"\n                }\n              } ]\n            }\n          } ]\n        }\n      }, {\n        \"localId\" : \"126\",\n        \"locator\" : \"188:1-190:69\",\n        \"name\" : \"High Risk Cyclophosphamide Administered after First Cancer Dx\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"126\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"High Risk Cyclophosphamide Administered after First Cancer Dx\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"125\",\n              \"s\" : [ {\n                \"r\" : \"123\",\n                \"s\" : [ {\n                  \"value\" : [ \"\\\"Cyclophosphamide Administered after First Cancer Dx\\\"\" ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\tunion \" ]\n              }, {\n                \"r\" : \"124\",\n                \"s\" : [ {\n                  \"value\" : [ \"\\\"Specific Mod Risk Chemo Administered after First Cancer Dx\\\"\" ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"125\",\n          \"locator\" : \"189:3-190:69\",\n          \"type\" : \"Union\",\n          \"operand\" : [ {\n            \"localId\" : \"123\",\n            \"locator\" : \"189:3-189:55\",\n            \"name\" : \"Cyclophosphamide Administered after First Cancer Dx\",\n            \"type\" : \"ExpressionRef\"\n          }, {\n            \"localId\" : \"124\",\n            \"locator\" : \"190:10-190:69\",\n            \"name\" : \"Specific Mod Risk Chemo Administered after First Cancer Dx\",\n            \"type\" : \"ExpressionRef\"\n          } ]\n        }\n      }, {\n        \"localId\" : \"130\",\n        \"locator\" : \"184:1-186:68\",\n        \"name\" : \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"130\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"129\",\n              \"s\" : [ {\n                \"r\" : \"127\",\n                \"s\" : [ {\n                  \"value\" : [ \"\\\"High Risk Cyclophosphamide Administered after First Cancer Dx\\\"\" ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\tunion \" ]\n              }, {\n                \"r\" : \"128\",\n                \"s\" : [ {\n                  \"value\" : [ \"\\\"High Emetic Risk Chemo Administered after First Cancer Dx\\\"\" ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"129\",\n          \"locator\" : \"185:3-186:68\",\n          \"type\" : \"Union\",\n          \"operand\" : [ {\n            \"localId\" : \"127\",\n            \"locator\" : \"185:3-185:65\",\n            \"name\" : \"High Risk Cyclophosphamide Administered after First Cancer Dx\",\n            \"type\" : \"ExpressionRef\"\n          }, {\n            \"localId\" : \"128\",\n            \"locator\" : \"186:10-186:68\",\n            \"name\" : \"High Emetic Risk Chemo Administered after First Cancer Dx\",\n            \"type\" : \"ExpressionRef\"\n          } ]\n        }\n      }, {\n        \"localId\" : \"141\",\n        \"locator\" : \"79:1-82:83\",\n        \"name\" : \"Clinical Trial Participant before start of High Emetic Risk Combo Chemotherapy\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"141\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Clinical Trial Participant before start of High Emetic Risk Combo Chemotherapy\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"140\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"122\",\n                  \"s\" : [ {\n                    \"r\" : \"121\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"121\",\n                      \"s\" : [ {\n                        \"value\" : [ \"[\", \"\\\"Care Goal\\\"\", \": \" ]\n                      }, {\n                        \"s\" : [ {\n                          \"value\" : [ \"\\\"Clinical Trial Participant\\\"\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"]\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"Trial\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"139\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"132\",\n                  \"s\" : [ {\n                    \"r\" : \"131\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"ComboChemo\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"138\",\n                  \"s\" : [ {\n                    \"r\" : \"134\",\n                    \"s\" : [ {\n                      \"r\" : \"133\",\n                      \"s\" : [ {\n                        \"value\" : [ \"Trial\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"134\",\n                      \"s\" : [ {\n                        \"value\" : [ \"relevantPeriod\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"r\" : \"138\",\n                    \"value\" : [ \" \", \"starts before\", \" \" ]\n                  }, {\n                    \"r\" : \"137\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"136\",\n                      \"s\" : [ {\n                        \"r\" : \"135\",\n                        \"s\" : [ {\n                          \"value\" : [ \"ComboChemo\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"136\",\n                        \"s\" : [ {\n                          \"value\" : [ \"relevantPeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"140\",\n          \"locator\" : \"80:3-82:83\",\n          \"type\" : \"Query\",\n          \"source\" : [ {\n            \"localId\" : \"122\",\n            \"locator\" : \"80:3-80:55\",\n            \"alias\" : \"Trial\",\n            \"expression\" : {\n              \"localId\" : \"121\",\n              \"locator\" : \"80:3-80:49\",\n              \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}CareGoal\",\n              \"codeProperty\" : \"code\",\n              \"type\" : \"Retrieve\",\n              \"codes\" : {\n                \"locator\" : \"80:19-80:46\",\n                \"name\" : \"Clinical Trial Participant\",\n                \"type\" : \"ValueSetRef\"\n              }\n            }\n          } ],\n          \"relationship\" : [ {\n            \"localId\" : \"139\",\n            \"locator\" : \"81:4-82:83\",\n            \"alias\" : \"ComboChemo\",\n            \"type\" : \"With\",\n            \"expression\" : {\n              \"localId\" : \"131\",\n              \"locator\" : \"81:9-81:86\",\n              \"name\" : \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\",\n              \"type\" : \"ExpressionRef\"\n            },\n            \"suchThat\" : {\n              \"localId\" : \"138\",\n              \"locator\" : \"82:15-82:83\",\n              \"type\" : \"Before\",\n              \"operand\" : [ {\n                \"locator\" : \"82:36-82:41\",\n                \"type\" : \"Start\",\n                \"operand\" : {\n                  \"localId\" : \"134\",\n                  \"locator\" : \"82:15-82:34\",\n                  \"path\" : \"relevantPeriod\",\n                  \"scope\" : \"Trial\",\n                  \"type\" : \"Property\"\n                }\n              }, {\n                \"localId\" : \"137\",\n                \"locator\" : \"82:50-82:83\",\n                \"type\" : \"Start\",\n                \"operand\" : {\n                  \"localId\" : \"136\",\n                  \"locator\" : \"82:59-82:83\",\n                  \"path\" : \"relevantPeriod\",\n                  \"scope\" : \"ComboChemo\",\n                  \"type\" : \"Property\"\n                }\n              } ]\n            }\n          } ]\n        }\n      }, {\n        \"localId\" : \"155\",\n        \"locator\" : \"84:1-87:97\",\n        \"name\" : \"Clinical Trial Participant within 7 days after start of High Emetic Risk Combo Chemotherapy\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"155\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Clinical Trial Participant within 7 days after start of High Emetic Risk Combo Chemotherapy\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"154\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"143\",\n                  \"s\" : [ {\n                    \"r\" : \"142\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"142\",\n                      \"s\" : [ {\n                        \"value\" : [ \"[\", \"\\\"Care Goal\\\"\", \": \" ]\n                      }, {\n                        \"s\" : [ {\n                          \"value\" : [ \"\\\"Clinical Trial Participant\\\"\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"]\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"Trial\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"153\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"145\",\n                  \"s\" : [ {\n                    \"r\" : \"144\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"ComboChemo\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"152\",\n                  \"s\" : [ {\n                    \"r\" : \"147\",\n                    \"s\" : [ {\n                      \"r\" : \"146\",\n                      \"s\" : [ {\n                        \"value\" : [ \"Trial\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"147\",\n                      \"s\" : [ {\n                        \"value\" : [ \"relevantPeriod\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \" ]\n                  }, {\n                    \"r\" : \"152\",\n                    \"s\" : [ {\n                      \"value\" : [ \"starts \" ]\n                    }, {\n                      \"r\" : \"151\",\n                      \"s\" : [ {\n                        \"value\" : [ \"7 \", \"days\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" or less after\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \" ]\n                  }, {\n                    \"r\" : \"150\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"149\",\n                      \"s\" : [ {\n                        \"r\" : \"148\",\n                        \"s\" : [ {\n                          \"value\" : [ \"ComboChemo\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"149\",\n                        \"s\" : [ {\n                          \"value\" : [ \"relevantPeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"154\",\n          \"locator\" : \"85:3-87:97\",\n          \"type\" : \"Query\",\n          \"source\" : [ {\n            \"localId\" : \"143\",\n            \"locator\" : \"85:3-85:55\",\n            \"alias\" : \"Trial\",\n            \"expression\" : {\n              \"localId\" : \"142\",\n              \"locator\" : \"85:3-85:49\",\n              \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}CareGoal\",\n              \"codeProperty\" : \"code\",\n              \"type\" : \"Retrieve\",\n              \"codes\" : {\n                \"locator\" : \"85:19-85:46\",\n                \"name\" : \"Clinical Trial Participant\",\n                \"type\" : \"ValueSetRef\"\n              }\n            }\n          } ],\n          \"relationship\" : [ {\n            \"localId\" : \"153\",\n            \"locator\" : \"86:4-87:97\",\n            \"alias\" : \"ComboChemo\",\n            \"type\" : \"With\",\n            \"expression\" : {\n              \"localId\" : \"144\",\n              \"locator\" : \"86:9-86:86\",\n              \"name\" : \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\",\n              \"type\" : \"ExpressionRef\"\n            },\n            \"suchThat\" : {\n              \"localId\" : \"152\",\n              \"locator\" : \"87:15-87:97\",\n              \"type\" : \"And\",\n              \"operand\" : [ {\n                \"locator\" : \"87:43-87:56\",\n                \"type\" : \"In\",\n                \"operand\" : [ {\n                  \"locator\" : \"87:36-87:41\",\n                  \"type\" : \"Start\",\n                  \"operand\" : {\n                    \"localId\" : \"147\",\n                    \"locator\" : \"87:15-87:34\",\n                    \"path\" : \"relevantPeriod\",\n                    \"scope\" : \"Trial\",\n                    \"type\" : \"Property\"\n                  }\n                }, {\n                  \"locator\" : \"87:43-87:56\",\n                  \"lowClosed\" : false,\n                  \"highClosed\" : true,\n                  \"type\" : \"Interval\",\n                  \"low\" : {\n                    \"localId\" : \"150\",\n                    \"locator\" : \"87:64-87:97\",\n                    \"type\" : \"Start\",\n                    \"operand\" : {\n                      \"localId\" : \"149\",\n                      \"locator\" : \"87:73-87:97\",\n                      \"path\" : \"relevantPeriod\",\n                      \"scope\" : \"ComboChemo\",\n                      \"type\" : \"Property\"\n                    }\n                  },\n                  \"high\" : {\n                    \"locator\" : \"87:64-87:97\",\n                    \"type\" : \"Add\",\n                    \"operand\" : [ {\n                      \"localId\" : \"150\",\n                      \"locator\" : \"87:64-87:97\",\n                      \"type\" : \"Start\",\n                      \"operand\" : {\n                        \"localId\" : \"149\",\n                        \"locator\" : \"87:73-87:97\",\n                        \"path\" : \"relevantPeriod\",\n                        \"scope\" : \"ComboChemo\",\n                        \"type\" : \"Property\"\n                      }\n                    }, {\n                      \"localId\" : \"151\",\n                      \"locator\" : \"87:43-87:48\",\n                      \"value\" : 7,\n                      \"unit\" : \"days\",\n                      \"type\" : \"Quantity\"\n                    } ]\n                  }\n                } ]\n              }, {\n                \"locator\" : \"87:43-87:56\",\n                \"type\" : \"Not\",\n                \"operand\" : {\n                  \"locator\" : \"87:43-87:56\",\n                  \"type\" : \"IsNull\",\n                  \"operand\" : {\n                    \"localId\" : \"150\",\n                    \"locator\" : \"87:64-87:97\",\n                    \"type\" : \"Start\",\n                    \"operand\" : {\n                      \"localId\" : \"149\",\n                      \"locator\" : \"87:73-87:97\",\n                      \"path\" : \"relevantPeriod\",\n                      \"scope\" : \"ComboChemo\",\n                      \"type\" : \"Property\"\n                    }\n                  }\n                }\n              } ]\n            }\n          } ]\n        }\n      }, {\n        \"localId\" : \"171\",\n        \"locator\" : \"89:1-93:100\",\n        \"name\" : \"Dexamethasone administered or ordered within 7 days after Combo High Risk Chemo\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"171\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Dexamethasone administered or ordered within 7 days after Combo High Risk Chemo\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"170\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"159\",\n                  \"s\" : [ {\n                    \"r\" : \"158\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"158\",\n                      \"s\" : [ {\n                        \"r\" : \"156\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Dexamethasone\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\tunion \" ]\n                      }, {\n                        \"r\" : \"157\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"Medication, Order\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Dexamethasone\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedAdmin\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"169\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"161\",\n                  \"s\" : [ {\n                    \"r\" : \"160\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"ComboChemo\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"168\",\n                  \"s\" : [ {\n                    \"r\" : \"163\",\n                    \"s\" : [ {\n                      \"r\" : \"162\",\n                      \"s\" : [ {\n                        \"value\" : [ \"MedAdmin\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"163\",\n                      \"s\" : [ {\n                        \"value\" : [ \"relevantPeriod\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \" ]\n                  }, {\n                    \"r\" : \"168\",\n                    \"s\" : [ {\n                      \"value\" : [ \"starts \" ]\n                    }, {\n                      \"r\" : \"167\",\n                      \"s\" : [ {\n                        \"value\" : [ \"7 \", \"days\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" or less after\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \" ]\n                  }, {\n                    \"r\" : \"166\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"165\",\n                      \"s\" : [ {\n                        \"r\" : \"164\",\n                        \"s\" : [ {\n                          \"value\" : [ \"ComboChemo\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"165\",\n                        \"s\" : [ {\n                          \"value\" : [ \"relevantPeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"170\",\n          \"locator\" : \"90:3-93:100\",\n          \"type\" : \"Query\",\n          \"source\" : [ {\n            \"localId\" : \"159\",\n            \"locator\" : \"90:3-91:58\",\n            \"alias\" : \"MedAdmin\",\n            \"expression\" : {\n              \"localId\" : \"158\",\n              \"locator\" : \"90:3-91:49\",\n              \"type\" : \"Union\",\n              \"operand\" : [ {\n                \"type\" : \"As\",\n                \"operand\" : {\n                  \"localId\" : \"156\",\n                  \"locator\" : \"90:5-90:49\",\n                  \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                  \"templateId\" : \"PositiveMedicationAdministered\",\n                  \"codeProperty\" : \"code\",\n                  \"type\" : \"Retrieve\",\n                  \"codes\" : {\n                    \"locator\" : \"90:34-90:48\",\n                    \"name\" : \"Dexamethasone\",\n                    \"type\" : \"ValueSetRef\"\n                  }\n                },\n                \"asTypeSpecifier\" : {\n                  \"type\" : \"ListTypeSpecifier\",\n                  \"elementType\" : {\n                    \"type\" : \"ChoiceTypeSpecifier\",\n                    \"choice\" : [ {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    }, {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    } ]\n                  }\n                }\n              }, {\n                \"type\" : \"As\",\n                \"operand\" : {\n                  \"localId\" : \"157\",\n                  \"locator\" : \"91:10-91:47\",\n                  \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                  \"templateId\" : \"PositiveMedicationOrder\",\n                  \"codeProperty\" : \"code\",\n                  \"type\" : \"Retrieve\",\n                  \"codes\" : {\n                    \"locator\" : \"91:32-91:46\",\n                    \"name\" : \"Dexamethasone\",\n                    \"type\" : \"ValueSetRef\"\n                  }\n                },\n                \"asTypeSpecifier\" : {\n                  \"type\" : \"ListTypeSpecifier\",\n                  \"elementType\" : {\n                    \"type\" : \"ChoiceTypeSpecifier\",\n                    \"choice\" : [ {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    }, {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    } ]\n                  }\n                }\n              } ]\n            }\n          } ],\n          \"relationship\" : [ {\n            \"localId\" : \"169\",\n            \"locator\" : \"92:4-93:100\",\n            \"alias\" : \"ComboChemo\",\n            \"type\" : \"With\",\n            \"expression\" : {\n              \"localId\" : \"160\",\n              \"locator\" : \"92:9-92:86\",\n              \"name\" : \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\",\n              \"type\" : \"ExpressionRef\"\n            },\n            \"suchThat\" : {\n              \"localId\" : \"168\",\n              \"locator\" : \"93:15-93:100\",\n              \"type\" : \"And\",\n              \"operand\" : [ {\n                \"locator\" : \"93:46-93:59\",\n                \"type\" : \"In\",\n                \"operand\" : [ {\n                  \"locator\" : \"93:39-93:44\",\n                  \"type\" : \"Start\",\n                  \"operand\" : {\n                    \"localId\" : \"163\",\n                    \"locator\" : \"93:15-93:37\",\n                    \"path\" : \"relevantPeriod\",\n                    \"scope\" : \"MedAdmin\",\n                    \"type\" : \"Property\"\n                  }\n                }, {\n                  \"locator\" : \"93:46-93:59\",\n                  \"lowClosed\" : false,\n                  \"highClosed\" : true,\n                  \"type\" : \"Interval\",\n                  \"low\" : {\n                    \"localId\" : \"166\",\n                    \"locator\" : \"93:67-93:100\",\n                    \"type\" : \"Start\",\n                    \"operand\" : {\n                      \"localId\" : \"165\",\n                      \"locator\" : \"93:76-93:100\",\n                      \"path\" : \"relevantPeriod\",\n                      \"scope\" : \"ComboChemo\",\n                      \"type\" : \"Property\"\n                    }\n                  },\n                  \"high\" : {\n                    \"locator\" : \"93:67-93:100\",\n                    \"type\" : \"Add\",\n                    \"operand\" : [ {\n                      \"localId\" : \"166\",\n                      \"locator\" : \"93:67-93:100\",\n                      \"type\" : \"Start\",\n                      \"operand\" : {\n                        \"localId\" : \"165\",\n                        \"locator\" : \"93:76-93:100\",\n                        \"path\" : \"relevantPeriod\",\n                        \"scope\" : \"ComboChemo\",\n                        \"type\" : \"Property\"\n                      }\n                    }, {\n                      \"localId\" : \"167\",\n                      \"locator\" : \"93:46-93:51\",\n                      \"value\" : 7,\n                      \"unit\" : \"days\",\n                      \"type\" : \"Quantity\"\n                    } ]\n                  }\n                } ]\n              }, {\n                \"locator\" : \"93:46-93:59\",\n                \"type\" : \"Not\",\n                \"operand\" : {\n                  \"locator\" : \"93:46-93:59\",\n                  \"type\" : \"IsNull\",\n                  \"operand\" : {\n                    \"localId\" : \"166\",\n                    \"locator\" : \"93:67-93:100\",\n                    \"type\" : \"Start\",\n                    \"operand\" : {\n                      \"localId\" : \"165\",\n                      \"locator\" : \"93:76-93:100\",\n                      \"path\" : \"relevantPeriod\",\n                      \"scope\" : \"ComboChemo\",\n                      \"type\" : \"Property\"\n                    }\n                  }\n                }\n              } ]\n            }\n          } ]\n        }\n      }, {\n        \"localId\" : \"186\",\n        \"locator\" : \"95:1-99:86\",\n        \"name\" : \"Dexamethasone administered or ordered before Combo High Risk Chemo\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"186\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Dexamethasone administered or ordered before Combo High Risk Chemo\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"185\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"175\",\n                  \"s\" : [ {\n                    \"r\" : \"174\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"174\",\n                      \"s\" : [ {\n                        \"r\" : \"172\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Dexamethasone\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\tunion \" ]\n                      }, {\n                        \"r\" : \"173\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"Medication, Order\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Dexamethasone\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedAdmin\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"184\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"177\",\n                  \"s\" : [ {\n                    \"r\" : \"176\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"ComboChemo\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"183\",\n                  \"s\" : [ {\n                    \"r\" : \"179\",\n                    \"s\" : [ {\n                      \"r\" : \"178\",\n                      \"s\" : [ {\n                        \"value\" : [ \"MedAdmin\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"179\",\n                      \"s\" : [ {\n                        \"value\" : [ \"relevantPeriod\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"r\" : \"183\",\n                    \"value\" : [ \" \", \"starts before\", \" \" ]\n                  }, {\n                    \"r\" : \"182\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"181\",\n                      \"s\" : [ {\n                        \"r\" : \"180\",\n                        \"s\" : [ {\n                          \"value\" : [ \"ComboChemo\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"181\",\n                        \"s\" : [ {\n                          \"value\" : [ \"relevantPeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"185\",\n          \"locator\" : \"96:3-99:86\",\n          \"type\" : \"Query\",\n          \"source\" : [ {\n            \"localId\" : \"175\",\n            \"locator\" : \"96:3-97:58\",\n            \"alias\" : \"MedAdmin\",\n            \"expression\" : {\n              \"localId\" : \"174\",\n              \"locator\" : \"96:3-97:49\",\n              \"type\" : \"Union\",\n              \"operand\" : [ {\n                \"type\" : \"As\",\n                \"operand\" : {\n                  \"localId\" : \"172\",\n                  \"locator\" : \"96:5-96:49\",\n                  \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                  \"templateId\" : \"PositiveMedicationAdministered\",\n                  \"codeProperty\" : \"code\",\n                  \"type\" : \"Retrieve\",\n                  \"codes\" : {\n                    \"locator\" : \"96:34-96:48\",\n                    \"name\" : \"Dexamethasone\",\n                    \"type\" : \"ValueSetRef\"\n                  }\n                },\n                \"asTypeSpecifier\" : {\n                  \"type\" : \"ListTypeSpecifier\",\n                  \"elementType\" : {\n                    \"type\" : \"ChoiceTypeSpecifier\",\n                    \"choice\" : [ {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    }, {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    } ]\n                  }\n                }\n              }, {\n                \"type\" : \"As\",\n                \"operand\" : {\n                  \"localId\" : \"173\",\n                  \"locator\" : \"97:10-97:47\",\n                  \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                  \"templateId\" : \"PositiveMedicationOrder\",\n                  \"codeProperty\" : \"code\",\n                  \"type\" : \"Retrieve\",\n                  \"codes\" : {\n                    \"locator\" : \"97:32-97:46\",\n                    \"name\" : \"Dexamethasone\",\n                    \"type\" : \"ValueSetRef\"\n                  }\n                },\n                \"asTypeSpecifier\" : {\n                  \"type\" : \"ListTypeSpecifier\",\n                  \"elementType\" : {\n                    \"type\" : \"ChoiceTypeSpecifier\",\n                    \"choice\" : [ {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    }, {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    } ]\n                  }\n                }\n              } ]\n            }\n          } ],\n          \"relationship\" : [ {\n            \"localId\" : \"184\",\n            \"locator\" : \"98:4-99:86\",\n            \"alias\" : \"ComboChemo\",\n            \"type\" : \"With\",\n            \"expression\" : {\n              \"localId\" : \"176\",\n              \"locator\" : \"98:9-98:86\",\n              \"name\" : \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\",\n              \"type\" : \"ExpressionRef\"\n            },\n            \"suchThat\" : {\n              \"localId\" : \"183\",\n              \"locator\" : \"99:15-99:86\",\n              \"type\" : \"Before\",\n              \"operand\" : [ {\n                \"locator\" : \"99:39-99:44\",\n                \"type\" : \"Start\",\n                \"operand\" : {\n                  \"localId\" : \"179\",\n                  \"locator\" : \"99:15-99:37\",\n                  \"path\" : \"relevantPeriod\",\n                  \"scope\" : \"MedAdmin\",\n                  \"type\" : \"Property\"\n                }\n              }, {\n                \"localId\" : \"182\",\n                \"locator\" : \"99:53-99:86\",\n                \"type\" : \"Start\",\n                \"operand\" : {\n                  \"localId\" : \"181\",\n                  \"locator\" : \"99:62-99:86\",\n                  \"path\" : \"relevantPeriod\",\n                  \"scope\" : \"ComboChemo\",\n                  \"type\" : \"Property\"\n                }\n              } ]\n            }\n          } ]\n        }\n      }, {\n        \"localId\" : \"201\",\n        \"locator\" : \"101:1-105:86\",\n        \"name\" : \"Palonosetron administered or ordered before Combo High Risk Chemo\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"201\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Palonosetron administered or ordered before Combo High Risk Chemo\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"200\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"190\",\n                  \"s\" : [ {\n                    \"r\" : \"189\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"189\",\n                      \"s\" : [ {\n                        \"r\" : \"187\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"NEPA Netupitant Palonosetron\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\tunion \" ]\n                      }, {\n                        \"r\" : \"188\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"Medication, Order\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"NEPA Netupitant Palonosetron\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedAdmin\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"199\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"192\",\n                  \"s\" : [ {\n                    \"r\" : \"191\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"ComboChemo\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"198\",\n                  \"s\" : [ {\n                    \"r\" : \"194\",\n                    \"s\" : [ {\n                      \"r\" : \"193\",\n                      \"s\" : [ {\n                        \"value\" : [ \"MedAdmin\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"194\",\n                      \"s\" : [ {\n                        \"value\" : [ \"relevantPeriod\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"r\" : \"198\",\n                    \"value\" : [ \" \", \"starts before\", \" \" ]\n                  }, {\n                    \"r\" : \"197\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"196\",\n                      \"s\" : [ {\n                        \"r\" : \"195\",\n                        \"s\" : [ {\n                          \"value\" : [ \"ComboChemo\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"196\",\n                        \"s\" : [ {\n                          \"value\" : [ \"relevantPeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"200\",\n          \"locator\" : \"102:3-105:86\",\n          \"type\" : \"Query\",\n          \"source\" : [ {\n            \"localId\" : \"190\",\n            \"locator\" : \"102:3-103:73\",\n            \"alias\" : \"MedAdmin\",\n            \"expression\" : {\n              \"localId\" : \"189\",\n              \"locator\" : \"102:3-103:64\",\n              \"type\" : \"Union\",\n              \"operand\" : [ {\n                \"type\" : \"As\",\n                \"operand\" : {\n                  \"localId\" : \"187\",\n                  \"locator\" : \"102:5-102:64\",\n                  \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                  \"templateId\" : \"PositiveMedicationAdministered\",\n                  \"codeProperty\" : \"code\",\n                  \"type\" : \"Retrieve\",\n                  \"codes\" : {\n                    \"locator\" : \"102:34-102:63\",\n                    \"name\" : \"NEPA Netupitant Palonosetron\",\n                    \"type\" : \"ValueSetRef\"\n                  }\n                },\n                \"asTypeSpecifier\" : {\n                  \"type\" : \"ListTypeSpecifier\",\n                  \"elementType\" : {\n                    \"type\" : \"ChoiceTypeSpecifier\",\n                    \"choice\" : [ {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    }, {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    } ]\n                  }\n                }\n              }, {\n                \"type\" : \"As\",\n                \"operand\" : {\n                  \"localId\" : \"188\",\n                  \"locator\" : \"103:10-103:62\",\n                  \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                  \"templateId\" : \"PositiveMedicationOrder\",\n                  \"codeProperty\" : \"code\",\n                  \"type\" : \"Retrieve\",\n                  \"codes\" : {\n                    \"locator\" : \"103:32-103:61\",\n                    \"name\" : \"NEPA Netupitant Palonosetron\",\n                    \"type\" : \"ValueSetRef\"\n                  }\n                },\n                \"asTypeSpecifier\" : {\n                  \"type\" : \"ListTypeSpecifier\",\n                  \"elementType\" : {\n                    \"type\" : \"ChoiceTypeSpecifier\",\n                    \"choice\" : [ {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    }, {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    } ]\n                  }\n                }\n              } ]\n            }\n          } ],\n          \"relationship\" : [ {\n            \"localId\" : \"199\",\n            \"locator\" : \"104:4-105:86\",\n            \"alias\" : \"ComboChemo\",\n            \"type\" : \"With\",\n            \"expression\" : {\n              \"localId\" : \"191\",\n              \"locator\" : \"104:9-104:86\",\n              \"name\" : \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\",\n              \"type\" : \"ExpressionRef\"\n            },\n            \"suchThat\" : {\n              \"localId\" : \"198\",\n              \"locator\" : \"105:15-105:86\",\n              \"type\" : \"Before\",\n              \"operand\" : [ {\n                \"locator\" : \"105:39-105:44\",\n                \"type\" : \"Start\",\n                \"operand\" : {\n                  \"localId\" : \"194\",\n                  \"locator\" : \"105:15-105:37\",\n                  \"path\" : \"relevantPeriod\",\n                  \"scope\" : \"MedAdmin\",\n                  \"type\" : \"Property\"\n                }\n              }, {\n                \"localId\" : \"197\",\n                \"locator\" : \"105:53-105:86\",\n                \"type\" : \"Start\",\n                \"operand\" : {\n                  \"localId\" : \"196\",\n                  \"locator\" : \"105:62-105:86\",\n                  \"path\" : \"relevantPeriod\",\n                  \"scope\" : \"ComboChemo\",\n                  \"type\" : \"Property\"\n                }\n              } ]\n            }\n          } ]\n        }\n      }, {\n        \"localId\" : \"217\",\n        \"locator\" : \"107:1-111:100\",\n        \"name\" : \"Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"217\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"216\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"205\",\n                  \"s\" : [ {\n                    \"r\" : \"204\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"204\",\n                      \"s\" : [ {\n                        \"r\" : \"202\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"NEPA Netupitant Palonosetron\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\tunion \" ]\n                      }, {\n                        \"r\" : \"203\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"Medication, Order\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"NEPA Netupitant Palonosetron\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedAdmin\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"215\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"207\",\n                  \"s\" : [ {\n                    \"r\" : \"206\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"ComboChemo\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"214\",\n                  \"s\" : [ {\n                    \"r\" : \"209\",\n                    \"s\" : [ {\n                      \"r\" : \"208\",\n                      \"s\" : [ {\n                        \"value\" : [ \"MedAdmin\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"209\",\n                      \"s\" : [ {\n                        \"value\" : [ \"relevantPeriod\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \" ]\n                  }, {\n                    \"r\" : \"214\",\n                    \"s\" : [ {\n                      \"value\" : [ \"starts \" ]\n                    }, {\n                      \"r\" : \"213\",\n                      \"s\" : [ {\n                        \"value\" : [ \"7 \", \"days\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" or less after\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \" ]\n                  }, {\n                    \"r\" : \"212\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"211\",\n                      \"s\" : [ {\n                        \"r\" : \"210\",\n                        \"s\" : [ {\n                          \"value\" : [ \"ComboChemo\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"211\",\n                        \"s\" : [ {\n                          \"value\" : [ \"relevantPeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"216\",\n          \"locator\" : \"108:3-111:100\",\n          \"type\" : \"Query\",\n          \"source\" : [ {\n            \"localId\" : \"205\",\n            \"locator\" : \"108:3-109:73\",\n            \"alias\" : \"MedAdmin\",\n            \"expression\" : {\n              \"localId\" : \"204\",\n              \"locator\" : \"108:3-109:64\",\n              \"type\" : \"Union\",\n              \"operand\" : [ {\n                \"type\" : \"As\",\n                \"operand\" : {\n                  \"localId\" : \"202\",\n                  \"locator\" : \"108:5-108:64\",\n                  \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                  \"templateId\" : \"PositiveMedicationAdministered\",\n                  \"codeProperty\" : \"code\",\n                  \"type\" : \"Retrieve\",\n                  \"codes\" : {\n                    \"locator\" : \"108:34-108:63\",\n                    \"name\" : \"NEPA Netupitant Palonosetron\",\n                    \"type\" : \"ValueSetRef\"\n                  }\n                },\n                \"asTypeSpecifier\" : {\n                  \"type\" : \"ListTypeSpecifier\",\n                  \"elementType\" : {\n                    \"type\" : \"ChoiceTypeSpecifier\",\n                    \"choice\" : [ {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    }, {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    } ]\n                  }\n                }\n              }, {\n                \"type\" : \"As\",\n                \"operand\" : {\n                  \"localId\" : \"203\",\n                  \"locator\" : \"109:10-109:62\",\n                  \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                  \"templateId\" : \"PositiveMedicationOrder\",\n                  \"codeProperty\" : \"code\",\n                  \"type\" : \"Retrieve\",\n                  \"codes\" : {\n                    \"locator\" : \"109:32-109:61\",\n                    \"name\" : \"NEPA Netupitant Palonosetron\",\n                    \"type\" : \"ValueSetRef\"\n                  }\n                },\n                \"asTypeSpecifier\" : {\n                  \"type\" : \"ListTypeSpecifier\",\n                  \"elementType\" : {\n                    \"type\" : \"ChoiceTypeSpecifier\",\n                    \"choice\" : [ {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    }, {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    } ]\n                  }\n                }\n              } ]\n            }\n          } ],\n          \"relationship\" : [ {\n            \"localId\" : \"215\",\n            \"locator\" : \"110:4-111:100\",\n            \"alias\" : \"ComboChemo\",\n            \"type\" : \"With\",\n            \"expression\" : {\n              \"localId\" : \"206\",\n              \"locator\" : \"110:9-110:86\",\n              \"name\" : \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\",\n              \"type\" : \"ExpressionRef\"\n            },\n            \"suchThat\" : {\n              \"localId\" : \"214\",\n              \"locator\" : \"111:15-111:100\",\n              \"type\" : \"And\",\n              \"operand\" : [ {\n                \"locator\" : \"111:46-111:59\",\n                \"type\" : \"In\",\n                \"operand\" : [ {\n                  \"locator\" : \"111:39-111:44\",\n                  \"type\" : \"Start\",\n                  \"operand\" : {\n                    \"localId\" : \"209\",\n                    \"locator\" : \"111:15-111:37\",\n                    \"path\" : \"relevantPeriod\",\n                    \"scope\" : \"MedAdmin\",\n                    \"type\" : \"Property\"\n                  }\n                }, {\n                  \"locator\" : \"111:46-111:59\",\n                  \"lowClosed\" : false,\n                  \"highClosed\" : true,\n                  \"type\" : \"Interval\",\n                  \"low\" : {\n                    \"localId\" : \"212\",\n                    \"locator\" : \"111:67-111:100\",\n                    \"type\" : \"Start\",\n                    \"operand\" : {\n                      \"localId\" : \"211\",\n                      \"locator\" : \"111:76-111:100\",\n                      \"path\" : \"relevantPeriod\",\n                      \"scope\" : \"ComboChemo\",\n                      \"type\" : \"Property\"\n                    }\n                  },\n                  \"high\" : {\n                    \"locator\" : \"111:67-111:100\",\n                    \"type\" : \"Add\",\n                    \"operand\" : [ {\n                      \"localId\" : \"212\",\n                      \"locator\" : \"111:67-111:100\",\n                      \"type\" : \"Start\",\n                      \"operand\" : {\n                        \"localId\" : \"211\",\n                        \"locator\" : \"111:76-111:100\",\n                        \"path\" : \"relevantPeriod\",\n                        \"scope\" : \"ComboChemo\",\n                        \"type\" : \"Property\"\n                      }\n                    }, {\n                      \"localId\" : \"213\",\n                      \"locator\" : \"111:46-111:51\",\n                      \"value\" : 7,\n                      \"unit\" : \"days\",\n                      \"type\" : \"Quantity\"\n                    } ]\n                  }\n                } ]\n              }, {\n                \"locator\" : \"111:46-111:59\",\n                \"type\" : \"Not\",\n                \"operand\" : {\n                  \"locator\" : \"111:46-111:59\",\n                  \"type\" : \"IsNull\",\n                  \"operand\" : {\n                    \"localId\" : \"212\",\n                    \"locator\" : \"111:67-111:100\",\n                    \"type\" : \"Start\",\n                    \"operand\" : {\n                      \"localId\" : \"211\",\n                      \"locator\" : \"111:76-111:100\",\n                      \"path\" : \"relevantPeriod\",\n                      \"scope\" : \"ComboChemo\",\n                      \"type\" : \"Property\"\n                    }\n                  }\n                }\n              } ]\n            }\n          } ]\n        }\n      }, {\n        \"localId\" : \"237\",\n        \"locator\" : \"113:1-119:100\",\n        \"name\" : \"First Gen Serotonin Antagonists or Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"237\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"First Gen Serotonin Antagonists or Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"236\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"225\",\n                  \"s\" : [ {\n                    \"r\" : \"224\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"224\",\n                      \"s\" : [ {\n                        \"r\" : \"222\",\n                        \"s\" : [ {\n                          \"r\" : \"220\",\n                          \"s\" : [ {\n                            \"r\" : \"218\",\n                            \"s\" : [ {\n                              \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                            }, {\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"First Generation Serotonin Antagonists\\\"\" ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"]\" ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"\\n  \\tunion \" ]\n                          }, {\n                            \"r\" : \"219\",\n                            \"s\" : [ {\n                              \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                            }, {\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"Palonosetron\\\"\" ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"]\" ]\n                            } ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"\\n  \\tunion \" ]\n                        }, {\n                          \"r\" : \"221\",\n                          \"s\" : [ {\n                            \"value\" : [ \"[\", \"\\\"Medication, Order\\\"\", \": \" ]\n                          }, {\n                            \"s\" : [ {\n                              \"value\" : [ \"\\\"First Generation Serotonin Antagonists\\\"\" ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"]\" ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\tunion \" ]\n                      }, {\n                        \"r\" : \"223\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"Medication, Order\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Palonosetron\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedAdmin\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"235\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"227\",\n                  \"s\" : [ {\n                    \"r\" : \"226\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"ComboChemo\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"234\",\n                  \"s\" : [ {\n                    \"r\" : \"229\",\n                    \"s\" : [ {\n                      \"r\" : \"228\",\n                      \"s\" : [ {\n                        \"value\" : [ \"MedAdmin\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"229\",\n                      \"s\" : [ {\n                        \"value\" : [ \"relevantPeriod\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \" ]\n                  }, {\n                    \"r\" : \"234\",\n                    \"s\" : [ {\n                      \"value\" : [ \"starts \" ]\n                    }, {\n                      \"r\" : \"233\",\n                      \"s\" : [ {\n                        \"value\" : [ \"7 \", \"days\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" or less after\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \" ]\n                  }, {\n                    \"r\" : \"232\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"231\",\n                      \"s\" : [ {\n                        \"r\" : \"230\",\n                        \"s\" : [ {\n                          \"value\" : [ \"ComboChemo\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"231\",\n                        \"s\" : [ {\n                          \"value\" : [ \"relevantPeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"236\",\n          \"locator\" : \"114:3-119:100\",\n          \"type\" : \"Query\",\n          \"source\" : [ {\n            \"localId\" : \"225\",\n            \"locator\" : \"114:3-117:57\",\n            \"alias\" : \"MedAdmin\",\n            \"expression\" : {\n              \"localId\" : \"224\",\n              \"locator\" : \"114:3-117:48\",\n              \"type\" : \"Union\",\n              \"operand\" : [ {\n                \"type\" : \"As\",\n                \"operand\" : {\n                  \"localId\" : \"222\",\n                  \"locator\" : \"114:5-116:72\",\n                  \"type\" : \"Union\",\n                  \"operand\" : [ {\n                    \"type\" : \"As\",\n                    \"operand\" : {\n                      \"localId\" : \"220\",\n                      \"locator\" : \"114:5-115:53\",\n                      \"type\" : \"Union\",\n                      \"operand\" : [ {\n                        \"localId\" : \"218\",\n                        \"locator\" : \"114:5-114:74\",\n                        \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                        \"templateId\" : \"PositiveMedicationAdministered\",\n                        \"codeProperty\" : \"code\",\n                        \"type\" : \"Retrieve\",\n                        \"codes\" : {\n                          \"locator\" : \"114:34-114:73\",\n                          \"name\" : \"First Generation Serotonin Antagonists\",\n                          \"type\" : \"ValueSetRef\"\n                        }\n                      }, {\n                        \"localId\" : \"219\",\n                        \"locator\" : \"115:10-115:53\",\n                        \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                        \"templateId\" : \"PositiveMedicationAdministered\",\n                        \"codeProperty\" : \"code\",\n                        \"type\" : \"Retrieve\",\n                        \"codes\" : {\n                          \"locator\" : \"115:39-115:52\",\n                          \"name\" : \"Palonosetron\",\n                          \"type\" : \"ValueSetRef\"\n                        }\n                      } ]\n                    },\n                    \"asTypeSpecifier\" : {\n                      \"type\" : \"ListTypeSpecifier\",\n                      \"elementType\" : {\n                        \"type\" : \"ChoiceTypeSpecifier\",\n                        \"choice\" : [ {\n                          \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        }, {\n                          \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        } ]\n                      }\n                    }\n                  }, {\n                    \"type\" : \"As\",\n                    \"operand\" : {\n                      \"localId\" : \"221\",\n                      \"locator\" : \"116:10-116:72\",\n                      \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                      \"templateId\" : \"PositiveMedicationOrder\",\n                      \"codeProperty\" : \"code\",\n                      \"type\" : \"Retrieve\",\n                      \"codes\" : {\n                        \"locator\" : \"116:32-116:71\",\n                        \"name\" : \"First Generation Serotonin Antagonists\",\n                        \"type\" : \"ValueSetRef\"\n                      }\n                    },\n                    \"asTypeSpecifier\" : {\n                      \"type\" : \"ListTypeSpecifier\",\n                      \"elementType\" : {\n                        \"type\" : \"ChoiceTypeSpecifier\",\n                        \"choice\" : [ {\n                          \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        }, {\n                          \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        } ]\n                      }\n                    }\n                  } ]\n                },\n                \"asTypeSpecifier\" : {\n                  \"type\" : \"ListTypeSpecifier\",\n                  \"elementType\" : {\n                    \"type\" : \"ChoiceTypeSpecifier\",\n                    \"choice\" : [ {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    }, {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    } ]\n                  }\n                }\n              }, {\n                \"type\" : \"As\",\n                \"operand\" : {\n                  \"localId\" : \"223\",\n                  \"locator\" : \"117:10-117:46\",\n                  \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                  \"templateId\" : \"PositiveMedicationOrder\",\n                  \"codeProperty\" : \"code\",\n                  \"type\" : \"Retrieve\",\n                  \"codes\" : {\n                    \"locator\" : \"117:32-117:45\",\n                    \"name\" : \"Palonosetron\",\n                    \"type\" : \"ValueSetRef\"\n                  }\n                },\n                \"asTypeSpecifier\" : {\n                  \"type\" : \"ListTypeSpecifier\",\n                  \"elementType\" : {\n                    \"type\" : \"ChoiceTypeSpecifier\",\n                    \"choice\" : [ {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    }, {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    } ]\n                  }\n                }\n              } ]\n            }\n          } ],\n          \"relationship\" : [ {\n            \"localId\" : \"235\",\n            \"locator\" : \"118:4-119:100\",\n            \"alias\" : \"ComboChemo\",\n            \"type\" : \"With\",\n            \"expression\" : {\n              \"localId\" : \"226\",\n              \"locator\" : \"118:9-118:86\",\n              \"name\" : \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\",\n              \"type\" : \"ExpressionRef\"\n            },\n            \"suchThat\" : {\n              \"localId\" : \"234\",\n              \"locator\" : \"119:15-119:100\",\n              \"type\" : \"And\",\n              \"operand\" : [ {\n                \"locator\" : \"119:46-119:59\",\n                \"type\" : \"In\",\n                \"operand\" : [ {\n                  \"locator\" : \"119:39-119:44\",\n                  \"type\" : \"Start\",\n                  \"operand\" : {\n                    \"localId\" : \"229\",\n                    \"locator\" : \"119:15-119:37\",\n                    \"path\" : \"relevantPeriod\",\n                    \"scope\" : \"MedAdmin\",\n                    \"type\" : \"Property\"\n                  }\n                }, {\n                  \"locator\" : \"119:46-119:59\",\n                  \"lowClosed\" : false,\n                  \"highClosed\" : true,\n                  \"type\" : \"Interval\",\n                  \"low\" : {\n                    \"localId\" : \"232\",\n                    \"locator\" : \"119:67-119:100\",\n                    \"type\" : \"Start\",\n                    \"operand\" : {\n                      \"localId\" : \"231\",\n                      \"locator\" : \"119:76-119:100\",\n                      \"path\" : \"relevantPeriod\",\n                      \"scope\" : \"ComboChemo\",\n                      \"type\" : \"Property\"\n                    }\n                  },\n                  \"high\" : {\n                    \"locator\" : \"119:67-119:100\",\n                    \"type\" : \"Add\",\n                    \"operand\" : [ {\n                      \"localId\" : \"232\",\n                      \"locator\" : \"119:67-119:100\",\n                      \"type\" : \"Start\",\n                      \"operand\" : {\n                        \"localId\" : \"231\",\n                        \"locator\" : \"119:76-119:100\",\n                        \"path\" : \"relevantPeriod\",\n                        \"scope\" : \"ComboChemo\",\n                        \"type\" : \"Property\"\n                      }\n                    }, {\n                      \"localId\" : \"233\",\n                      \"locator\" : \"119:46-119:51\",\n                      \"value\" : 7,\n                      \"unit\" : \"days\",\n                      \"type\" : \"Quantity\"\n                    } ]\n                  }\n                } ]\n              }, {\n                \"locator\" : \"119:46-119:59\",\n                \"type\" : \"Not\",\n                \"operand\" : {\n                  \"locator\" : \"119:46-119:59\",\n                  \"type\" : \"IsNull\",\n                  \"operand\" : {\n                    \"localId\" : \"232\",\n                    \"locator\" : \"119:67-119:100\",\n                    \"type\" : \"Start\",\n                    \"operand\" : {\n                      \"localId\" : \"231\",\n                      \"locator\" : \"119:76-119:100\",\n                      \"path\" : \"relevantPeriod\",\n                      \"scope\" : \"ComboChemo\",\n                      \"type\" : \"Property\"\n                    }\n                  }\n                }\n              } ]\n            }\n          } ]\n        }\n      }, {\n        \"localId\" : \"256\",\n        \"locator\" : \"121:1-127:86\",\n        \"name\" : \"First Gen Serotonin Antagonists or Palonosetron administered or ordered before Combo High Risk Chemo\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"256\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"First Gen Serotonin Antagonists or Palonosetron administered or ordered before Combo High Risk Chemo\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"255\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"245\",\n                  \"s\" : [ {\n                    \"r\" : \"244\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"244\",\n                      \"s\" : [ {\n                        \"r\" : \"242\",\n                        \"s\" : [ {\n                          \"r\" : \"240\",\n                          \"s\" : [ {\n                            \"r\" : \"238\",\n                            \"s\" : [ {\n                              \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                            }, {\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"First Generation Serotonin Antagonists\\\"\" ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"]\" ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"\\n  \\tunion \" ]\n                          }, {\n                            \"r\" : \"239\",\n                            \"s\" : [ {\n                              \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                            }, {\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"Palonosetron\\\"\" ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"]\" ]\n                            } ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"\\n  \\tunion \" ]\n                        }, {\n                          \"r\" : \"241\",\n                          \"s\" : [ {\n                            \"value\" : [ \"[\", \"\\\"Medication, Order\\\"\", \": \" ]\n                          }, {\n                            \"s\" : [ {\n                              \"value\" : [ \"\\\"First Generation Serotonin Antagonists\\\"\" ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"]\" ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\tunion \" ]\n                      }, {\n                        \"r\" : \"243\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"Medication, Order\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Palonosetron\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedAdmin\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"254\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"247\",\n                  \"s\" : [ {\n                    \"r\" : \"246\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"ComboChemo\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"253\",\n                  \"s\" : [ {\n                    \"r\" : \"249\",\n                    \"s\" : [ {\n                      \"r\" : \"248\",\n                      \"s\" : [ {\n                        \"value\" : [ \"MedAdmin\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"249\",\n                      \"s\" : [ {\n                        \"value\" : [ \"relevantPeriod\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"r\" : \"253\",\n                    \"value\" : [ \" \", \"starts before\", \" \" ]\n                  }, {\n                    \"r\" : \"252\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"251\",\n                      \"s\" : [ {\n                        \"r\" : \"250\",\n                        \"s\" : [ {\n                          \"value\" : [ \"ComboChemo\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"251\",\n                        \"s\" : [ {\n                          \"value\" : [ \"relevantPeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"255\",\n          \"locator\" : \"122:3-127:86\",\n          \"type\" : \"Query\",\n          \"source\" : [ {\n            \"localId\" : \"245\",\n            \"locator\" : \"122:3-125:57\",\n            \"alias\" : \"MedAdmin\",\n            \"expression\" : {\n              \"localId\" : \"244\",\n              \"locator\" : \"122:3-125:48\",\n              \"type\" : \"Union\",\n              \"operand\" : [ {\n                \"type\" : \"As\",\n                \"operand\" : {\n                  \"localId\" : \"242\",\n                  \"locator\" : \"122:5-124:72\",\n                  \"type\" : \"Union\",\n                  \"operand\" : [ {\n                    \"type\" : \"As\",\n                    \"operand\" : {\n                      \"localId\" : \"240\",\n                      \"locator\" : \"122:5-123:53\",\n                      \"type\" : \"Union\",\n                      \"operand\" : [ {\n                        \"localId\" : \"238\",\n                        \"locator\" : \"122:5-122:74\",\n                        \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                        \"templateId\" : \"PositiveMedicationAdministered\",\n                        \"codeProperty\" : \"code\",\n                        \"type\" : \"Retrieve\",\n                        \"codes\" : {\n                          \"locator\" : \"122:34-122:73\",\n                          \"name\" : \"First Generation Serotonin Antagonists\",\n                          \"type\" : \"ValueSetRef\"\n                        }\n                      }, {\n                        \"localId\" : \"239\",\n                        \"locator\" : \"123:10-123:53\",\n                        \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                        \"templateId\" : \"PositiveMedicationAdministered\",\n                        \"codeProperty\" : \"code\",\n                        \"type\" : \"Retrieve\",\n                        \"codes\" : {\n                          \"locator\" : \"123:39-123:52\",\n                          \"name\" : \"Palonosetron\",\n                          \"type\" : \"ValueSetRef\"\n                        }\n                      } ]\n                    },\n                    \"asTypeSpecifier\" : {\n                      \"type\" : \"ListTypeSpecifier\",\n                      \"elementType\" : {\n                        \"type\" : \"ChoiceTypeSpecifier\",\n                        \"choice\" : [ {\n                          \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        }, {\n                          \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        } ]\n                      }\n                    }\n                  }, {\n                    \"type\" : \"As\",\n                    \"operand\" : {\n                      \"localId\" : \"241\",\n                      \"locator\" : \"124:10-124:72\",\n                      \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                      \"templateId\" : \"PositiveMedicationOrder\",\n                      \"codeProperty\" : \"code\",\n                      \"type\" : \"Retrieve\",\n                      \"codes\" : {\n                        \"locator\" : \"124:32-124:71\",\n                        \"name\" : \"First Generation Serotonin Antagonists\",\n                        \"type\" : \"ValueSetRef\"\n                      }\n                    },\n                    \"asTypeSpecifier\" : {\n                      \"type\" : \"ListTypeSpecifier\",\n                      \"elementType\" : {\n                        \"type\" : \"ChoiceTypeSpecifier\",\n                        \"choice\" : [ {\n                          \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        }, {\n                          \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        } ]\n                      }\n                    }\n                  } ]\n                },\n                \"asTypeSpecifier\" : {\n                  \"type\" : \"ListTypeSpecifier\",\n                  \"elementType\" : {\n                    \"type\" : \"ChoiceTypeSpecifier\",\n                    \"choice\" : [ {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    }, {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    } ]\n                  }\n                }\n              }, {\n                \"type\" : \"As\",\n                \"operand\" : {\n                  \"localId\" : \"243\",\n                  \"locator\" : \"125:10-125:46\",\n                  \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                  \"templateId\" : \"PositiveMedicationOrder\",\n                  \"codeProperty\" : \"code\",\n                  \"type\" : \"Retrieve\",\n                  \"codes\" : {\n                    \"locator\" : \"125:32-125:45\",\n                    \"name\" : \"Palonosetron\",\n                    \"type\" : \"ValueSetRef\"\n                  }\n                },\n                \"asTypeSpecifier\" : {\n                  \"type\" : \"ListTypeSpecifier\",\n                  \"elementType\" : {\n                    \"type\" : \"ChoiceTypeSpecifier\",\n                    \"choice\" : [ {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    }, {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    } ]\n                  }\n                }\n              } ]\n            }\n          } ],\n          \"relationship\" : [ {\n            \"localId\" : \"254\",\n            \"locator\" : \"126:4-127:86\",\n            \"alias\" : \"ComboChemo\",\n            \"type\" : \"With\",\n            \"expression\" : {\n              \"localId\" : \"246\",\n              \"locator\" : \"126:9-126:86\",\n              \"name\" : \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\",\n              \"type\" : \"ExpressionRef\"\n            },\n            \"suchThat\" : {\n              \"localId\" : \"253\",\n              \"locator\" : \"127:15-127:86\",\n              \"type\" : \"Before\",\n              \"operand\" : [ {\n                \"locator\" : \"127:39-127:44\",\n                \"type\" : \"Start\",\n                \"operand\" : {\n                  \"localId\" : \"249\",\n                  \"locator\" : \"127:15-127:37\",\n                  \"path\" : \"relevantPeriod\",\n                  \"scope\" : \"MedAdmin\",\n                  \"type\" : \"Property\"\n                }\n              }, {\n                \"localId\" : \"252\",\n                \"locator\" : \"127:53-127:86\",\n                \"type\" : \"Start\",\n                \"operand\" : {\n                  \"localId\" : \"251\",\n                  \"locator\" : \"127:62-127:86\",\n                  \"path\" : \"relevantPeriod\",\n                  \"scope\" : \"ComboChemo\",\n                  \"type\" : \"Property\"\n                }\n              } ]\n            }\n          } ]\n        }\n      }, {\n        \"localId\" : \"293\",\n        \"locator\" : \"132:1-144:72\",\n        \"name\" : \"Reasons for Not prescribing or Ordering First Gen Serotonin Antagonists, Aprepitant, Fosprepitant or Netupitant\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"293\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Reasons for Not prescribing or Ordering First Gen Serotonin Antagonists, Aprepitant, Fosprepitant or Netupitant\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"292\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"272\",\n                  \"s\" : [ {\n                    \"r\" : \"271\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"271\",\n                      \"s\" : [ {\n                        \"r\" : \"269\",\n                        \"s\" : [ {\n                          \"r\" : \"267\",\n                          \"s\" : [ {\n                            \"r\" : \"265\",\n                            \"s\" : [ {\n                              \"r\" : \"263\",\n                              \"s\" : [ {\n                                \"r\" : \"261\",\n                                \"s\" : [ {\n                                  \"r\" : \"259\",\n                                  \"s\" : [ {\n                                    \"r\" : \"257\",\n                                    \"s\" : [ {\n                                      \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                                    }, {\n                                      \"s\" : [ {\n                                        \"value\" : [ \"\\\"First Generation Serotonin Antagonists\\\"\" ]\n                                      } ]\n                                    }, {\n                                      \"value\" : [ \"]\" ]\n                                    } ]\n                                  }, {\n                                    \"value\" : [ \"\\n  \\tunion \" ]\n                                  }, {\n                                    \"r\" : \"258\",\n                                    \"s\" : [ {\n                                      \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                                    }, {\n                                      \"s\" : [ {\n                                        \"value\" : [ \"\\\"Aprepitant\\\"\" ]\n                                      } ]\n                                    }, {\n                                      \"value\" : [ \"]\" ]\n                                    } ]\n                                  } ]\n                                }, {\n                                  \"value\" : [ \"\\n  \\tunion \" ]\n                                }, {\n                                  \"r\" : \"260\",\n                                  \"s\" : [ {\n                                    \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                                  }, {\n                                    \"s\" : [ {\n                                      \"value\" : [ \"\\\"Fosaprepitant\\\"\" ]\n                                    } ]\n                                  }, {\n                                    \"value\" : [ \"]\" ]\n                                  } ]\n                                } ]\n                              }, {\n                                \"value\" : [ \"\\n  \\tunion \" ]\n                              }, {\n                                \"r\" : \"262\",\n                                \"s\" : [ {\n                                  \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                                }, {\n                                  \"s\" : [ {\n                                    \"value\" : [ \"\\\"Netupitant\\\"\" ]\n                                  } ]\n                                }, {\n                                  \"value\" : [ \"]\" ]\n                                } ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"\\n  \\tunion \" ]\n                            }, {\n                              \"r\" : \"264\",\n                              \"s\" : [ {\n                                \"value\" : [ \"[\", \"\\\"Medication, Order\\\"\", \": \" ]\n                              }, {\n                                \"s\" : [ {\n                                  \"value\" : [ \"\\\"First Generation Serotonin Antagonists\\\"\" ]\n                                } ]\n                              }, {\n                                \"value\" : [ \"]\" ]\n                              } ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"\\n  \\tunion \" ]\n                          }, {\n                            \"r\" : \"266\",\n                            \"s\" : [ {\n                              \"value\" : [ \"[\", \"\\\"Medication, Order\\\"\", \": \" ]\n                            }, {\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"Aprepitant\\\"\" ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"]\" ]\n                            } ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"\\n  \\tunion \" ]\n                        }, {\n                          \"r\" : \"268\",\n                          \"s\" : [ {\n                            \"value\" : [ \"[\", \"\\\"Medication, Order\\\"\", \": \" ]\n                          }, {\n                            \"s\" : [ {\n                              \"value\" : [ \"\\\"Fosaprepitant\\\"\" ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"]\" ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\tunion \" ]\n                      }, {\n                        \"r\" : \"270\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"Medication, Order\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Netupitant\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedNotOrdered\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"291\",\n                \"s\" : [ {\n                  \"value\" : [ \"where \" ]\n                }, {\n                  \"r\" : \"291\",\n                  \"s\" : [ {\n                    \"r\" : \"281\",\n                    \"s\" : [ {\n                      \"r\" : \"276\",\n                      \"s\" : [ {\n                        \"r\" : \"274\",\n                        \"s\" : [ {\n                          \"r\" : \"273\",\n                          \"s\" : [ {\n                            \"value\" : [ \"MedNotOrdered\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \".\" ]\n                        }, {\n                          \"r\" : \"274\",\n                          \"s\" : [ {\n                            \"value\" : [ \"negationRationale\" ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \" in \" ]\n                      }, {\n                        \"r\" : \"275\",\n                        \"s\" : [ {\n                          \"value\" : [ \"\\\"Medical Reason\\\"\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \"\\n  \\t\\tor \" ]\n                    }, {\n                      \"r\" : \"280\",\n                      \"s\" : [ {\n                        \"r\" : \"278\",\n                        \"s\" : [ {\n                          \"r\" : \"277\",\n                          \"s\" : [ {\n                            \"value\" : [ \"MedNotOrdered\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \".\" ]\n                        }, {\n                          \"r\" : \"278\",\n                          \"s\" : [ {\n                            \"value\" : [ \"negationRationale\" ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \" in \" ]\n                      }, {\n                        \"r\" : \"279\",\n                        \"s\" : [ {\n                          \"value\" : [ \"\\\"Patient Reason\\\"\" ]\n                        } ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \"\\n  \\t\\tor \" ]\n                  }, {\n                    \"r\" : \"290\",\n                    \"s\" : [ {\n                      \"r\" : \"285\",\n                      \"s\" : [ {\n                        \"r\" : \"283\",\n                        \"s\" : [ {\n                          \"r\" : \"282\",\n                          \"s\" : [ {\n                            \"value\" : [ \"MedNotOrdered\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \".\" ]\n                        }, {\n                          \"r\" : \"283\",\n                          \"s\" : [ {\n                            \"value\" : [ \"negationRationale\" ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \" in \" ]\n                      }, {\n                        \"r\" : \"284\",\n                        \"s\" : [ {\n                          \"value\" : [ \"\\\"System Reason\\\"\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \"\\n  \\t\\t\\tand \" ]\n                    }, {\n                      \"r\" : \"289\",\n                      \"s\" : [ {\n                        \"r\" : \"287\",\n                        \"s\" : [ {\n                          \"r\" : \"286\",\n                          \"s\" : [ {\n                            \"value\" : [ \"MedNotOrdered\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \".\" ]\n                        }, {\n                          \"r\" : \"287\",\n                          \"s\" : [ {\n                            \"value\" : [ \"relevantPeriod\" ]\n                          } ]\n                        } ]\n                      }, {\n                        \"r\" : \"289\",\n                        \"value\" : [ \" \", \"starts during\", \" \" ]\n                      }, {\n                        \"r\" : \"288\",\n                        \"s\" : [ {\n                          \"value\" : [ \"\\\"Measurement Period\\\"\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"292\",\n          \"locator\" : \"133:3-144:72\",\n          \"type\" : \"Query\",\n          \"source\" : [ {\n            \"localId\" : \"272\",\n            \"locator\" : \"133:3-140:60\",\n            \"alias\" : \"MedNotOrdered\",\n            \"expression\" : {\n              \"localId\" : \"271\",\n              \"locator\" : \"133:3-140:46\",\n              \"type\" : \"Union\",\n              \"operand\" : [ {\n                \"type\" : \"As\",\n                \"operand\" : {\n                  \"localId\" : \"269\",\n                  \"locator\" : \"133:5-139:47\",\n                  \"type\" : \"Union\",\n                  \"operand\" : [ {\n                    \"type\" : \"As\",\n                    \"operand\" : {\n                      \"localId\" : \"267\",\n                      \"locator\" : \"133:5-138:44\",\n                      \"type\" : \"Union\",\n                      \"operand\" : [ {\n                        \"type\" : \"As\",\n                        \"operand\" : {\n                          \"localId\" : \"265\",\n                          \"locator\" : \"133:5-137:72\",\n                          \"type\" : \"Union\",\n                          \"operand\" : [ {\n                            \"type\" : \"As\",\n                            \"operand\" : {\n                              \"localId\" : \"263\",\n                              \"locator\" : \"133:5-136:51\",\n                              \"type\" : \"Union\",\n                              \"operand\" : [ {\n                                \"localId\" : \"259\",\n                                \"locator\" : \"133:5-134:51\",\n                                \"type\" : \"Union\",\n                                \"operand\" : [ {\n                                  \"localId\" : \"257\",\n                                  \"locator\" : \"133:5-133:74\",\n                                  \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                                  \"templateId\" : \"PositiveMedicationAdministered\",\n                                  \"codeProperty\" : \"code\",\n                                  \"type\" : \"Retrieve\",\n                                  \"codes\" : {\n                                    \"locator\" : \"133:34-133:73\",\n                                    \"name\" : \"First Generation Serotonin Antagonists\",\n                                    \"type\" : \"ValueSetRef\"\n                                  }\n                                }, {\n                                  \"localId\" : \"258\",\n                                  \"locator\" : \"134:10-134:51\",\n                                  \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                                  \"templateId\" : \"PositiveMedicationAdministered\",\n                                  \"codeProperty\" : \"code\",\n                                  \"type\" : \"Retrieve\",\n                                  \"codes\" : {\n                                    \"locator\" : \"134:39-134:50\",\n                                    \"name\" : \"Aprepitant\",\n                                    \"type\" : \"ValueSetRef\"\n                                  }\n                                } ]\n                              }, {\n                                \"type\" : \"Union\",\n                                \"operand\" : [ {\n                                  \"localId\" : \"260\",\n                                  \"locator\" : \"135:10-135:54\",\n                                  \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                                  \"templateId\" : \"PositiveMedicationAdministered\",\n                                  \"codeProperty\" : \"code\",\n                                  \"type\" : \"Retrieve\",\n                                  \"codes\" : {\n                                    \"locator\" : \"135:39-135:53\",\n                                    \"name\" : \"Fosaprepitant\",\n                                    \"type\" : \"ValueSetRef\"\n                                  }\n                                }, {\n                                  \"localId\" : \"262\",\n                                  \"locator\" : \"136:10-136:51\",\n                                  \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                                  \"templateId\" : \"PositiveMedicationAdministered\",\n                                  \"codeProperty\" : \"code\",\n                                  \"type\" : \"Retrieve\",\n                                  \"codes\" : {\n                                    \"locator\" : \"136:39-136:50\",\n                                    \"name\" : \"Netupitant\",\n                                    \"type\" : \"ValueSetRef\"\n                                  }\n                                } ]\n                              } ]\n                            },\n                            \"asTypeSpecifier\" : {\n                              \"type\" : \"ListTypeSpecifier\",\n                              \"elementType\" : {\n                                \"type\" : \"ChoiceTypeSpecifier\",\n                                \"choice\" : [ {\n                                  \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                                  \"type\" : \"NamedTypeSpecifier\"\n                                }, {\n                                  \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                                  \"type\" : \"NamedTypeSpecifier\"\n                                } ]\n                              }\n                            }\n                          }, {\n                            \"type\" : \"As\",\n                            \"operand\" : {\n                              \"localId\" : \"264\",\n                              \"locator\" : \"137:10-137:72\",\n                              \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                              \"templateId\" : \"PositiveMedicationOrder\",\n                              \"codeProperty\" : \"code\",\n                              \"type\" : \"Retrieve\",\n                              \"codes\" : {\n                                \"locator\" : \"137:32-137:71\",\n                                \"name\" : \"First Generation Serotonin Antagonists\",\n                                \"type\" : \"ValueSetRef\"\n                              }\n                            },\n                            \"asTypeSpecifier\" : {\n                              \"type\" : \"ListTypeSpecifier\",\n                              \"elementType\" : {\n                                \"type\" : \"ChoiceTypeSpecifier\",\n                                \"choice\" : [ {\n                                  \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                                  \"type\" : \"NamedTypeSpecifier\"\n                                }, {\n                                  \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                                  \"type\" : \"NamedTypeSpecifier\"\n                                } ]\n                              }\n                            }\n                          } ]\n                        },\n                        \"asTypeSpecifier\" : {\n                          \"type\" : \"ListTypeSpecifier\",\n                          \"elementType\" : {\n                            \"type\" : \"ChoiceTypeSpecifier\",\n                            \"choice\" : [ {\n                              \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                              \"type\" : \"NamedTypeSpecifier\"\n                            }, {\n                              \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                              \"type\" : \"NamedTypeSpecifier\"\n                            } ]\n                          }\n                        }\n                      }, {\n                        \"type\" : \"As\",\n                        \"operand\" : {\n                          \"localId\" : \"266\",\n                          \"locator\" : \"138:10-138:44\",\n                          \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                          \"templateId\" : \"PositiveMedicationOrder\",\n                          \"codeProperty\" : \"code\",\n                          \"type\" : \"Retrieve\",\n                          \"codes\" : {\n                            \"locator\" : \"138:32-138:43\",\n                            \"name\" : \"Aprepitant\",\n                            \"type\" : \"ValueSetRef\"\n                          }\n                        },\n                        \"asTypeSpecifier\" : {\n                          \"type\" : \"ListTypeSpecifier\",\n                          \"elementType\" : {\n                            \"type\" : \"ChoiceTypeSpecifier\",\n                            \"choice\" : [ {\n                              \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                              \"type\" : \"NamedTypeSpecifier\"\n                            }, {\n                              \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                              \"type\" : \"NamedTypeSpecifier\"\n                            } ]\n                          }\n                        }\n                      } ]\n                    },\n                    \"asTypeSpecifier\" : {\n                      \"type\" : \"ListTypeSpecifier\",\n                      \"elementType\" : {\n                        \"type\" : \"ChoiceTypeSpecifier\",\n                        \"choice\" : [ {\n                          \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        }, {\n                          \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        } ]\n                      }\n                    }\n                  }, {\n                    \"type\" : \"As\",\n                    \"operand\" : {\n                      \"localId\" : \"268\",\n                      \"locator\" : \"139:10-139:47\",\n                      \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                      \"templateId\" : \"PositiveMedicationOrder\",\n                      \"codeProperty\" : \"code\",\n                      \"type\" : \"Retrieve\",\n                      \"codes\" : {\n                        \"locator\" : \"139:32-139:46\",\n                        \"name\" : \"Fosaprepitant\",\n                        \"type\" : \"ValueSetRef\"\n                      }\n                    },\n                    \"asTypeSpecifier\" : {\n                      \"type\" : \"ListTypeSpecifier\",\n                      \"elementType\" : {\n                        \"type\" : \"ChoiceTypeSpecifier\",\n                        \"choice\" : [ {\n                          \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        }, {\n                          \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        } ]\n                      }\n                    }\n                  } ]\n                },\n                \"asTypeSpecifier\" : {\n                  \"type\" : \"ListTypeSpecifier\",\n                  \"elementType\" : {\n                    \"type\" : \"ChoiceTypeSpecifier\",\n                    \"choice\" : [ {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    }, {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    } ]\n                  }\n                }\n              }, {\n                \"type\" : \"As\",\n                \"operand\" : {\n                  \"localId\" : \"270\",\n                  \"locator\" : \"140:10-140:44\",\n                  \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                  \"templateId\" : \"PositiveMedicationOrder\",\n                  \"codeProperty\" : \"code\",\n                  \"type\" : \"Retrieve\",\n                  \"codes\" : {\n                    \"locator\" : \"140:32-140:43\",\n                    \"name\" : \"Netupitant\",\n                    \"type\" : \"ValueSetRef\"\n                  }\n                },\n                \"asTypeSpecifier\" : {\n                  \"type\" : \"ListTypeSpecifier\",\n                  \"elementType\" : {\n                    \"type\" : \"ChoiceTypeSpecifier\",\n                    \"choice\" : [ {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    }, {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    } ]\n                  }\n                }\n              } ]\n            }\n          } ],\n          \"relationship\" : [ ],\n          \"where\" : {\n            \"localId\" : \"291\",\n            \"locator\" : \"141:4-144:72\",\n            \"type\" : \"Or\",\n            \"operand\" : [ {\n              \"localId\" : \"281\",\n              \"locator\" : \"141:10-142:58\",\n              \"type\" : \"Or\",\n              \"operand\" : [ {\n                \"localId\" : \"276\",\n                \"locator\" : \"141:10-141:60\",\n                \"type\" : \"InValueSet\",\n                \"code\" : {\n                  \"localId\" : \"274\",\n                  \"locator\" : \"141:10-141:40\",\n                  \"path\" : \"negationRationale\",\n                  \"scope\" : \"MedNotOrdered\",\n                  \"type\" : \"Property\"\n                },\n                \"valueset\" : {\n                  \"localId\" : \"275\",\n                  \"locator\" : \"141:45-141:60\",\n                  \"name\" : \"Medical Reason\"\n                }\n              }, {\n                \"localId\" : \"280\",\n                \"locator\" : \"142:8-142:58\",\n                \"type\" : \"InValueSet\",\n                \"code\" : {\n                  \"localId\" : \"278\",\n                  \"locator\" : \"142:8-142:38\",\n                  \"path\" : \"negationRationale\",\n                  \"scope\" : \"MedNotOrdered\",\n                  \"type\" : \"Property\"\n                },\n                \"valueset\" : {\n                  \"localId\" : \"279\",\n                  \"locator\" : \"142:43-142:58\",\n                  \"name\" : \"Patient Reason\"\n                }\n              } ]\n            }, {\n              \"localId\" : \"290\",\n              \"locator\" : \"143:8-144:72\",\n              \"type\" : \"And\",\n              \"operand\" : [ {\n                \"localId\" : \"285\",\n                \"locator\" : \"143:8-143:57\",\n                \"type\" : \"InValueSet\",\n                \"code\" : {\n                  \"localId\" : \"283\",\n                  \"locator\" : \"143:8-143:38\",\n                  \"path\" : \"negationRationale\",\n                  \"scope\" : \"MedNotOrdered\",\n                  \"type\" : \"Property\"\n                },\n                \"valueset\" : {\n                  \"localId\" : \"284\",\n                  \"locator\" : \"143:43-143:57\",\n                  \"name\" : \"System Reason\"\n                }\n              }, {\n                \"localId\" : \"289\",\n                \"locator\" : \"144:10-144:72\",\n                \"type\" : \"In\",\n                \"operand\" : [ {\n                  \"locator\" : \"144:39-144:44\",\n                  \"type\" : \"Start\",\n                  \"operand\" : {\n                    \"localId\" : \"287\",\n                    \"locator\" : \"144:10-144:37\",\n                    \"path\" : \"relevantPeriod\",\n                    \"scope\" : \"MedNotOrdered\",\n                    \"type\" : \"Property\"\n                  }\n                }, {\n                  \"localId\" : \"288\",\n                  \"locator\" : \"144:53-144:72\",\n                  \"name\" : \"Measurement Period\",\n                  \"type\" : \"ParameterRef\"\n                } ]\n              } ]\n            } ]\n          }\n        }\n      }, {\n        \"localId\" : \"296\",\n        \"locator\" : \"129:1-130:122\",\n        \"name\" : \"Denominator Exceptions\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"296\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Denominator Exceptions\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"295\",\n              \"s\" : [ {\n                \"value\" : [ \"exists \" ]\n              }, {\n                \"r\" : \"294\",\n                \"s\" : [ {\n                  \"value\" : [ \"\\\"Reasons for Not prescribing or Ordering First Gen Serotonin Antagonists, Aprepitant, Fosprepitant or Netupitant\\\"\" ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"295\",\n          \"locator\" : \"130:3-130:122\",\n          \"type\" : \"Exists\",\n          \"operand\" : {\n            \"localId\" : \"294\",\n            \"locator\" : \"130:10-130:122\",\n            \"name\" : \"Reasons for Not prescribing or Ordering First Gen Serotonin Antagonists, Aprepitant, Fosprepitant or Netupitant\",\n            \"type\" : \"ExpressionRef\"\n          }\n        }\n      }, {\n        \"localId\" : \"319\",\n        \"locator\" : \"146:1-154:86\",\n        \"name\" : \"Aprepitant, Fosaprepitant or Netupitant  administered or ordered before Combo High Risk Chemo\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"319\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Aprepitant, Fosaprepitant or Netupitant  administered or ordered before Combo High Risk Chemo\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"318\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"308\",\n                  \"s\" : [ {\n                    \"r\" : \"307\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"307\",\n                      \"s\" : [ {\n                        \"r\" : \"305\",\n                        \"s\" : [ {\n                          \"r\" : \"303\",\n                          \"s\" : [ {\n                            \"r\" : \"301\",\n                            \"s\" : [ {\n                              \"r\" : \"299\",\n                              \"s\" : [ {\n                                \"r\" : \"297\",\n                                \"s\" : [ {\n                                  \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                                }, {\n                                  \"s\" : [ {\n                                    \"value\" : [ \"\\\"Aprepitant\\\"\" ]\n                                  } ]\n                                }, {\n                                  \"value\" : [ \"]\" ]\n                                } ]\n                              }, {\n                                \"value\" : [ \"\\n  \\tunion \" ]\n                              }, {\n                                \"r\" : \"298\",\n                                \"s\" : [ {\n                                  \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                                }, {\n                                  \"s\" : [ {\n                                    \"value\" : [ \"\\\"Fosaprepitant\\\"\" ]\n                                  } ]\n                                }, {\n                                  \"value\" : [ \"]\" ]\n                                } ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"\\n  \\tunion \" ]\n                            }, {\n                              \"r\" : \"300\",\n                              \"s\" : [ {\n                                \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                              }, {\n                                \"s\" : [ {\n                                  \"value\" : [ \"\\\"Netupitant\\\"\" ]\n                                } ]\n                              }, {\n                                \"value\" : [ \"]\" ]\n                              } ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"\\n  \\tunion \" ]\n                          }, {\n                            \"r\" : \"302\",\n                            \"s\" : [ {\n                              \"value\" : [ \"[\", \"\\\"Medication, Order\\\"\", \": \" ]\n                            }, {\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"Aprepitant\\\"\" ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"]\" ]\n                            } ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"\\n  \\tunion \" ]\n                        }, {\n                          \"r\" : \"304\",\n                          \"s\" : [ {\n                            \"value\" : [ \"[\", \"\\\"Medication, Order\\\"\", \": \" ]\n                          }, {\n                            \"s\" : [ {\n                              \"value\" : [ \"\\\"Fosaprepitant\\\"\" ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"]\" ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\tunion \" ]\n                      }, {\n                        \"r\" : \"306\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"Medication, Order\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Netupitant\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedAdmin\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"317\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"310\",\n                  \"s\" : [ {\n                    \"r\" : \"309\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"ComboChemo\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"316\",\n                  \"s\" : [ {\n                    \"r\" : \"312\",\n                    \"s\" : [ {\n                      \"r\" : \"311\",\n                      \"s\" : [ {\n                        \"value\" : [ \"MedAdmin\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"312\",\n                      \"s\" : [ {\n                        \"value\" : [ \"relevantPeriod\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"r\" : \"316\",\n                    \"value\" : [ \" \", \"starts before\", \" \" ]\n                  }, {\n                    \"r\" : \"315\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"314\",\n                      \"s\" : [ {\n                        \"r\" : \"313\",\n                        \"s\" : [ {\n                          \"value\" : [ \"ComboChemo\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"314\",\n                        \"s\" : [ {\n                          \"value\" : [ \"relevantPeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"318\",\n          \"locator\" : \"147:3-154:86\",\n          \"type\" : \"Query\",\n          \"source\" : [ {\n            \"localId\" : \"308\",\n            \"locator\" : \"147:3-152:55\",\n            \"alias\" : \"MedAdmin\",\n            \"expression\" : {\n              \"localId\" : \"307\",\n              \"locator\" : \"147:3-152:46\",\n              \"type\" : \"Union\",\n              \"operand\" : [ {\n                \"type\" : \"As\",\n                \"operand\" : {\n                  \"localId\" : \"305\",\n                  \"locator\" : \"147:5-151:47\",\n                  \"type\" : \"Union\",\n                  \"operand\" : [ {\n                    \"type\" : \"As\",\n                    \"operand\" : {\n                      \"localId\" : \"303\",\n                      \"locator\" : \"147:5-150:44\",\n                      \"type\" : \"Union\",\n                      \"operand\" : [ {\n                        \"type\" : \"As\",\n                        \"operand\" : {\n                          \"localId\" : \"299\",\n                          \"locator\" : \"147:5-148:54\",\n                          \"type\" : \"Union\",\n                          \"operand\" : [ {\n                            \"localId\" : \"297\",\n                            \"locator\" : \"147:5-147:46\",\n                            \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                            \"templateId\" : \"PositiveMedicationAdministered\",\n                            \"codeProperty\" : \"code\",\n                            \"type\" : \"Retrieve\",\n                            \"codes\" : {\n                              \"locator\" : \"147:34-147:45\",\n                              \"name\" : \"Aprepitant\",\n                              \"type\" : \"ValueSetRef\"\n                            }\n                          }, {\n                            \"localId\" : \"298\",\n                            \"locator\" : \"148:10-148:54\",\n                            \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                            \"templateId\" : \"PositiveMedicationAdministered\",\n                            \"codeProperty\" : \"code\",\n                            \"type\" : \"Retrieve\",\n                            \"codes\" : {\n                              \"locator\" : \"148:39-148:53\",\n                              \"name\" : \"Fosaprepitant\",\n                              \"type\" : \"ValueSetRef\"\n                            }\n                          } ]\n                        },\n                        \"asTypeSpecifier\" : {\n                          \"type\" : \"ListTypeSpecifier\",\n                          \"elementType\" : {\n                            \"type\" : \"ChoiceTypeSpecifier\",\n                            \"choice\" : [ {\n                              \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                              \"type\" : \"NamedTypeSpecifier\"\n                            }, {\n                              \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                              \"type\" : \"NamedTypeSpecifier\"\n                            } ]\n                          }\n                        }\n                      }, {\n                        \"type\" : \"As\",\n                        \"operand\" : {\n                          \"type\" : \"Union\",\n                          \"operand\" : [ {\n                            \"type\" : \"As\",\n                            \"operand\" : {\n                              \"localId\" : \"300\",\n                              \"locator\" : \"149:10-149:51\",\n                              \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                              \"templateId\" : \"PositiveMedicationAdministered\",\n                              \"codeProperty\" : \"code\",\n                              \"type\" : \"Retrieve\",\n                              \"codes\" : {\n                                \"locator\" : \"149:39-149:50\",\n                                \"name\" : \"Netupitant\",\n                                \"type\" : \"ValueSetRef\"\n                              }\n                            },\n                            \"asTypeSpecifier\" : {\n                              \"type\" : \"ListTypeSpecifier\",\n                              \"elementType\" : {\n                                \"type\" : \"ChoiceTypeSpecifier\",\n                                \"choice\" : [ {\n                                  \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                                  \"type\" : \"NamedTypeSpecifier\"\n                                }, {\n                                  \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                                  \"type\" : \"NamedTypeSpecifier\"\n                                } ]\n                              }\n                            }\n                          }, {\n                            \"type\" : \"As\",\n                            \"operand\" : {\n                              \"localId\" : \"302\",\n                              \"locator\" : \"150:10-150:44\",\n                              \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                              \"templateId\" : \"PositiveMedicationOrder\",\n                              \"codeProperty\" : \"code\",\n                              \"type\" : \"Retrieve\",\n                              \"codes\" : {\n                                \"locator\" : \"150:32-150:43\",\n                                \"name\" : \"Aprepitant\",\n                                \"type\" : \"ValueSetRef\"\n                              }\n                            },\n                            \"asTypeSpecifier\" : {\n                              \"type\" : \"ListTypeSpecifier\",\n                              \"elementType\" : {\n                                \"type\" : \"ChoiceTypeSpecifier\",\n                                \"choice\" : [ {\n                                  \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                                  \"type\" : \"NamedTypeSpecifier\"\n                                }, {\n                                  \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                                  \"type\" : \"NamedTypeSpecifier\"\n                                } ]\n                              }\n                            }\n                          } ]\n                        },\n                        \"asTypeSpecifier\" : {\n                          \"type\" : \"ListTypeSpecifier\",\n                          \"elementType\" : {\n                            \"type\" : \"ChoiceTypeSpecifier\",\n                            \"choice\" : [ {\n                              \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                              \"type\" : \"NamedTypeSpecifier\"\n                            }, {\n                              \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                              \"type\" : \"NamedTypeSpecifier\"\n                            } ]\n                          }\n                        }\n                      } ]\n                    },\n                    \"asTypeSpecifier\" : {\n                      \"type\" : \"ListTypeSpecifier\",\n                      \"elementType\" : {\n                        \"type\" : \"ChoiceTypeSpecifier\",\n                        \"choice\" : [ {\n                          \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        }, {\n                          \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        } ]\n                      }\n                    }\n                  }, {\n                    \"type\" : \"As\",\n                    \"operand\" : {\n                      \"localId\" : \"304\",\n                      \"locator\" : \"151:10-151:47\",\n                      \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                      \"templateId\" : \"PositiveMedicationOrder\",\n                      \"codeProperty\" : \"code\",\n                      \"type\" : \"Retrieve\",\n                      \"codes\" : {\n                        \"locator\" : \"151:32-151:46\",\n                        \"name\" : \"Fosaprepitant\",\n                        \"type\" : \"ValueSetRef\"\n                      }\n                    },\n                    \"asTypeSpecifier\" : {\n                      \"type\" : \"ListTypeSpecifier\",\n                      \"elementType\" : {\n                        \"type\" : \"ChoiceTypeSpecifier\",\n                        \"choice\" : [ {\n                          \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        }, {\n                          \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        } ]\n                      }\n                    }\n                  } ]\n                },\n                \"asTypeSpecifier\" : {\n                  \"type\" : \"ListTypeSpecifier\",\n                  \"elementType\" : {\n                    \"type\" : \"ChoiceTypeSpecifier\",\n                    \"choice\" : [ {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    }, {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    } ]\n                  }\n                }\n              }, {\n                \"type\" : \"As\",\n                \"operand\" : {\n                  \"localId\" : \"306\",\n                  \"locator\" : \"152:10-152:44\",\n                  \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                  \"templateId\" : \"PositiveMedicationOrder\",\n                  \"codeProperty\" : \"code\",\n                  \"type\" : \"Retrieve\",\n                  \"codes\" : {\n                    \"locator\" : \"152:32-152:43\",\n                    \"name\" : \"Netupitant\",\n                    \"type\" : \"ValueSetRef\"\n                  }\n                },\n                \"asTypeSpecifier\" : {\n                  \"type\" : \"ListTypeSpecifier\",\n                  \"elementType\" : {\n                    \"type\" : \"ChoiceTypeSpecifier\",\n                    \"choice\" : [ {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    }, {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    } ]\n                  }\n                }\n              } ]\n            }\n          } ],\n          \"relationship\" : [ {\n            \"localId\" : \"317\",\n            \"locator\" : \"153:4-154:86\",\n            \"alias\" : \"ComboChemo\",\n            \"type\" : \"With\",\n            \"expression\" : {\n              \"localId\" : \"309\",\n              \"locator\" : \"153:9-153:86\",\n              \"name\" : \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\",\n              \"type\" : \"ExpressionRef\"\n            },\n            \"suchThat\" : {\n              \"localId\" : \"316\",\n              \"locator\" : \"154:15-154:86\",\n              \"type\" : \"Before\",\n              \"operand\" : [ {\n                \"locator\" : \"154:39-154:44\",\n                \"type\" : \"Start\",\n                \"operand\" : {\n                  \"localId\" : \"312\",\n                  \"locator\" : \"154:15-154:37\",\n                  \"path\" : \"relevantPeriod\",\n                  \"scope\" : \"MedAdmin\",\n                  \"type\" : \"Property\"\n                }\n              }, {\n                \"localId\" : \"315\",\n                \"locator\" : \"154:53-154:86\",\n                \"type\" : \"Start\",\n                \"operand\" : {\n                  \"localId\" : \"314\",\n                  \"locator\" : \"154:62-154:86\",\n                  \"path\" : \"relevantPeriod\",\n                  \"scope\" : \"ComboChemo\",\n                  \"type\" : \"Property\"\n                }\n              } ]\n            }\n          } ]\n        }\n      }, {\n        \"localId\" : \"343\",\n        \"locator\" : \"156:1-164:100\",\n        \"name\" : \"Aprepitant, Fosaprepitant or Netupitant  administered or ordered within 7 days after Combo High Risk Chemo\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"343\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Aprepitant, Fosaprepitant or Netupitant  administered or ordered within 7 days after Combo High Risk Chemo\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"342\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"331\",\n                  \"s\" : [ {\n                    \"r\" : \"330\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"330\",\n                      \"s\" : [ {\n                        \"r\" : \"328\",\n                        \"s\" : [ {\n                          \"r\" : \"326\",\n                          \"s\" : [ {\n                            \"r\" : \"324\",\n                            \"s\" : [ {\n                              \"r\" : \"322\",\n                              \"s\" : [ {\n                                \"r\" : \"320\",\n                                \"s\" : [ {\n                                  \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                                }, {\n                                  \"s\" : [ {\n                                    \"value\" : [ \"\\\"Aprepitant\\\"\" ]\n                                  } ]\n                                }, {\n                                  \"value\" : [ \"]\" ]\n                                } ]\n                              }, {\n                                \"value\" : [ \"\\n  \\tunion \" ]\n                              }, {\n                                \"r\" : \"321\",\n                                \"s\" : [ {\n                                  \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                                }, {\n                                  \"s\" : [ {\n                                    \"value\" : [ \"\\\"Fosaprepitant\\\"\" ]\n                                  } ]\n                                }, {\n                                  \"value\" : [ \"]\" ]\n                                } ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"\\n  \\tunion \" ]\n                            }, {\n                              \"r\" : \"323\",\n                              \"s\" : [ {\n                                \"value\" : [ \"[\", \"\\\"Medication, Administered\\\"\", \": \" ]\n                              }, {\n                                \"s\" : [ {\n                                  \"value\" : [ \"\\\"Netupitant\\\"\" ]\n                                } ]\n                              }, {\n                                \"value\" : [ \"]\" ]\n                              } ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"\\n  \\tunion \" ]\n                          }, {\n                            \"r\" : \"325\",\n                            \"s\" : [ {\n                              \"value\" : [ \"[\", \"\\\"Medication, Order\\\"\", \": \" ]\n                            }, {\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"Aprepitant\\\"\" ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"]\" ]\n                            } ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"\\n  \\tunion \" ]\n                        }, {\n                          \"r\" : \"327\",\n                          \"s\" : [ {\n                            \"value\" : [ \"[\", \"\\\"Medication, Order\\\"\", \": \" ]\n                          }, {\n                            \"s\" : [ {\n                              \"value\" : [ \"\\\"Fosaprepitant\\\"\" ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"]\" ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\tunion \" ]\n                      }, {\n                        \"r\" : \"329\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"Medication, Order\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Netupitant\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedAdmin\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"341\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"333\",\n                  \"s\" : [ {\n                    \"r\" : \"332\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"ComboChemo\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"340\",\n                  \"s\" : [ {\n                    \"r\" : \"335\",\n                    \"s\" : [ {\n                      \"r\" : \"334\",\n                      \"s\" : [ {\n                        \"value\" : [ \"MedAdmin\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"335\",\n                      \"s\" : [ {\n                        \"value\" : [ \"relevantPeriod\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \" ]\n                  }, {\n                    \"r\" : \"340\",\n                    \"s\" : [ {\n                      \"value\" : [ \"starts \" ]\n                    }, {\n                      \"r\" : \"339\",\n                      \"s\" : [ {\n                        \"value\" : [ \"7 \", \"days\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" or less after\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \" ]\n                  }, {\n                    \"r\" : \"338\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"337\",\n                      \"s\" : [ {\n                        \"r\" : \"336\",\n                        \"s\" : [ {\n                          \"value\" : [ \"ComboChemo\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"337\",\n                        \"s\" : [ {\n                          \"value\" : [ \"relevantPeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"342\",\n          \"locator\" : \"157:3-164:100\",\n          \"type\" : \"Query\",\n          \"source\" : [ {\n            \"localId\" : \"331\",\n            \"locator\" : \"157:3-162:55\",\n            \"alias\" : \"MedAdmin\",\n            \"expression\" : {\n              \"localId\" : \"330\",\n              \"locator\" : \"157:3-162:46\",\n              \"type\" : \"Union\",\n              \"operand\" : [ {\n                \"type\" : \"As\",\n                \"operand\" : {\n                  \"localId\" : \"328\",\n                  \"locator\" : \"157:5-161:47\",\n                  \"type\" : \"Union\",\n                  \"operand\" : [ {\n                    \"type\" : \"As\",\n                    \"operand\" : {\n                      \"localId\" : \"326\",\n                      \"locator\" : \"157:5-160:44\",\n                      \"type\" : \"Union\",\n                      \"operand\" : [ {\n                        \"type\" : \"As\",\n                        \"operand\" : {\n                          \"localId\" : \"322\",\n                          \"locator\" : \"157:5-158:54\",\n                          \"type\" : \"Union\",\n                          \"operand\" : [ {\n                            \"localId\" : \"320\",\n                            \"locator\" : \"157:5-157:46\",\n                            \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                            \"templateId\" : \"PositiveMedicationAdministered\",\n                            \"codeProperty\" : \"code\",\n                            \"type\" : \"Retrieve\",\n                            \"codes\" : {\n                              \"locator\" : \"157:34-157:45\",\n                              \"name\" : \"Aprepitant\",\n                              \"type\" : \"ValueSetRef\"\n                            }\n                          }, {\n                            \"localId\" : \"321\",\n                            \"locator\" : \"158:10-158:54\",\n                            \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                            \"templateId\" : \"PositiveMedicationAdministered\",\n                            \"codeProperty\" : \"code\",\n                            \"type\" : \"Retrieve\",\n                            \"codes\" : {\n                              \"locator\" : \"158:39-158:53\",\n                              \"name\" : \"Fosaprepitant\",\n                              \"type\" : \"ValueSetRef\"\n                            }\n                          } ]\n                        },\n                        \"asTypeSpecifier\" : {\n                          \"type\" : \"ListTypeSpecifier\",\n                          \"elementType\" : {\n                            \"type\" : \"ChoiceTypeSpecifier\",\n                            \"choice\" : [ {\n                              \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                              \"type\" : \"NamedTypeSpecifier\"\n                            }, {\n                              \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                              \"type\" : \"NamedTypeSpecifier\"\n                            } ]\n                          }\n                        }\n                      }, {\n                        \"type\" : \"As\",\n                        \"operand\" : {\n                          \"type\" : \"Union\",\n                          \"operand\" : [ {\n                            \"type\" : \"As\",\n                            \"operand\" : {\n                              \"localId\" : \"323\",\n                              \"locator\" : \"159:10-159:51\",\n                              \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                              \"templateId\" : \"PositiveMedicationAdministered\",\n                              \"codeProperty\" : \"code\",\n                              \"type\" : \"Retrieve\",\n                              \"codes\" : {\n                                \"locator\" : \"159:39-159:50\",\n                                \"name\" : \"Netupitant\",\n                                \"type\" : \"ValueSetRef\"\n                              }\n                            },\n                            \"asTypeSpecifier\" : {\n                              \"type\" : \"ListTypeSpecifier\",\n                              \"elementType\" : {\n                                \"type\" : \"ChoiceTypeSpecifier\",\n                                \"choice\" : [ {\n                                  \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                                  \"type\" : \"NamedTypeSpecifier\"\n                                }, {\n                                  \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                                  \"type\" : \"NamedTypeSpecifier\"\n                                } ]\n                              }\n                            }\n                          }, {\n                            \"type\" : \"As\",\n                            \"operand\" : {\n                              \"localId\" : \"325\",\n                              \"locator\" : \"160:10-160:44\",\n                              \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                              \"templateId\" : \"PositiveMedicationOrder\",\n                              \"codeProperty\" : \"code\",\n                              \"type\" : \"Retrieve\",\n                              \"codes\" : {\n                                \"locator\" : \"160:32-160:43\",\n                                \"name\" : \"Aprepitant\",\n                                \"type\" : \"ValueSetRef\"\n                              }\n                            },\n                            \"asTypeSpecifier\" : {\n                              \"type\" : \"ListTypeSpecifier\",\n                              \"elementType\" : {\n                                \"type\" : \"ChoiceTypeSpecifier\",\n                                \"choice\" : [ {\n                                  \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                                  \"type\" : \"NamedTypeSpecifier\"\n                                }, {\n                                  \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                                  \"type\" : \"NamedTypeSpecifier\"\n                                } ]\n                              }\n                            }\n                          } ]\n                        },\n                        \"asTypeSpecifier\" : {\n                          \"type\" : \"ListTypeSpecifier\",\n                          \"elementType\" : {\n                            \"type\" : \"ChoiceTypeSpecifier\",\n                            \"choice\" : [ {\n                              \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                              \"type\" : \"NamedTypeSpecifier\"\n                            }, {\n                              \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                              \"type\" : \"NamedTypeSpecifier\"\n                            } ]\n                          }\n                        }\n                      } ]\n                    },\n                    \"asTypeSpecifier\" : {\n                      \"type\" : \"ListTypeSpecifier\",\n                      \"elementType\" : {\n                        \"type\" : \"ChoiceTypeSpecifier\",\n                        \"choice\" : [ {\n                          \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        }, {\n                          \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        } ]\n                      }\n                    }\n                  }, {\n                    \"type\" : \"As\",\n                    \"operand\" : {\n                      \"localId\" : \"327\",\n                      \"locator\" : \"161:10-161:47\",\n                      \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                      \"templateId\" : \"PositiveMedicationOrder\",\n                      \"codeProperty\" : \"code\",\n                      \"type\" : \"Retrieve\",\n                      \"codes\" : {\n                        \"locator\" : \"161:32-161:46\",\n                        \"name\" : \"Fosaprepitant\",\n                        \"type\" : \"ValueSetRef\"\n                      }\n                    },\n                    \"asTypeSpecifier\" : {\n                      \"type\" : \"ListTypeSpecifier\",\n                      \"elementType\" : {\n                        \"type\" : \"ChoiceTypeSpecifier\",\n                        \"choice\" : [ {\n                          \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        }, {\n                          \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        } ]\n                      }\n                    }\n                  } ]\n                },\n                \"asTypeSpecifier\" : {\n                  \"type\" : \"ListTypeSpecifier\",\n                  \"elementType\" : {\n                    \"type\" : \"ChoiceTypeSpecifier\",\n                    \"choice\" : [ {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    }, {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    } ]\n                  }\n                }\n              }, {\n                \"type\" : \"As\",\n                \"operand\" : {\n                  \"localId\" : \"329\",\n                  \"locator\" : \"162:10-162:44\",\n                  \"dataType\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                  \"templateId\" : \"PositiveMedicationOrder\",\n                  \"codeProperty\" : \"code\",\n                  \"type\" : \"Retrieve\",\n                  \"codes\" : {\n                    \"locator\" : \"162:32-162:43\",\n                    \"name\" : \"Netupitant\",\n                    \"type\" : \"ValueSetRef\"\n                  }\n                },\n                \"asTypeSpecifier\" : {\n                  \"type\" : \"ListTypeSpecifier\",\n                  \"elementType\" : {\n                    \"type\" : \"ChoiceTypeSpecifier\",\n                    \"choice\" : [ {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationOrder\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    }, {\n                      \"name\" : \"{urn:healthit-gov:qdm:v5_4}PositiveMedicationAdministered\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    } ]\n                  }\n                }\n              } ]\n            }\n          } ],\n          \"relationship\" : [ {\n            \"localId\" : \"341\",\n            \"locator\" : \"163:4-164:100\",\n            \"alias\" : \"ComboChemo\",\n            \"type\" : \"With\",\n            \"expression\" : {\n              \"localId\" : \"332\",\n              \"locator\" : \"163:9-163:86\",\n              \"name\" : \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\",\n              \"type\" : \"ExpressionRef\"\n            },\n            \"suchThat\" : {\n              \"localId\" : \"340\",\n              \"locator\" : \"164:15-164:100\",\n              \"type\" : \"And\",\n              \"operand\" : [ {\n                \"locator\" : \"164:46-164:59\",\n                \"type\" : \"In\",\n                \"operand\" : [ {\n                  \"locator\" : \"164:39-164:44\",\n                  \"type\" : \"Start\",\n                  \"operand\" : {\n                    \"localId\" : \"335\",\n                    \"locator\" : \"164:15-164:37\",\n                    \"path\" : \"relevantPeriod\",\n                    \"scope\" : \"MedAdmin\",\n                    \"type\" : \"Property\"\n                  }\n                }, {\n                  \"locator\" : \"164:46-164:59\",\n                  \"lowClosed\" : false,\n                  \"highClosed\" : true,\n                  \"type\" : \"Interval\",\n                  \"low\" : {\n                    \"localId\" : \"338\",\n                    \"locator\" : \"164:67-164:100\",\n                    \"type\" : \"Start\",\n                    \"operand\" : {\n                      \"localId\" : \"337\",\n                      \"locator\" : \"164:76-164:100\",\n                      \"path\" : \"relevantPeriod\",\n                      \"scope\" : \"ComboChemo\",\n                      \"type\" : \"Property\"\n                    }\n                  },\n                  \"high\" : {\n                    \"locator\" : \"164:67-164:100\",\n                    \"type\" : \"Add\",\n                    \"operand\" : [ {\n                      \"localId\" : \"338\",\n                      \"locator\" : \"164:67-164:100\",\n                      \"type\" : \"Start\",\n                      \"operand\" : {\n                        \"localId\" : \"337\",\n                        \"locator\" : \"164:76-164:100\",\n                        \"path\" : \"relevantPeriod\",\n                        \"scope\" : \"ComboChemo\",\n                        \"type\" : \"Property\"\n                      }\n                    }, {\n                      \"localId\" : \"339\",\n                      \"locator\" : \"164:46-164:51\",\n                      \"value\" : 7,\n                      \"unit\" : \"days\",\n                      \"type\" : \"Quantity\"\n                    } ]\n                  }\n                } ]\n              }, {\n                \"locator\" : \"164:46-164:59\",\n                \"type\" : \"Not\",\n                \"operand\" : {\n                  \"locator\" : \"164:46-164:59\",\n                  \"type\" : \"IsNull\",\n                  \"operand\" : {\n                    \"localId\" : \"338\",\n                    \"locator\" : \"164:67-164:100\",\n                    \"type\" : \"Start\",\n                    \"operand\" : {\n                      \"localId\" : \"337\",\n                      \"locator\" : \"164:76-164:100\",\n                      \"path\" : \"relevantPeriod\",\n                      \"scope\" : \"ComboChemo\",\n                      \"type\" : \"Property\"\n                    }\n                  }\n                }\n              } ]\n            }\n          } ]\n        }\n      }, {\n        \"localId\" : \"373\",\n        \"locator\" : \"166:1-182:4\",\n        \"name\" : \"Numerator\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"373\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Numerator\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"372\",\n              \"s\" : [ {\n                \"r\" : \"348\",\n                \"s\" : [ {\n                  \"r\" : \"345\",\n                  \"s\" : [ {\n                    \"value\" : [ \"exists \" ]\n                  }, {\n                    \"r\" : \"344\",\n                    \"s\" : [ {\n                      \"value\" : [ \"\\\"Clinical Trial Participant within 7 days after start of High Emetic Risk Combo Chemotherapy\\\"\" ]\n                    } ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\tor \" ]\n                }, {\n                  \"r\" : \"347\",\n                  \"s\" : [ {\n                    \"value\" : [ \"exists \" ]\n                  }, {\n                    \"r\" : \"346\",\n                    \"s\" : [ {\n                      \"value\" : [ \"\\\"Clinical Trial Participant before start of High Emetic Risk Combo Chemotherapy\\\"\" ]\n                    } ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\tor \" ]\n              }, {\n                \"r\" : \"371\",\n                \"s\" : [ {\n                  \"value\" : [ \"( \" ]\n                }, {\n                  \"r\" : \"371\",\n                  \"s\" : [ {\n                    \"r\" : \"359\",\n                    \"s\" : [ {\n                      \"r\" : \"353\",\n                      \"s\" : [ {\n                        \"value\" : [ \"( \" ]\n                      }, {\n                        \"r\" : \"353\",\n                        \"s\" : [ {\n                          \"r\" : \"350\",\n                          \"s\" : [ {\n                            \"value\" : [ \"exists \" ]\n                          }, {\n                            \"r\" : \"349\",\n                            \"s\" : [ {\n                              \"value\" : [ \"\\\"Dexamethasone administered or ordered within 7 days after Combo High Risk Chemo\\\"\" ]\n                            } ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"\\n  \\t\\t\\t\\tor \" ]\n                        }, {\n                          \"r\" : \"352\",\n                          \"s\" : [ {\n                            \"value\" : [ \"exists \" ]\n                          }, {\n                            \"r\" : \"351\",\n                            \"s\" : [ {\n                              \"value\" : [ \"\\\"Dexamethasone administered or ordered before Combo High Risk Chemo\\\"\" ]\n                            } ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\t\\t)\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \"\\n  \\t\\t\\tand \" ]\n                    }, {\n                      \"r\" : \"358\",\n                      \"s\" : [ {\n                        \"value\" : [ \"( \" ]\n                      }, {\n                        \"r\" : \"358\",\n                        \"s\" : [ {\n                          \"r\" : \"355\",\n                          \"s\" : [ {\n                            \"value\" : [ \"exists \" ]\n                          }, {\n                            \"r\" : \"354\",\n                            \"s\" : [ {\n                              \"value\" : [ \"\\\"Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\\\"\" ]\n                            } ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"\\n  \\t\\t\\t\\t\\tor \" ]\n                        }, {\n                          \"r\" : \"357\",\n                          \"s\" : [ {\n                            \"value\" : [ \"exists \" ]\n                          }, {\n                            \"r\" : \"356\",\n                            \"s\" : [ {\n                              \"value\" : [ \"\\\"Palonosetron administered or ordered before Combo High Risk Chemo\\\"\" ]\n                            } ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\t\\t\\t)\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \"\\n  \\t\\t\\tor \" ]\n                  }, {\n                    \"r\" : \"370\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"370\",\n                      \"s\" : [ {\n                        \"r\" : \"364\",\n                        \"s\" : [ {\n                          \"value\" : [ \"( \" ]\n                        }, {\n                          \"r\" : \"364\",\n                          \"s\" : [ {\n                            \"r\" : \"361\",\n                            \"s\" : [ {\n                              \"value\" : [ \"exists \" ]\n                            }, {\n                              \"r\" : \"360\",\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"Aprepitant, Fosaprepitant or Netupitant  administered or ordered within 7 days after Combo High Risk Chemo\\\"\" ]\n                              } ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"\\n  \\t\\t\\t\\t\\t\\tor \" ]\n                          }, {\n                            \"r\" : \"363\",\n                            \"s\" : [ {\n                              \"value\" : [ \"exists \" ]\n                            }, {\n                              \"r\" : \"362\",\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"Aprepitant, Fosaprepitant or Netupitant  administered or ordered before Combo High Risk Chemo\\\"\" ]\n                              } ]\n                            } ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"\\n  \\t\\t\\t\\t)\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\t\\t\\t\\t\\tand \" ]\n                      }, {\n                        \"r\" : \"369\",\n                        \"s\" : [ {\n                          \"value\" : [ \"( \" ]\n                        }, {\n                          \"r\" : \"369\",\n                          \"s\" : [ {\n                            \"r\" : \"366\",\n                            \"s\" : [ {\n                              \"value\" : [ \"exists \" ]\n                            }, {\n                              \"r\" : \"365\",\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"First Gen Serotonin Antagonists or Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\\\"\" ]\n                              } ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"\\n  \\t\\t\\t\\t\\t\\t\\tor \" ]\n                          }, {\n                            \"r\" : \"368\",\n                            \"s\" : [ {\n                              \"value\" : [ \"exists \" ]\n                            }, {\n                              \"r\" : \"367\",\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"First Gen Serotonin Antagonists or Palonosetron administered or ordered before Combo High Risk Chemo\\\"\" ]\n                              } ]\n                            } ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"\\n  \\t\\t\\t\\t\\t)\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \"\\n  \\t\\t\\t)\" ]\n                    } ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t)\" ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"372\",\n          \"locator\" : \"167:3-182:4\",\n          \"type\" : \"Or\",\n          \"operand\" : [ {\n            \"localId\" : \"348\",\n            \"locator\" : \"167:3-168:93\",\n            \"type\" : \"Or\",\n            \"operand\" : [ {\n              \"localId\" : \"345\",\n              \"locator\" : \"167:3-167:102\",\n              \"type\" : \"Exists\",\n              \"operand\" : {\n                \"localId\" : \"344\",\n                \"locator\" : \"167:10-167:102\",\n                \"name\" : \"Clinical Trial Participant within 7 days after start of High Emetic Risk Combo Chemotherapy\",\n                \"type\" : \"ExpressionRef\"\n              }\n            }, {\n              \"localId\" : \"347\",\n              \"locator\" : \"168:7-168:93\",\n              \"type\" : \"Exists\",\n              \"operand\" : {\n                \"localId\" : \"346\",\n                \"locator\" : \"168:14-168:93\",\n                \"name\" : \"Clinical Trial Participant before start of High Emetic Risk Combo Chemotherapy\",\n                \"type\" : \"ExpressionRef\"\n              }\n            } ]\n          }, {\n            \"localId\" : \"371\",\n            \"locator\" : \"169:7-182:4\",\n            \"type\" : \"Or\",\n            \"operand\" : [ {\n              \"localId\" : \"359\",\n              \"locator\" : \"169:9-174:6\",\n              \"type\" : \"And\",\n              \"operand\" : [ {\n                \"localId\" : \"353\",\n                \"locator\" : \"169:9-171:5\",\n                \"type\" : \"Or\",\n                \"operand\" : [ {\n                  \"localId\" : \"350\",\n                  \"locator\" : \"169:11-169:98\",\n                  \"type\" : \"Exists\",\n                  \"operand\" : {\n                    \"localId\" : \"349\",\n                    \"locator\" : \"169:18-169:98\",\n                    \"name\" : \"Dexamethasone administered or ordered within 7 days after Combo High Risk Chemo\",\n                    \"type\" : \"ExpressionRef\"\n                  }\n                }, {\n                  \"localId\" : \"352\",\n                  \"locator\" : \"170:10-170:84\",\n                  \"type\" : \"Exists\",\n                  \"operand\" : {\n                    \"localId\" : \"351\",\n                    \"locator\" : \"170:17-170:84\",\n                    \"name\" : \"Dexamethasone administered or ordered before Combo High Risk Chemo\",\n                    \"type\" : \"ExpressionRef\"\n                  }\n                } ]\n              }, {\n                \"localId\" : \"358\",\n                \"locator\" : \"172:10-174:6\",\n                \"type\" : \"Or\",\n                \"operand\" : [ {\n                  \"localId\" : \"355\",\n                  \"locator\" : \"172:12-172:98\",\n                  \"type\" : \"Exists\",\n                  \"operand\" : {\n                    \"localId\" : \"354\",\n                    \"locator\" : \"172:19-172:98\",\n                    \"name\" : \"Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\",\n                    \"type\" : \"ExpressionRef\"\n                  }\n                }, {\n                  \"localId\" : \"357\",\n                  \"locator\" : \"173:11-173:84\",\n                  \"type\" : \"Exists\",\n                  \"operand\" : {\n                    \"localId\" : \"356\",\n                    \"locator\" : \"173:18-173:84\",\n                    \"name\" : \"Palonosetron administered or ordered before Combo High Risk Chemo\",\n                    \"type\" : \"ExpressionRef\"\n                  }\n                } ]\n              } ]\n            }, {\n              \"localId\" : \"370\",\n              \"locator\" : \"175:9-181:6\",\n              \"type\" : \"And\",\n              \"operand\" : [ {\n                \"localId\" : \"364\",\n                \"locator\" : \"175:11-177:7\",\n                \"type\" : \"Or\",\n                \"operand\" : [ {\n                  \"localId\" : \"361\",\n                  \"locator\" : \"175:13-175:127\",\n                  \"type\" : \"Exists\",\n                  \"operand\" : {\n                    \"localId\" : \"360\",\n                    \"locator\" : \"175:20-175:127\",\n                    \"name\" : \"Aprepitant, Fosaprepitant or Netupitant  administered or ordered within 7 days after Combo High Risk Chemo\",\n                    \"type\" : \"ExpressionRef\"\n                  }\n                }, {\n                  \"localId\" : \"363\",\n                  \"locator\" : \"176:12-176:113\",\n                  \"type\" : \"Exists\",\n                  \"operand\" : {\n                    \"localId\" : \"362\",\n                    \"locator\" : \"176:19-176:113\",\n                    \"name\" : \"Aprepitant, Fosaprepitant or Netupitant  administered or ordered before Combo High Risk Chemo\",\n                    \"type\" : \"ExpressionRef\"\n                  }\n                } ]\n              }, {\n                \"localId\" : \"369\",\n                \"locator\" : \"178:12-180:8\",\n                \"type\" : \"Or\",\n                \"operand\" : [ {\n                  \"localId\" : \"366\",\n                  \"locator\" : \"178:14-178:135\",\n                  \"type\" : \"Exists\",\n                  \"operand\" : {\n                    \"localId\" : \"365\",\n                    \"locator\" : \"178:21-178:135\",\n                    \"name\" : \"First Gen Serotonin Antagonists or Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\",\n                    \"type\" : \"ExpressionRef\"\n                  }\n                }, {\n                  \"localId\" : \"368\",\n                  \"locator\" : \"179:13-179:121\",\n                  \"type\" : \"Exists\",\n                  \"operand\" : {\n                    \"localId\" : \"367\",\n                    \"locator\" : \"179:20-179:121\",\n                    \"name\" : \"First Gen Serotonin Antagonists or Palonosetron administered or ordered before Combo High Risk Chemo\",\n                    \"type\" : \"ExpressionRef\"\n                  }\n                } ]\n              } ]\n            } ]\n          } ]\n        }\n      }, {\n        \"localId\" : \"384\",\n        \"locator\" : \"192:1-197:72\",\n        \"name\" : \"Denominator\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"384\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Denominator\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"383\",\n              \"s\" : [ {\n                \"r\" : \"380\",\n                \"s\" : [ {\n                  \"r\" : \"374\",\n                  \"s\" : [ {\n                    \"value\" : [ \"\\\"Initial Population\\\"\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\tand \" ]\n                }, {\n                  \"r\" : \"379\",\n                  \"s\" : [ {\n                    \"value\" : [ \"( \" ]\n                  }, {\n                    \"r\" : \"379\",\n                    \"s\" : [ {\n                      \"r\" : \"376\",\n                      \"s\" : [ {\n                        \"value\" : [ \"exists \" ]\n                      }, {\n                        \"r\" : \"375\",\n                        \"s\" : [ {\n                          \"value\" : [ \"\\\"Cyclophosphamide Administered after First Cancer Dx\\\"\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \"\\n  \\t\\t\\tand \" ]\n                    }, {\n                      \"r\" : \"378\",\n                      \"s\" : [ {\n                        \"value\" : [ \"exists \" ]\n                      }, {\n                        \"r\" : \"377\",\n                        \"s\" : [ {\n                          \"value\" : [ \"\\\"Specific Mod Risk Chemo Administered after First Cancer Dx\\\"\" ]\n                        } ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \"\\n  \\t)\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\tor \" ]\n              }, {\n                \"r\" : \"382\",\n                \"s\" : [ {\n                  \"value\" : [ \"exists \" ]\n                }, {\n                  \"r\" : \"381\",\n                  \"s\" : [ {\n                    \"value\" : [ \"\\\"High Emetic Risk Chemo Administered after First Cancer Dx\\\"\" ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"383\",\n          \"locator\" : \"193:3-197:72\",\n          \"type\" : \"Or\",\n          \"operand\" : [ {\n            \"localId\" : \"380\",\n            \"locator\" : \"193:3-196:4\",\n            \"type\" : \"And\",\n            \"operand\" : [ {\n              \"localId\" : \"374\",\n              \"locator\" : \"193:3-193:22\",\n              \"name\" : \"Initial Population\",\n              \"type\" : \"ExpressionRef\"\n            }, {\n              \"localId\" : \"379\",\n              \"locator\" : \"194:8-196:4\",\n              \"type\" : \"And\",\n              \"operand\" : [ {\n                \"localId\" : \"376\",\n                \"locator\" : \"194:10-194:69\",\n                \"type\" : \"Exists\",\n                \"operand\" : {\n                  \"localId\" : \"375\",\n                  \"locator\" : \"194:17-194:69\",\n                  \"name\" : \"Cyclophosphamide Administered after First Cancer Dx\",\n                  \"type\" : \"ExpressionRef\"\n                }\n              }, {\n                \"localId\" : \"378\",\n                \"locator\" : \"195:10-195:76\",\n                \"type\" : \"Exists\",\n                \"operand\" : {\n                  \"localId\" : \"377\",\n                  \"locator\" : \"195:17-195:76\",\n                  \"name\" : \"Specific Mod Risk Chemo Administered after First Cancer Dx\",\n                  \"type\" : \"ExpressionRef\"\n                }\n              } ]\n            } ]\n          }, {\n            \"localId\" : \"382\",\n            \"locator\" : \"197:7-197:72\",\n            \"type\" : \"Exists\",\n            \"operand\" : {\n              \"localId\" : \"381\",\n              \"locator\" : \"197:14-197:72\",\n              \"name\" : \"High Emetic Risk Chemo Administered after First Cancer Dx\",\n              \"type\" : \"ExpressionRef\"\n            }\n          } ]\n        }\n      }, {\n        \"localId\" : \"386\",\n        \"locator\" : \"199:1-200:6\",\n        \"name\" : \"Actionability\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"386\",\n            \"s\" : [ {\n              \"r\" : \"385\",\n              \"value\" : [ \"define \", \"\\\"Actionability\\\"\", \":\\n  \", \"true\" ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"385\",\n          \"locator\" : \"200:3-200:6\",\n          \"valueType\" : \"{urn:hl7-org:elm-types:r1}Boolean\",\n          \"value\" : \"true\",\n          \"type\" : \"Literal\"\n        }\n      }, {\n        \"localId\" : \"391\",\n        \"locator\" : \"202:1-203:106\",\n        \"name\" : \"Actionability Start Date\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"391\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Actionability Start Date\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"390\",\n              \"s\" : [ {\n                \"value\" : [ \"First\", \"(\" ]\n              }, {\n                \"r\" : \"389\",\n                \"s\" : [ {\n                  \"r\" : \"388\",\n                  \"s\" : [ {\n                    \"r\" : \"387\",\n                    \"s\" : [ {\n                      \"value\" : [ \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \".\" ]\n                  }, {\n                    \"r\" : \"388\",\n                    \"s\" : [ {\n                      \"value\" : [ \"relevantPeriod\" ]\n                    } ]\n                  } ]\n                }, {\n                  \"value\" : [ \".\" ]\n                }, {\n                  \"r\" : \"389\",\n                  \"s\" : [ {\n                    \"value\" : [ \"low\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \")\" ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"390\",\n          \"locator\" : \"203:3-203:106\",\n          \"type\" : \"First\",\n          \"source\" : {\n            \"localId\" : \"389\",\n            \"locator\" : \"203:9-203:105\",\n            \"type\" : \"Query\",\n            \"source\" : [ {\n              \"alias\" : \"$this\",\n              \"expression\" : {\n                \"localId\" : \"388\",\n                \"locator\" : \"203:9-203:101\",\n                \"type\" : \"Query\",\n                \"source\" : [ {\n                  \"alias\" : \"$this\",\n                  \"expression\" : {\n                    \"localId\" : \"387\",\n                    \"locator\" : \"203:9-203:86\",\n                    \"name\" : \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\",\n                    \"type\" : \"ExpressionRef\"\n                  }\n                } ],\n                \"where\" : {\n                  \"type\" : \"Not\",\n                  \"operand\" : {\n                    \"type\" : \"IsNull\",\n                    \"operand\" : {\n                      \"path\" : \"relevantPeriod\",\n                      \"type\" : \"Property\",\n                      \"source\" : {\n                        \"name\" : \"$this\",\n                        \"type\" : \"AliasRef\"\n                      }\n                    }\n                  }\n                },\n                \"return\" : {\n                  \"expression\" : {\n                    \"path\" : \"relevantPeriod\",\n                    \"type\" : \"Property\",\n                    \"source\" : {\n                      \"name\" : \"$this\",\n                      \"type\" : \"AliasRef\"\n                    }\n                  }\n                }\n              }\n            } ],\n            \"where\" : {\n              \"type\" : \"Not\",\n              \"operand\" : {\n                \"type\" : \"IsNull\",\n                \"operand\" : {\n                  \"path\" : \"low\",\n                  \"type\" : \"Property\",\n                  \"source\" : {\n                    \"name\" : \"$this\",\n                    \"type\" : \"AliasRef\"\n                  }\n                }\n              }\n            },\n            \"return\" : {\n              \"expression\" : {\n                \"path\" : \"low\",\n                \"type\" : \"Property\",\n                \"source\" : {\n                  \"name\" : \"$this\",\n                  \"type\" : \"AliasRef\"\n                }\n              }\n            }\n          }\n        }\n      }, {\n        \"localId\" : \"395\",\n        \"locator\" : \"205:1-206:37\",\n        \"name\" : \"Actionability End Date\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"395\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Actionability End Date\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"394\",\n              \"s\" : [ {\n                \"r\" : \"392\",\n                \"s\" : [ {\n                  \"value\" : [ \"\\\"Actionability Start Date\\\"\" ]\n                } ]\n              }, {\n                \"value\" : [ \" + \" ]\n              }, {\n                \"r\" : \"393\",\n                \"s\" : [ {\n                  \"value\" : [ \"7 \", \"days\" ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"394\",\n          \"locator\" : \"206:3-206:37\",\n          \"type\" : \"Add\",\n          \"operand\" : [ {\n            \"localId\" : \"392\",\n            \"locator\" : \"206:3-206:28\",\n            \"name\" : \"Actionability Start Date\",\n            \"type\" : \"ExpressionRef\"\n          }, {\n            \"localId\" : \"393\",\n            \"locator\" : \"206:32-206:37\",\n            \"value\" : 7,\n            \"unit\" : \"days\",\n            \"type\" : \"Quantity\"\n          } ]\n        }\n      } ]\n    }\n  }\n}",
        "cqlConversionErrors": [],
        "matCqlConversionErrors": [],
        "fhirCql": "library JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4 version '1.0.000' \n\nusing FHIR version '4.0.0'\n\ncodesystem \"LOINC\": 'urn:oid:2.16.840.1.113883.6.1' \ncodesystem \"SNOMEDCT\": 'urn:oid:2.16.840.1.113883.6.96' \n\nvalueset \"Aprepitant\": 'urn:oid:2.16.840.1.113762.1.4.1116.222' \nvalueset \"Cancer\": 'urn:oid:2.16.840.1.113762.1.4.1116.231' \nvalueset \"Clinical Trial Participant\": 'urn:oid:2.16.840.1.113762.1.4.1116.150' \nvalueset \"Cyclophosphamide\": 'urn:oid:2.16.840.1.113762.1.4.1116.167' \nvalueset \"Daunorubicin\": 'urn:oid:2.16.840.1.113762.1.4.1116.332' \nvalueset \"Dexamethasone\": 'urn:oid:2.16.840.1.113762.1.4.1116.80' \nvalueset \"Doxorubicin\": 'urn:oid:2.16.840.1.113762.1.4.1116.168' \nvalueset \"Epirubicin\": 'urn:oid:2.16.840.1.113762.1.4.1116.200' \nvalueset \"Ethnicity\": 'urn:oid:2.16.840.1.114222.4.11.837' \nvalueset \"First Generation Serotonin Antagonists\": 'urn:oid:2.16.840.1.113762.1.4.1116.82' \nvalueset \"Fosaprepitant\": 'urn:oid:2.16.840.1.113762.1.4.1116.223' \nvalueset \"High Emetigenic Risk Chemotherapy\": 'urn:oid:2.16.840.1.113762.1.4.1116.331' \nvalueset \"Idarubicin\": 'urn:oid:2.16.840.1.113762.1.4.1116.199' \nvalueset \"Medical Reason\": 'urn:oid:2.16.840.1.113883.3.526.2.313' \nvalueset \"NEPA Netupitant Palonosetron\": 'urn:oid:2.16.840.1.113762.1.4.1116.334' \nvalueset \"Netupitant\": 'urn:oid:2.16.840.1.113762.1.4.1116.335' \nvalueset \"Office Visit\": 'urn:oid:2.16.840.1.113883.3.464.1003.101.11.1005' \nvalueset \"ONC Administrative Sex\": 'urn:oid:2.16.840.1.113762.1.4.1' \nvalueset \"Palonosetron\": 'urn:oid:2.16.840.1.113762.1.4.1116.81' \nvalueset \"Patient Provider Interaction\": 'urn:oid:2.16.840.1.113883.3.526.3.1012' \nvalueset \"Patient Reason\": 'urn:oid:2.16.840.1.113883.3.526.2.311' \nvalueset \"Payer\": 'urn:oid:2.16.840.1.114222.4.11.3591' \nvalueset \"Race\": 'urn:oid:2.16.840.1.114222.4.11.836' \nvalueset \"System Reason\": 'urn:oid:2.16.840.1.113883.3.526.2.310' \n\ncode \"Birthdate\": '21112-8' from \"LOINC\" display 'Birthdate'\ncode \"Dead\": '419099009' from \"SNOMEDCT\" display 'Dead'\n\nparameter \"Measurement Period\" Interval<DateTime>\n\ncontext Patient\n\ndefine \"SDE Ethnicity\":\n  [\"Patient Characteristic Ethnicity\": \"Ethnicity\"]\n\ndefine \"SDE Payer\":\n  [\"Patient Characteristic Payer\": \"Payer\"]\n\ndefine \"SDE Race\":\n  [\"Patient Characteristic Race\": \"Race\"]\n\ndefine \"SDE Sex\":\n  [\"Patient Characteristic Sex\": \"ONC Administrative Sex\"]\n\ndefine \"Office Visits\":\n  ( [\"Encounter\": \"Office Visit\"]\n  \tunion [\"Encounter\": \"Patient Provider Interaction\"] ) Enc\n  \twhere Enc.period starts during \"Measurement Period\"\n\ndefine \"Cyclophosphamide Administered after First Cancer Dx\":\n  [\"MedicationStatement\": \"Cyclophosphamide\"] MedAdmin\n  \twith \"First Cancer Dx\" Dx\n  \t\tsuch that MedAdmin.effectiveDateTime starts after start of Dx.prevalencePeriod\n\ndefine \"Initial Population\":\n  Count(\"Office Visits\")>= 2\n  \tand \"First Cancer Dx\" is not null\n\ndefine \"High Emetic Risk Chemo Administered after First Cancer Dx\":\n  [\"MedicationStatement\": \"High Emetigenic Risk Chemotherapy\"] MedAdmin\n  \twith \"First Cancer Dx\" Dx\n  \t\tsuch that MedAdmin.effectiveDateTime starts after start of Dx.prevalencePeriod\n\ndefine \"Specific Mod Risk Chemo Administered after First Cancer Dx\":\n  ( [\"MedicationStatement\": \"Doxorubicin\"]\n  \tunion [\"MedicationStatement\": \"Epirubicin\"]\n  \tunion [\"MedicationStatement\": \"Idarubicin\"]\n  \tunion [\"MedicationStatement\": \"Daunorubicin\"] ) MedAdmin\n  \twith \"First Cancer Dx\" Dx\n  \t\tsuch that MedAdmin.effectiveDateTime starts after start of Dx.prevalencePeriod\n\ndefine \"Clinical Trial Participant before start of High Emetic Risk Combo Chemotherapy\":\n  ( [\"Observation\": \"Clinical Trial Participant\"] ) Trial\n  \twith \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\" ComboChemo\n  \t\tsuch that Trial.target starts before start of ComboChemo.relevantPeriod\n\ndefine \"Clinical Trial Participant within 7 days after start of High Emetic Risk Combo Chemotherapy\":\n  ( [\"Observation\": \"Clinical Trial Participant\"] ) Trial\n  \twith \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\" ComboChemo\n  \t\tsuch that Trial.target starts 7 days or less after start of ComboChemo.relevantPeriod\n\ndefine \"Dexamethasone administered or ordered within 7 days after Combo High Risk Chemo\":\n  ( [\"MedicationStatement\": \"Dexamethasone\"]\n  \tunion [\"MedicationRequest\": \"Dexamethasone\"] ) MedAdmin\n  \twith \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\" ComboChemo\n  \t\tsuch that MedAdmin.dispenseRequest.validityPeriod starts 7 days or less after start of ComboChemo.relevantPeriod\n\ndefine \"Dexamethasone administered or ordered before Combo High Risk Chemo\":\n  ( [\"MedicationStatement\": \"Dexamethasone\"]\n  \tunion [\"MedicationRequest\": \"Dexamethasone\"] ) MedAdmin\n  \twith \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\" ComboChemo\n  \t\tsuch that MedAdmin.dispenseRequest.validityPeriod starts before start of ComboChemo.relevantPeriod\n\ndefine \"Palonosetron administered or ordered before Combo High Risk Chemo\":\n  ( [\"MedicationStatement\": \"NEPA Netupitant Palonosetron\"]\n  \tunion [\"MedicationRequest\": \"NEPA Netupitant Palonosetron\"] ) MedAdmin\n  \twith \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\" ComboChemo\n  \t\tsuch that MedAdmin.dispenseRequest.validityPeriod starts before start of ComboChemo.relevantPeriod\n\ndefine \"Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\":\n  ( [\"MedicationStatement\": \"NEPA Netupitant Palonosetron\"]\n  \tunion [\"MedicationRequest\": \"NEPA Netupitant Palonosetron\"] ) MedAdmin\n  \twith \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\" ComboChemo\n  \t\tsuch that MedAdmin.dispenseRequest.validityPeriod starts 7 days or less after start of ComboChemo.relevantPeriod\n\ndefine \"First Gen Serotonin Antagonists or Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\":\n  ( [\"MedicationStatement\": \"First Generation Serotonin Antagonists\"]\n  \tunion [\"MedicationStatement\": \"Palonosetron\"]\n  \tunion [\"MedicationRequest\": \"First Generation Serotonin Antagonists\"]\n  \tunion [\"MedicationRequest\": \"Palonosetron\"] ) MedAdmin\n  \twith \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\" ComboChemo\n  \t\tsuch that MedAdmin.dispenseRequest.validityPeriod starts 7 days or less after start of ComboChemo.relevantPeriod\n\ndefine \"First Gen Serotonin Antagonists or Palonosetron administered or ordered before Combo High Risk Chemo\":\n  ( [\"MedicationStatement\": \"First Generation Serotonin Antagonists\"]\n  \tunion [\"MedicationStatement\": \"Palonosetron\"]\n  \tunion [\"MedicationRequest\": \"First Generation Serotonin Antagonists\"]\n  \tunion [\"MedicationRequest\": \"Palonosetron\"] ) MedAdmin\n  \twith \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\" ComboChemo\n  \t\tsuch that MedAdmin.dispenseRequest.validityPeriod starts before start of ComboChemo.relevantPeriod\n\ndefine \"Denominator Exceptions\":\n  exists \"Reasons for Not prescribing or Ordering First Gen Serotonin Antagonists, Aprepitant, Fosprepitant or Netupitant\"\n\ndefine \"Reasons for Not prescribing or Ordering First Gen Serotonin Antagonists, Aprepitant, Fosprepitant or Netupitant\":\n  ( [\"MedicationStatement\": \"First Generation Serotonin Antagonists\"]\n  \tunion [\"MedicationStatement\": \"Aprepitant\"]\n  \tunion [\"MedicationStatement\": \"Fosaprepitant\"]\n  \tunion [\"MedicationStatement\": \"Netupitant\"]\n  \tunion [\"MedicationRequest\": \"First Generation Serotonin Antagonists\"]\n  \tunion [\"MedicationRequest\": \"Aprepitant\"]\n  \tunion [\"MedicationRequest\": \"Fosaprepitant\"]\n  \tunion [\"MedicationRequest\": \"Netupitant\"] ) MedNotOrdered\n  \twhere MedNotOrdered.Unknown in \"Medical Reason\"\n  \t\tor MedNotOrdered.Unknown in \"Patient Reason\"\n  \t\tor MedNotOrdered.Unknown in \"System Reason\"\n  \t\t\tand MedNotOrdered.dispenseRequest.validityPeriod starts during \"Measurement Period\"\n\ndefine \"Aprepitant, Fosaprepitant or Netupitant  administered or ordered before Combo High Risk Chemo\":\n  ( [\"MedicationStatement\": \"Aprepitant\"]\n  \tunion [\"MedicationStatement\": \"Fosaprepitant\"]\n  \tunion [\"MedicationStatement\": \"Netupitant\"]\n  \tunion [\"MedicationRequest\": \"Aprepitant\"]\n  \tunion [\"MedicationRequest\": \"Fosaprepitant\"]\n  \tunion [\"MedicationRequest\": \"Netupitant\"] ) MedAdmin\n  \twith \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\" ComboChemo\n  \t\tsuch that MedAdmin.dispenseRequest.validityPeriod starts before start of ComboChemo.relevantPeriod\n\ndefine \"Aprepitant, Fosaprepitant or Netupitant  administered or ordered within 7 days after Combo High Risk Chemo\":\n  ( [\"MedicationStatement\": \"Aprepitant\"]\n  \tunion [\"MedicationStatement\": \"Fosaprepitant\"]\n  \tunion [\"MedicationStatement\": \"Netupitant\"]\n  \tunion [\"MedicationRequest\": \"Aprepitant\"]\n  \tunion [\"MedicationRequest\": \"Fosaprepitant\"]\n  \tunion [\"MedicationRequest\": \"Netupitant\"] ) MedAdmin\n  \twith \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\" ComboChemo\n  \t\tsuch that MedAdmin.dispenseRequest.validityPeriod starts 7 days or less after start of ComboChemo.relevantPeriod\n\ndefine \"Numerator\":\n  exists \"Clinical Trial Participant within 7 days after start of High Emetic Risk Combo Chemotherapy\"\n  \tor exists \"Clinical Trial Participant before start of High Emetic Risk Combo Chemotherapy\"\n  \tor ( ( exists \"Dexamethasone administered or ordered within 7 days after Combo High Risk Chemo\"\n  \t\t\t\tor exists \"Dexamethasone administered or ordered before Combo High Risk Chemo\"\n  \t\t)\n  \t\t\tand ( exists \"Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\"\n  \t\t\t\t\tor exists \"Palonosetron administered or ordered before Combo High Risk Chemo\"\n  \t\t\t)\n  \t\t\tor ( ( exists \"Aprepitant, Fosaprepitant or Netupitant  administered or ordered within 7 days after Combo High Risk Chemo\"\n  \t\t\t\t\t\tor exists \"Aprepitant, Fosaprepitant or Netupitant  administered or ordered before Combo High Risk Chemo\"\n  \t\t\t\t)\n  \t\t\t\t\tand ( exists \"First Gen Serotonin Antagonists or Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\"\n  \t\t\t\t\t\t\tor exists \"First Gen Serotonin Antagonists or Palonosetron administered or ordered before Combo High Risk Chemo\"\n  \t\t\t\t\t)\n  \t\t\t)\n  \t)\n\ndefine \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\":\n  \"High Risk Cyclophosphamide Administered after First Cancer Dx\"\n  \tunion \"High Emetic Risk Chemo Administered after First Cancer Dx\"\n\ndefine \"High Risk Cyclophosphamide Administered after First Cancer Dx\":\n  \"Cyclophosphamide Administered after First Cancer Dx\"\n  \tunion \"Specific Mod Risk Chemo Administered after First Cancer Dx\"\n\ndefine \"Denominator\":\n  \"Initial Population\"\n  \tand ( exists \"Cyclophosphamide Administered after First Cancer Dx\"\n  \t\t\tand exists \"Specific Mod Risk Chemo Administered after First Cancer Dx\"\n  \t)\n  \tor exists \"High Emetic Risk Chemo Administered after First Cancer Dx\"\n\ndefine \"Actionability\":\n  true\n\ndefine \"Actionability Start Date\":\n  First(\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\".relevantPeriod.low)\n\ndefine \"Actionability End Date\":\n  \"Actionability Start Date\" + 7 days\n\ndefine \"First Cancer Dx\":\n  First((([\"Condition\": \"Cancer\"])Dx\n  \t\twhere Dx.onsetDateTime starts during \"Measurement Period\")DD\n  \t\tsort by start of prevalencePeriod\n  )\n\n",
        "fhirElm": "{\n  \"library\" : {\n    \"identifier\" : {\n      \"id\" : \"JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4\",\n      \"version\" : \"1.0.000\"\n    },\n    \"schemaIdentifier\" : {\n      \"id\" : \"urn:hl7-org:elm\",\n      \"version\" : \"r1\"\n    },\n    \"usings\" : {\n      \"def\" : [ {\n        \"localIdentifier\" : \"System\",\n        \"uri\" : \"urn:hl7-org:elm-types:r1\"\n      }, {\n        \"localId\" : \"1\",\n        \"locator\" : \"3:1-3:26\",\n        \"localIdentifier\" : \"FHIR\",\n        \"uri\" : \"http://hl7.org/fhir\",\n        \"version\" : \"4.0.0\"\n      } ]\n    },\n    \"parameters\" : {\n      \"def\" : [ {\n        \"localId\" : \"34\",\n        \"locator\" : \"36:1-36:49\",\n        \"name\" : \"Measurement Period\",\n        \"accessLevel\" : \"Public\",\n        \"parameterTypeSpecifier\" : {\n          \"localId\" : \"33\",\n          \"locator\" : \"36:32-36:49\",\n          \"type\" : \"IntervalTypeSpecifier\",\n          \"pointType\" : {\n            \"localId\" : \"32\",\n            \"locator\" : \"36:41-36:48\",\n            \"name\" : \"{urn:hl7-org:elm-types:r1}DateTime\",\n            \"type\" : \"NamedTypeSpecifier\"\n          }\n        }\n      } ]\n    },\n    \"codeSystems\" : {\n      \"def\" : [ {\n        \"localId\" : \"2\",\n        \"locator\" : \"5:1-5:51\",\n        \"name\" : \"LOINC\",\n        \"id\" : \"urn:oid:2.16.840.1.113883.6.1\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"3\",\n        \"locator\" : \"6:1-6:55\",\n        \"name\" : \"SNOMEDCT\",\n        \"id\" : \"urn:oid:2.16.840.1.113883.6.96\",\n        \"accessLevel\" : \"Public\"\n      } ]\n    },\n    \"valueSets\" : {\n      \"def\" : [ {\n        \"localId\" : \"4\",\n        \"locator\" : \"8:1-8:63\",\n        \"name\" : \"Aprepitant\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.222\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"5\",\n        \"locator\" : \"9:1-9:59\",\n        \"name\" : \"Cancer\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.231\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"6\",\n        \"locator\" : \"10:1-10:79\",\n        \"name\" : \"Clinical Trial Participant\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.150\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"7\",\n        \"locator\" : \"11:1-11:69\",\n        \"name\" : \"Cyclophosphamide\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.167\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"8\",\n        \"locator\" : \"12:1-12:65\",\n        \"name\" : \"Daunorubicin\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.332\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"9\",\n        \"locator\" : \"13:1-13:65\",\n        \"name\" : \"Dexamethasone\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.80\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"10\",\n        \"locator\" : \"14:1-14:64\",\n        \"name\" : \"Doxorubicin\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.168\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"11\",\n        \"locator\" : \"15:1-15:63\",\n        \"name\" : \"Epirubicin\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.200\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"12\",\n        \"locator\" : \"16:1-16:58\",\n        \"name\" : \"Ethnicity\",\n        \"id\" : \"urn:oid:2.16.840.1.114222.4.11.837\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"13\",\n        \"locator\" : \"17:1-17:90\",\n        \"name\" : \"First Generation Serotonin Antagonists\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.82\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"14\",\n        \"locator\" : \"18:1-18:66\",\n        \"name\" : \"Fosaprepitant\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.223\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"15\",\n        \"locator\" : \"19:1-19:86\",\n        \"name\" : \"High Emetigenic Risk Chemotherapy\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.331\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"16\",\n        \"locator\" : \"20:1-20:63\",\n        \"name\" : \"Idarubicin\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.199\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"17\",\n        \"locator\" : \"21:1-21:66\",\n        \"name\" : \"Medical Reason\",\n        \"id\" : \"urn:oid:2.16.840.1.113883.3.526.2.313\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"18\",\n        \"locator\" : \"22:1-22:81\",\n        \"name\" : \"NEPA Netupitant Palonosetron\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.334\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"19\",\n        \"locator\" : \"23:1-23:63\",\n        \"name\" : \"Netupitant\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.335\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"20\",\n        \"locator\" : \"24:1-24:75\",\n        \"name\" : \"Office Visit\",\n        \"id\" : \"urn:oid:2.16.840.1.113883.3.464.1003.101.11.1005\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"21\",\n        \"locator\" : \"25:1-25:68\",\n        \"name\" : \"ONC Administrative Sex\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"22\",\n        \"locator\" : \"26:1-26:64\",\n        \"name\" : \"Palonosetron\",\n        \"id\" : \"urn:oid:2.16.840.1.113762.1.4.1116.81\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"23\",\n        \"locator\" : \"27:1-27:81\",\n        \"name\" : \"Patient Provider Interaction\",\n        \"id\" : \"urn:oid:2.16.840.1.113883.3.526.3.1012\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"24\",\n        \"locator\" : \"28:1-28:66\",\n        \"name\" : \"Patient Reason\",\n        \"id\" : \"urn:oid:2.16.840.1.113883.3.526.2.311\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"25\",\n        \"locator\" : \"29:1-29:55\",\n        \"name\" : \"Payer\",\n        \"id\" : \"urn:oid:2.16.840.1.114222.4.11.3591\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"26\",\n        \"locator\" : \"30:1-30:53\",\n        \"name\" : \"Race\",\n        \"id\" : \"urn:oid:2.16.840.1.114222.4.11.836\",\n        \"accessLevel\" : \"Public\"\n      }, {\n        \"localId\" : \"27\",\n        \"locator\" : \"31:1-31:65\",\n        \"name\" : \"System Reason\",\n        \"id\" : \"urn:oid:2.16.840.1.113883.3.526.2.310\",\n        \"accessLevel\" : \"Public\"\n      } ]\n    },\n    \"codes\" : {\n      \"def\" : [ {\n        \"localId\" : \"29\",\n        \"locator\" : \"33:1-33:60\",\n        \"name\" : \"Birthdate\",\n        \"id\" : \"21112-8\",\n        \"display\" : \"Birthdate\",\n        \"accessLevel\" : \"Public\",\n        \"codeSystem\" : {\n          \"localId\" : \"28\",\n          \"locator\" : \"33:34-33:40\",\n          \"name\" : \"LOINC\"\n        }\n      }, {\n        \"localId\" : \"31\",\n        \"locator\" : \"34:1-34:55\",\n        \"name\" : \"Dead\",\n        \"id\" : \"419099009\",\n        \"display\" : \"Dead\",\n        \"accessLevel\" : \"Public\",\n        \"codeSystem\" : {\n          \"localId\" : \"30\",\n          \"locator\" : \"34:31-34:40\",\n          \"name\" : \"SNOMEDCT\"\n        }\n      } ]\n    },\n    \"statements\" : {\n      \"def\" : [ {\n        \"locator\" : \"38:1-38:15\",\n        \"name\" : \"Patient\",\n        \"context\" : \"Patient\",\n        \"expression\" : {\n          \"type\" : \"SingletonFrom\",\n          \"operand\" : {\n            \"locator\" : \"38:1-38:15\",\n            \"dataType\" : \"{http://hl7.org/fhir}Patient\",\n            \"type\" : \"Retrieve\"\n          }\n        }\n      }, {\n        \"localId\" : \"36\",\n        \"locator\" : \"40:1-41:51\",\n        \"name\" : \"SDE Ethnicity\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"36\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"SDE Ethnicity\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"35\",\n              \"s\" : [ {\n                \"value\" : [ \"[\", \"\\\"Patient Characteristic Ethnicity\\\"\", \": \\\"Ethnicity\\\"]\" ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"35\",\n          \"locator\" : \"41:3-41:51\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"38\",\n        \"locator\" : \"43:1-44:43\",\n        \"name\" : \"SDE Payer\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"38\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"SDE Payer\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"37\",\n              \"s\" : [ {\n                \"value\" : [ \"[\", \"\\\"Patient Characteristic Payer\\\"\", \": \\\"Payer\\\"]\" ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"37\",\n          \"locator\" : \"44:3-44:43\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"40\",\n        \"locator\" : \"46:1-47:41\",\n        \"name\" : \"SDE Race\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"40\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"SDE Race\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"39\",\n              \"s\" : [ {\n                \"value\" : [ \"[\", \"\\\"Patient Characteristic Race\\\"\", \": \\\"Race\\\"]\" ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"39\",\n          \"locator\" : \"47:3-47:41\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"42\",\n        \"locator\" : \"49:1-50:58\",\n        \"name\" : \"SDE Sex\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"42\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"SDE Sex\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"41\",\n              \"s\" : [ {\n                \"value\" : [ \"[\", \"\\\"Patient Characteristic Sex\\\"\", \": \\\"ONC Administrative Sex\\\"]\" ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"41\",\n          \"locator\" : \"50:3-50:58\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"53\",\n        \"locator\" : \"52:1-55:54\",\n        \"name\" : \"Office Visits\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"53\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Office Visits\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"52\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"46\",\n                  \"s\" : [ {\n                    \"r\" : \"45\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"45\",\n                      \"s\" : [ {\n                        \"r\" : \"43\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"Encounter\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Office Visit\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\tunion \" ]\n                      }, {\n                        \"r\" : \"44\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"Encounter\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Patient Provider Interaction\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"Enc\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"51\",\n                \"s\" : [ {\n                  \"value\" : [ \"where \" ]\n                }, {\n                  \"r\" : \"50\",\n                  \"s\" : [ {\n                    \"r\" : \"48\",\n                    \"s\" : [ {\n                      \"r\" : \"47\",\n                      \"s\" : [ {\n                        \"value\" : [ \"Enc\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"48\",\n                      \"s\" : [ {\n                        \"value\" : [ \"period\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"r\" : \"50\",\n                    \"value\" : [ \" \", \"starts during\", \" \" ]\n                  }, {\n                    \"r\" : \"49\",\n                    \"s\" : [ {\n                      \"value\" : [ \"\\\"Measurement Period\\\"\" ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"52\",\n          \"locator\" : \"53:3-55:54\",\n          \"type\" : \"Query\",\n          \"source\" : [ {\n            \"localId\" : \"46\",\n            \"locator\" : \"53:3-54:60\",\n            \"alias\" : \"Enc\",\n            \"expression\" : {\n              \"localId\" : \"45\",\n              \"locator\" : \"53:3-54:56\",\n              \"type\" : \"Union\",\n              \"operand\" : [ {\n                \"localId\" : \"43\",\n                \"locator\" : \"53:5-53:33\",\n                \"dataType\" : \"{http://hl7.org/fhir}Encounter\",\n                \"codeProperty\" : \"type\",\n                \"type\" : \"Retrieve\",\n                \"codes\" : {\n                  \"locator\" : \"53:19-53:32\",\n                  \"name\" : \"Office Visit\",\n                  \"type\" : \"ValueSetRef\"\n                }\n              }, {\n                \"localId\" : \"44\",\n                \"locator\" : \"54:10-54:54\",\n                \"dataType\" : \"{http://hl7.org/fhir}Encounter\",\n                \"codeProperty\" : \"type\",\n                \"type\" : \"Retrieve\",\n                \"codes\" : {\n                  \"locator\" : \"54:24-54:53\",\n                  \"name\" : \"Patient Provider Interaction\",\n                  \"type\" : \"ValueSetRef\"\n                }\n              } ]\n            }\n          } ],\n          \"relationship\" : [ ],\n          \"where\" : {\n            \"localId\" : \"51\",\n            \"locator\" : \"55:4-55:54\",\n            \"type\" : \"Null\"\n          }\n        }\n      }, {\n        \"localId\" : \"71\",\n        \"locator\" : \"208:1-212:3\",\n        \"name\" : \"First Cancer Dx\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"71\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"First Cancer Dx\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"70\",\n              \"s\" : [ {\n                \"value\" : [ \"First\", \"(\" ]\n              }, {\n                \"r\" : \"69\",\n                \"s\" : [ {\n                  \"s\" : [ {\n                    \"r\" : \"64\",\n                    \"s\" : [ {\n                      \"r\" : \"63\",\n                      \"s\" : [ {\n                        \"value\" : [ \"(\" ]\n                      }, {\n                        \"r\" : \"63\",\n                        \"s\" : [ {\n                          \"s\" : [ {\n                            \"r\" : \"57\",\n                            \"s\" : [ {\n                              \"r\" : \"56\",\n                              \"s\" : [ {\n                                \"value\" : [ \"(\" ]\n                              }, {\n                                \"r\" : \"56\",\n                                \"s\" : [ {\n                                  \"value\" : [ \"[\", \"\\\"Condition\\\"\", \": \" ]\n                                }, {\n                                  \"s\" : [ {\n                                    \"value\" : [ \"\\\"Cancer\\\"\" ]\n                                  } ]\n                                }, {\n                                  \"value\" : [ \"]\" ]\n                                } ]\n                              }, {\n                                \"value\" : [ \")\" ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"Dx\" ]\n                            } ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"\\n  \\t\\t\" ]\n                        }, {\n                          \"r\" : \"62\",\n                          \"s\" : [ {\n                            \"value\" : [ \"where \" ]\n                          }, {\n                            \"r\" : \"61\",\n                            \"s\" : [ {\n                              \"r\" : \"59\",\n                              \"s\" : [ {\n                                \"r\" : \"58\",\n                                \"s\" : [ {\n                                  \"value\" : [ \"Dx\" ]\n                                } ]\n                              }, {\n                                \"value\" : [ \".\" ]\n                              }, {\n                                \"r\" : \"59\",\n                                \"s\" : [ {\n                                  \"value\" : [ \"onsetDateTime\" ]\n                                } ]\n                              } ]\n                            }, {\n                              \"r\" : \"61\",\n                              \"value\" : [ \" \", \"starts during\", \" \" ]\n                            }, {\n                              \"r\" : \"60\",\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"Measurement Period\\\"\" ]\n                              } ]\n                            } ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \")\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \"DD\" ]\n                    } ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\t\" ]\n                }, {\n                  \"r\" : \"68\",\n                  \"s\" : [ {\n                    \"value\" : [ \"sort by \" ]\n                  }, {\n                    \"r\" : \"67\",\n                    \"s\" : [ {\n                      \"r\" : \"66\",\n                      \"s\" : [ {\n                        \"value\" : [ \"start of \" ]\n                      }, {\n                        \"r\" : \"65\",\n                        \"s\" : [ {\n                          \"value\" : [ \"prevalencePeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  )\" ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"70\",\n          \"locator\" : \"209:3-212:3\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"82\",\n        \"locator\" : \"57:1-60:82\",\n        \"name\" : \"Cyclophosphamide Administered after First Cancer Dx\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"82\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Cyclophosphamide Administered after First Cancer Dx\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"81\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"55\",\n                  \"s\" : [ {\n                    \"r\" : \"54\",\n                    \"s\" : [ {\n                      \"r\" : \"54\",\n                      \"s\" : [ {\n                        \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                      }, {\n                        \"s\" : [ {\n                          \"value\" : [ \"\\\"Cyclophosphamide\\\"\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"]\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedAdmin\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"80\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"73\",\n                  \"s\" : [ {\n                    \"r\" : \"72\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"Dx\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"79\",\n                  \"s\" : [ {\n                    \"r\" : \"75\",\n                    \"s\" : [ {\n                      \"r\" : \"74\",\n                      \"s\" : [ {\n                        \"value\" : [ \"MedAdmin\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"75\",\n                      \"s\" : [ {\n                        \"value\" : [ \"effectiveDateTime\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"r\" : \"79\",\n                    \"value\" : [ \" \", \"starts after\", \" \" ]\n                  }, {\n                    \"r\" : \"78\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"77\",\n                      \"s\" : [ {\n                        \"r\" : \"76\",\n                        \"s\" : [ {\n                          \"value\" : [ \"Dx\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"77\",\n                        \"s\" : [ {\n                          \"value\" : [ \"prevalencePeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"81\",\n          \"locator\" : \"58:3-60:82\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"90\",\n        \"locator\" : \"62:1-64:36\",\n        \"name\" : \"Initial Population\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"90\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Initial Population\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"89\",\n              \"s\" : [ {\n                \"r\" : \"86\",\n                \"s\" : [ {\n                  \"r\" : \"84\",\n                  \"s\" : [ {\n                    \"value\" : [ \"Count\", \"(\" ]\n                  }, {\n                    \"r\" : \"83\",\n                    \"s\" : [ {\n                      \"value\" : [ \"\\\"Office Visits\\\"\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \")\" ]\n                  } ]\n                }, {\n                  \"r\" : \"85\",\n                  \"value\" : [ \">=\", \" \", \"2\" ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\tand \" ]\n              }, {\n                \"r\" : \"88\",\n                \"s\" : [ {\n                  \"r\" : \"87\",\n                  \"s\" : [ {\n                    \"value\" : [ \"\\\"First Cancer Dx\\\"\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \" is not null\" ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"89\",\n          \"locator\" : \"63:3-64:36\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"103\",\n        \"locator\" : \"66:1-69:82\",\n        \"name\" : \"High Emetic Risk Chemo Administered after First Cancer Dx\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"103\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"High Emetic Risk Chemo Administered after First Cancer Dx\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"102\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"92\",\n                  \"s\" : [ {\n                    \"r\" : \"91\",\n                    \"s\" : [ {\n                      \"r\" : \"91\",\n                      \"s\" : [ {\n                        \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                      }, {\n                        \"s\" : [ {\n                          \"value\" : [ \"\\\"High Emetigenic Risk Chemotherapy\\\"\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"]\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedAdmin\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"101\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"94\",\n                  \"s\" : [ {\n                    \"r\" : \"93\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"Dx\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"100\",\n                  \"s\" : [ {\n                    \"r\" : \"96\",\n                    \"s\" : [ {\n                      \"r\" : \"95\",\n                      \"s\" : [ {\n                        \"value\" : [ \"MedAdmin\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"96\",\n                      \"s\" : [ {\n                        \"value\" : [ \"effectiveDateTime\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"r\" : \"100\",\n                    \"value\" : [ \" \", \"starts after\", \" \" ]\n                  }, {\n                    \"r\" : \"99\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"98\",\n                      \"s\" : [ {\n                        \"r\" : \"97\",\n                        \"s\" : [ {\n                          \"value\" : [ \"Dx\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"98\",\n                        \"s\" : [ {\n                          \"value\" : [ \"prevalencePeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"102\",\n          \"locator\" : \"67:3-69:82\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"122\",\n        \"locator\" : \"71:1-77:82\",\n        \"name\" : \"Specific Mod Risk Chemo Administered after First Cancer Dx\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"122\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Specific Mod Risk Chemo Administered after First Cancer Dx\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"121\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"111\",\n                  \"s\" : [ {\n                    \"r\" : \"110\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"110\",\n                      \"s\" : [ {\n                        \"r\" : \"108\",\n                        \"s\" : [ {\n                          \"r\" : \"106\",\n                          \"s\" : [ {\n                            \"r\" : \"104\",\n                            \"s\" : [ {\n                              \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                            }, {\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"Doxorubicin\\\"\" ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"]\" ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"\\n  \\tunion \" ]\n                          }, {\n                            \"r\" : \"105\",\n                            \"s\" : [ {\n                              \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                            }, {\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"Epirubicin\\\"\" ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"]\" ]\n                            } ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"\\n  \\tunion \" ]\n                        }, {\n                          \"r\" : \"107\",\n                          \"s\" : [ {\n                            \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                          }, {\n                            \"s\" : [ {\n                              \"value\" : [ \"\\\"Idarubicin\\\"\" ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"]\" ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\tunion \" ]\n                      }, {\n                        \"r\" : \"109\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Daunorubicin\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedAdmin\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"120\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"113\",\n                  \"s\" : [ {\n                    \"r\" : \"112\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"Dx\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"119\",\n                  \"s\" : [ {\n                    \"r\" : \"115\",\n                    \"s\" : [ {\n                      \"r\" : \"114\",\n                      \"s\" : [ {\n                        \"value\" : [ \"MedAdmin\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"115\",\n                      \"s\" : [ {\n                        \"value\" : [ \"effectiveDateTime\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"r\" : \"119\",\n                    \"value\" : [ \" \", \"starts after\", \" \" ]\n                  }, {\n                    \"r\" : \"118\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"117\",\n                      \"s\" : [ {\n                        \"r\" : \"116\",\n                        \"s\" : [ {\n                          \"value\" : [ \"Dx\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"117\",\n                        \"s\" : [ {\n                          \"value\" : [ \"prevalencePeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"121\",\n          \"locator\" : \"72:3-77:82\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"128\",\n        \"locator\" : \"188:1-190:69\",\n        \"name\" : \"High Risk Cyclophosphamide Administered after First Cancer Dx\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"128\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"High Risk Cyclophosphamide Administered after First Cancer Dx\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"127\",\n              \"s\" : [ {\n                \"r\" : \"125\",\n                \"s\" : [ {\n                  \"value\" : [ \"\\\"Cyclophosphamide Administered after First Cancer Dx\\\"\" ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\tunion \" ]\n              }, {\n                \"r\" : \"126\",\n                \"s\" : [ {\n                  \"value\" : [ \"\\\"Specific Mod Risk Chemo Administered after First Cancer Dx\\\"\" ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"127\",\n          \"locator\" : \"189:3-190:69\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"132\",\n        \"locator\" : \"184:1-186:68\",\n        \"name\" : \"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"132\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"131\",\n              \"s\" : [ {\n                \"r\" : \"129\",\n                \"s\" : [ {\n                  \"value\" : [ \"\\\"High Risk Cyclophosphamide Administered after First Cancer Dx\\\"\" ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\tunion \" ]\n              }, {\n                \"r\" : \"130\",\n                \"s\" : [ {\n                  \"value\" : [ \"\\\"High Emetic Risk Chemo Administered after First Cancer Dx\\\"\" ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"131\",\n          \"locator\" : \"185:3-186:68\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"143\",\n        \"locator\" : \"79:1-82:75\",\n        \"name\" : \"Clinical Trial Participant before start of High Emetic Risk Combo Chemotherapy\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"143\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Clinical Trial Participant before start of High Emetic Risk Combo Chemotherapy\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"142\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"124\",\n                  \"s\" : [ {\n                    \"r\" : \"123\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"123\",\n                      \"s\" : [ {\n                        \"value\" : [ \"[\", \"\\\"Observation\\\"\", \": \" ]\n                      }, {\n                        \"s\" : [ {\n                          \"value\" : [ \"\\\"Clinical Trial Participant\\\"\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"]\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"Trial\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"141\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"134\",\n                  \"s\" : [ {\n                    \"r\" : \"133\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"ComboChemo\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"140\",\n                  \"s\" : [ {\n                    \"r\" : \"136\",\n                    \"s\" : [ {\n                      \"r\" : \"135\",\n                      \"s\" : [ {\n                        \"value\" : [ \"Trial\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"136\",\n                      \"s\" : [ {\n                        \"value\" : [ \"target\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"r\" : \"140\",\n                    \"value\" : [ \" \", \"starts before\", \" \" ]\n                  }, {\n                    \"r\" : \"139\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"138\",\n                      \"s\" : [ {\n                        \"r\" : \"137\",\n                        \"s\" : [ {\n                          \"value\" : [ \"ComboChemo\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"138\",\n                        \"s\" : [ {\n                          \"value\" : [ \"relevantPeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"142\",\n          \"locator\" : \"80:3-82:75\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"156\",\n        \"locator\" : \"84:1-87:89\",\n        \"name\" : \"Clinical Trial Participant within 7 days after start of High Emetic Risk Combo Chemotherapy\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"156\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Clinical Trial Participant within 7 days after start of High Emetic Risk Combo Chemotherapy\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"155\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"145\",\n                  \"s\" : [ {\n                    \"r\" : \"144\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"144\",\n                      \"s\" : [ {\n                        \"value\" : [ \"[\", \"\\\"Observation\\\"\", \": \" ]\n                      }, {\n                        \"s\" : [ {\n                          \"value\" : [ \"\\\"Clinical Trial Participant\\\"\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"]\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"Trial\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"154\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"147\",\n                  \"s\" : [ {\n                    \"r\" : \"146\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"ComboChemo\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"153\",\n                  \"s\" : [ {\n                    \"r\" : \"149\",\n                    \"s\" : [ {\n                      \"r\" : \"148\",\n                      \"s\" : [ {\n                        \"value\" : [ \"Trial\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"149\",\n                      \"s\" : [ {\n                        \"value\" : [ \"target\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"r\" : \"153\",\n                    \"value\" : [ \" \", \"starts 7 days or less after\", \" \" ]\n                  }, {\n                    \"r\" : \"152\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"151\",\n                      \"s\" : [ {\n                        \"r\" : \"150\",\n                        \"s\" : [ {\n                          \"value\" : [ \"ComboChemo\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"151\",\n                        \"s\" : [ {\n                          \"value\" : [ \"relevantPeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"155\",\n          \"locator\" : \"85:3-87:89\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"172\",\n        \"locator\" : \"89:1-93:116\",\n        \"name\" : \"Dexamethasone administered or ordered within 7 days after Combo High Risk Chemo\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"172\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Dexamethasone administered or ordered within 7 days after Combo High Risk Chemo\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"171\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"160\",\n                  \"s\" : [ {\n                    \"r\" : \"159\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"159\",\n                      \"s\" : [ {\n                        \"r\" : \"157\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Dexamethasone\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\tunion \" ]\n                      }, {\n                        \"r\" : \"158\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"MedicationRequest\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Dexamethasone\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedAdmin\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"170\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"162\",\n                  \"s\" : [ {\n                    \"r\" : \"161\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"ComboChemo\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"169\",\n                  \"s\" : [ {\n                    \"r\" : \"165\",\n                    \"s\" : [ {\n                      \"r\" : \"164\",\n                      \"s\" : [ {\n                        \"r\" : \"163\",\n                        \"s\" : [ {\n                          \"value\" : [ \"MedAdmin\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"164\",\n                        \"s\" : [ {\n                          \"value\" : [ \"dispenseRequest\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"165\",\n                      \"s\" : [ {\n                        \"value\" : [ \"validityPeriod\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"r\" : \"169\",\n                    \"value\" : [ \" \", \"starts 7 days or less after\", \" \" ]\n                  }, {\n                    \"r\" : \"168\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"167\",\n                      \"s\" : [ {\n                        \"r\" : \"166\",\n                        \"s\" : [ {\n                          \"value\" : [ \"ComboChemo\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"167\",\n                        \"s\" : [ {\n                          \"value\" : [ \"relevantPeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"171\",\n          \"locator\" : \"90:3-93:116\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"188\",\n        \"locator\" : \"95:1-99:102\",\n        \"name\" : \"Dexamethasone administered or ordered before Combo High Risk Chemo\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"188\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Dexamethasone administered or ordered before Combo High Risk Chemo\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"187\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"176\",\n                  \"s\" : [ {\n                    \"r\" : \"175\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"175\",\n                      \"s\" : [ {\n                        \"r\" : \"173\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Dexamethasone\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\tunion \" ]\n                      }, {\n                        \"r\" : \"174\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"MedicationRequest\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Dexamethasone\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedAdmin\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"186\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"178\",\n                  \"s\" : [ {\n                    \"r\" : \"177\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"ComboChemo\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"185\",\n                  \"s\" : [ {\n                    \"r\" : \"181\",\n                    \"s\" : [ {\n                      \"r\" : \"180\",\n                      \"s\" : [ {\n                        \"r\" : \"179\",\n                        \"s\" : [ {\n                          \"value\" : [ \"MedAdmin\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"180\",\n                        \"s\" : [ {\n                          \"value\" : [ \"dispenseRequest\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"181\",\n                      \"s\" : [ {\n                        \"value\" : [ \"validityPeriod\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"r\" : \"185\",\n                    \"value\" : [ \" \", \"starts before\", \" \" ]\n                  }, {\n                    \"r\" : \"184\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"183\",\n                      \"s\" : [ {\n                        \"r\" : \"182\",\n                        \"s\" : [ {\n                          \"value\" : [ \"ComboChemo\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"183\",\n                        \"s\" : [ {\n                          \"value\" : [ \"relevantPeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"187\",\n          \"locator\" : \"96:3-99:102\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"204\",\n        \"locator\" : \"101:1-105:102\",\n        \"name\" : \"Palonosetron administered or ordered before Combo High Risk Chemo\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"204\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Palonosetron administered or ordered before Combo High Risk Chemo\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"203\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"192\",\n                  \"s\" : [ {\n                    \"r\" : \"191\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"191\",\n                      \"s\" : [ {\n                        \"r\" : \"189\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"NEPA Netupitant Palonosetron\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\tunion \" ]\n                      }, {\n                        \"r\" : \"190\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"MedicationRequest\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"NEPA Netupitant Palonosetron\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedAdmin\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"202\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"194\",\n                  \"s\" : [ {\n                    \"r\" : \"193\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"ComboChemo\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"201\",\n                  \"s\" : [ {\n                    \"r\" : \"197\",\n                    \"s\" : [ {\n                      \"r\" : \"196\",\n                      \"s\" : [ {\n                        \"r\" : \"195\",\n                        \"s\" : [ {\n                          \"value\" : [ \"MedAdmin\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"196\",\n                        \"s\" : [ {\n                          \"value\" : [ \"dispenseRequest\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"197\",\n                      \"s\" : [ {\n                        \"value\" : [ \"validityPeriod\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"r\" : \"201\",\n                    \"value\" : [ \" \", \"starts before\", \" \" ]\n                  }, {\n                    \"r\" : \"200\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"199\",\n                      \"s\" : [ {\n                        \"r\" : \"198\",\n                        \"s\" : [ {\n                          \"value\" : [ \"ComboChemo\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"199\",\n                        \"s\" : [ {\n                          \"value\" : [ \"relevantPeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"203\",\n          \"locator\" : \"102:3-105:102\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"220\",\n        \"locator\" : \"107:1-111:116\",\n        \"name\" : \"Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"220\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"219\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"208\",\n                  \"s\" : [ {\n                    \"r\" : \"207\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"207\",\n                      \"s\" : [ {\n                        \"r\" : \"205\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"NEPA Netupitant Palonosetron\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\tunion \" ]\n                      }, {\n                        \"r\" : \"206\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"MedicationRequest\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"NEPA Netupitant Palonosetron\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedAdmin\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"218\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"210\",\n                  \"s\" : [ {\n                    \"r\" : \"209\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"ComboChemo\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"217\",\n                  \"s\" : [ {\n                    \"r\" : \"213\",\n                    \"s\" : [ {\n                      \"r\" : \"212\",\n                      \"s\" : [ {\n                        \"r\" : \"211\",\n                        \"s\" : [ {\n                          \"value\" : [ \"MedAdmin\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"212\",\n                        \"s\" : [ {\n                          \"value\" : [ \"dispenseRequest\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"213\",\n                      \"s\" : [ {\n                        \"value\" : [ \"validityPeriod\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"r\" : \"217\",\n                    \"value\" : [ \" \", \"starts 7 days or less after\", \" \" ]\n                  }, {\n                    \"r\" : \"216\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"215\",\n                      \"s\" : [ {\n                        \"r\" : \"214\",\n                        \"s\" : [ {\n                          \"value\" : [ \"ComboChemo\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"215\",\n                        \"s\" : [ {\n                          \"value\" : [ \"relevantPeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"219\",\n          \"locator\" : \"108:3-111:116\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"240\",\n        \"locator\" : \"113:1-119:116\",\n        \"name\" : \"First Gen Serotonin Antagonists or Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"240\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"First Gen Serotonin Antagonists or Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"239\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"228\",\n                  \"s\" : [ {\n                    \"r\" : \"227\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"227\",\n                      \"s\" : [ {\n                        \"r\" : \"225\",\n                        \"s\" : [ {\n                          \"r\" : \"223\",\n                          \"s\" : [ {\n                            \"r\" : \"221\",\n                            \"s\" : [ {\n                              \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                            }, {\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"First Generation Serotonin Antagonists\\\"\" ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"]\" ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"\\n  \\tunion \" ]\n                          }, {\n                            \"r\" : \"222\",\n                            \"s\" : [ {\n                              \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                            }, {\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"Palonosetron\\\"\" ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"]\" ]\n                            } ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"\\n  \\tunion \" ]\n                        }, {\n                          \"r\" : \"224\",\n                          \"s\" : [ {\n                            \"value\" : [ \"[\", \"\\\"MedicationRequest\\\"\", \": \" ]\n                          }, {\n                            \"s\" : [ {\n                              \"value\" : [ \"\\\"First Generation Serotonin Antagonists\\\"\" ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"]\" ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\tunion \" ]\n                      }, {\n                        \"r\" : \"226\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"MedicationRequest\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Palonosetron\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedAdmin\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"238\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"230\",\n                  \"s\" : [ {\n                    \"r\" : \"229\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"ComboChemo\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"237\",\n                  \"s\" : [ {\n                    \"r\" : \"233\",\n                    \"s\" : [ {\n                      \"r\" : \"232\",\n                      \"s\" : [ {\n                        \"r\" : \"231\",\n                        \"s\" : [ {\n                          \"value\" : [ \"MedAdmin\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"232\",\n                        \"s\" : [ {\n                          \"value\" : [ \"dispenseRequest\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"233\",\n                      \"s\" : [ {\n                        \"value\" : [ \"validityPeriod\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"r\" : \"237\",\n                    \"value\" : [ \" \", \"starts 7 days or less after\", \" \" ]\n                  }, {\n                    \"r\" : \"236\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"235\",\n                      \"s\" : [ {\n                        \"r\" : \"234\",\n                        \"s\" : [ {\n                          \"value\" : [ \"ComboChemo\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"235\",\n                        \"s\" : [ {\n                          \"value\" : [ \"relevantPeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"239\",\n          \"locator\" : \"114:3-119:116\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"260\",\n        \"locator\" : \"121:1-127:102\",\n        \"name\" : \"First Gen Serotonin Antagonists or Palonosetron administered or ordered before Combo High Risk Chemo\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"260\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"First Gen Serotonin Antagonists or Palonosetron administered or ordered before Combo High Risk Chemo\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"259\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"248\",\n                  \"s\" : [ {\n                    \"r\" : \"247\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"247\",\n                      \"s\" : [ {\n                        \"r\" : \"245\",\n                        \"s\" : [ {\n                          \"r\" : \"243\",\n                          \"s\" : [ {\n                            \"r\" : \"241\",\n                            \"s\" : [ {\n                              \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                            }, {\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"First Generation Serotonin Antagonists\\\"\" ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"]\" ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"\\n  \\tunion \" ]\n                          }, {\n                            \"r\" : \"242\",\n                            \"s\" : [ {\n                              \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                            }, {\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"Palonosetron\\\"\" ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"]\" ]\n                            } ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"\\n  \\tunion \" ]\n                        }, {\n                          \"r\" : \"244\",\n                          \"s\" : [ {\n                            \"value\" : [ \"[\", \"\\\"MedicationRequest\\\"\", \": \" ]\n                          }, {\n                            \"s\" : [ {\n                              \"value\" : [ \"\\\"First Generation Serotonin Antagonists\\\"\" ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"]\" ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\tunion \" ]\n                      }, {\n                        \"r\" : \"246\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"MedicationRequest\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Palonosetron\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedAdmin\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"258\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"250\",\n                  \"s\" : [ {\n                    \"r\" : \"249\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"ComboChemo\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"257\",\n                  \"s\" : [ {\n                    \"r\" : \"253\",\n                    \"s\" : [ {\n                      \"r\" : \"252\",\n                      \"s\" : [ {\n                        \"r\" : \"251\",\n                        \"s\" : [ {\n                          \"value\" : [ \"MedAdmin\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"252\",\n                        \"s\" : [ {\n                          \"value\" : [ \"dispenseRequest\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"253\",\n                      \"s\" : [ {\n                        \"value\" : [ \"validityPeriod\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"r\" : \"257\",\n                    \"value\" : [ \" \", \"starts before\", \" \" ]\n                  }, {\n                    \"r\" : \"256\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"255\",\n                      \"s\" : [ {\n                        \"r\" : \"254\",\n                        \"s\" : [ {\n                          \"value\" : [ \"ComboChemo\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"255\",\n                        \"s\" : [ {\n                          \"value\" : [ \"relevantPeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"259\",\n          \"locator\" : \"122:3-127:102\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"299\",\n        \"locator\" : \"132:1-144:88\",\n        \"name\" : \"Reasons for Not prescribing or Ordering First Gen Serotonin Antagonists, Aprepitant, Fosprepitant or Netupitant\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"299\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Reasons for Not prescribing or Ordering First Gen Serotonin Antagonists, Aprepitant, Fosprepitant or Netupitant\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"298\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"276\",\n                  \"s\" : [ {\n                    \"r\" : \"275\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"275\",\n                      \"s\" : [ {\n                        \"r\" : \"273\",\n                        \"s\" : [ {\n                          \"r\" : \"271\",\n                          \"s\" : [ {\n                            \"r\" : \"269\",\n                            \"s\" : [ {\n                              \"r\" : \"267\",\n                              \"s\" : [ {\n                                \"r\" : \"265\",\n                                \"s\" : [ {\n                                  \"r\" : \"263\",\n                                  \"s\" : [ {\n                                    \"r\" : \"261\",\n                                    \"s\" : [ {\n                                      \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                                    }, {\n                                      \"s\" : [ {\n                                        \"value\" : [ \"\\\"First Generation Serotonin Antagonists\\\"\" ]\n                                      } ]\n                                    }, {\n                                      \"value\" : [ \"]\" ]\n                                    } ]\n                                  }, {\n                                    \"value\" : [ \"\\n  \\tunion \" ]\n                                  }, {\n                                    \"r\" : \"262\",\n                                    \"s\" : [ {\n                                      \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                                    }, {\n                                      \"s\" : [ {\n                                        \"value\" : [ \"\\\"Aprepitant\\\"\" ]\n                                      } ]\n                                    }, {\n                                      \"value\" : [ \"]\" ]\n                                    } ]\n                                  } ]\n                                }, {\n                                  \"value\" : [ \"\\n  \\tunion \" ]\n                                }, {\n                                  \"r\" : \"264\",\n                                  \"s\" : [ {\n                                    \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                                  }, {\n                                    \"s\" : [ {\n                                      \"value\" : [ \"\\\"Fosaprepitant\\\"\" ]\n                                    } ]\n                                  }, {\n                                    \"value\" : [ \"]\" ]\n                                  } ]\n                                } ]\n                              }, {\n                                \"value\" : [ \"\\n  \\tunion \" ]\n                              }, {\n                                \"r\" : \"266\",\n                                \"s\" : [ {\n                                  \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                                }, {\n                                  \"s\" : [ {\n                                    \"value\" : [ \"\\\"Netupitant\\\"\" ]\n                                  } ]\n                                }, {\n                                  \"value\" : [ \"]\" ]\n                                } ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"\\n  \\tunion \" ]\n                            }, {\n                              \"r\" : \"268\",\n                              \"s\" : [ {\n                                \"value\" : [ \"[\", \"\\\"MedicationRequest\\\"\", \": \" ]\n                              }, {\n                                \"s\" : [ {\n                                  \"value\" : [ \"\\\"First Generation Serotonin Antagonists\\\"\" ]\n                                } ]\n                              }, {\n                                \"value\" : [ \"]\" ]\n                              } ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"\\n  \\tunion \" ]\n                          }, {\n                            \"r\" : \"270\",\n                            \"s\" : [ {\n                              \"value\" : [ \"[\", \"\\\"MedicationRequest\\\"\", \": \" ]\n                            }, {\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"Aprepitant\\\"\" ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"]\" ]\n                            } ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"\\n  \\tunion \" ]\n                        }, {\n                          \"r\" : \"272\",\n                          \"s\" : [ {\n                            \"value\" : [ \"[\", \"\\\"MedicationRequest\\\"\", \": \" ]\n                          }, {\n                            \"s\" : [ {\n                              \"value\" : [ \"\\\"Fosaprepitant\\\"\" ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"]\" ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\tunion \" ]\n                      }, {\n                        \"r\" : \"274\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"MedicationRequest\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Netupitant\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedNotOrdered\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"297\",\n                \"s\" : [ {\n                  \"value\" : [ \"where \" ]\n                }, {\n                  \"r\" : \"296\",\n                  \"s\" : [ {\n                    \"r\" : \"285\",\n                    \"s\" : [ {\n                      \"r\" : \"280\",\n                      \"s\" : [ {\n                        \"r\" : \"278\",\n                        \"s\" : [ {\n                          \"r\" : \"277\",\n                          \"s\" : [ {\n                            \"value\" : [ \"MedNotOrdered\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \".\" ]\n                        }, {\n                          \"r\" : \"278\",\n                          \"s\" : [ {\n                            \"value\" : [ \"Unknown\" ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \" in \" ]\n                      }, {\n                        \"r\" : \"279\",\n                        \"s\" : [ {\n                          \"value\" : [ \"\\\"Medical Reason\\\"\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \"\\n  \\t\\tor \" ]\n                    }, {\n                      \"r\" : \"284\",\n                      \"s\" : [ {\n                        \"r\" : \"282\",\n                        \"s\" : [ {\n                          \"r\" : \"281\",\n                          \"s\" : [ {\n                            \"value\" : [ \"MedNotOrdered\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \".\" ]\n                        }, {\n                          \"r\" : \"282\",\n                          \"s\" : [ {\n                            \"value\" : [ \"Unknown\" ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \" in \" ]\n                      }, {\n                        \"r\" : \"283\",\n                        \"s\" : [ {\n                          \"value\" : [ \"\\\"Patient Reason\\\"\" ]\n                        } ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \"\\n  \\t\\tor \" ]\n                  }, {\n                    \"r\" : \"295\",\n                    \"s\" : [ {\n                      \"r\" : \"289\",\n                      \"s\" : [ {\n                        \"r\" : \"287\",\n                        \"s\" : [ {\n                          \"r\" : \"286\",\n                          \"s\" : [ {\n                            \"value\" : [ \"MedNotOrdered\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \".\" ]\n                        }, {\n                          \"r\" : \"287\",\n                          \"s\" : [ {\n                            \"value\" : [ \"Unknown\" ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \" in \" ]\n                      }, {\n                        \"r\" : \"288\",\n                        \"s\" : [ {\n                          \"value\" : [ \"\\\"System Reason\\\"\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \"\\n  \\t\\t\\tand \" ]\n                    }, {\n                      \"r\" : \"294\",\n                      \"s\" : [ {\n                        \"r\" : \"292\",\n                        \"s\" : [ {\n                          \"r\" : \"291\",\n                          \"s\" : [ {\n                            \"r\" : \"290\",\n                            \"s\" : [ {\n                              \"value\" : [ \"MedNotOrdered\" ]\n                            } ]\n                          }, {\n                            \"value\" : [ \".\" ]\n                          }, {\n                            \"r\" : \"291\",\n                            \"s\" : [ {\n                              \"value\" : [ \"dispenseRequest\" ]\n                            } ]\n                          } ]\n                        }, {\n                          \"value\" : [ \".\" ]\n                        }, {\n                          \"r\" : \"292\",\n                          \"s\" : [ {\n                            \"value\" : [ \"validityPeriod\" ]\n                          } ]\n                        } ]\n                      }, {\n                        \"r\" : \"294\",\n                        \"value\" : [ \" \", \"starts during\", \" \" ]\n                      }, {\n                        \"r\" : \"293\",\n                        \"s\" : [ {\n                          \"value\" : [ \"\\\"Measurement Period\\\"\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"298\",\n          \"locator\" : \"133:3-144:88\",\n          \"type\" : \"Query\",\n          \"source\" : [ {\n            \"localId\" : \"276\",\n            \"locator\" : \"133:3-140:60\",\n            \"alias\" : \"MedNotOrdered\",\n            \"expression\" : {\n              \"localId\" : \"275\",\n              \"locator\" : \"133:3-140:46\",\n              \"type\" : \"Union\",\n              \"operand\" : [ {\n                \"type\" : \"As\",\n                \"operand\" : {\n                  \"localId\" : \"273\",\n                  \"locator\" : \"133:5-139:47\",\n                  \"type\" : \"Union\",\n                  \"operand\" : [ {\n                    \"type\" : \"As\",\n                    \"operand\" : {\n                      \"localId\" : \"271\",\n                      \"locator\" : \"133:5-138:44\",\n                      \"type\" : \"Union\",\n                      \"operand\" : [ {\n                        \"type\" : \"As\",\n                        \"operand\" : {\n                          \"localId\" : \"269\",\n                          \"locator\" : \"133:5-137:72\",\n                          \"type\" : \"Union\",\n                          \"operand\" : [ {\n                            \"type\" : \"As\",\n                            \"operand\" : {\n                              \"localId\" : \"267\",\n                              \"locator\" : \"133:5-136:46\",\n                              \"type\" : \"Union\",\n                              \"operand\" : [ {\n                                \"localId\" : \"263\",\n                                \"locator\" : \"133:5-134:46\",\n                                \"type\" : \"Union\",\n                                \"operand\" : [ {\n                                  \"localId\" : \"261\",\n                                  \"locator\" : \"133:5-133:69\",\n                                  \"dataType\" : \"{http://hl7.org/fhir}MedicationStatement\",\n                                  \"codeProperty\" : \"medication\",\n                                  \"type\" : \"Retrieve\",\n                                  \"codes\" : {\n                                    \"locator\" : \"133:29-133:68\",\n                                    \"name\" : \"First Generation Serotonin Antagonists\",\n                                    \"type\" : \"ValueSetRef\"\n                                  }\n                                }, {\n                                  \"localId\" : \"262\",\n                                  \"locator\" : \"134:10-134:46\",\n                                  \"dataType\" : \"{http://hl7.org/fhir}MedicationStatement\",\n                                  \"codeProperty\" : \"medication\",\n                                  \"type\" : \"Retrieve\",\n                                  \"codes\" : {\n                                    \"locator\" : \"134:34-134:45\",\n                                    \"name\" : \"Aprepitant\",\n                                    \"type\" : \"ValueSetRef\"\n                                  }\n                                } ]\n                              }, {\n                                \"type\" : \"Union\",\n                                \"operand\" : [ {\n                                  \"localId\" : \"264\",\n                                  \"locator\" : \"135:10-135:49\",\n                                  \"dataType\" : \"{http://hl7.org/fhir}MedicationStatement\",\n                                  \"codeProperty\" : \"medication\",\n                                  \"type\" : \"Retrieve\",\n                                  \"codes\" : {\n                                    \"locator\" : \"135:34-135:48\",\n                                    \"name\" : \"Fosaprepitant\",\n                                    \"type\" : \"ValueSetRef\"\n                                  }\n                                }, {\n                                  \"localId\" : \"266\",\n                                  \"locator\" : \"136:10-136:46\",\n                                  \"dataType\" : \"{http://hl7.org/fhir}MedicationStatement\",\n                                  \"codeProperty\" : \"medication\",\n                                  \"type\" : \"Retrieve\",\n                                  \"codes\" : {\n                                    \"locator\" : \"136:34-136:45\",\n                                    \"name\" : \"Netupitant\",\n                                    \"type\" : \"ValueSetRef\"\n                                  }\n                                } ]\n                              } ]\n                            },\n                            \"asTypeSpecifier\" : {\n                              \"type\" : \"ListTypeSpecifier\",\n                              \"elementType\" : {\n                                \"type\" : \"ChoiceTypeSpecifier\",\n                                \"choice\" : [ {\n                                  \"name\" : \"{http://hl7.org/fhir}MedicationRequest\",\n                                  \"type\" : \"NamedTypeSpecifier\"\n                                }, {\n                                  \"name\" : \"{http://hl7.org/fhir}MedicationStatement\",\n                                  \"type\" : \"NamedTypeSpecifier\"\n                                } ]\n                              }\n                            }\n                          }, {\n                            \"type\" : \"As\",\n                            \"operand\" : {\n                              \"localId\" : \"268\",\n                              \"locator\" : \"137:10-137:72\",\n                              \"dataType\" : \"{http://hl7.org/fhir}MedicationRequest\",\n                              \"codeProperty\" : \"medication\",\n                              \"type\" : \"Retrieve\",\n                              \"codes\" : {\n                                \"locator\" : \"137:32-137:71\",\n                                \"name\" : \"First Generation Serotonin Antagonists\",\n                                \"type\" : \"ValueSetRef\"\n                              }\n                            },\n                            \"asTypeSpecifier\" : {\n                              \"type\" : \"ListTypeSpecifier\",\n                              \"elementType\" : {\n                                \"type\" : \"ChoiceTypeSpecifier\",\n                                \"choice\" : [ {\n                                  \"name\" : \"{http://hl7.org/fhir}MedicationRequest\",\n                                  \"type\" : \"NamedTypeSpecifier\"\n                                }, {\n                                  \"name\" : \"{http://hl7.org/fhir}MedicationStatement\",\n                                  \"type\" : \"NamedTypeSpecifier\"\n                                } ]\n                              }\n                            }\n                          } ]\n                        },\n                        \"asTypeSpecifier\" : {\n                          \"type\" : \"ListTypeSpecifier\",\n                          \"elementType\" : {\n                            \"type\" : \"ChoiceTypeSpecifier\",\n                            \"choice\" : [ {\n                              \"name\" : \"{http://hl7.org/fhir}MedicationRequest\",\n                              \"type\" : \"NamedTypeSpecifier\"\n                            }, {\n                              \"name\" : \"{http://hl7.org/fhir}MedicationStatement\",\n                              \"type\" : \"NamedTypeSpecifier\"\n                            } ]\n                          }\n                        }\n                      }, {\n                        \"type\" : \"As\",\n                        \"operand\" : {\n                          \"localId\" : \"270\",\n                          \"locator\" : \"138:10-138:44\",\n                          \"dataType\" : \"{http://hl7.org/fhir}MedicationRequest\",\n                          \"codeProperty\" : \"medication\",\n                          \"type\" : \"Retrieve\",\n                          \"codes\" : {\n                            \"locator\" : \"138:32-138:43\",\n                            \"name\" : \"Aprepitant\",\n                            \"type\" : \"ValueSetRef\"\n                          }\n                        },\n                        \"asTypeSpecifier\" : {\n                          \"type\" : \"ListTypeSpecifier\",\n                          \"elementType\" : {\n                            \"type\" : \"ChoiceTypeSpecifier\",\n                            \"choice\" : [ {\n                              \"name\" : \"{http://hl7.org/fhir}MedicationRequest\",\n                              \"type\" : \"NamedTypeSpecifier\"\n                            }, {\n                              \"name\" : \"{http://hl7.org/fhir}MedicationStatement\",\n                              \"type\" : \"NamedTypeSpecifier\"\n                            } ]\n                          }\n                        }\n                      } ]\n                    },\n                    \"asTypeSpecifier\" : {\n                      \"type\" : \"ListTypeSpecifier\",\n                      \"elementType\" : {\n                        \"type\" : \"ChoiceTypeSpecifier\",\n                        \"choice\" : [ {\n                          \"name\" : \"{http://hl7.org/fhir}MedicationRequest\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        }, {\n                          \"name\" : \"{http://hl7.org/fhir}MedicationStatement\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        } ]\n                      }\n                    }\n                  }, {\n                    \"type\" : \"As\",\n                    \"operand\" : {\n                      \"localId\" : \"272\",\n                      \"locator\" : \"139:10-139:47\",\n                      \"dataType\" : \"{http://hl7.org/fhir}MedicationRequest\",\n                      \"codeProperty\" : \"medication\",\n                      \"type\" : \"Retrieve\",\n                      \"codes\" : {\n                        \"locator\" : \"139:32-139:46\",\n                        \"name\" : \"Fosaprepitant\",\n                        \"type\" : \"ValueSetRef\"\n                      }\n                    },\n                    \"asTypeSpecifier\" : {\n                      \"type\" : \"ListTypeSpecifier\",\n                      \"elementType\" : {\n                        \"type\" : \"ChoiceTypeSpecifier\",\n                        \"choice\" : [ {\n                          \"name\" : \"{http://hl7.org/fhir}MedicationRequest\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        }, {\n                          \"name\" : \"{http://hl7.org/fhir}MedicationStatement\",\n                          \"type\" : \"NamedTypeSpecifier\"\n                        } ]\n                      }\n                    }\n                  } ]\n                },\n                \"asTypeSpecifier\" : {\n                  \"type\" : \"ListTypeSpecifier\",\n                  \"elementType\" : {\n                    \"type\" : \"ChoiceTypeSpecifier\",\n                    \"choice\" : [ {\n                      \"name\" : \"{http://hl7.org/fhir}MedicationRequest\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    }, {\n                      \"name\" : \"{http://hl7.org/fhir}MedicationStatement\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    } ]\n                  }\n                }\n              }, {\n                \"type\" : \"As\",\n                \"operand\" : {\n                  \"localId\" : \"274\",\n                  \"locator\" : \"140:10-140:44\",\n                  \"dataType\" : \"{http://hl7.org/fhir}MedicationRequest\",\n                  \"codeProperty\" : \"medication\",\n                  \"type\" : \"Retrieve\",\n                  \"codes\" : {\n                    \"locator\" : \"140:32-140:43\",\n                    \"name\" : \"Netupitant\",\n                    \"type\" : \"ValueSetRef\"\n                  }\n                },\n                \"asTypeSpecifier\" : {\n                  \"type\" : \"ListTypeSpecifier\",\n                  \"elementType\" : {\n                    \"type\" : \"ChoiceTypeSpecifier\",\n                    \"choice\" : [ {\n                      \"name\" : \"{http://hl7.org/fhir}MedicationRequest\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    }, {\n                      \"name\" : \"{http://hl7.org/fhir}MedicationStatement\",\n                      \"type\" : \"NamedTypeSpecifier\"\n                    } ]\n                  }\n                }\n              } ]\n            }\n          } ],\n          \"relationship\" : [ ],\n          \"where\" : {\n            \"localId\" : \"297\",\n            \"locator\" : \"141:4-144:88\",\n            \"type\" : \"Null\"\n          }\n        }\n      }, {\n        \"localId\" : \"302\",\n        \"locator\" : \"129:1-130:122\",\n        \"name\" : \"Denominator Exceptions\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"302\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Denominator Exceptions\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"301\",\n              \"s\" : [ {\n                \"value\" : [ \"exists \" ]\n              }, {\n                \"r\" : \"300\",\n                \"s\" : [ {\n                  \"value\" : [ \"\\\"Reasons for Not prescribing or Ordering First Gen Serotonin Antagonists, Aprepitant, Fosprepitant or Netupitant\\\"\" ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"301\",\n          \"locator\" : \"130:3-130:122\",\n          \"type\" : \"Exists\",\n          \"operand\" : {\n            \"localId\" : \"300\",\n            \"locator\" : \"130:10-130:122\",\n            \"name\" : \"Reasons for Not prescribing or Ordering First Gen Serotonin Antagonists, Aprepitant, Fosprepitant or Netupitant\",\n            \"type\" : \"ExpressionRef\"\n          }\n        }\n      }, {\n        \"localId\" : \"326\",\n        \"locator\" : \"146:1-154:102\",\n        \"name\" : \"Aprepitant, Fosaprepitant or Netupitant  administered or ordered before Combo High Risk Chemo\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"326\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Aprepitant, Fosaprepitant or Netupitant  administered or ordered before Combo High Risk Chemo\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"325\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"314\",\n                  \"s\" : [ {\n                    \"r\" : \"313\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"313\",\n                      \"s\" : [ {\n                        \"r\" : \"311\",\n                        \"s\" : [ {\n                          \"r\" : \"309\",\n                          \"s\" : [ {\n                            \"r\" : \"307\",\n                            \"s\" : [ {\n                              \"r\" : \"305\",\n                              \"s\" : [ {\n                                \"r\" : \"303\",\n                                \"s\" : [ {\n                                  \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                                }, {\n                                  \"s\" : [ {\n                                    \"value\" : [ \"\\\"Aprepitant\\\"\" ]\n                                  } ]\n                                }, {\n                                  \"value\" : [ \"]\" ]\n                                } ]\n                              }, {\n                                \"value\" : [ \"\\n  \\tunion \" ]\n                              }, {\n                                \"r\" : \"304\",\n                                \"s\" : [ {\n                                  \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                                }, {\n                                  \"s\" : [ {\n                                    \"value\" : [ \"\\\"Fosaprepitant\\\"\" ]\n                                  } ]\n                                }, {\n                                  \"value\" : [ \"]\" ]\n                                } ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"\\n  \\tunion \" ]\n                            }, {\n                              \"r\" : \"306\",\n                              \"s\" : [ {\n                                \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                              }, {\n                                \"s\" : [ {\n                                  \"value\" : [ \"\\\"Netupitant\\\"\" ]\n                                } ]\n                              }, {\n                                \"value\" : [ \"]\" ]\n                              } ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"\\n  \\tunion \" ]\n                          }, {\n                            \"r\" : \"308\",\n                            \"s\" : [ {\n                              \"value\" : [ \"[\", \"\\\"MedicationRequest\\\"\", \": \" ]\n                            }, {\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"Aprepitant\\\"\" ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"]\" ]\n                            } ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"\\n  \\tunion \" ]\n                        }, {\n                          \"r\" : \"310\",\n                          \"s\" : [ {\n                            \"value\" : [ \"[\", \"\\\"MedicationRequest\\\"\", \": \" ]\n                          }, {\n                            \"s\" : [ {\n                              \"value\" : [ \"\\\"Fosaprepitant\\\"\" ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"]\" ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\tunion \" ]\n                      }, {\n                        \"r\" : \"312\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"MedicationRequest\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Netupitant\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedAdmin\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"324\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"316\",\n                  \"s\" : [ {\n                    \"r\" : \"315\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"ComboChemo\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"323\",\n                  \"s\" : [ {\n                    \"r\" : \"319\",\n                    \"s\" : [ {\n                      \"r\" : \"318\",\n                      \"s\" : [ {\n                        \"r\" : \"317\",\n                        \"s\" : [ {\n                          \"value\" : [ \"MedAdmin\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"318\",\n                        \"s\" : [ {\n                          \"value\" : [ \"dispenseRequest\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"319\",\n                      \"s\" : [ {\n                        \"value\" : [ \"validityPeriod\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"r\" : \"323\",\n                    \"value\" : [ \" \", \"starts before\", \" \" ]\n                  }, {\n                    \"r\" : \"322\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"321\",\n                      \"s\" : [ {\n                        \"r\" : \"320\",\n                        \"s\" : [ {\n                          \"value\" : [ \"ComboChemo\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"321\",\n                        \"s\" : [ {\n                          \"value\" : [ \"relevantPeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"325\",\n          \"locator\" : \"147:3-154:102\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"350\",\n        \"locator\" : \"156:1-164:116\",\n        \"name\" : \"Aprepitant, Fosaprepitant or Netupitant  administered or ordered within 7 days after Combo High Risk Chemo\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"350\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Aprepitant, Fosaprepitant or Netupitant  administered or ordered within 7 days after Combo High Risk Chemo\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"349\",\n              \"s\" : [ {\n                \"s\" : [ {\n                  \"r\" : \"338\",\n                  \"s\" : [ {\n                    \"r\" : \"337\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"337\",\n                      \"s\" : [ {\n                        \"r\" : \"335\",\n                        \"s\" : [ {\n                          \"r\" : \"333\",\n                          \"s\" : [ {\n                            \"r\" : \"331\",\n                            \"s\" : [ {\n                              \"r\" : \"329\",\n                              \"s\" : [ {\n                                \"r\" : \"327\",\n                                \"s\" : [ {\n                                  \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                                }, {\n                                  \"s\" : [ {\n                                    \"value\" : [ \"\\\"Aprepitant\\\"\" ]\n                                  } ]\n                                }, {\n                                  \"value\" : [ \"]\" ]\n                                } ]\n                              }, {\n                                \"value\" : [ \"\\n  \\tunion \" ]\n                              }, {\n                                \"r\" : \"328\",\n                                \"s\" : [ {\n                                  \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                                }, {\n                                  \"s\" : [ {\n                                    \"value\" : [ \"\\\"Fosaprepitant\\\"\" ]\n                                  } ]\n                                }, {\n                                  \"value\" : [ \"]\" ]\n                                } ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"\\n  \\tunion \" ]\n                            }, {\n                              \"r\" : \"330\",\n                              \"s\" : [ {\n                                \"value\" : [ \"[\", \"\\\"MedicationStatement\\\"\", \": \" ]\n                              }, {\n                                \"s\" : [ {\n                                  \"value\" : [ \"\\\"Netupitant\\\"\" ]\n                                } ]\n                              }, {\n                                \"value\" : [ \"]\" ]\n                              } ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"\\n  \\tunion \" ]\n                          }, {\n                            \"r\" : \"332\",\n                            \"s\" : [ {\n                              \"value\" : [ \"[\", \"\\\"MedicationRequest\\\"\", \": \" ]\n                            }, {\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"Aprepitant\\\"\" ]\n                              } ]\n                            }, {\n                              \"value\" : [ \"]\" ]\n                            } ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"\\n  \\tunion \" ]\n                        }, {\n                          \"r\" : \"334\",\n                          \"s\" : [ {\n                            \"value\" : [ \"[\", \"\\\"MedicationRequest\\\"\", \": \" ]\n                          }, {\n                            \"s\" : [ {\n                              \"value\" : [ \"\\\"Fosaprepitant\\\"\" ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"]\" ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\tunion \" ]\n                      }, {\n                        \"r\" : \"336\",\n                        \"s\" : [ {\n                          \"value\" : [ \"[\", \"\\\"MedicationRequest\\\"\", \": \" ]\n                        }, {\n                          \"s\" : [ {\n                            \"value\" : [ \"\\\"Netupitant\\\"\" ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"]\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \" )\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"MedAdmin\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\t\" ]\n              }, {\n                \"r\" : \"348\",\n                \"s\" : [ {\n                  \"value\" : [ \"with \" ]\n                }, {\n                  \"r\" : \"340\",\n                  \"s\" : [ {\n                    \"r\" : \"339\",\n                    \"s\" : [ {\n                      \"s\" : [ {\n                        \"value\" : [ \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \" \", \"ComboChemo\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t\\tsuch that \" ]\n                }, {\n                  \"r\" : \"347\",\n                  \"s\" : [ {\n                    \"r\" : \"343\",\n                    \"s\" : [ {\n                      \"r\" : \"342\",\n                      \"s\" : [ {\n                        \"r\" : \"341\",\n                        \"s\" : [ {\n                          \"value\" : [ \"MedAdmin\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"342\",\n                        \"s\" : [ {\n                          \"value\" : [ \"dispenseRequest\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \".\" ]\n                    }, {\n                      \"r\" : \"343\",\n                      \"s\" : [ {\n                        \"value\" : [ \"validityPeriod\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"r\" : \"347\",\n                    \"value\" : [ \" \", \"starts 7 days or less after\", \" \" ]\n                  }, {\n                    \"r\" : \"346\",\n                    \"s\" : [ {\n                      \"value\" : [ \"start of \" ]\n                    }, {\n                      \"r\" : \"345\",\n                      \"s\" : [ {\n                        \"r\" : \"344\",\n                        \"s\" : [ {\n                          \"value\" : [ \"ComboChemo\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \".\" ]\n                      }, {\n                        \"r\" : \"345\",\n                        \"s\" : [ {\n                          \"value\" : [ \"relevantPeriod\" ]\n                        } ]\n                      } ]\n                    } ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"349\",\n          \"locator\" : \"157:3-164:116\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"380\",\n        \"locator\" : \"166:1-182:4\",\n        \"name\" : \"Numerator\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"380\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Numerator\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"379\",\n              \"s\" : [ {\n                \"r\" : \"355\",\n                \"s\" : [ {\n                  \"r\" : \"352\",\n                  \"s\" : [ {\n                    \"value\" : [ \"exists \" ]\n                  }, {\n                    \"r\" : \"351\",\n                    \"s\" : [ {\n                      \"value\" : [ \"\\\"Clinical Trial Participant within 7 days after start of High Emetic Risk Combo Chemotherapy\\\"\" ]\n                    } ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\tor \" ]\n                }, {\n                  \"r\" : \"354\",\n                  \"s\" : [ {\n                    \"value\" : [ \"exists \" ]\n                  }, {\n                    \"r\" : \"353\",\n                    \"s\" : [ {\n                      \"value\" : [ \"\\\"Clinical Trial Participant before start of High Emetic Risk Combo Chemotherapy\\\"\" ]\n                    } ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\tor \" ]\n              }, {\n                \"r\" : \"378\",\n                \"s\" : [ {\n                  \"value\" : [ \"( \" ]\n                }, {\n                  \"r\" : \"378\",\n                  \"s\" : [ {\n                    \"r\" : \"366\",\n                    \"s\" : [ {\n                      \"r\" : \"360\",\n                      \"s\" : [ {\n                        \"value\" : [ \"( \" ]\n                      }, {\n                        \"r\" : \"360\",\n                        \"s\" : [ {\n                          \"r\" : \"357\",\n                          \"s\" : [ {\n                            \"value\" : [ \"exists \" ]\n                          }, {\n                            \"r\" : \"356\",\n                            \"s\" : [ {\n                              \"value\" : [ \"\\\"Dexamethasone administered or ordered within 7 days after Combo High Risk Chemo\\\"\" ]\n                            } ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"\\n  \\t\\t\\t\\tor \" ]\n                        }, {\n                          \"r\" : \"359\",\n                          \"s\" : [ {\n                            \"value\" : [ \"exists \" ]\n                          }, {\n                            \"r\" : \"358\",\n                            \"s\" : [ {\n                              \"value\" : [ \"\\\"Dexamethasone administered or ordered before Combo High Risk Chemo\\\"\" ]\n                            } ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\t\\t)\" ]\n                      } ]\n                    }, {\n                      \"value\" : [ \"\\n  \\t\\t\\tand \" ]\n                    }, {\n                      \"r\" : \"365\",\n                      \"s\" : [ {\n                        \"value\" : [ \"( \" ]\n                      }, {\n                        \"r\" : \"365\",\n                        \"s\" : [ {\n                          \"r\" : \"362\",\n                          \"s\" : [ {\n                            \"value\" : [ \"exists \" ]\n                          }, {\n                            \"r\" : \"361\",\n                            \"s\" : [ {\n                              \"value\" : [ \"\\\"Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\\\"\" ]\n                            } ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"\\n  \\t\\t\\t\\t\\tor \" ]\n                        }, {\n                          \"r\" : \"364\",\n                          \"s\" : [ {\n                            \"value\" : [ \"exists \" ]\n                          }, {\n                            \"r\" : \"363\",\n                            \"s\" : [ {\n                              \"value\" : [ \"\\\"Palonosetron administered or ordered before Combo High Risk Chemo\\\"\" ]\n                            } ]\n                          } ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\t\\t\\t)\" ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \"\\n  \\t\\t\\tor \" ]\n                  }, {\n                    \"r\" : \"377\",\n                    \"s\" : [ {\n                      \"value\" : [ \"( \" ]\n                    }, {\n                      \"r\" : \"377\",\n                      \"s\" : [ {\n                        \"r\" : \"371\",\n                        \"s\" : [ {\n                          \"value\" : [ \"( \" ]\n                        }, {\n                          \"r\" : \"371\",\n                          \"s\" : [ {\n                            \"r\" : \"368\",\n                            \"s\" : [ {\n                              \"value\" : [ \"exists \" ]\n                            }, {\n                              \"r\" : \"367\",\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"Aprepitant, Fosaprepitant or Netupitant  administered or ordered within 7 days after Combo High Risk Chemo\\\"\" ]\n                              } ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"\\n  \\t\\t\\t\\t\\t\\tor \" ]\n                          }, {\n                            \"r\" : \"370\",\n                            \"s\" : [ {\n                              \"value\" : [ \"exists \" ]\n                            }, {\n                              \"r\" : \"369\",\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"Aprepitant, Fosaprepitant or Netupitant  administered or ordered before Combo High Risk Chemo\\\"\" ]\n                              } ]\n                            } ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"\\n  \\t\\t\\t\\t)\" ]\n                        } ]\n                      }, {\n                        \"value\" : [ \"\\n  \\t\\t\\t\\t\\tand \" ]\n                      }, {\n                        \"r\" : \"376\",\n                        \"s\" : [ {\n                          \"value\" : [ \"( \" ]\n                        }, {\n                          \"r\" : \"376\",\n                          \"s\" : [ {\n                            \"r\" : \"373\",\n                            \"s\" : [ {\n                              \"value\" : [ \"exists \" ]\n                            }, {\n                              \"r\" : \"372\",\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"First Gen Serotonin Antagonists or Palonosetron administered or ordered within 7 days after Combo High Risk Chemo\\\"\" ]\n                              } ]\n                            } ]\n                          }, {\n                            \"value\" : [ \"\\n  \\t\\t\\t\\t\\t\\t\\tor \" ]\n                          }, {\n                            \"r\" : \"375\",\n                            \"s\" : [ {\n                              \"value\" : [ \"exists \" ]\n                            }, {\n                              \"r\" : \"374\",\n                              \"s\" : [ {\n                                \"value\" : [ \"\\\"First Gen Serotonin Antagonists or Palonosetron administered or ordered before Combo High Risk Chemo\\\"\" ]\n                              } ]\n                            } ]\n                          } ]\n                        }, {\n                          \"value\" : [ \"\\n  \\t\\t\\t\\t\\t)\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \"\\n  \\t\\t\\t)\" ]\n                    } ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\t)\" ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"379\",\n          \"locator\" : \"167:3-182:4\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"391\",\n        \"locator\" : \"192:1-197:72\",\n        \"name\" : \"Denominator\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"391\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Denominator\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"390\",\n              \"s\" : [ {\n                \"r\" : \"387\",\n                \"s\" : [ {\n                  \"r\" : \"381\",\n                  \"s\" : [ {\n                    \"value\" : [ \"\\\"Initial Population\\\"\" ]\n                  } ]\n                }, {\n                  \"value\" : [ \"\\n  \\tand \" ]\n                }, {\n                  \"r\" : \"386\",\n                  \"s\" : [ {\n                    \"value\" : [ \"( \" ]\n                  }, {\n                    \"r\" : \"386\",\n                    \"s\" : [ {\n                      \"r\" : \"383\",\n                      \"s\" : [ {\n                        \"value\" : [ \"exists \" ]\n                      }, {\n                        \"r\" : \"382\",\n                        \"s\" : [ {\n                          \"value\" : [ \"\\\"Cyclophosphamide Administered after First Cancer Dx\\\"\" ]\n                        } ]\n                      } ]\n                    }, {\n                      \"value\" : [ \"\\n  \\t\\t\\tand \" ]\n                    }, {\n                      \"r\" : \"385\",\n                      \"s\" : [ {\n                        \"value\" : [ \"exists \" ]\n                      }, {\n                        \"r\" : \"384\",\n                        \"s\" : [ {\n                          \"value\" : [ \"\\\"Specific Mod Risk Chemo Administered after First Cancer Dx\\\"\" ]\n                        } ]\n                      } ]\n                    } ]\n                  }, {\n                    \"value\" : [ \"\\n  \\t)\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \"\\n  \\tor \" ]\n              }, {\n                \"r\" : \"389\",\n                \"s\" : [ {\n                  \"value\" : [ \"exists \" ]\n                }, {\n                  \"r\" : \"388\",\n                  \"s\" : [ {\n                    \"value\" : [ \"\\\"High Emetic Risk Chemo Administered after First Cancer Dx\\\"\" ]\n                  } ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"390\",\n          \"locator\" : \"193:3-197:72\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"393\",\n        \"locator\" : \"199:1-200:6\",\n        \"name\" : \"Actionability\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"393\",\n            \"s\" : [ {\n              \"r\" : \"392\",\n              \"value\" : [ \"define \", \"\\\"Actionability\\\"\", \":\\n  \", \"true\" ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"392\",\n          \"locator\" : \"200:3-200:6\",\n          \"valueType\" : \"{urn:hl7-org:elm-types:r1}Boolean\",\n          \"value\" : \"true\",\n          \"type\" : \"Literal\"\n        }\n      }, {\n        \"localId\" : \"398\",\n        \"locator\" : \"202:1-203:106\",\n        \"name\" : \"Actionability Start Date\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"398\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Actionability Start Date\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"397\",\n              \"s\" : [ {\n                \"value\" : [ \"First\", \"(\" ]\n              }, {\n                \"r\" : \"396\",\n                \"s\" : [ {\n                  \"r\" : \"395\",\n                  \"s\" : [ {\n                    \"r\" : \"394\",\n                    \"s\" : [ {\n                      \"value\" : [ \"\\\"Combination High Emetic Risk Chemotherapy administered after First Cancer Dx\\\"\" ]\n                    } ]\n                  }, {\n                    \"value\" : [ \".\" ]\n                  }, {\n                    \"r\" : \"395\",\n                    \"s\" : [ {\n                      \"value\" : [ \"relevantPeriod\" ]\n                    } ]\n                  } ]\n                }, {\n                  \"value\" : [ \".\" ]\n                }, {\n                  \"r\" : \"396\",\n                  \"s\" : [ {\n                    \"value\" : [ \"low\" ]\n                  } ]\n                } ]\n              }, {\n                \"value\" : [ \")\" ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"397\",\n          \"locator\" : \"203:3-203:106\",\n          \"type\" : \"Null\"\n        }\n      }, {\n        \"localId\" : \"402\",\n        \"locator\" : \"205:1-206:37\",\n        \"name\" : \"Actionability End Date\",\n        \"context\" : \"Patient\",\n        \"accessLevel\" : \"Public\",\n        \"annotation\" : [ {\n          \"type\" : \"Annotation\",\n          \"s\" : {\n            \"r\" : \"402\",\n            \"s\" : [ {\n              \"value\" : [ \"define \", \"\\\"Actionability End Date\\\"\", \":\\n  \" ]\n            }, {\n              \"r\" : \"401\",\n              \"s\" : [ {\n                \"r\" : \"399\",\n                \"s\" : [ {\n                  \"value\" : [ \"\\\"Actionability Start Date\\\"\" ]\n                } ]\n              }, {\n                \"value\" : [ \" + \" ]\n              }, {\n                \"r\" : \"400\",\n                \"s\" : [ {\n                  \"value\" : [ \"7 \", \"days\" ]\n                } ]\n              } ]\n            } ]\n          }\n        } ],\n        \"expression\" : {\n          \"localId\" : \"401\",\n          \"locator\" : \"206:3-206:37\",\n          \"type\" : \"Null\"\n        }\n      } ]\n    }\n  }\n}",
        "fhirCqlConversionErrors": [
          {
            "startLine": 41,
            "startChar": 3,
            "endLine": 41,
            "endChar": 51,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not resolve type name Patient Characteristic Ethnicity.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 44,
            "startChar": 3,
            "endLine": 44,
            "endChar": 43,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not resolve type name Patient Characteristic Payer.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 47,
            "startChar": 3,
            "endLine": 47,
            "endChar": 41,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not resolve type name Patient Characteristic Race.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 50,
            "startChar": 3,
            "endLine": 50,
            "endChar": 58,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not resolve type name Patient Characteristic Sex.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 55,
            "startChar": 21,
            "endLine": 55,
            "endChar": 33,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not resolve library name FHIRHelpers.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 55,
            "startChar": 4,
            "endLine": 55,
            "endChar": 54,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Expected an expression of type 'System.Boolean', but found an expression of type '<unknown>'.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 210,
            "startChar": 14,
            "endLine": 210,
            "endChar": 26,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member onsetDateTime not found for type FHIR.Condition.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 210,
            "startChar": 28,
            "endLine": 210,
            "endChar": 40,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Start.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 210,
            "startChar": 5,
            "endLine": 210,
            "endChar": 61,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Expected an expression of type 'System.Boolean', but found an expression of type '<unknown>'.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 211,
            "startChar": 22,
            "endLine": 211,
            "endChar": 37,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not resolve identifier prevalencePeriod in the current library.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 211,
            "startChar": 13,
            "endLine": 211,
            "endChar": 37,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Start.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 209,
            "startChar": 9,
            "endLine": 211,
            "endChar": 37,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Less.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 209,
            "startChar": 3,
            "endLine": 212,
            "endChar": 3,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator First.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 59,
            "startChar": 9,
            "endLine": 59,
            "endChar": 25,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression First Cancer Dx because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 60,
            "startChar": 24,
            "endLine": 60,
            "endChar": 40,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member effectiveDateTime not found for type FHIR.MedicationStatement.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 60,
            "startChar": 67,
            "endLine": 60,
            "endChar": 82,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member prevalencePeriod not found for type null.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 60,
            "startChar": 55,
            "endLine": 60,
            "endChar": 82,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Start.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 60,
            "startChar": 42,
            "endLine": 60,
            "endChar": 53,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Start.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 59,
            "startChar": 4,
            "endLine": 60,
            "endChar": 82,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Expected an expression of type 'System.Boolean', but found an expression of type '<unknown>'.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 58,
            "startChar": 3,
            "endLine": 60,
            "endChar": 82,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "class org.hl7.elm.r1.Null cannot be cast to class org.hl7.elm.r1.RelationshipClause (org.hl7.elm.r1.Null and org.hl7.elm.r1.RelationshipClause are in unnamed module of loader org.springframework.boot.loader.LaunchedURLClassLoader @643b1d11)",
            "type": "CqlToElmError"
          },
          {
            "startLine": 64,
            "startChar": 8,
            "endLine": 64,
            "endChar": 24,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression First Cancer Dx because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 64,
            "startChar": 8,
            "endLine": 64,
            "endChar": 36,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.IsNull.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 63,
            "startChar": 3,
            "endLine": 64,
            "endChar": 36,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.And.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 68,
            "startChar": 9,
            "endLine": 68,
            "endChar": 25,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression First Cancer Dx because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 69,
            "startChar": 24,
            "endLine": 69,
            "endChar": 40,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member effectiveDateTime not found for type FHIR.MedicationStatement.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 69,
            "startChar": 67,
            "endLine": 69,
            "endChar": 82,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member prevalencePeriod not found for type null.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 69,
            "startChar": 55,
            "endLine": 69,
            "endChar": 82,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Start.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 69,
            "startChar": 42,
            "endLine": 69,
            "endChar": 53,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Start.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 68,
            "startChar": 4,
            "endLine": 69,
            "endChar": 82,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Expected an expression of type 'System.Boolean', but found an expression of type '<unknown>'.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 67,
            "startChar": 3,
            "endLine": 69,
            "endChar": 82,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "class org.hl7.elm.r1.Null cannot be cast to class org.hl7.elm.r1.RelationshipClause (org.hl7.elm.r1.Null and org.hl7.elm.r1.RelationshipClause are in unnamed module of loader org.springframework.boot.loader.LaunchedURLClassLoader @643b1d11)",
            "type": "CqlToElmError"
          },
          {
            "startLine": 76,
            "startChar": 9,
            "endLine": 76,
            "endChar": 25,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression First Cancer Dx because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 77,
            "startChar": 24,
            "endLine": 77,
            "endChar": 40,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member effectiveDateTime not found for type FHIR.MedicationStatement.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 77,
            "startChar": 67,
            "endLine": 77,
            "endChar": 82,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member prevalencePeriod not found for type null.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 77,
            "startChar": 55,
            "endLine": 77,
            "endChar": 82,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Start.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 77,
            "startChar": 42,
            "endLine": 77,
            "endChar": 53,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Start.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 76,
            "startChar": 4,
            "endLine": 77,
            "endChar": 82,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Expected an expression of type 'System.Boolean', but found an expression of type '<unknown>'.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 72,
            "startChar": 3,
            "endLine": 77,
            "endChar": 82,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "class org.hl7.elm.r1.Null cannot be cast to class org.hl7.elm.r1.RelationshipClause (org.hl7.elm.r1.Null and org.hl7.elm.r1.RelationshipClause are in unnamed module of loader org.springframework.boot.loader.LaunchedURLClassLoader @643b1d11)",
            "type": "CqlToElmError"
          },
          {
            "startLine": 189,
            "startChar": 3,
            "endLine": 189,
            "endChar": 55,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Cyclophosphamide Administered after First Cancer Dx because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 190,
            "startChar": 10,
            "endLine": 190,
            "endChar": 69,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Specific Mod Risk Chemo Administered after First Cancer Dx because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 189,
            "startChar": 3,
            "endLine": 190,
            "endChar": 69,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Union.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 185,
            "startChar": 3,
            "endLine": 185,
            "endChar": 65,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression High Risk Cyclophosphamide Administered after First Cancer Dx because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 186,
            "startChar": 10,
            "endLine": 186,
            "endChar": 68,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression High Emetic Risk Chemo Administered after First Cancer Dx because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 185,
            "startChar": 3,
            "endLine": 186,
            "endChar": 68,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Union.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 81,
            "startChar": 9,
            "endLine": 81,
            "endChar": 86,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Combination High Emetic Risk Chemotherapy administered after First Cancer Dx because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 82,
            "startChar": 21,
            "endLine": 82,
            "endChar": 26,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member target not found for type FHIR.Observation.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 82,
            "startChar": 62,
            "endLine": 82,
            "endChar": 75,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member relevantPeriod not found for type null.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 82,
            "startChar": 42,
            "endLine": 82,
            "endChar": 75,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Start.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 82,
            "startChar": 28,
            "endLine": 82,
            "endChar": 40,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Start.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 81,
            "startChar": 4,
            "endLine": 82,
            "endChar": 75,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Expected an expression of type 'System.Boolean', but found an expression of type '<unknown>'.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 80,
            "startChar": 3,
            "endLine": 82,
            "endChar": 75,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "class org.hl7.elm.r1.Null cannot be cast to class org.hl7.elm.r1.RelationshipClause (org.hl7.elm.r1.Null and org.hl7.elm.r1.RelationshipClause are in unnamed module of loader org.springframework.boot.loader.LaunchedURLClassLoader @643b1d11)",
            "type": "CqlToElmError"
          },
          {
            "startLine": 86,
            "startChar": 9,
            "endLine": 86,
            "endChar": 86,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Combination High Emetic Risk Chemotherapy administered after First Cancer Dx because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 87,
            "startChar": 21,
            "endLine": 87,
            "endChar": 26,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member target not found for type FHIR.Observation.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 87,
            "startChar": 76,
            "endLine": 87,
            "endChar": 89,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member relevantPeriod not found for type null.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 87,
            "startChar": 56,
            "endLine": 87,
            "endChar": 89,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Start.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 87,
            "startChar": 28,
            "endLine": 87,
            "endChar": 54,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Start.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 86,
            "startChar": 4,
            "endLine": 87,
            "endChar": 89,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Expected an expression of type 'System.Boolean', but found an expression of type '<unknown>'.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 85,
            "startChar": 3,
            "endLine": 87,
            "endChar": 89,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "class org.hl7.elm.r1.Null cannot be cast to class org.hl7.elm.r1.RelationshipClause (org.hl7.elm.r1.Null and org.hl7.elm.r1.RelationshipClause are in unnamed module of loader org.springframework.boot.loader.LaunchedURLClassLoader @643b1d11)",
            "type": "CqlToElmError"
          },
          {
            "startLine": 92,
            "startChar": 9,
            "endLine": 92,
            "endChar": 86,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Combination High Emetic Risk Chemotherapy administered after First Cancer Dx because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 93,
            "startChar": 103,
            "endLine": 93,
            "endChar": 116,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member relevantPeriod not found for type null.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 93,
            "startChar": 83,
            "endLine": 93,
            "endChar": 116,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Start.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 93,
            "startChar": 55,
            "endLine": 93,
            "endChar": 81,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not resolve library name FHIRHelpers.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 92,
            "startChar": 4,
            "endLine": 93,
            "endChar": 116,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Expected an expression of type 'System.Boolean', but found an expression of type '<unknown>'.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 90,
            "startChar": 3,
            "endLine": 93,
            "endChar": 116,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "class org.hl7.elm.r1.Null cannot be cast to class org.hl7.elm.r1.RelationshipClause (org.hl7.elm.r1.Null and org.hl7.elm.r1.RelationshipClause are in unnamed module of loader org.springframework.boot.loader.LaunchedURLClassLoader @643b1d11)",
            "type": "CqlToElmError"
          },
          {
            "startLine": 98,
            "startChar": 9,
            "endLine": 98,
            "endChar": 86,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Combination High Emetic Risk Chemotherapy administered after First Cancer Dx because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 99,
            "startChar": 89,
            "endLine": 99,
            "endChar": 102,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member relevantPeriod not found for type null.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 99,
            "startChar": 69,
            "endLine": 99,
            "endChar": 102,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Start.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 99,
            "startChar": 55,
            "endLine": 99,
            "endChar": 67,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not resolve library name FHIRHelpers.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 98,
            "startChar": 4,
            "endLine": 99,
            "endChar": 102,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Expected an expression of type 'System.Boolean', but found an expression of type '<unknown>'.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 96,
            "startChar": 3,
            "endLine": 99,
            "endChar": 102,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "class org.hl7.elm.r1.Null cannot be cast to class org.hl7.elm.r1.RelationshipClause (org.hl7.elm.r1.Null and org.hl7.elm.r1.RelationshipClause are in unnamed module of loader org.springframework.boot.loader.LaunchedURLClassLoader @643b1d11)",
            "type": "CqlToElmError"
          },
          {
            "startLine": 104,
            "startChar": 9,
            "endLine": 104,
            "endChar": 86,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Combination High Emetic Risk Chemotherapy administered after First Cancer Dx because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 105,
            "startChar": 89,
            "endLine": 105,
            "endChar": 102,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member relevantPeriod not found for type null.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 105,
            "startChar": 69,
            "endLine": 105,
            "endChar": 102,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Start.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 105,
            "startChar": 55,
            "endLine": 105,
            "endChar": 67,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not resolve library name FHIRHelpers.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 104,
            "startChar": 4,
            "endLine": 105,
            "endChar": 102,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Expected an expression of type 'System.Boolean', but found an expression of type '<unknown>'.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 102,
            "startChar": 3,
            "endLine": 105,
            "endChar": 102,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "class org.hl7.elm.r1.Null cannot be cast to class org.hl7.elm.r1.RelationshipClause (org.hl7.elm.r1.Null and org.hl7.elm.r1.RelationshipClause are in unnamed module of loader org.springframework.boot.loader.LaunchedURLClassLoader @643b1d11)",
            "type": "CqlToElmError"
          },
          {
            "startLine": 110,
            "startChar": 9,
            "endLine": 110,
            "endChar": 86,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Combination High Emetic Risk Chemotherapy administered after First Cancer Dx because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 111,
            "startChar": 103,
            "endLine": 111,
            "endChar": 116,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member relevantPeriod not found for type null.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 111,
            "startChar": 83,
            "endLine": 111,
            "endChar": 116,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Start.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 111,
            "startChar": 55,
            "endLine": 111,
            "endChar": 81,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not resolve library name FHIRHelpers.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 110,
            "startChar": 4,
            "endLine": 111,
            "endChar": 116,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Expected an expression of type 'System.Boolean', but found an expression of type '<unknown>'.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 108,
            "startChar": 3,
            "endLine": 111,
            "endChar": 116,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "class org.hl7.elm.r1.Null cannot be cast to class org.hl7.elm.r1.RelationshipClause (org.hl7.elm.r1.Null and org.hl7.elm.r1.RelationshipClause are in unnamed module of loader org.springframework.boot.loader.LaunchedURLClassLoader @643b1d11)",
            "type": "CqlToElmError"
          },
          {
            "startLine": 118,
            "startChar": 9,
            "endLine": 118,
            "endChar": 86,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Combination High Emetic Risk Chemotherapy administered after First Cancer Dx because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 119,
            "startChar": 103,
            "endLine": 119,
            "endChar": 116,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member relevantPeriod not found for type null.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 119,
            "startChar": 83,
            "endLine": 119,
            "endChar": 116,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Start.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 119,
            "startChar": 55,
            "endLine": 119,
            "endChar": 81,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not resolve library name FHIRHelpers.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 118,
            "startChar": 4,
            "endLine": 119,
            "endChar": 116,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Expected an expression of type 'System.Boolean', but found an expression of type '<unknown>'.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 114,
            "startChar": 3,
            "endLine": 119,
            "endChar": 116,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "class org.hl7.elm.r1.Null cannot be cast to class org.hl7.elm.r1.RelationshipClause (org.hl7.elm.r1.Null and org.hl7.elm.r1.RelationshipClause are in unnamed module of loader org.springframework.boot.loader.LaunchedURLClassLoader @643b1d11)",
            "type": "CqlToElmError"
          },
          {
            "startLine": 126,
            "startChar": 9,
            "endLine": 126,
            "endChar": 86,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Combination High Emetic Risk Chemotherapy administered after First Cancer Dx because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 127,
            "startChar": 89,
            "endLine": 127,
            "endChar": 102,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member relevantPeriod not found for type null.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 127,
            "startChar": 69,
            "endLine": 127,
            "endChar": 102,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Start.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 127,
            "startChar": 55,
            "endLine": 127,
            "endChar": 67,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not resolve library name FHIRHelpers.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 126,
            "startChar": 4,
            "endLine": 127,
            "endChar": 102,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Expected an expression of type 'System.Boolean', but found an expression of type '<unknown>'.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 122,
            "startChar": 3,
            "endLine": 127,
            "endChar": 102,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "class org.hl7.elm.r1.Null cannot be cast to class org.hl7.elm.r1.RelationshipClause (org.hl7.elm.r1.Null and org.hl7.elm.r1.RelationshipClause are in unnamed module of loader org.springframework.boot.loader.LaunchedURLClassLoader @643b1d11)",
            "type": "CqlToElmError"
          },
          {
            "startLine": 141,
            "startChar": 24,
            "endLine": 141,
            "endChar": 30,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member Unknown not found for type choice<FHIR.MedicationRequest,FHIR.MedicationStatement>.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 141,
            "startChar": 10,
            "endLine": 141,
            "endChar": 50,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.InValueSet.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 142,
            "startChar": 22,
            "endLine": 142,
            "endChar": 28,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member Unknown not found for type choice<FHIR.MedicationRequest,FHIR.MedicationStatement>.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 142,
            "startChar": 8,
            "endLine": 142,
            "endChar": 48,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.InValueSet.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 141,
            "startChar": 10,
            "endLine": 142,
            "endChar": 48,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Or.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 143,
            "startChar": 22,
            "endLine": 143,
            "endChar": 28,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member Unknown not found for type choice<FHIR.MedicationRequest,FHIR.MedicationStatement>.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 143,
            "startChar": 8,
            "endLine": 143,
            "endChar": 47,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.InValueSet.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 144,
            "startChar": 55,
            "endLine": 144,
            "endChar": 67,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not resolve library name FHIRHelpers.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 143,
            "startChar": 8,
            "endLine": 144,
            "endChar": 88,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.And.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 141,
            "startChar": 10,
            "endLine": 144,
            "endChar": 88,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Or.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 141,
            "startChar": 4,
            "endLine": 144,
            "endChar": 88,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Expected an expression of type 'System.Boolean', but found an expression of type '<unknown>'.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 153,
            "startChar": 9,
            "endLine": 153,
            "endChar": 86,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Combination High Emetic Risk Chemotherapy administered after First Cancer Dx because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 154,
            "startChar": 89,
            "endLine": 154,
            "endChar": 102,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member relevantPeriod not found for type null.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 154,
            "startChar": 69,
            "endLine": 154,
            "endChar": 102,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Start.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 154,
            "startChar": 55,
            "endLine": 154,
            "endChar": 67,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not resolve library name FHIRHelpers.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 153,
            "startChar": 4,
            "endLine": 154,
            "endChar": 102,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Expected an expression of type 'System.Boolean', but found an expression of type '<unknown>'.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 147,
            "startChar": 3,
            "endLine": 154,
            "endChar": 102,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "class org.hl7.elm.r1.Null cannot be cast to class org.hl7.elm.r1.RelationshipClause (org.hl7.elm.r1.Null and org.hl7.elm.r1.RelationshipClause are in unnamed module of loader org.springframework.boot.loader.LaunchedURLClassLoader @643b1d11)",
            "type": "CqlToElmError"
          },
          {
            "startLine": 163,
            "startChar": 9,
            "endLine": 163,
            "endChar": 86,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Combination High Emetic Risk Chemotherapy administered after First Cancer Dx because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 164,
            "startChar": 103,
            "endLine": 164,
            "endChar": 116,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member relevantPeriod not found for type null.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 164,
            "startChar": 83,
            "endLine": 164,
            "endChar": 116,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Start.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 164,
            "startChar": 55,
            "endLine": 164,
            "endChar": 81,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not resolve library name FHIRHelpers.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 163,
            "startChar": 4,
            "endLine": 164,
            "endChar": 116,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Expected an expression of type 'System.Boolean', but found an expression of type '<unknown>'.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 157,
            "startChar": 3,
            "endLine": 164,
            "endChar": 116,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "class org.hl7.elm.r1.Null cannot be cast to class org.hl7.elm.r1.RelationshipClause (org.hl7.elm.r1.Null and org.hl7.elm.r1.RelationshipClause are in unnamed module of loader org.springframework.boot.loader.LaunchedURLClassLoader @643b1d11)",
            "type": "CqlToElmError"
          },
          {
            "startLine": 167,
            "startChar": 10,
            "endLine": 167,
            "endChar": 102,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Clinical Trial Participant within 7 days after start of High Emetic Risk Combo Chemotherapy because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 167,
            "startChar": 3,
            "endLine": 167,
            "endChar": 102,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Exists.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 168,
            "startChar": 14,
            "endLine": 168,
            "endChar": 93,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Clinical Trial Participant before start of High Emetic Risk Combo Chemotherapy because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 168,
            "startChar": 7,
            "endLine": 168,
            "endChar": 93,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Exists.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 167,
            "startChar": 3,
            "endLine": 168,
            "endChar": 93,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Or.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 169,
            "startChar": 18,
            "endLine": 169,
            "endChar": 98,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Dexamethasone administered or ordered within 7 days after Combo High Risk Chemo because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 169,
            "startChar": 11,
            "endLine": 169,
            "endChar": 98,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Exists.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 170,
            "startChar": 17,
            "endLine": 170,
            "endChar": 84,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Dexamethasone administered or ordered before Combo High Risk Chemo because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 170,
            "startChar": 10,
            "endLine": 170,
            "endChar": 84,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Exists.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 169,
            "startChar": 11,
            "endLine": 170,
            "endChar": 84,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Or.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 172,
            "startChar": 19,
            "endLine": 172,
            "endChar": 98,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Palonosetron administered or ordered within 7 days after Combo High Risk Chemo because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 172,
            "startChar": 12,
            "endLine": 172,
            "endChar": 98,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Exists.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 173,
            "startChar": 18,
            "endLine": 173,
            "endChar": 84,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Palonosetron administered or ordered before Combo High Risk Chemo because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 173,
            "startChar": 11,
            "endLine": 173,
            "endChar": 84,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Exists.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 172,
            "startChar": 12,
            "endLine": 173,
            "endChar": 84,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Or.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 169,
            "startChar": 9,
            "endLine": 174,
            "endChar": 6,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.And.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 175,
            "startChar": 20,
            "endLine": 175,
            "endChar": 127,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Aprepitant, Fosaprepitant or Netupitant  administered or ordered within 7 days after Combo High Risk Chemo because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 175,
            "startChar": 13,
            "endLine": 175,
            "endChar": 127,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Exists.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 176,
            "startChar": 19,
            "endLine": 176,
            "endChar": 113,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Aprepitant, Fosaprepitant or Netupitant  administered or ordered before Combo High Risk Chemo because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 176,
            "startChar": 12,
            "endLine": 176,
            "endChar": 113,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Exists.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 175,
            "startChar": 13,
            "endLine": 176,
            "endChar": 113,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Or.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 178,
            "startChar": 21,
            "endLine": 178,
            "endChar": 135,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression First Gen Serotonin Antagonists or Palonosetron administered or ordered within 7 days after Combo High Risk Chemo because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 178,
            "startChar": 14,
            "endLine": 178,
            "endChar": 135,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Exists.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 179,
            "startChar": 20,
            "endLine": 179,
            "endChar": 121,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression First Gen Serotonin Antagonists or Palonosetron administered or ordered before Combo High Risk Chemo because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 179,
            "startChar": 13,
            "endLine": 179,
            "endChar": 121,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Exists.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 178,
            "startChar": 14,
            "endLine": 179,
            "endChar": 121,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Or.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 175,
            "startChar": 11,
            "endLine": 180,
            "endChar": 8,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.And.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 169,
            "startChar": 9,
            "endLine": 181,
            "endChar": 6,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Or.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 167,
            "startChar": 3,
            "endLine": 182,
            "endChar": 4,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Or.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 193,
            "startChar": 3,
            "endLine": 193,
            "endChar": 22,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Initial Population because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 194,
            "startChar": 17,
            "endLine": 194,
            "endChar": 69,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Cyclophosphamide Administered after First Cancer Dx because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 194,
            "startChar": 10,
            "endLine": 194,
            "endChar": 69,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Exists.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 195,
            "startChar": 17,
            "endLine": 195,
            "endChar": 76,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Specific Mod Risk Chemo Administered after First Cancer Dx because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 195,
            "startChar": 10,
            "endLine": 195,
            "endChar": 76,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Exists.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 194,
            "startChar": 10,
            "endLine": 195,
            "endChar": 76,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.And.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 193,
            "startChar": 3,
            "endLine": 196,
            "endChar": 4,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.And.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 197,
            "startChar": 14,
            "endLine": 197,
            "endChar": 72,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression High Emetic Risk Chemo Administered after First Cancer Dx because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 197,
            "startChar": 7,
            "endLine": 197,
            "endChar": 72,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Exists.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 193,
            "startChar": 3,
            "endLine": 197,
            "endChar": 72,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Or.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 203,
            "startChar": 9,
            "endLine": 203,
            "endChar": 86,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Combination High Emetic Risk Chemotherapy administered after First Cancer Dx because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 203,
            "startChar": 88,
            "endLine": 203,
            "endChar": 101,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member relevantPeriod not found for type null.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 203,
            "startChar": 103,
            "endLine": 203,
            "endChar": 105,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Member low not found for type null.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 203,
            "startChar": 3,
            "endLine": 203,
            "endChar": 106,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator First.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 206,
            "startChar": 3,
            "endLine": 206,
            "endChar": 28,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not validate reference to expression Actionability Start Date because its definition contains errors.",
            "type": "CqlToElmError"
          },
          {
            "startLine": 206,
            "startChar": 3,
            "endLine": 206,
            "endChar": 37,
            "errorType": "semantic",
            "errorSeverity": "error",
            "targetIncludeLibraryId": null,
            "targetIncludeLibraryVersionId": null,
            "message": "Could not determine signature for invocation of operator System.Add.",
            "type": "CqlToElmError"
          }
        ],
        "fhirMatCqlConversionErrors": [
          {
            "startLine": 53,
            "startChar": 5,
            "endLine": 53,
            "endChar": 33,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 54,
            "startChar": 10,
            "endLine": 54,
            "endChar": 54,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 58,
            "startChar": 3,
            "endLine": 58,
            "endChar": 45,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 209,
            "startChar": 11,
            "endLine": 209,
            "endChar": 33,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 67,
            "startChar": 3,
            "endLine": 67,
            "endChar": 62,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 72,
            "startChar": 5,
            "endLine": 72,
            "endChar": 42,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 73,
            "startChar": 10,
            "endLine": 73,
            "endChar": 46,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 74,
            "startChar": 10,
            "endLine": 74,
            "endChar": 46,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 75,
            "startChar": 10,
            "endLine": 75,
            "endChar": 48,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 80,
            "startChar": 5,
            "endLine": 80,
            "endChar": 49,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 85,
            "startChar": 5,
            "endLine": 85,
            "endChar": 49,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 90,
            "startChar": 5,
            "endLine": 90,
            "endChar": 44,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 91,
            "startChar": 10,
            "endLine": 91,
            "endChar": 47,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 96,
            "startChar": 5,
            "endLine": 96,
            "endChar": 44,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 97,
            "startChar": 10,
            "endLine": 97,
            "endChar": 47,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 102,
            "startChar": 5,
            "endLine": 102,
            "endChar": 59,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 103,
            "startChar": 10,
            "endLine": 103,
            "endChar": 62,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 108,
            "startChar": 5,
            "endLine": 108,
            "endChar": 59,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 109,
            "startChar": 10,
            "endLine": 109,
            "endChar": 62,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 114,
            "startChar": 5,
            "endLine": 114,
            "endChar": 69,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 115,
            "startChar": 10,
            "endLine": 115,
            "endChar": 48,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 116,
            "startChar": 10,
            "endLine": 116,
            "endChar": 72,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 117,
            "startChar": 10,
            "endLine": 117,
            "endChar": 46,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 122,
            "startChar": 5,
            "endLine": 122,
            "endChar": 69,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 123,
            "startChar": 10,
            "endLine": 123,
            "endChar": 48,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 124,
            "startChar": 10,
            "endLine": 124,
            "endChar": 72,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 125,
            "startChar": 10,
            "endLine": 125,
            "endChar": 46,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 133,
            "startChar": 5,
            "endLine": 133,
            "endChar": 69,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 134,
            "startChar": 10,
            "endLine": 134,
            "endChar": 46,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 135,
            "startChar": 10,
            "endLine": 135,
            "endChar": 49,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 136,
            "startChar": 10,
            "endLine": 136,
            "endChar": 46,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 137,
            "startChar": 10,
            "endLine": 137,
            "endChar": 72,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 138,
            "startChar": 10,
            "endLine": 138,
            "endChar": 44,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 139,
            "startChar": 10,
            "endLine": 139,
            "endChar": 47,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 140,
            "startChar": 10,
            "endLine": 140,
            "endChar": 44,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 147,
            "startChar": 5,
            "endLine": 147,
            "endChar": 41,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 148,
            "startChar": 10,
            "endLine": 148,
            "endChar": 49,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 149,
            "startChar": 10,
            "endLine": 149,
            "endChar": 46,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 150,
            "startChar": 10,
            "endLine": 150,
            "endChar": 44,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 151,
            "startChar": 10,
            "endLine": 151,
            "endChar": 47,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 152,
            "startChar": 10,
            "endLine": 152,
            "endChar": 44,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 157,
            "startChar": 5,
            "endLine": 157,
            "endChar": 41,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 158,
            "startChar": 10,
            "endLine": 158,
            "endChar": 49,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 159,
            "startChar": 10,
            "endLine": 159,
            "endChar": 46,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 160,
            "startChar": 10,
            "endLine": 160,
            "endChar": 44,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 161,
            "startChar": 10,
            "endLine": 161,
            "endChar": 47,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          },
          {
            "startLine": 162,
            "startChar": 10,
            "endLine": 162,
            "endChar": 44,
            "errorType": null,
            "errorSeverity": "Warning",
            "targetIncludeLibraryId": "JEK_AT_AntiemeticTherapyPrescribedforHighlyEmetogenicChemotherapyRisk_FHIR4",
            "targetIncludeLibraryVersionId": "1.0.000",
            "type": null,
            "message": "Could not resolve membership operator for terminology target of the retrieve."
          }
        ]
      }
    }
  ]
}
